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ABSTRACT 
Bioactive peptides can be produced in vitro by fermentation of milk inoculated with starter or non-starter 
cultures or by digestion of milk proteins with one or more proteolytic enzymes. In vitro casein hydrolysis by 
gastrointestinal enzymes is also capable of generating bioactive peptides. 
Our study has focused on the fraction of bioactive peptides called casein phosphopeptides (CPPs). The 
negatively charged side chains of phosphoserines make the phosphorylated residues capable to chelate 
macroelements, such as Ca, Mg and Fe, as well as oligoelements, such as Zn, Ba, Cr, Ni, Co and Se, as 
suitable metal ion carriers from which derive their biological activity. 
CPPs are also resulted very good markers of raw material quality, process and authenticity of dairy products 
beyond their bioactivity.  
Native and partially dephosphorylated CPPs are markers of: 
1) Raw milk from infected subjects with high somatic cell count (SCC); 
2) Heat treatment intensity of commercial milks; 
3) Parmigiano Reggiano (PR) cheese at different age of ripening: younger cheeses (up to 15 months) 
were distinguished from those older than 26 month; 
4) Adulterated water buffalo milk (or ovine and caprine) with cheaper bovine milk used for producing 
cheese made from single-species milk. 
In milk with high SCC, the majority of the peptides identified by LC-ESI-Q-TOF-MS  originated  from  αs1-, 
αs2-, β- and   κ-casein (CN), as a result of degradation by plasmin (PL) and enzymes of somatic cells. 
Moreover, seventeen native and twenty partially dephosphorylated CPPs were identified through selective 
enrichment on hydroxyapatite (HA) and matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF-MS) analysis. The degree of phosphorylation was well correlated with the 
alkaline phosphatase (ALP) activity of milk.  
The CPP enrichment on HA of heat-treated milk samples has allowed detection of CPPs, ordinarily 
suppressed by the co-existence of non-phosphorylated peptides. Most CPPs had C-terminal lysine probably 
derived from the proteolytic activity of endogenous PL present in milk.  αs1-,  αs2- and  β-CN are preferentially 
hydrolyzed based on their affinity for PL, according to the decreasing order:   β- >  αs2- >  αs1-CN. Several 
phosphopeptides belonging  to  the  β-CN family and  to  the  αs2-CN were detected in raw and heat treated milk. 
A synthetic peptide analogue of   β-CN (f1-28) 4P was used as internal standard to measure the rate of 
proteolysis  of  β-CN. β-CN was found to have released ~4.3% of  the  β-CN (f1-28) 4P, in raw milk. Moreover, 
CPPs underwent partial lactosylation by milk heating or drying. Lactosylated CPPs, β-CN (f1-29) 4P, (f1-28) 
4P, (f1-27)  4P  and  αs2-CN (f1-21) 4P, (f1-24) 4P, were observed especially in liquid and powder milk. Raw 
and thermized/pasteurized milk did not contain lactosylated peptides/proteins whereas they were specific of 
intensely heated milks. The limit of detection for spiked raw or pasteurized milk with Ultra High 
Temperature milk was ~10%. 
Using MALDI-TOF, pH 4.6-soluble CPPs of different cheese varieties, including PR, selectively enriched on 
HA were identified. The rate of proteolysis and dephosphorylation phenomenon is resulted to change in 
cheeses from raw or pasteurized milk. Heat treatments modified the peptide profile by increasing the content 
of larger peptides whereas the shorter CPPs, containing the multi-phosphorylated motif -SerP-SerP-SerP-
Glu-Glu- more resistant to proteolytic enzymes, accumulated in long-ripened cheeses made from raw milk. 
The  β-,  αs1- and  αs2-CN CPPs were isolated from PR cheese samples aged 5,  15,  26  and  35  months  (mo).  β-
CN  was  hydrolyzed  within  the  first  15  mo  of  ripening  faster  than  αs1- and  αs2-CN  did.  In  contrast,  αs1-CN was 
more hydrolyzed in 26- and 35-mo-old cheeses  than  β-CN,  and  αs1-CN (f67-79)  3P,  αs1-CN (f71-79) 1P, αs1-
CN (f64-74) 2P, αs1-CN (f66-74)  3P  and  αs1-CN (f67-74) 2P were detected just in these older samples. There 
was a significant hydrolysis of αs1-CN at 26 mo of ripening; afterwards, the increase slowed down with time. 
On  the  other  hand,  the  shorter  CPPs,  αs1-CN (f65-74)  3P  and  αs1-CN (f64-74) 3P, accumulated in the 35-mo-
old PR cheese. Unlike cheese-milk, proteolysis proceeded in the PR cheese sequentially in the decreasing 
order:  β- >  αs1- >  αs2-CN. On the basis of CPP monitoring, the findings have allowed to categorize PR cheese 
according to the age, i.e. young, within 5- and 15-mo-old, and old, aged more than 26 mo.  
The MALDI analysis of proteotypic CPPs for bovine (B) and water buffalo (WB) milk has allowed to set up 
a proteomics methodology for the false-positive detection of B milk in genuine WB milk and derived cheese. 
Tryptic   phosphopeptides   β-CN (f1-25)   4P   and   β-CN (f1-28) 4P, selectively bound to HA, were used as 
markers of B and WB species, respectively. The actual percentage of adulterating B milk was calculated 
using a calibration plot with a detection limit of 0.5% via MALDI-TOF-MS analysis of species markers. The 
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detection  of  B  β-CN (f1-25) 4P in CN digests of WB Mozzarella cheese samples have allowed to measure 
the percentage of B adulterant. The excellent specificity of proteotypic peptides opens the possibility to 
broaden the application to other species’ milk or to any food protein of which is known the protein sequence. 
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RIASSUNTO 
Peptidi bioattivi possono essere rilasciati in vitro dalle fermentazioni batteriche di colture, starter o non-
starter, inoculate nel latte o dalla digestione delle proteine del latte mediante l’utilizzo di uno o più enzimi 
proteolitici. Anche la proteolisi in vivo per opera di enzimi gastrointestinali è in grado di rilasciare tali 
peptidi.  
Il nostro studio si è focalizzato su una frazione di peptidi bioattivi chiamati caseinofosfopeptidi (CPPs). Le 
cariche negative delle catene laterali delle fosfoserine rendono i residui fosforilati in grado di chelare sia 
macroelementi, quali Ca, Mg e Fe, che oligoelementi, del tipo dello Zn, Ba, Cr, Ni, Co e Se, e quindi possono 
trasportare ioni metallici. Da ciò deriva la loro attività biologica. 
Al di là della loro bioattività, i CPPs sono risultati buoni indicatori della qualità della materia prima, del 
processo produttivo e dell’autenticità del prodotto. I CPPs, nella loro forma nativa o parzialmente 
defosforilata, sono marcatori di: 
1) latte crudo con un elevato numero di cellule somatiche (SCC), proveniente da animali infetti; 
2) intensità del trattamento termico di latti commerciali;  
3) formaggio Parmigiano Reggiano (PR), a diverse età di maturazione; pertanto, formaggi giovani (fino 
a 15 mesi) sono stati differenziati da quelli invecchiati per più di 26 mesi; 
4) latte di bufala (o ovino e caprino) adulterato con latte bovino più conveniente, per la produzione di 
formaggi a singola specie. 
Nei latti con alto SCC, la maggior parte dei peptidi, identificati mediante spettrometro di massa LC-ESI Q-
TOF MS, derivava dalla proteolisi delle frazioni caseiniche, αs1-, αs2-, β- and κ-casein (CN), per azione della 
plasmina (PL) e degli enzimi delle cellule somatiche. Inoltre, in questi latti, sono stati identificati diciassette 
CPPs nella loro forma nativa e venti CPPs parzialmente fosforilati, grazie all’utilizzo di una tecnica di 
arricchimento selettiva, basata su microgranuli di idrossiapatite (HA) e l’analisi MALDI. È stato mostrato 
che il grado di fosforilazione delle frazioni caseiniche ben si correlava all’attività della fosfatasi alcalina 
(ALP) del latte. 
L’arricchimento su HA dei CPPs di campioni di latte, trattato termicamente, ha consentito di rilevare peptidi 
fosforilati, il cui segnale di massa sarebbe stato soppresso dalla co-presenza di peptidi non-fosforilati. La 
maggior parte dei CPPs, rilevati nei campioni, derivava dall’azione proteolitica della PL endogena del latte. È 
stato mostrato che le frazioni caseiniche, αs1-, αs2-, and β-CN, venivano idrolizzate secondo l’ordine 
decrescente di affinità alla PL: β- > αs2- > αs1-CN. Diversi fosfopeptidi appartenenti alla β-CN e all’αs2-CN 
sono stati rilevati nel latte crudo e nei campioni di latte trattato termicamente. Un fosfopeptide sintetico 
analogo alla β-CN (f1-28) 4P è stato usato come standard interno per misurare il livello di proteolisi della β-
CN nel latte crudo. É risultato che è stato rilasciato dalla β-CN ~ il 4.3% del fosfopeptide β-CN (f1-28) 4P 
nel latte crudo. Inoltre, i CPPs subivano una parziale lattosilazione in funzione del trattamento termico. I 
CPPs lattosilati della β-CN, (f1-29) 4P, (f1-28) 4P e (f1-27) 4P e quelli dell’αs2-CN, αs2-CN (f1-21) 4P e (f1-
24) 4P, sono stati rilevati principalmente nei latti in polvere. Il latte crudo e quello termizzato/pastorizzato 
non contenevano peptidi o proteine lattosilate, il che rendeva questi peptidi specifici del trattamento termico. 
L’analisi dei CPPs del latte pastorizzato, in miscela con diverse percentuali di latte UHT, ha consentito di 
rilevare fino al 10% di aggiunta di latte UHT. 
I CPPs estratti dalla frazione solubile a pH 4.6 di diverse varietà di formaggio, incluso il PR, sono stati 
selettivamente arricchiti su HA ed identificati mediante l’utilizzo del MALDI-TOF. I nostri risultati mostrano 
che il tasso di proteolisi e di defosforilazione variava nei formaggi prodotti da latte crudo o da latte 
pastorizzato. Il trattamento termico modificava il profilo fosfopeptidico, aumentando il contenuto dei peptidi 
più lunghi. I CPPs più corti, contenenti la sequenza aminoacidica -SerP-SerP-SerP-Glu-Glu- risultata più 
resistenti agli enzimi proteolitici, si accumululavano nei formaggi a lunga maturazione, a partire da latte 
crudo. I CPPs delle frazioni caseiniche, β-, αs1- and αs2-CN, sono stati isolati nei diversi campioni di PR  a 5, 
15, 26 e 35 mesi di stagionatura. I risultati hanno evidenziato che la β-CN era idrolizzata più velocemente nei 
primi 15 mesi rispetto all’αs1- e all’αs2-CN. Al contrario, αs1-CN era idrolizzata più intensamente tra 26 e 35 
mesi, per cui i CPPs, i. e. αs1-CN (f67-79) 3P, αs1-CN (f71-79) 1P, αs1-CN (f64-74) 2P, αs1-CN (f66-74) 3P e 
αs1-CN (f67-74) 2P, sono stati rilevati esclusivamente nei campioni di formaggio a maggior tempo di 
stagionatura. Un significativo incremento dei CPPs dell’αs1-CN è stato osservato nei formaggi a 26 mesi di 
stagionatura. Dopo il 26° mese, il numero dei CPPs non aumentava ulteriormente, sebbene l’accumulo dei 
CPPs più corti, quali αs1-CN (f65-74) 3P and αs1-CN (f64-74) 3P, si verificava principalmente nei formaggi a 
35 mesi. A differenza del latte, nel PR, la proteolisi procedeva seguendo il seguente ordine: β- > αs1- > αs2-
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CN. Il monitoraggio dei CPPs nei diversi campioni di PR ci ha consentito di caratterizzare i campioni di PR 
in funzione dell’età, distinguendo i formaggi più giovani, di 5 e 15 mesi, da quelli maturati più di 26 mesi. 
Infine, l’analisi MALDI dei CPPs proteotipici del latte bovino (B) e di bufala (B) ha permesso di mettere a 
punto una metodologia analitica per la rilevazione di falsi-positivi per aggiunte di latte B in latte WB, usato 
per la produzione di formaggi fatti da un’unica specie. I CPPs triptici, B β-CN (f1-25) 4P e WB β-CN (f1-28) 
4P, selettivamente arricchiti su HA, sono stati usati come marcatori delle due specie. La percentuale di 
aggiunta del latte B in latte WB è stata calcolata utilizzando la curva di calibrazione dei due CPPs, costruita 
grazie all’analisi MALDI. Il limite di rilevabilità è stato dello 0.5%. La presenza di B β-CN (f1-25) 4P nei 
digeriti triptici della CN, estratta dalla Mozzarella di bufala, ha permesso di determinare l’aggiunta 
percentuale di latte B. L’eccellente specificità della tecnica consente di estendere la sua applicazione ad altre 
specie lattifere o ad altre proteine alimentari delle quali si conosca la sequenza proteica. 
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1 STATE OF ART 
An impressive increase of data is supporting the bioactive role of food proteins and derived peptides beyond 
their nutritional impact. Specific biological properties relative to the different dietary proteins make these 
components potential ingredients of functional or health-promoting foods. The absorption of intact food 
proteins in the human gastrointestinal tract is widely limited by their molecular size. Most of them shows 
specific biological activity after the gastrointestinal digestion. Actually, many of protein properties are 
attributed to peptides encrypted in their inherent amino acid sequence, exerting biological functions after 
their release from the intact protein. They are 3 to 20 residue long peptides although some have been reported 
to have >20 amino acid residues. These peptides are inactive within the sequence of parent protein and can be 
released during gastrointestinal digestion, fermentations or food processing. Various physiologically 
functional peptides are reported to exert a wide range of functions including antihypertensive, antioxidative, 
opioid agonistic, immunomodulatory, antimicrobial, prebiotic, mineral binding, antithrombotic and 
hypocholesterolemic activities. For instance, purified hydrolysates from cooked eggs release seven ACE-
inhibitory peptides, five tripeptides (VDF, LPF, MPF, IPF, and TTI) and two pentapeptides (YTAGV, 
ERYPI), exhibiting in vivo antihypertensive activity (Majumder & Wu, 2009) as well as many ACE-
inhibitory peptides are originated from food sources such as soybean, mung bean, sunflower, rice, corn, 
wheat, buckwheat, broccoli, mushroom, garlic, spinach and wine (Guang & Phillips, 2009). Small peptides 
and free amino acids (FAA) in mackerel hydrolysates exhibit strong antioxidant activity in vitro (Wu et al., 
2003) as well as this activity is exhibited by papain hydrolysates of porcine myofibrillar proteins (Saiga et al., 
2003). Moreover, there are two different groups of proteins that can interact with minerals. To the first group 
belong the proteins with specific binding site(s) for mineral ions, such as  lactoferrin  and  α-lactalbumin (α-La) 
from milk and ovotransferrin from egg yolk. The other group includes proteins rich in acidic residues binding 
positive charges of metals through electrostatic interactions, such as casein (CN), the major fraction of milk 
proteins, and phosvitin, the major fraction of hen egg yolk phosphoproteins. The presence of highly acidic 
clusters in food proteins explains their powerful ability to sequester divalent cations (up to 60 iron atoms per 
phosvitin molecule, Webb et al., 1973) and their resistance to proteolytic enzymes. Therefore, an elevated 
number of phosphate groups is often considered nutritionally negative due to lowering the bioavailability of 
iron, as occurs in the case of phosvitin (Ishikawa et al., 2007). The apparent absorption of cations (calcium, 
magnesium, iron etc) from a yolk protein-based diet is found to be lower than that from CN, attributing this 
effect to the higher resistance of yolk phosvitin to proteolytic action (Ishikawa, et al., 2007). 
1.1 Casein phosphopeptides 
CN, representing 80% of total milk proteins, consists   of   four   αs1-,   αs2-,   β-,   and   κ-CN families in the 
approximate ratio 38:11:38:13, respectively. These fractions exhibit different level of phosphorylation: the 
maximum level of phosphorylation is 13  phosphate  groups  for  bovine  αs2-CN,  9  for  αs1-CN, 5 for  β-CN and 2 
for   κ-CN. A direct relationship between the phosphorylation level and mineral chelating ability has been 
already reported (Kitts, 1994) so that their ability   follows  the  order  αs2-CN  >  αs1-CN  >  β-CN  >  κ-CN. The 
importance of phosphorylated residues for the CN functionality (e.g. the formation of micelles and the 
binding of Ca2+) is emphasized by the high conservation of the phosphorylation sites (Fiat & Jollès, 1989). 
CN phosphorylation is a post-translational event that occurs during the transfer of the completed polypeptide 
chains from the smooth endoplasmic reticulum to the mammary gland Golgi apparatus, where most of 
phosphate incorporation presumably takes place (Mercier, 1981). Evidence supports that the polypeptide 
chain of CN is synthesized prior to the incorporation of phosphate and that a pool of non-phosphorylated or 
partially phosphorylated CN exists in the mammary gland (Singh et al., 1967). Casein kinase in the lactating 
mammary gland is believed to be the enzyme responsible of the phosphorylation of partially phosphorylated 
CN, by using ATP as a phosphate donor in the presence of divalent cations (Mg2+, Ca2+, Mn2+ or Co2+). 
Casein kinase is an enzyme with a higher specificity for dephosphorylated CN.  
All the phosphorylated hydroxy-amino acid residues in CN from different species occur in tripeptide 
sequences Ser/Thr-X-A, when X represents any amino acid residue, but Pro, and A an acidic residue such as 
SerP, Glu or Asp (Mercier, 1981). The occurrence of the consensus sequence is a necessary but not sufficient 
condition for the CN phosphorylation. Possible factors of constraint are involved such as different intrinsic 
properties of phosphate acceptor residues and acidic determinants, the characteristics of the local 
environment in terms of overall charge and hydrophilicity, secondary structure, steric hindrance and 
insufficient available pool of casein kinase(s) (Mercier, 1981).  
Bioactive peptides with the three-phosphorylated motif, -SerP-SerP-SerP-Glu-Glu-, called casein 
phosphopeptides (CPPs), are released by in vivo and/or in vitro enzyme-mediated proteolysis of CN and 
show multifunctional bioactivities. The negatively charged side chains of phosphoserines make the 
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phosphorylated residues capable of chelate macroelements such as Ca, Mg and Fe, as well as oligoelements 
such as Zn, Ba, Cr, Ni, Co and Se. The Ca-binding activity of the CPPs may be further influenced by amino 
acids around the phosphorylated binding sites (Meisel, 1998). It involves phosphoserine residues, as well as 
the free carboxyl groups of Glu; a Ca2+ bridge results to be formed between SerP and Glu. The hydrophobic 
tail protects this complex from further interactions and hence prevents formation of insoluble calcium 
phosphate (Meisel, 1998). Moreover, the glutamic acid may catalyze the formation of CN micelle through the 
bridge SerP-Ca (Dijk, 1990). According to the theory of van Dijk (Dijk, 1990), the elimination of Glu 
residues adjacent to SerP might cause the loss of the peptide ability to form Ca complexes. In addition, the 
negative charges of phosphate groups and side chains make CPPs resistant to the gastrointestinal enzymatic 
digestion and thus suitable as carriers for metal ions (FitzGerals, 1998). Therefore, CPPs are reported to 
enhance intestinal absorption of Ca2+, to exert anticarie (Iijima et al., 2010), cytomodulatory (Meisel & 
FitzGerald, 2003), immunoenhancing activity (Otani et al., 2000).  
1.2 Casein hydrolyzed and CPPs 
Peptides with various bioactivities can be produced in vitro i) by fermentation of milk inoculated with starter 
or non-starter cultures; ii) by digestion of milk proteins with one or more proteolytic enzymes or in vivo by 
gastrointestinal enzymes. 
(i) Bioactive peptides can be generated by the starter and non-starter bacteria used in the manufacture 
of fermented dairy products. For instance, the proteolytic system of lactococci is able to degrade CN using 
cell-wall bound proteinases (PrtP), releasing oligo-, tri-, dipeptides and/or amino acids, which support their 
own growth. Oligopeptides, containing 4 up to 35 amino acid residues, are taken up by the oligopeptide 
transport system (Opp), while the ion-linked transporters (DtpT and Dpp) facilitate the uptake of di- and 
tripeptides (Mark et al., 2005). Internalized peptides are further hydrolyzed into amino acids by a large array 
of intracellular peptidases (Figure 1). 
 
Figure 1. A simplified model presenting proteolysis, transport, peptidolysis and regulation of the proteolytic 
system of Lactococcus lactis on casein breakdown (Savijoki et al., 2006). Intracellular peptidases, PepO and 
PepF are endopeptidases, PepN/PepC/PepP are general aminopeptidases, PepX is X-prolyldipeptidyl 
aminopeptidase, PepT is tripeptidase, PepQ is prolidase, PepR is prolinase, PepI is proline iminopeptidase, 
and PepD and PepV are dipeptidases D and V. The role of PepL, PepI, PepQ, PepT, PepV, PepR, PepD and 
peptidolytic cycles are depicted schematically (various alternative routes of breakdown are possible for most 
peptides).  
The first intracellular enzymes acting on internalized oligopeptides are endopeptidases, (PepO and PepF), 
general aminopeptidases (PepN/PepC/PepP) and X-prolyl dipeptidyl aminopeptidase (PepX) (Savijoki, et al., 
2006). Di- and tripeptides generated by these enzymes are further subjected to additional cleavage by the 
tripeptidase, PepT, and dipeptidases, PepV and PepD (Figure 1). Other peptidases with high substrate 
specificity include: PepA, which liberates N-terminal acidic residues from 3 to 9 residue long peptides; PepP, 
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which prefers tripeptides carrying proline in the middle position; PepR and PepI, which act on dipeptides 
containing proline in the penultimate position; PepQ, which cleaves dipeptides carrying proline in the second 
position and PepS, which shows preference for peptides containing two to five residues with Arg or aromatic 
amino acid residues in the N-terminal position (Christensen et al., 1999; Kunji et al., 1996; Fernandez-Espla 
& Rul, 1999; Savijoki et al., 2006). In a comprehensive review of literature, no enzyme with 
carboxypeptidase (CPase) activity has been reported for lactococci (Léonil, 2000; Kunji et al., 1996), while 
activity of Lactobacillus (Lb) helveticus CPases were deduced from the identification of several N- and C-
terminally truncated peptides (Caira et al., 2003). In addition to the proteolytic systems, lactococcal 
cytoplasm peptidases, released consequently to cell autolysis, can further contribute to the higher levels of 
proteolysis into the curd/cheese (Crow et al., 1995). In this manner, bacteria proteinases play a primary role, 
as they are able to generate specific bioactive peptides. Proteins released in cheese from a starter-based 
thermophilic lactic acid bacteria (LAB), such as Lb. helveticus, Lb. delbruecki subsp. lactis and 
Streptococcus salivarius subsp. thermophilus and Propionibacterium freudenreichii, have been identified 
using 2D-PAGE and mass spectrometry (MS) analysis (Gagnaire et al., 2004). Similarly, bioactive peptides 
have been determined using high performance liquid chromatography (HPLC) and offline matrix-assisted 
laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) (Saz & Marina, 2008). The 
combination of the LAB bacteria and proteolytic enzymes could serve to increase the range of bioactive 
peptides. 
(ii) In vitro enzymatic hydrolysis can produce a wide range of bioactive peptides. Endopeptidase P shows a 
broad specificity and preferentially cleaves hydrophobic, especially aromatic, residues. Trypsin specifically 
hydrolyses peptide bonds just after Lys or Arg residues of  β-CN A1 and A2 variants (11 and 4, respectively), 
κ-CN A and B (9 and 5), αs2-CN  A   (23   and   6)   or   αs1-CN (14 and 6). We have demonstrated that CN 
hydrolysates by action in succession of pepsin and trypsin do not contain peptides with molecular mass 
greater than 2431 Da (Table 1). A high number of peptides with antimicrobial, anti-hypertensive and opiod-
like activity has been identified, some of which exactly matched those described in the literature for potential 
bioactivity (Table 1). Moreover, different CPPs derived from   β-CN,   αs1-CN   and   αs2-CN are released by 
sequential digestion of milk proteins, using the combined action of PT (Table 1). 
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Table 1. Identity of bioactive peptides found in the PT digests of milk protein powder sample. The 
bioactivity of the peptides from which they derive and the references are reported below. 
Identity of bioactive 
peptides Bioactivity References PT peptides 
β-­CN  (f60-­70);;  (f59-­61);;  
(f59-64); (f60-68) Opiod Teschemacher et al., 1997; Meisel, 1986 (f58-68); (f59-63); (f59-62)
β-­CN  (f74-­76) (f69-80); (f71-80); (f75-80)
β-­CN  (f80-­90);;  (f84-­86) (f80-88); (f81-89); (f81-88); (f81-92); (f81-93); (f81-94)
β-­CN  (f108-­113) (f108-103)
β-­CN  (f140-­143) (f139-142)
β-­CN  (f177-­183) (f177-183); (f177-184); (f179-182)
β-­CN  (f169-­174)   (f169-176); (f172-176)
β-­CN  (f193-­198)   (f193-199)
β-­CN  (f193-­202)   (f193-202)
β-­CN  (f1-­25)4P  
M ineral carrier, 
immunomodulatory, 
cy tomodulatory
Sato et al., 1986; Reynolds, 1997; Meisel & 
Olieman, 1998; Hala et al., 1998; Hal et  al., 1999
(f12-17) 1P; (f12-25) 3P; (f12-25) 4P; (f15-25) 2P;    
(f15-25) 3P; (f19-25) 1P; (f19-25) 2P
β-­CN  (f29-­41)1P   M ineral carrier FitzGerald, 1998 (f33-42) 1P; (f33-43) 1P; (f33-44) 1P
β-­CN  (f84-­86)   (f80-87); (f81-88); (f81-89); (f81-92); (f81-93); (f81-94)
αs1-CN (f23-34) (f24-32)
αs1-CN (f25-27) (f25-31)
αs1-CN (f90-96); (f90-95); 
(f91-95)
Opiod (agonist)
Loukas et  al., 1983; Loukas et al., 1990; Pihlanto-
Leppälä  et al., 1994 (f92-95); (f91-95); (f90-95)
αs1-CN (f142-147) (f142-145); (f143-146); (f143-150); (f144-149)
αs1-CN (f157-164) (f155-164)
αs1-CN (f194-199) (f194-199); (f197-199); (f193-199)
αs1-CN (f110-119) 1P
αs1-CN (f41-55) 1P; (f68-79) 2P
αs2-CN (f174-179) (f174-179)
αs1-CN (f189-193) (f189-193)
αs2-CN (f138-146) 1P
αs2-CN (f124-137) 2P; (f126-136) 2P; (f126-137) 2P
κ-­CN  (f33-­38)   Opiod (antagonist) (f58-65) 1P
ACE-Inhibitory
ACE-Inhibitory
ACE-Inhibitory
ACE-Inhibitory
M ineral carrier
M ineral carrier
Ondetti & Cushman DW, 1982; Bruneval et al., 
1986; M eisel, 1993
Ondetti & Cushman DW, 1982; Bruneval et al., 
1986; M eisel, 1993
Ondetti & Cushman DW, 1982; Bruneval et al., 
1986; M eisel, 1993
FitzGerald, 1998
Ondetti & Cushman DW, 1982; Bruneval et al., 
1986; M eisel, 1993
FitzGerald, 1998
 
PT= Pepsin and Trypsin action; P= Phosphate group 
β-CN resulted extensively hydrolyzed into a high number of oligopeptides by using proteases with well-
known cleavage specificity. The choice of digestion enzyme needs to be evaluated carefully because it 
influences the final composition of hydrolysates. 
The in vitro sequential use of pepsin, pancreatic proteases and extracts of human intestinal brush border 
membranes, mimicking the gastric, duodenal and jejuneal in vivo digestion of CN, respectively, exhibits 
considerable bioactive effects. A limited number of CN and whey protein peptides survives the in vitro 
simulated gastrointestinal digestion. The anionic character seems to confer a marked resistance to multi-CPP 
hydrolysis by endoprotease. Ten out of 19 CPP contain SerP available for binding minerals and four of these 
peptides,  αs1-CN (f57-90) 5P,  αs1-CN (f56-90) 5P,  αs1-CN (f55-76) 5P,  β-CN (f1-52) 5P, are reported for the 
ﬁrst  time  in  the  CN  digests  (Miquel et al., 2006). Other studies show that phosphorylated clusters are almost 
completely hydrolyzed and only  β-CN (f1-25) 4P, 3P and 2P survive the simulated gastrointestinal digest of 
CN (Picariello et al., 2010).  
Finally, the in vivo digestion of milk proteins takes place mainly in the stomach, under the action of pepsins, 
gastric digestive proteinases, able to digest ~20% proteins. Afterwards, the pepsin digests pass to the 
duodenum where peptides are further hydrolyzed by pancreatic enzymes. The digestion is completed by 
membrane proteases and a variety of peptidases embedded in the brush border of the small intestine and/or 
released by the intestinal microflora. The peptidases release an amino acid residue or a dipeptide from the N- 
and C-terminal side of oligopeptides (Kenny & Maroux, 1982; Yoshioka et al., 1987; Erickson et al., 1989). 
Phosphatase(s), located in the brush border of the apical membrane of enterocytes, act(s) in removing 
phosphate groups, thus promoting partial or full dephosphorylation of peptides. The phosphorylated sequence 
is responsible, at the intestinal pH, for binding Ca2+, Zn2+ and Mg2+ and for its in vivo resistance to 
gastrointestinal proteases (Mellander & Folsch, 1972).   Fe   complexed   to   β-CN (f15-25) 4P is scarcely 
hydrolyzed throughout the digestion, suggesting that the coordination of iron ions to CPPs inhibits the action 
of both phosphatase and peptidases (Boutrou et al., 2010). Brush border alkaline phosphatase (ALP) activity 
could improve the absorption of complexed Fe by its release from CPPs. Also zinc absorption can be 
enhanced by the formation of complexes with CCPs,  in  particular  β-CN (f1-25) 4P (Pérès et al., 1998). Some 
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CPPs, formed in the small intestine, are found in the feces of rats fed with a CN-based diet (Kasai et al., 
1995). CPPs have been for the ﬁrst  time  detected  in  human  ileostomy  ﬂuid,  conﬁrming  their  ability  to  survive  
gastrointestinal passage into the human distal ileum (Meisel & Frister, 1988). The in vivo formation of 
bovine CPPs is demonstrated in the small intestinal ﬂuid  of  minipigs  after  ingestion  of  a  diet  containing  CN  
(Meisel & Frister, 1988) and in the stomach and duodenum after ingestion of milk or yogurt (Chabance et al., 
1998).  
The peptides seem to interact directly with the plasma membrane. One possible mode of CPP action on the 
transmembrane flux of calcium is that CPPs might insert themselves into the plasma membrane by forming 
some calcium selective channels or by acting as calcium-carrier peptides rapidly internalized via endocytosis 
or other processes (Ferraretto et al., 2001). The results of in vivo studies regarding intestinal CPP absorption 
are still too controversial. There are many factors that affect Ca availability, among which the co-present of 
various dietary compounds in the intestinal lumen. The most of diet components, reaching the ileum, make 
soluble calcium or keep it in solution. The in vivo survival of CPPs to the prolonged intestinal passage in the 
distal small intestine is a prerequisite for their function as bioactive substances (Meisel et al., 2003).  
Whole casein or individual casein fractions are used as raw materials to obtain CPPs as dietary supplements. 
CPPs have already been produced on an industrial-scale and have been used for application as ingredients in 
both ‘functional foods’ and pharmaceutical preparations. On the other hand, CPPs have already approved as 
foods for specified health uses (FOSHU) in Japan (Shimizu, 2003). CPPs in commercial hydrolysed casein 
(Arla Foods Ingredients, Sweden) seem to help the absorption of chelated calcium, iron, copper, zinc and 
manganese in the intestine. Moreover, CPP-amorphous calcium phosphate (ACP) displayed anticariogenic 
effect when added to dentifrices or oral care products by localizing calcium and phosphate ions at the tooth 
surface. Similarly, it has been claimed that a chewing gum or other confectionery product containing a 
combination of CPP-ACP and sodium bicarbonate as active ingredients can provide dental health benefits 
(Luo SJ, Wong LL. Oral care confections and method of using. US Patent 6733818).  
1.3 CPP detection in raw milk and dairy products  
CPP bioactivity has encouraged their search in different dairy products. This study suggests that they are very 
good marker of raw milk quality, process and authenticity beyond their bioactivity. In particular, native and 
partially dephosphorylated CPPs are possible markers of: 
5) Raw milk from infected subjects with high somatic cell count (SCC); 
6) Heat treatment intensity of commercial milks 
7) Parmigiano reggiano (PR) cheese at different age of ripening: younger cheeses (up to 15 months) 
from those older than 26 month; 
8) Adulterated water buffalo milk (or ovine and caprine) with cheaper bovine milk used for producing 
cheese of single species. 
1.3.1 Proteolysis and partial dephosphorylation of casein in sheep milk with high somatic cell count 
Mastitis defined as “an inflammatory reaction of the mammary gland” (IDF. 1987) is the most important and 
costly disease in dairy production. While clinical mastitis (CM) is easier to detect, subclinical mastitis (SCM) 
is difficult to find because of the few literature data on small and ruminants and the lack of reliable diagnostic 
methods (Leitner et al., 2004). SCC is resulted the indicator of udder health more widely used by dairy cow, 
sheep and goat farmers. Herds with high SCC bulk milk are very likely to be affected by infecting pathogens 
present in the farm environment. The EU Directives don’t establish threshold values for SCC in ewe and goat 
milk. Nevertheless, a limit of 1,500,000 cells/ml has been recommended for small ruminant milk (Barbosa et 
al., 1994). The milk of healthy ewes often contains more than 1,000,000 SCC/ml of milk (Bufano et al., 
1996). Invasion of pathogens activates the immune defense in the udder, manifesting in milk the increase of 
somatic cells (SC) (Poutrel et al., 1981), predominantly white blood cells or leukocytes, including 
lymphocytes, polymorphonuclear neutrophils (PMNs) and macrophages. In nearly bacteria-free milk, 
macrophages (Concha et al., 1986) and epithelial cells (Leitner et al., 2000) are the predominant cell type 
(35-79%) followed by PMNs (3-26%), lymphocytes (10-24 %) and epithelial cells (2-15%) (Sohn et al., 
2007). After pathogens invade the mammary gland, macrophages release chemo-attractants, which trigger the 
migration of PMNs from the blood toward the infection in the gland (Le Roux et al., 2003). Therefore, the 
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PMNs are increased from a basal level of 5-25% of the total cell population to approximately 90% 
(Silanikove et al., 2006). Upon host infection, PMNs ingest and destroy invading pathogens via reactive 
oxygen species and a wide range of proteolytic enzymes (Paape et al., 1979). Several studies have suggested 
that the dairy products made from high SCC milk showed a more intense proteolytic activity of lysosomal 
enzymes (Cooney et al., 2000). Enzymes, including neutral and acidic proteases, such as elastase (EC 
3.4.21.36), G (EC 3.4.21.20), B (EC 3.4.22.1) and D (EC 3.4.23.5) cathepsins, originate from SC, as well as 
an ALP is present in substantial amounts in the PMN cytoplasm (Bank & Ansorge, 2001; Considine et al., 
2004; Owen & Campbell, 1999). Two different mechanisms can be involved in the CN proteolysis by PMN 
enzymes: contact proteolysis and proteolysis by internalization (Le Roux et al., 2003).  
The first one consists of direct proteolysis of milk protein. The PMN degranulation releases several 
proteolytic enzymes in milk. Proteolytic activity of neutral proteases such as elastase, collagenase, cathepsin 
G etc. (Owen & Campbell, 1999) is more relevant than that of acidic proteases such as cathepsins B, C, D or 
L as the latter are not at their optimal pH after degranulation (milk pH tends to neutrality). The main role of 
acid proteinases is in intracellular protein digestion, which occurs within the acidic environment of 
lysosomes. Nonetheless, these proteinases may degrade caseins in the neutral pH of milk if they are released 
at high enough concentrations or in the microenvironment of external periphery that allows the local 
maintenance of an acid pH.  
The second one involves the phagocytic capacity of SC. Casein peptides are internalized in vesicles via 
endocytosis by milk PMNs. These vesicles would fusion with lysosomes where the acidic pH would permit 
an optimal function of acidic proteases. The resulting degradation products would be partly or completely 
released in milk (Le Roux et al., 2003). 
Moreover, the transit of serum constituents, such as plasminogen and numerous other enzymes, from the 
blood toward the mammary gland into in the milk, causes a higher proteolytic activity during SCM compared 
to normal milk (Sordillo et al., 1997). Plasmin (PL) (EC 3.4.21.7), the predominant indigenous milk 
proteinase, originate from the blood and enter the gland, mixing with the milk. An increase of the milk SCC 
results in an 8-fold enhance in plasminogen activator activity per cell which in turn activate plasminogen into 
PL (Zachos et al., 1992). PL activity in milk is positively correlated with SCC. An increase of the SCC from 
100,000 cells/ml to 1,300,000 cells/ml was associated with a 2.3-fold increase in PL (Politis et al., 1989). PL 
preferentially cleaves peptide bonds at C-terminal of Lys residues and, to a lesser extent, arginine Arg 
residues (Ueshima et al., 1996). β-CN is the preferred substrate for PL that partly converted native  β-CN into 
pH  4.6  insoluble  γ-CN and complementary soluble proteose peptones (PP) (Andrews et al., 1983). PP include 
peptides such   as   β-CN (f1-105/107) (component PP5), (f1-28) (component PP8-fast), (f29-105/107) 1P 
(component PP8-slow) (Andrews et al., 2006; Farrell et al., 2004). αs1-CN (McSweeney et al.,  1993)  and  αs2-
CN (Le Bars et al., 1989) are also susceptible to PL hydrolysis  and  the  former  gives  rise  to  λ-CN (Aimutis et 
al.,  1983).  κ-CN appears to be quite resistant to PL action (Diaz et al., 1996), whereas cathepsins B and D 
produce   the   glycomacropeptide,   κ-CN (f106-169). Moreover, ALP, released primarily from the liver and 
bone into the blood, is further transferred to milk at a higher rate because of damage to the blood-milk barrier 
by infection (Yang et al., 2011). ALP activity is significantly higher during SCM compared to normal milk 
(Yang et al., 2011; Mauriello et al., 2007). The increase of serum ALP in infected milk suggests its important 
role in the pathogenesis of the disease (Vangroenweghe, 2004) and as a marker of mastitis milk (Akerstedt et 
al., 2011). The strong level of casein dephosphorylation depends on the increased amount of ALP and these 
values are associated with a high SCC (Mauriello et al., 2007). Phosphorylation could occur simultaneously 
at  many  different  sites,  as  previously  observed  for  ovine  and  caprine  β-CN (Chianese et al., 1992; Neveu et 
al., 2002). Moreover, the ALP activity could compromise the bioavailability of CPPs through the modulation 
of the phosphorylation level of CN.  
Our study has concentrated on the casein proteolysis in milk of infected subjects by using a proteomic 
approach. Specific casein peptides and partially dephosphorylated CN/CPPs have been identified as 
indicators of SCM in infected milks.  
1.3.2 Lactosylated CPPs as specific indicators of heated milks  
Intense heating processes affect the bioactivity of CPPs, causing dephosphorylation of phosphoserine 
residues and formation of dehydroalanine (Meisel, 1991). Dehydroalanine may further react with Lys 
residues leading to lysinoalanine or with the thiol group of cystein to form lanthionine (De Koning & Van 
Rooijen, 1982). Hydrolysis  of  phosphoseryl  esters  and  not  β-elimination to dehydroalanine is considered the 
prevailing mechanism of heat degradation of CPPs (Meisel, 1991). Phosphoseryl residues, occurring in 
cluster sequence -SerP-SerP-SerP-Glu-Glu-, do not contribute preferentially to the formation of 
lysinoalanine, as shown by structural studies of Manson and Carolan (Manson W & Carolan T, 1980) while 
phosphoseryl residues which occupy isolated positions in the casein sequences are mainly involved in 
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lysinoalanyl formation. Moreover, in heat-treated liquid and powder milk, the   ε-amino group of Lys or 
amino-termini residues can react with the carbonyl group of lactose with formation of lactosylated 
proteins/peptides. In the initial step of the Maillard reaction, lactosylation occurs during heating and, to a 
lesser extent, during milk powder storage (Guyomarc’h et al., 2000). Although determined for whey proteins 
and CN, lactosylation of CN peptides has not been deeply evaluated to distinguish various types of milk 
(Arena et al., 2011). It is known that the degree of lactosylation  of  β-CN increases steadily with temperature 
between 37 °C and 60 °C (Groubet et al., 1999). Lactose specifically binds to Lys34 in  αs1-CN and to Lys107 
in   β-CN under moderate heat treatment conditions (72–85 °C for 15–30 s). The number of binding sites 
increases  to  seven  for  αs1-CN  and  five  for  β-CN after intensive treatment (142–145 °C for 2–5 min) (Scaloni 
et al., 2002). Especially in highly heated milk, casein proteolysis is greatly affected by the quality of raw 
milk. Raw milk of good quality has 1-2 mg/ml PP, which can increase during storage. A significant 
accumulation of PP5 has been reported for commercially packaged pasteurized milk (De Noni et al., 2007). 
Due to the specificity of PL, milk heating could induce lactosylation of the side chains of released peptide at 
basic C-terminal residues (mainly Lys or Arg). β-CN (f1-28) 4P produced by PL during milk storage ranges 
from  8%  to  12%  PP  and  matches  the  formation  of  γ1-CN  and  β-CN (f29-209) (Andrews, 1978). Lysosomal 
enzymes of PMNs can contribute to the release of peptides in poor quality heated milks. Due to plethora of 
milk peptides, we have focused on signature CPPs released in definite number by milk proteinases.  
The goal of our study is the detection of both native and lactosylated CPPs by direct MALDI-TOF analysis 
of CPPs in situ immobilized on hydroxyapatite (HA) microgranules. The comparison between the potentially 
lactosylable and actually lactosylated sites could serve to differentiate processed milks according to heat 
intensity. Moreover, the use of low value ingredients such as Ultra High Temperature (UHT) and milk 
powder in raw or pasteurized milk (PM) is strictly prohibited. Specific temperature/time combinations for the 
production of pasteurized and UHT milk are established by European Union Directives (92/46 CEE and 
94/71 CEE). Nowadays, rapid methods are mainly based on the evaluation of furosine, a useful indicator of 
heat damage in processed milk. In our work, the lactosylated CPPs have been used for discriminating raw 
and pasteurized from UHT milk. Therefore, the finding of lactosylated β-CN (f1-28) 4P in mixtures of UHT 
and pasteurized milk has allowed to detect UHT milk in amounts not lower than 10%. 
1.3.3 CPP profiling of Parmigiano Reggiano cheese at different ripening ages 
The combined action of proteinases/peptidases and phosphatases plays an important role in cheese quality. 
Due to proteolytic activity, an elevated number of water-soluble peptides, most of which are multi-CPP, is 
released in cheeses, which significantly increases during ripening of cheese. In particular, chymosin, pepsin 
and other enzymes released by LAB autolysis  are  responsible  for  the  progressive  degradation  of  αs1-,  αs2-,  β- 
and  κ-CN fractions even if they are inactivated by curd cooking at 55 °C in cooked cheeses. The enzymatic 
digestion of CN could be reduced by milk thermal treatment but PL activity seems to enhance likely owing to 
an increase in plasminogen activation at higher temperature (Richardson, 2006). Even if PM completely 
inactivates indigenous ALP, this enzyme is stable at temperatures slightly higher than those required to kill 
pathogens in milk (Kay & Graham, 1935). In cheeses made from PM, indigenous acid phosphatase or 
bacterial phosphatases are probably responsible for casein dephosphorylation while, in raw milk cheese, e.g. 
PR or Grana Padano (GP), ALP may play an important role (Pellegrino et al., 1997). In the cooked cheeses, 
molding causes a slow cooling of the rind from 55 °C to room temperature but the core remains at 52-56 °C 
for 8-10 h. For this reason, ALP is inactivated in the wheel core although its activity remains at 3x105 mU/kg 
or more in the rind (Pellegrino et al., 1997). Anyway, several studies suggest that partial dephosphorylation 
of water-soluble CPPs occurs during cheese ripening (Ferranti et al., 1997; Singh et al., 1997; Silva et al., 
1987).  
Our study has focused on CPPs of PR, an cooked, semi-fat hard cheese made from raw, naturally skimmed 
cow's milk according to the EU Standards of Identity (Official Journal of the European Union C 87 of 16 
April 2009, 2011/C 215/16). The PR cheese wheels have to ripen for at least 12 month (mo) but can be aged 
for 3 years or longer. During this long period of ripening, an intense proteolysis of casein fractions occurs in 
the cheeses. During cheese ripening, the number of whey starter thermophilic lactobacilli such as Lb 
helveticus, Lb delbrueckii subsp. lactis and Lb delbrueckii subsp. bulgaricus decreases (Cocconcelli et al., 
1997; Zambonelli et al., 2002), whereas that of mesophilic heterofermentative LAB becomes dominant until 
5 mo (Coppola et al., 2000). Mesophilic heterofermentative LAB belonging to Lb. casei are frequently 
detected in 12-mo-old PR cheese samples, suggesting that they play not only a passive role in releasing 
enzymes capable of hydrolyzing CN by cell autolysis but also an active role in the advanced stages of PR 
ripening (Gala et al., 2008) It is known that CN degradation produces high-molecular mass (HMM) peptides, 
soluble low-molecular mass (LMM) peptides and FAA. Parent β- and αs1-CN and newly formed HMM 
peptides have been simultaneously detected, using gel isoelectric focusing (IEF) and immunoblotting with 
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polyclonal antibodies against the parent CN fraction (Addeo et al., 1995). PP (HMM CPPs) have been 
detected by HPLC to evaluate the age of packaged pasteurized milk (De Noni et al., 2007) or the proteolysis 
of semi-hard Herrgard cheese (Ardö et al., 2007). CPPs belonging to LMM peptides accumulate in the cheese 
owing to their well-known resistance to further breakdown into smaller fragments (Ferranti et al., 1997). For 
this reason, long-ripened PR cheese is considered a rich source of multi-CPPs, able to interact with colloidal 
calcium phosphate and to manifest anticariogenic properties in human and animal experiments (Rosen et al., 
1984; Krobicka et al., 1987). CPPs binding calcium and phosphate buffer these ions when the increase of 
solubility of dental HA decreases pH.   β-,   αs1-,   αs2- and   κ-CN derived CPPs inhibit the adhesion of 
Streptococcus mutans to saliva-coated HA through their binding in solution (Schüpbach et al., 1996).  
Several data on CPP enrichment from cheese are available in the literature. Collection of the Ba-CPP 
precipitates by the addition of an equal volume of 96% ethanol to the CPP solution allows the isolation of 
CPPs and the subsequent analysis by HPLC (Ferranti et al., 1997). An improvement in the recovery of singly 
and multiply CPPs in Herrgard, PR (Lund & Ardö, 2004) and Beaufort cheeses (Dupas et al., 2009) has been 
obtained using cation-exchange chromatography followed by immobilized metal-ion affinity chromatography 
(IMAC). 
In the present work, CPP enrichment based on in-batch HA (Pinto et al., 2010) has been used for profiling 
CPPs from the pH 4.6-soluble fraction of PR at different periods of ripening: 5-, 15-, 26- and 35-mo. Such 
profiles greatly enable us to characterize the proteolytic events that occur during ripening of brine-salted hard 
cheese. Moreover, the MALDI analysis of CPPs bound to HA allows the distinction of young PR cheeses (5- 
to 15-mo-old) from those aged more than 26 month (mo). 
1.3.4 Milk speciation through the monitoring of proteotypic CPPs 
A fraudulent practice, commonly implemented by producers, is the substitution, partial or full, of water 
buffalo (WB) milk with cheaper and all year available bovine (B) milk. In particular, in the manufacturing of 
WB Mozzarella cheese, the use of B milk is drastically increasing in order to satisfy the growing demand of 
consumers, especially during the summer period corresponding to lean peak. The use of adulterant B milk 
can endanger the consumer safety because of possible occurrence of allergic reactions and stomach irritation 
to sensitive consumers. Currently, cheese made from non-bovine milk is considered adulterated when the 
error in the evaluation of the extraneous milk does not exceed 1% (European Commission, EC 213/2001. 
Off. J. Eur. Comm, 44, L37/31).  
Recent researches have focused on the discovery of markers to detect adulterating milk of other species for 
the production of cheese made exclusively from WB, ovine or caprine milk. B milk adulterating WB milk 
has been recognized by HPLC analysis using β-lactoglobulin (β-Lg) A as B marker (Official Gazette of the 
Republic of Italy 11 June 1996. Off. J. Ital. Rep. 1996; 135: 12). Similar procedures have been developed for 
detecting B milk in binary (Official Gazette of the Republic of Italy 17 April 2003. Off. J. Ital. Rep. 2003; 
90: 9.6) or tertiary milk mixtures by capillary electrophoresis (Herrero-Martinez et al., 2000). These methods 
give good results, as they are able to detect the presence of adulterant milk at levels as low as 0.5-1.0%, but 
they are very slow and laborious. Fast detection of B α-La and β-Lg in WB and ovine milk is reported to 
show a linear MALDI-TOF response up to a limit of 2% (Cozzolino et al., 2002). Among protein-based 
methods for the detection of adulterant milk, it is now widely recognised that CN is a more useful indicator 
than heat-sensitive whey proteins. Presently, IEF of CN is the European reference method for cow’s milk 
detection (Commission Regulation No 273/2008, Official Journal of the European Union, L 88, 53-115). 
This reference method is based on the detection of hydrolysis product of B β-CN,  γ2- and  γ3-CN, by detecting 
low levels (0.5%) of added cow’s milk. A version more simplified than IEF profile has been obtained using 
anti-peptide antibodies able   to  detect  almost  exclusively  γ2-CN, with a limit of detection (LOD) of 0.25% 
(Addeo et al., 2009). Recently, our strategy has combined MS and synthetic peptide analogues as internal 
standards (IS) to quantify species-specific CN peptides with a LOD of 0.5% (B milk) and of 1% (caprine 
milk) using either MALDI or the liquid chromatography–electrospray ionisation-mass spectrometry (LC-
ESI-MS) analysis (Cuollo et al., 2010). The high degree of homology among the CN sequences of different 
species involves the careful selection of the proteotypic peptides. The amino acid substitutions occur also 
within the CPP sequence. Some sequences of CPPs, released from in vitro hydrolysis of milk different 
species, are different enough to be detected by MS techniques. 
In our study, tryptic CPPs such  as  bovine  β-CN (f1-25) 4P and  water  buffalo  β-CN (f1-28) 4P have been 
identified and then used as markers of B milk contaminating WB milk, respectively. The method provides an 
alternative analytical means for detecting adulterated milks/cheeses with 0.5% LOD, using direct MALDI-
TOF-MS analysis of HA-CPP complexes. 
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2 AIM OF THE STUDY 
The main aim of the work is the study of CPPs in different dairy products by an enrichment method based on 
HA. The CPP bioactivity is affected from their full or partial dephosphorylation, which could occur in milk 
of poor quality, in intensely heated milk or in long ripened cheese. Moreover, the research work has focused 
on on the discovery of markers of cheese-milk adulteration by mixing milks from different species through 
the monitoring of proteotypic CPPs. 
Therefore, the work has achieved the following goals:  
1) The identification of specific CN peptides and partially dephosphorylated CPPs as possible 
indicators of SCM in milk from infected subjects; 
2) The identification of CPPs as suitable markers of the heat treatment intensity. The method has 
allowed to discriminate the UHT milk added to the pasteurized milk in amount up to 10%; 
3) The CPP profiling of PR cheese at different age of ripening. The chromatographic procedure 
resulted useful to distinguish between younger cheese (up to 15 months) and that older than 26-mo; 
4) The identification of proteotypic CPPs as markers of adulterated water buffalo milk (or ovine and 
caprine) with cheaper bovine milk used for producing cheese of single species. 
The advantages of using signature phosphopeptides as analytical surrogates of the proteins are that (1) it is 
easier to separate and detect peptides than proteins, (2) structure of the CPPs does not alter during the 
analysis, (3) putative peptides suggested from databases can be easily recognized and synthesized for 
quantitative analysis.  
The developed method could be applied in the molecular design and control of other dairy and non-dairy 
products. 
2.1 Techniques of phosphopeptide detection and Workflow  
The study of phosphorylated component has posed a difficult challenge in proteomic field. Phosphorylated 
peptides escape detection by MS analysis because of their substoichiometric concentration, poor 
ionization/detection efficiency and the low m/z values of MS2 fragment ions (Steen et al., 2006). The 
negative charge of phosphorylated residues affects ionization and detection efficiency of the phosphopeptides 
(they remain negatively charged even at pH 2), under acidic conditions used for MS experiments in positive 
ion mode (Steen et al., 2006). It is reported that their desorption/ionization efficiency is an order of 
magnitude lower than that recorded for the non-phosphorylated counterpart and it becomes increasingly 
difficult with the number of phosphate groups (Craig et al., 1994). Many MS-based methods have been 
developed for the identification of phosphorylated peptides and the assignment of phosphorylation sites. 
Multiply and singly, tryptic phosphopeptides can be simultaneously detected using MALDI-TOF and the 
location of phosphate groups can be obtained by a combination of tandem mass spectrometry (MS/MS) and 
computer-assisted database search programs (e.g. SEQUEST, Trademark, University of Washington, Seattle 
Wash) (McCormack et al., 1997; Eng et al., 1994). Direct analysis of phosphopeptides can use two 
orthogonal MS scanning techniques, both based on the production of specific marker ions at m/z 63 and/or 
79, in the negative ion mode (Annan et al., 2001). These scanning methods combined with the ESI and nano-
ESI-MS/MS allow to selectively detect and identify phosphopeptides even in complex proteolytic digests. An 
alternative strategy uses the precursor neutral loss scanning by using ESI-MS/MS. In this way, 
phosphopeptides can be recognised from neutral loss mass of m/z 98 (phosphoric acid is released from β-
elimination of phosphoserine or phosphothreonine residues upon fragmentation in MS), while an additional 
fragmentation of the product of the precursor neutral loss can be obtained by multi-stage activation MS3 
experiments (Schlosser et al., 2001). Anyway, the methods of phosphoproteins/phosphopeptides enrichment 
prior to MS analysis have been widely used in studies of phosphoproteome to greatly improve their 
identification and characterization. An ancient technique consisted of the phosphopeptide precipitation as 
insoluble barium salts and their recovery by centrifugation, as according to the Manson & Annan method 
(Manson & Annan, 1971). High-throughput phosphoproteome technologies currently rely on combining pre-
separation of proteins, most commonly by high-resolution two-dimensional polyacrylamide gel, in-gel tryptic 
cleavage of proteins and subsequent MALDI-TOF or ESI-MS/MS mass spectrometry analysis of peptides 
(Thiyagarajan et al., 2009). Alternative methods are based on chemical derivatization. For example,   β-
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elimination reactions by strong base such as NaOH or Ba(OH)2 are able to form dehydroalanine or 
dehydroaminobutyric acid by cleavage of the phosphoester bonds of phosphoserine and phosphothreonine, 
respectively. Dehydroalanine or dehydroaminobutyric acid are further able to react with different 
nucleophiles, such as ethanedithiol (EDT) or dithiothreitol (DTT). EDT or DTT-labeled amino acid residues 
can be linked to immobilizing agents or affinity tag. For instance, biotinylated residues can produce the ion 
fragments observed at m/z = 446 in the MS/MS spectra because of the facile cleavage of peptide bonds or 
can be captured by avidin purification (Oda et al., 2001). An interesting approach for high-throughput 
phosphoproteome quantitation employs isotope coded affinity tags (ICAT) (Gygi et al., 1999). This method 
involves derivatization of two distinct proteomes with the light and heavy versions of the ICAT reagent 
where eight hydrogen atoms in the linker arm of the light reagent (D0) have been substituted by eight 
deuterium atoms in the heavy reagent (D8). Although the derivatization methods are highly selective, they 
are not widely applied in phosphoproteome studies due to sample loss by the multiple reaction steps and 
unavoidable side reactions (Zhou et al., 2001). The affinity chromatography-based methods have been found 
to be advantageous for selective phosphopeptide enrichment. IMAC (with Fe3+, Ga3+, Ni2+ and Zr4+ metal 
ions) and metal oxide affinity chromatography (MOAC, with TiO2, ZrO2, Al2O3 and Nb2O5) have been 
widely used for the quantitative binding of phosphopeptides on resin or adsorbent. Iminodiacetic acid (IDA, a 
tridentate metal-chelator) or nitrilotriacetic acid (NTA, a quadradentate metal chelator) are often used as 
IMAC functional matrices. Multivalent metal ions (e.g. Fe3+, Ga3+ and Al3+) are usually bound to a chelating 
support to provide positive charges useful for the phosphopeptides enrichment (Posewitz & Tempst, 1999; 
Kokubu, 2005). The negatively charged phosphopeptides can also selectively interact with TiO2 
microspheres via bidentate binding at the dioxide surface (Pinkse et al., 2004; Rinalducci et al., 2006.; 
Thingholm et al., 2006). Phosphopeptides bound to affinity resins can be released by increasing either pH or 
the phosphate concentration in the buffer (Thingholm, et al., 2006; Zhou et al., 2007; Thingholm & Jensen 
2009). The main problem associated with the chelating resins is the metal-ion leaching, which leads to CPP 
loss during the enrichment procedure. The selectivity of these methods was somewhat compromised by the 
detection of several acidic non-CPPs co-eluted by the resins (Dunn et al., 2010). To overcome this drawback, 
the carboxyl groups can be methyl esterified, which eliminates the non-specific adsorption of acidic peptides 
on IMAC (Moser & White, 2006). Considerable efforts have been expended to remove acidic non-CPPs by 
using aromatic modifier such as 2,5-dihydroxybenzoic acid (DHB) or phthalic acid in loading buffer 
(Thingholm et al., 2006). It has been found that aliphatic hydroxyl acid modified metal oxide works more 
efficiently and more specifically than aromatic modifiers in titania and zirconia MOC (Sugiyama et al., 
2007). However, all affinity techniques developed for the current enrichment strategies of CPPs gave 
reproducible but incomplete results due to poor binding of low concentrations of CPPs and the insufficient 
recovery of multiple phosphorylated peptides (McLachlin & Chait, 2001). Recently, a robust and sensitive 
phosphoproteomic strategy (collectively abbreviated "TiSH") combines an initial TiO2 pre-enrichment step 
(to eliminate most of non-phosphorylated peptides), a post-fractionation using sequential elution from IMAC 
(SIMAC) (to fractionate mono-phosphorylated peptides from multi-phosphorylated) and hydrophilic 
interaction liquid chromatography (HILIC) (to fractionate further the mono-phosphorylated peptides) prior to 
LC-MS/MS analysis (Engholm-Keller et al., 2012).  
An easier procedure based on HA mocrogranules has been recently developed for specific 
phosphoprotein/CPP enrichment from complex mixtures (Pinto et al., 2010; Mamone et al., 2010). Salt of 
calcium phosphate in the form of HA (formula [Ca10(PO4)6(OH)2]), found in bone and tooth tissue, has been 
previously used to enrich bone proteins (Zhou et al., 1998). The phosphate groups of 
phosphoproteins/phosphopeptides interact with crystalline lattice Ca2+ more strongly than do the carboxyl 
groups (Kawasaki, 1991). Moreover, the higher phosphorylation level leads to tighter binding of the 
proteins/CPPs to HA so that the affinity of the multi-phosphorylated proteins/peptides for HA results 
significantly higher than that of the same components with lower phosphorylation (Schmidt et al., 2007). The 
procedure employs ceramic HA microgranules as a solid-phase adsorbent to efficiently capture 
phosphoproteins and CPPs through their phosphate groups while the non phosphorylated components are 
washed out using various buffers (Figure 2).  
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Figure 2. Workflow of the CPP enrichment technique based on HA microgranules. The samples were 
enriched and analyzed as follows. An aliquot of the solution containing casein and/or peptide mixture was 
mixed with the HA microgranules to capture the phosphorylated components. Another aliquot containing 
HA-bound casein or tryptic CPPs was spotted on the target plate, covered with the MALDI matrix solution 
containing exogenous acids (TFA for phosphoproteins, shown in blue; PA for CPPs, shown in violet) and the 
protein/peptide ions desorbed from the MALDI-TOF matrix. The HA-based protein/peptide enrichment 
procedure was tested using MALDI-TOF to discriminate the phosphoanalytes in two distinct mass ranges. 
The presence of phosphoanalytes in the mixture was verified through phosphate-specific reactions (e.g., 
sensitivity to alkaline phosphatase). Moreover, HA-bound CPPs can be dissolved, desalted and analyzed by 
LC-ESI-MS/MS. 
Phosphoproteins/CPPs immobilized on HA microgranules form a complex that can be loaded directly on the 
MALDI-TOF plate. Moreover, HA-trytic CPPs can be obtained by in situ digestion with trypsin; non-
phosphorylated peptides were released in the flow-through while the dried HA-trytic CPP microgranules 
included in the co-crystallization matrix were analyzed directly by MALDI-TOF (Pinto et al., 2010). 
Sequencing by LC-ESI-MS/MS allows to confirm the CPP sequences as well as to establish their level of 
phosphorylation (Pinto et al., 2010). 
Phosphoproteins/peptides compete for the C-sites on ceramic HA over a wide pH range (Schmidt et al., 
2007) and both are eluted for MALDI analysis (Mamone et al., 2010; Addeo et al., 1977). In a previous 
article, CPPs immobilized on HA were progressively eluted with increasing phosphate buffers and then 
identified by off-line MALDI-MS (Mamone et al., 2010). Our procedure did not use elution because the HA-
phosphocaseins/CPP complexes were directly solubilized by spotting on the MALDI plate matrix mixed to 
trifluoroacetic acid (TFA) (for caseins) or phosphoric acid (PA) (for CPPs) (Figure 2). PA enhances the 
detection of phosphopeptide ions by MALDI-TOF (Kjellstrom & Jensen, 2004). This procedure was 
accelerated by the removal of elution step, and CPP losses during elution were minimized. This method is 
useful for measuring the phosphorylation level of phosphoproteins/CPPs quickly, with less than 2 h including 
the readout of the MALDI spectra (excluding the trypsinolysis step).  
In conclusion, the more important advantages of the procedure are the possibility of (1) detecting 
phosphorylated proteins/peptides even in complex mixtures, (2) determining phosphorylated sites and those 
dephosphorylated by phosphatase, (3) attaining information regarding weakly and heavily phosphorylated 
peptides and (4) the quickness and simplicity of the enrichment steps. 
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3 RESULTS AND DISCUSSION 
3.1 Topic 1: Proteolysis and partial dephosphorylation of casein in sheep milk with high somatic cell 
count 
In the present work, the direct analysis of proteins by ESI-Q-TOF-MS has allowed to identify partially 
dephosphorylated CN/CPPs that are released in the milk of infected subjects with high SCC. In order to 
improve our knowledge of the peptide bonds that are hydrolyzed by PL and the dephosphorylated SerP sites, 
HA-enriched tryptic CPPs have been studied. These CPPs resulted useful for the unambiguous assignment of 
phosphorylation level of parent CN by MS. The presence of specific CN peptides and partially 
dephosphorylated CPPs may be possible indicators of SCM in milk. 
3.2 Materials and methods 1 
3.2.1 Chemicals 
Milk from ovine Sarda breed was obtained from local dairy farms. A flock of 120 sheeps was milked once 
daily half-udder separately by the opposite half-udder, for a total of 240 samples. Milks with the three 
different levels of SC, SCC<500,000, 500,000<SCC<1,500,000 and SCC>1,500,000 were obtained from all 
of animals primiparous and homogeneous for lambing date, feeding scheme and stage of lactation. Upon 
milking, a sample was taken from the milk of each half-udder in order to determine the SCC (Fossomatic, 
Foss Electric, Hillerød, Denmark) while the rest was conserved in a plastic bag and stored at 4 °C up to SCC 
analysis. On the basis of the SCC, each sample of milk was then blended to have three bulk milks 
corresponding to the pre-established SCC thresholds. Isoelectric CN was obtained from skimmed milk after 
centrifugation at 3,000 x g for 10 min by the addition of acetate buffer according to the procedure of 
Aschaffenburg & Drewry (Aschaffenburg & Drewry, 1959). Tris(hydroxymethyl) aminomethane 
hydrochloride (Tris-HCl), potassium chloride (KCl), urea, TFA, acetonitrile (ACN) HPLC grade, 85% PA, 
ammonium bicarbonate (AMBIC), formic acid (FA), potassium phosphate monobasic (KH2PO4) and di-
Sodium hydrogen phosphate anhydrous (Na2HPO4) were purchased from Carlo Erba (Milan, Italy). HA 
(Macro-Prep Ceramic Hydroxyapatite TYPE I) was supplied from Bio-Rad (Milan, Italy). Coomassie 
Brilliant Blue G-250 (CBB) and TPCK-treated trypsin from bovine pancreas was obtained from Sigma-
Aldrich (Milan, Italy). DTT, Sodium acetate (AcNa) trihydrate, 3,3-diaminobenzidine, DHB, and nickel 
chloride hexahydrate (NiCl2) were obtained from Fluka (Milan, Italy). All other reagents were of analytical 
grade and were used without further purification.  
ALP was evaluated according to the spectrophotometric Official Method established by the Commission of 
the European Community (1991).  
3.2.2 Electrophoresis and immunoblotting  
IEF was performed on small, ultrathin-layer polyacrylamide gel (thickness, 0.25 mm). A pH gradient in the 
range of 2.5-6.5 was obtained by mixing Pharmalyte (GE Healthcare, Uppsala, Sweden) 2.5-5.0, 4.5-5.4 and 
4.0-6.5 at a ratio of 1.6:1.4:1 (v/v/v). Protein separation was performed on the PhastSystem apparatus 
(Pharmacia, Uppsala, Sweden) according to the procedure previously described (Moio et al., 1989). After gel 
electrophoresis, the proteins were transferred to a nitrocellulose membrane by capillary diffusion. The 
present procedure differed from that described by Chianese (Chianese et al., 1992) since the blocking 
solution was replaced with PBS (1.5 mM KH2PO4, 8.1 mM Na2HPO4, 136 mM NaCl, 2.7 mM KCl, pH 7.4) 
containing 10% heat-inactivated horse serum (v/v). 
Immunostaining was performed using anti-peptide antisera as the primary reagent and horseradish peroxidase 
(HRP)-labeled goat anti-rabbit IgG polyclonal antibodies as the secondary reagent (Bio-Rad, Hercules, CA). 
For CN detection, the nitrocellulose was placed in 10 mM Tris-HCl, pH 7.5, containing 0.5 mg/ml 3,3’-
diaminobenzidine (Fluka, Buchs, Switzerland) and 0.06% (w/v) NiCl2 hexahydrate. To initiate the reaction 
between the HRP-labeled goat anti-rabbit IgG antibodies and the 3,3’-diaminobenzidine, 20 µl 30% (v/v) 
hydrogen peroxide was added. Incubation of the nitrocellulose membrane was performed at room 
temperature with gentle shaking. The membrane was examined periodically until the protein band color was 
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converted to a red-brown (1–5 min). When the desired intensity of red-brown color was achieved, the 
reaction was stopped by rinsing several times the membrane in distilled water. 
3.2.3 Synthetic peptides and production of the antisera  
We chemically synthesized a number of peptides corresponding to their amino acid sequences. These 
peptides mimicked the sequence of the natural protein and were purified using reverse phase HPLC (Primm, 
Milan, Italy). A cysteine residue was added to each N- or C-terminal peptide for conjugation with ovalbumin 
according to the coupling procedure described by Mattson (Mattson et al., 1993). The cysteine was added to 
the N-terminal of the peptides corresponding to amino acids 195-209 and to the C-terminal peptides 
corresponding to amino acids 1-28  of  β-CN. The cysteine was then added to the N-terminus of the αs1-CN 
peptides containing the amino acid sequence 186-199 and to the C-terminus of the αs1-CN peptides 
containing the amino acid sequence 1-22. The cysteine was added to the N-terminus of the peptide containing 
amino acids 193-207  of  αs2-CN and to the N-terminus of the peptides containing the amino acid sequence 92-
111  of  κ-CN. The peptides were quality-controlled using MALDI-TOF-MS. The ovalbumin conjugates were 
used to immunize two rabbits. Finally, the antisera were filtered through a 0.45 µm membrane (Millipore, 
Bedford, MA) and were divided into two 1 ml portions, which were stored at -20 °C until use.  
3.2.4 HA-based enrichment of tryptic CPPs  
Solutions of ovine CN (10 mg) from infected udders were loaded on HA (100 mg), previously equilibrated 
with the sample loading buffer (50 mM Tris-HCl, 0.2 M KCl, 4.5 M urea and 10 mM DTT, pH 8.0). The 
HA-bound proteins were incubated for 15 min at room temperature and centrifuged at 4,000 x g for 2 min. 
HA was successively washed with three different buffers: 1 mL of loading buffer, 1 mL of 50 mMTris-HCl, 
pH 8.0 (washing buffer), and 1 mL of buffer containing 20mM Tris-HCl, pH 8.0 and 20% ACN (v/v). The 
resin was washed with 1 mL of Milli-Q water and freeze-dried with a SpeedVac concentrator system 
(Thermo Electron, Milford, MA) (Pinto et al., 2010). The proteolysis/peptidolysis of HA-bound 
phosphoproteins/CPPs was performed in situ with trypsin, which was added to the suspension at an 
enzyme/substrate ratio of 1:50 (w/w) in 50 mM Tris-HCl buffer, pH 8.0 containing 0.2 M KCl, 4.5 M urea 
and 10 mM DTT at pH 8.0. The reaction was performed at 37 °C overnight. The reaction was stopped by 
centrifuging the HA-CPP microgranules at 4,000 x g for 2 min and the microgranules were washed as 
previously described. Finally, after washing with Milli-Q water, the HA microgranules were subsequently 
dried and analyzed by MALDI-TOF (Pinto et al., 2010). 
3.2.5 MALDI-TOF MS analysis 
The MALDI-TOF mass spectra were recorded using a Voyager DE-PRO mass spectrometer (Applied 
Biosystems, Framingham, USA) in positive linear mode. All spectra were acquired in the range of 1–4 kDa 
for the peptides with the following settings: an accelerating voltage of 20 kV and a grid voltage 95% of the 
accelerating voltage, a guide wire of 0.05% and a delayed ion extraction time of 175 ns. The laser power was 
set immediately above the ion generation threshold to obtain peaks with the highest possible signal-to-noise 
ratio. All spectra were acquired with 200 shots in three replicates. The measured molecular masses with a 
±0.5 Da tolerance, matching the calculated masses, enabled the identification of the ion signals. The MALDI 
matrix solution was freshly prepared before analysis. DHB (10 mg) was dissolved in 1 ml H2O/ACN/PA 
(49/50/1) using an ultrasonic bath. HA-tryptic CPP complexes were deposited onto the MALDI plate and 
covered with the DHB matrix (0.5 µl), which promoted the analyte/matrix co-crystallization in the presence 
of 1% PA (Pinto et al., 2010).  
3.2.6 LC-ESI-MS analysis 
LC-ESI-MS analysis of whole CN was performed using an Agilent 1100 Series LC/MSD system with a 
single quadrupole mass detector (Agilent Technologies, Avondale, PA, USA) in the positive mode. The mass 
spectrometer was coupled to a Hewlett Packard LC system. Solvent A was 0.1% TFA (v/v) in ultrapure water 
and solvent B was 0.1% TFA (v/v) in ACN. A solution (200 µl) containing 1 mg CN sample/ml solvent A 
was loaded onto a Vydac C4 column (214TP54 5 µm, 250 mm × 2.1 mm internal diameter column, Vydac, 
Hesperia, CA, USA) with a detection wavelength of 220 nm. The elution program involved a gradient from 
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30 to 50% solvent B over 40 min and 50 to 100% B over 2 min at a flow rate of 1 ml/min. The optimum 
mass spectrometric parameters were as follows: capillary voltage, 4.0 kV; cone voltage, 80 V; heated N2 gas 
(350 °C, 10 l/min); and compressed N2 gas (13 psi). The mass spectra of the CN components were scanned 
from 1800 to 400 at a scan cycle of 5 sec/scan. The LC-MS data were acquired with the Hewlett Packard 
1100 series ChemStation Chromatographic analysis software (Hewlett-Packard Company, Waldbronn, 
Germany). 
3.2.7 ESI-Q-TOF-MS analysis  
Native whole CN was analyzed on a CapLC nano-flow high-pressure pump system (Waters/Micromass, 
Manchester, UK) interfaced with an ESI-tandem MS. The mass spectrometer was the Q-TOF™ hybrid Q-
TOF (Micromass Ltd., Manchester, UK) equipped with a Z-spray ion source in the positive ion mode (ESI-
Q-TOF and MS/MS). Chromatographic separations were performed on a reversed phase Atlantis dC18 
capillary column (75 µm i.d.). The mobile phase was water (A) and ACN (B) with 0.1% FA. A linear 
gradient from 5 to 70% B was applied to the pre-column and column over a 45 min period at a flow-rate of 
approximately 300 nl/min pre-column  splitting  using  a  pump  operating  at  5  µl  min-1. The source conditions 
were as follows: capillary voltage, 2.6 kV; cone voltage, 100 V; and RF1 lens, 40 V. External calibrations 
with apomyoglobin from equine skeletal muscle (A8673 Sigma Aldrich) and [Glu1]-Fibrinopeptide B 
(human) (GFP) (F3261, Sigma Aldrich) were performed over mass ranges of 600 to 2,000 and 400 to 1,600 
m/z, respectively. All spectra were acquired with the TOF analyzer in “V-mode” (9.1 kV TOF) and the MCP 
voltage was set at 2000 V. The masses were calculated using the MaxEnt3 deconvolution algorithm. The raw 
data were processed using the MassLynx 4.0 ProteinLynx software.  
3.3 Results and discussion 1 
3.3.1 Identification of CN from healthy and infected ovine by LC-ESI-MS 
Ovine CN fractions secreted from a healthy udder (SCC/ml, 46 x 103/ml), the contralateral infected udder 
(SCC/ml 4,897 x 103/ml) and an intermediate udder (SCC 1,041 x 103/ml) were simultaneously compared. 
The effect of the udder health on CN breakdown was preliminarily visualized using antibodies against the N-
terminal  β-, αs1-, αs2- and κ-CN peptides and against the C-terminal  β- and αs1-CN peptides (Figure 3). 
 
Figure 3. CBB stained SDS-PAGE gel (panel a) of ovine casein from the right and left udder with medium 
(lanes 1), normal (lane 2) and high (lane 3) SCC content. The other gels show an immunoblot of the same 
samples probed with polyclonal anti N-terminal  β-, αs1-,  αs2-CN peptide antibodies (all the panels b) and anti-
C  terminal  β-, αs1-CN and antiN-terminal  κ-CN peptide antibodies (all the panels c). 
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The   intensity   of   the   three   γ-CN bands is significantly higher in the milk with higher SCC content as 
visualized using antibodies against the C-terminal  β-CN peptides (Figure 3, first gel, panel c). A number of 
major polypeptides identified using antibodies against the N-terminal  β-CN peptides moved  faster  than  the  β-
CN  and  slower  than  the  αs1-CN (Figure 3, first gel, panel b). These polypeptides, identifiable with PP, were 
produced by the action of proteases associated with a high SCC. The presence of a subclinical intramammary 
infection has been reported to involve an increase   of   the   PP   fraction   and   a   decrease   of   β-CN (Martí-De 
Olives et al., 2011). High concentrations of PL in mastitic or high SCC quarter milk could explain this 
finding (Le Roux et al., 1995). Moreover, the immunoblots of high SCC milk showed both high and low 
mobility peptides using antibodies against the C-terminal peptides of  the  αs1-CN (Figure 3, second gel, panel 
c). A possible explanation is that cathepsin D and other enzymes could hydrolyze the N-terminal region of 
the  αs1-CN, forming N-terminally truncated peptides, whereas the C-terminal portion remained intact. αs2-CN 
and  κ-CN fractions were probed using a specific anti-peptide antibody preparation for each peptide (Figure 3, 
third  gel).  The  immunoblot  profile  of  αs2-CN in milk with high SCC significantly differed from the control 
CN for the presence of the three intense bands at a higher pI, whereas the   intensity   of   the   native   αs2-CN 
simultaneously decreased (Figure 3, third gel, panel b). The immunoblotting procedure with regard to the 
native κ-CN profiling gave results  quite  similar  to  the  αs2-CN as several bands were formed at the higher pI 
(Figure 3, third gel, panel c). There are little  data  available  regarding  the  hydrolytic  products  of  κ-CN. This 
finding  confirms  that  the  native  κ-CN survives the enzymatic degradation, even in milk samples with high 
SCC.  In  conclusion,  the  higher  the  SCC,  the  more  intense  is  the  proteolytic  phenomenon,  except  for  κ-CN. 
Grieve & Kitchen reported that the results for CN degradation by leukocyte proteases were  in  the  order  αs1- > 
β- >>  κ-CN (Grieve & Kitchen, 1985). The propensity for degradation varied according to the CN fraction 
that was exposed to proteolysis and also varied with the incubation time (Haddadi et al., 2005). The results of 
this study support the  previous  findings  that  β-CN  and  αs2-CN  are  more  susceptible  than  αs1-CN  and  κ-CN to 
degradation in the order β- >  αs2- >  αs1- >>  κ-CN. 
Although new electrophoretic bands have been observed as a result of enzymatic activity increase in high 
SCC milk, the exact identity of the bands remained unknown. 
MS has provided a valid alternative to conventional electrophoretic and other descriptive methods. It has 
allowed to characterize the peptides derived from the hydrolysis and the dephosphorylation of ovine CN. LC-
ESI-MS analysis was used to identify CN fractions and peptides in samples with low and high SCC (Figure 
4). 
 
Figure 4. LC-ESI-MS profile of ovine casein fractions isolated from milk secreted by a healthy (a) and 
infected (b) udder.  
Although the LC patterns of the CN samples with low (healthy) and high (infected) SCC seemed to be 
similar, a greater heterogeneity was observed (Figure 4a and 4b): the ovine CN sample from a healthy udder 
gives six peaks (Figure 4a), while there are seventeen peaks for the infected udder sample (Figure 4b). The 
comparison of CN fractions from healthy and infected udder and the relative abundance (RA) of the 
phosphorylated forms within each CN family are reported in Table 2.  
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Table 2. Main components of ovine casein fractions from a healthy and infected udder separated by LC 
(Figure 4a and 4b) and identified by online ESI-MS analysis. 
Healthy milk RA of the phosphorylated form Infected milk 
RA of the 
phosphorylated 
form αs2(f1-208)-(34-42) 11P 
9P>8P>7P> 
11P>10P 
αs2(1-208)-(34-42) 11P 
11P>10P>9P>8P>7P 
αs2(f1-208)-(34-42) 10P αs2(1-208)-(34-42) 10P 
αs2(f1-208)-(34-42) 9P αs2(1-208)-(34-42) 9P 
αs2(f1-208)-(34-42) 8P αs2(1-208)-(34-42) 8P 
αs2(f1-208)-(34-42) 7P αs2(1-208)-(34-42) 7P 
αs2(f1-208) 12P 
11P>12P≥10P>8P>9P>7P 
αs2(1-208) 12P 
12P>10P> 
11P>9P>8P 
>7P 
 
αs2(f1-208) 11P αs2(1-208) 11P 
αs2(f1-208) 10P αs2(1-208) 10P 
αs2(f1-208) 9P αs2(1-208) 9P 
αs2(f1-208) 8P αs2(1-208) 8P 
αs2(f1-208) 7P αs2(1-208) 7P 
αs1(f1-199)-(110-117) 8P 
6P>7P>8P 
n.d. (not detected) 
6P>7P αs1(f1-199)-(110-117) 7P αs1(1-199)-(110-117) 7P 
αs1(f1-199)-(110-117) 6P αs1(1-199)-(110-117) 6P 
αs1(f1-199)-(Gln78) 10P 
8P>9P>10P 
n.d. 
7P>8P>9P αs1(f1-199)-(Gln78) 9P αs1(1-199)-(Gln78) 9P αs1(f1-199)-(Gln78) 8P αs1(1-199)-(Gln78) 8P 
n.d.  αs1(1-199)-(Gln78) 7P 
αs1(f1-199) 10P 
7P>8P>9P 
>10P 
n.d. 
8P>7P>9P αs1(f1-199) 9P αs1(1-199) 9P αs1(f1-199) 8P αs1(1-199) 8P 
αs1(f1-199) 7P αs1(1-199) 7P 
β(f1-207) 6P 
5P>4P>6P 
>3P 
β(1-207) 6P 
5P>4P>3P> 
6P>2P>1P 
β(f1-207) 5P β(1-207) 5P 
β(f1-207) 4P β(1-207) 4P 
β(f1-207) 3P β(1-207) 3P 
n.d. β(1-207) 2P 
n.d. β(1-207) 1P 
κ(f1-171) 2P 2P>1P κ(1-171) 2P 2P>1P κ(f1-171) 1P κ(1-171) 1P 
 
 
RA = the relative abundance of the components within each CN family 
The disappearance of the fully phosphorylated forms of CN fractions and the appearance of those less 
phosphorylated  is  particularly  evident  for  αs1-CN  and  its  deleted  form  αs1-CN–Gln78 and for β-CN (Table 2). 
Moreover, a different RA was observed in the samples from healthy and infected milk. These results were 
confirmed by the measurement of ALP activity in the different milks with different SCC (Table 3).  
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Table 3. Measurement of ALP activity in milk samples with different SCC.  
Milk 
Samples  
SCC ALP mU/l 
Healthy Infected Healthy Infected 
IZ5073 79,000 1,041,000 767.0 1,697.2 
IZ5073 273,000 1,054,000 460.0 1,763.4 
IZ4346 46,000 4,897,000 308.5 2,051.2 
IZ4741 67,000 2,040,000 947.9 2,652.9 
OS6107 78,000 2,465,000 117.2 1,011.8 
0S7339 118,000 13,341,000 2,548.1 11,492.0 
 
 
In any case, the ALP activity is higher in milk from SCM than healthy controls. ALP can dephosphorylate 
CN based on its activity in the milk of SCM-affected cows. The ALP activity could explain the appearance of 
partially dephosphorylated CN fractions,  such  as  β-CN 1P and 2P and αs1-CN–Gln78 7P and the concomitant 
disappearance of the αs1-CN–Gln78 10P in milk with high SCC. Therefore, the phosphorylation degree of β-
CN varied in the range of 6P to 1P, whereas the β-CN peak area did not change significantly with respect to 
the control CN. In healthy milk, internally deleted counterpart αs1-CN–(f110-117) shows a phosphorylation 
level lower than full-length  αs1-CN because of loss of deleted mono-CPP. Although the αs1-CN–(f110-117) 
form had nine sites potentially phosphorylable, the αs1-CN–(f110-117) 9P was not detected in any sample. 
Despite the different number of SCC, the proportion of native κ-CN 1P and 2P was similar. Moreover, in 
both milk samples, the quantity of full-length   αs2-CN was greater than the homologous internally deleted 
counterpart, although the deleted peptide, αs2-CN (f34-42), did not contain any phosphorylated residue within 
its   sequence.  Notably,   the   internally   deleted   αs2-CN lacks the Lys-containing peptide, which causes a less 
efficient interaction with PL and the full-length  αs2-CN. The proportion of  native  αs2-CN globally decreased 
in the CN sample from the infected udder because of the modification of either partially dephosphorylated 
αs2-CN (Table 2) or the degradation into shorter peptides  (Table  4),  such  as  the  αs2-derived peptides (f151-
208), (f152-208), (f1-114) (3P-2P). 
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Table 4. Main peptides of ovine CN from a healthy and infected udder separated by LC (Figure 4a and 4b) 
and identified by online ESI-MS analysis. 
Healthy milk Infected milk RA of the phosphorylated form 
n.d. (not detected) β(49-207)  
n.d. β(49-198)  
n.d. β(98-207)  
   
n.d. β(1-105) 5P 
5P>4P>2P>3P 
n.d. β(1-105) 4P 
n.d. β(1-105) 3P 
n.d. β(1-105) 2P 
 
n.d. β(106-206)  
n.d. β(106-207)  
  
n.d. β(1-97) 5P 
4P>2P>5P>3P 
n.d. β(1-97) 4P 
n.d. β(1-97) 3P 
n.d. β(1-97) 2P 
  
n.d. β(170-207)  
n.d. β(1-29) 4P  
n.d. β(84-113)  
n.d αs2(1-114) 3P 
2P>3P n.d. αs2(1-114) 2P 
  
n.d. αs2(151-208)  
αs2(f152-208) αs2(152-208)  
n.d. αs1(1-60) 3P 
2P>1P>3P>0P 
n.d. αs1(1-60) 2P 
n.d. αs1(1-60) 1P 
n.d. αs1(1-60) 
  
n.d. αs1(24-79) 6P 4P>3P>5P>6P 
n.d. αs1(24-79) 5P  
n.d. αs1(24-79) 4P  
n.d. αs1(24-79) 3P  
   
n.d. αs1(24-72) 2P 
0P>1P>2P n.d. αs1(24-72) 1P 
n.d. αs1(24-72) 
 
 
RA = the relative abundance of the components within each CN family 
β-,  αs1-,  and  αs2-CN derived peptides were αs1-CN (f24-72) (2P-0P), (f24-79) (6P-3P), (f1-60) (3P-0P),  αs2-
CN (f151-208), (f152-208), (1-114) (3P-2P)   and   β-CN (f84-113), (f1-29) 4P, (f170-207), (f1-97) (5P-2P), 
(f106-206), (f106-207), (f1-105) (5P-2P) (f98-207), (f49-198), (f49-207), as shown in Table 4. The control 
sample had only  an  extra  peptide,  αs2-CN (f152-208)  (Table  4).  PP,  β-CN (f1-29) 4P  and  β-CN (f1-105) 5P, 
as  well   as   β-CN (f1-97) 5P were PL-mediated CPPs. The non-phosphorylated counterparts, such as β-CN 
(f98-207), (f106-206), (f106-207) and (f98-207), were concurrently detected in the infected milk samples. 
Other peptides were released by PL action on Lys49-Ile50, Lys169-Val170 and Lys113-Tyr114 bonds   of   β-CN. 
Three   peptides   of   αs2-CN, i.e. αs2-CN (f151-208), (f152-208), (1-114) 3P, originated from PL. All these 
peptides were justified  by  higher  susceptibility  of  the  β-CN and as2-CN to PL hydrolysis. The influx of PMNs 
into the milk due to the weakening of the milk-blood barrier caused the increase of SC proteinases such as 
cathepsin D (Capony et al., 1989). Partially purified cathepsin D from milk was reported to release two 
complementary peptide αs1-CN (f1-23) and αs1-CN (f24-199) (as1-I-CN) (McSweeney et al., 1995). The αs1-I-
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CN peptide is further degraded by cathepsin D in vitro (Larsen et al., 1996). Therefore, αs1-CN (f24-79) is 
released by the co-presence of PL and cathepsin D.  
Other enzymes are responsible for the cleavage of the peptide bonds Phe-Val, Gln-Met, Val-Pro, Leu-Val 
and Pro-Val in the target sequence. These results provide evidence that the CN degradation is ascribed to PL 
and proteases from the PMNs. Lysosomal proteinases, such as elastase and cathepsin B, almost certainly 
occur in milk from cows suffering from mastitis (Napoli et al., 2007; Considine et al., 2000; Considine et al., 
2002).  Cathepsin  G  preferentially  cleaves  the  oxidized  β-chain of insulin between Leu15 and Tyr16 (Blow et 
al., 1977), whereas elastase cleaves the bonds of non-charged aromatic amino acids.  
3.3.2 Identification of HA enriched tryptic CPPs in ovine CN sample from high SCC milk 
The objective of our study is to estimate the post-translational modifications of CN fractions in order to 
detect the markers of infected milk. Therefore, the HA-based method was applied to the tryptic digests of 
high SCC ovine CN (Pinto et al., 2010) to confirm the phosphorylation level of CN fractions. The direct 
analysis of the HA-bound CPPs, co-crystallized with MALDI matrix containing PA, produced the spectrum 
shown in Figure 5. 
 
Figure 5. The MALDI partial view for the mass range 1.0–3.7 kDa for the HA-bound tryptic ovine CPPs 
from infected milk with an SCC of 7,750,000.  
The identification of tryptic CPPs was obtained using the program FindPept 
(http://www.expasy.ch/tools/findpept.html) (Table 5). 
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Table 5. Tryptic CPPs detected by MALDI spectrum (Figure 5) and relative phosphorylation level.  αs2-CN 
derived CPPs with non-specific tryptic cleavage are also listed below. 
Amino acid sequence of tryptic peptides CPPs 
REQEELNVVGETVESLSSSEESITHINK/(K) β-CN (f1-28) 5P, 4P, 3P, 2P, 1P 
(K)/FQSEEQQQTEDELQDK/(I) β-CN (f33-48) 1P 
KHKMEHVSSSEEPINISQEIYKQEK(N) αs2-CN (f1-25) 4P, 3P, 2P, 1P 
KHKMEHVSSSEEPINISQEIYK/(Q) αs2-CN (f1-22) 4P, 3P, 2P, 1P 
(K)/MEHVSSSEEPINISQEIYK/(Q) αs2-CN (f4-22) 4P, 3P, 2P 
(R)/SSSEESAEVAPEEVK/(I) αs2-CN (f57-71) 4P, 3P 
(R)/EQLSTSEENSKK/(T) αs2-CN (f126-137) 2P 
(R)/EQLSTSEENSK/(K) αs2-CN (f126-136) 2P 
(K)/ENINELSKDIGSESIEDQAMEDAK/(Q) αs1-CN (f35-58) 3P, 2P 
(K)/DIGSESIEDQAMEDAKQMK/(A) αs1-CN (f43-61) 2P 
(K)/SAEEQLHSMK/(E) αs1-CN (f115-124) 1P 
(K)/AGSSSSSEEIVPNSAEK/(Y) αs1-CN (f62-78)-Gln78 6P, 5P, 4P 
(K)/AGSSSSSEEIVPNSAEQK/(Y) αs1-CN (f62-79) 6P, 5P, 4P, 3P 
Amino acid sequence of non-specific peptides CPPs 
KHKMEHVSSSEEPINISQEI Y(K) αs2-CN (1-21) 4P 
(K)HKMEHVSSSEEPINISQEIY(K) αs2-CN (2-21) 4P 
(K)MEHVSSSEEPINISQEIY(K) αs2-CN (4-21) 4P 
(Y)SIRSSSEESAEVAPEEVK/(I) αs2-CN (54-71) 4P, 3P 
 
 
The non-CPPs were absent after enrichment on HA, whereas the presence of partially dephosphorylated 
forms was confirmed, particularly in the high SCC CN samples. Fully and partially CPPs were detected as an 
effect of ALP activity, which shifts the peptide signals by multiples of 80 Da corresponding to the phosphate 
group (H3PO4) loss. These results demonstrated the efficacy of CPP enrichment on HA and suggested that 
the procedure will be of general use in phosphoproteome studies (Table 5) (Pinto et al., 2010). We have not 
attempted to identify the phosphorylated sites but to provide more information regarding the phosphorylation 
level of CPPs. The complementary information was acquired by the multiply phosphorylated peptides 
enriched on HA at low abundance, which can be lost during the ESI-MS analysis. The ESI-MS analysis of 
infected ovine  CN  detected  six  phosphorylated  forms  of  β-CN  with  a  molecular  weight  corresponding  to  β-
CN 6P,  5P,  4P,  3P,  2P  and  1P  (Table  2).  The  presence  of  tryptic  CPPs,  such  as  β-CN (f1-28) (5P-1P)  and  β-
CN (f33-48) 1P (Table 5), confirmed that   β-CN was intensely dephosphorylated in milk with high SCC. 
Other  partially  dephosphorylated  αs1-CN  and  αs2-CN CPPs were identified in high SCC milk samples. The 
tryptic CPPs,  such  as  αs1-CN (f62-79) (6P-3P)  and  its  internally  deleted  form,  αs1-CN (f62-78)–Gln78 (6P-4P), 
bound HA  together  with  αs1-CN (f35-58) (3P-2P),  αs1-CN (f43-61)  and  αs1-CN (f115-124) 1P (Table 5). The 
80-Da multiple loss value confirmed the  presence  of  αs1-CN (9P-7P)  and  αs1-CN (9P-7P)–Gln78. In infected 
milk,  the  detection  of  αs1-CN (f62-79) 3P suggested the  presence  of  αs1-CN 6P that was not detected by ESI 
analysis (Table 2). Moreover, the results of the ESI/MS analysis showed that  native  forms  of  αs1-CN 10P and 
αs1-CN–Gln78 10P were suppressed by more abundant less phosphorylated species (Table 2). Similar 
observations   can   be   made   for   αs2-CN CPPs. Among the tryptic CPPs, three had a different N-terminal 
extension, 1-25, 1-22 and 4-22.  αs2-CN (f1-25) and (f1-22) were the most affected by dephosphorylation and 
showed a phosphorylation level from 4P to 1P. The non-specific tryptic cleavage of the C-terminal Tyr21-
Lys22 bond gave rise to αs2-CN (f1-21) 4P,  αs2-CN (f2-21) 4P  and  αs2-CN (f4-21) 4P, whereas cleavage at 
Tyr53-Ser54 produced  αs2-CN (54-71) (4P-3P). In our study, we do not investigate the exact identities of the 
SC proteases or other proteases responsible for these hydrolysis products but we observe the released CPPs 
from enzymatic activity. The proteolytic release of peptides and the dephosphorylation of those 
phosphorylated occur almost simultaneously as demonstrated by the presence of CPPs shorter than the 
control CN (Table 4). However, the data suggest that a marked increase of SC in milk determines the CN 
modifications, which essentially consists of dephosphorylation and proteolysis. Notably, changes of milk 
casein have allowed to identify some signature peptides that are available for the early detection of SCM.  
39 
 
3.4 Conclusions 1 
The CN proteolysis and dephosphorylation in milk of healthy and infected ewes have been well defined 
using different proteomic techniques. The results on CN phosphoproteome include also the detection of 
tryptic CPPs by enrichment on HA microgranules. In this manner, deeper information has been obtained 
regarding low-abundance, mono- and multi-CPPs. Follow-up work on healthy ovine milk, i.e. raw milk with 
low SCC, has confirmed that no sensible alteration of the CN sequence occurs compared to that observed in 
raw milk with high SCC. The overall data on the CN proteolysis have also provided at least one signature 
CPP from each CN fraction, excluded  κ-CN. These signature peptides are particularly useful for evaluating 
the severity of the attack by proteolytic enzymes associated to a high level SC of milk. A low level of SC 
affords  the  formation  of  almost  exclusively  β-CN peptides by action of endogenous PL, followed  by  αs2-CN 
and αs1-hydrolytic  products.  κ-CN is the most resistant to proteolysis by PL and other enzymes associated to 
SC as its hydrolysis could cause destabilization of the CN micelles and the resulting coagulation of milk in 
the mammary gland. The influence of high levels of SC affects the CN micelle by proteolysis according the 
hydrolysis order, i.e. β->  αs2->  αs1->>  κ-CN. The assumption that high SCC of raw milk reduces the shelf-life 
and flavor quality of pasteurized fluid milk is substantiated by partially dephosphorylated CN and derived 
tryptic peptides. Moreover, the intense dephosphorylation reduces the bioactivity of CPPs relative to binding 
capacity of phosphate groups. From the economic point of view, processing the milk with a high SCC 
reduces the cheese yield. Therefore, bonus would be paid to dairy farmers able to supply milks with low 
levels of SC to the cheese factory. 
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3.6 Topic 2: Lactosylated CPPs as specific indicators of heated milks 
In our study, we have focused on the detection of heated milks through signature CPPs that undergo 
lactosylation once released by proteinases. The comparison between the native and lactosylated CPPs has 
been used to differentiate processed milks according to heat intensity. Lactosylation sites have been localized 
on peptide sequence by post-source decay (PSD) fragmentation. In this work, the lactosylated CPPs have 
allowed us to detect the addition of UHT milk, in amounts not lower than 10% for spiked raw or pasteurized 
milk with UHT milk. We suggest extending this approach to the analysis of any dairy product with suspected 
addition of UHT milk, milk protein or milk powder.  
3.7 Materials and methods 2 
3.7.1 Sample preparation  
Raw milk was from local dairy farms. The pasteurized and UHT milks were purchased from a local store. 
Milk protein (casein + whey) powder and milk powder were supplied by Sacco Industry (Milan, Italy). The 
chemical composition of milk samples as well as the time/temperature combinations is reported in Table 6.  
Table 6. Protein and lactose content in heat-treated commercial milk samples 
Sample % protein % lactose Heating treatment 
Time/temperature 
combinations 
Raw milk 3.2 4.9 No No 
Pasteurized 
milk 3.2 4.9 Pasteurization 15 sec/71.7 °C 
UHT milk 3.1 4.9 Direct Ultra High Temperature processing  2 sec/135 °C 
Milk protein 
powder  46 5 
Membrane filtration*and 
Spray-drying 
Air temperature at 
200°C 
Milk powder 36 56 Spray-drying Air temperature at 200°C 
* Concentrated commercial milk proteins were obtained by milk ultrafiltration on membrane 
Each sample, including raw, pasteurized and UHT milk, protein or milk powder in solution, was treated with 
HA as described below. Pasteurized milk was added of UHT milk to the final concentration from 90 to 1%. 
3.7.2 HA-based phosphoprotein/CPP enrichment from various milk samples  
HA (100 mg), previously equilibrated with the loading buffer (50 mM Tris-HCl, 0.2 M KCl, 4.5 M urea and 
10 mM DTT, pH 8.0), were put in contact with proteins in solution (10 mg) or equivalent amounts of raw, 
pasteurized and UHT milk. The HA-bound proteins/CPPs were incubated for 15 min at room temperature 
and centrifuged at 4,000 x g for 2 min. The resin was successively washed and freeze-dried as above 
described. Solid milk samples (1 mg/ml) were solubilized in H2O/ACN (50:50) solution with 0.1% TFA. 
Liquid milk samples (10 µL) were diluted 1:100 with the same solution. Each protein solution (0.5 µl) was 
loaded on the MALDI plate well and covered with DHB matrix (0.5 µl) for the preliminary analysis.The HA-
bound CPPs were then analyzed by MALDI as described above. 
In order to confirm the degree of lactosylation, the dried HA-bound CPPs (1 mg) were dissolved in a 5% 
aqueous   PA   solution   (120   µl),   desalted   with   a   ZipTip   C18   pipette   tip   and   dephosphorylated   with   ALP  
according to the procedure previously described (Pinto et al., 2012). The HA-bound CPPs were also analysed 
by PSD-MALDI-TOF. 
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3.7.3 PSD-MALDI-TOF experiments 
PSD fragment ion spectra were acquired after isolation of the appropriate precursor ions by using timed ion 
selection.   In   this   manner,   the   spectra   of   lactosylated   β-CN (f1-28) 4P (m/z 3,803 Da) and its 
unphosphorylated counterpart (m/z 3,483 Da) were acquired. Acquisition was performed with the following 
settings: accelerating voltage 20 kV, grid voltage 80% of the accelerating voltage, guide wire 0.02 and 
delayed time 100 ns. Each spectrum was the average of 300 shots in three replicates.  
3.7.4 Synthesis of peptide analogues 
The β-CN (1-25) 4P peptide was synthesized by solid-phase methods using the 9-fluorenylmethyloxycarbonyl 
(Fmoc) strategy on a Pioneer peptide synthesizer (Synthesis System 9050 instrument; PE-Biosystems, 
Framingham, MA, USA). The level of the β-CN (f1-28) 4P was chosen as the index for quantification of β-
CN proteolysis. The natural and the analogue synthesized peptides were used to generate a calibration curve 
(Table 7). 
Table 7. The amino acid sequences of synthesized natural and modified peptides are shown. The 
differentiating Trp (W) and Leu (L) residues are underlined. Sp indicates phosphorylated serine residue. 
Synthetic natural 
peptide [M+H] Sequence 
β-CN (f1-28) 4P 3,478.5 Da RELEELNVPGEIVESpLSpSpSpEESITRINK 
Synthetic modified 
peptide [M+H]
 Sequence 
β-CN (1-25) 4P 3,196.3 Da REWEELNVPGEIVESpLSpSpSpEESITR 
A  constant  concentration  (10  µg/µl)  of  synthesized  modified  peptides  was  used  to  spike  different solutions of 
synthesized natural peptides to create a calibration curve, with the natural/modified area ratio as a function of 
the concentration ratio of the corresponding peptides. The   amount   of   β-CN (f1-28) 4P was obtained by 
spiking 10   µl of raw milk with 10   µg/µl   IS   and   calculating   the   quantity   of   this   peptide   according   to   the  
equation of the calibration plot. 
3.8 Results and discussion 2 
3.8.1 MALDI analysis of protein lactosylation  
A preliminary study was carried out to evaluate the lactosylation of intact proteins in the raw, pasteurized, 
UHT, milk protein powder and milk powder samples. Our results indicated that MALDI analysis was useful 
to identify lactosylation during heating or spray-drying through the monitoring of the molecular mass shift of 
+324 Da per lactose molecule. These post-translational modifications were clearly visualized by MALDI 
analysis especially for milk whey proteins:  β-Lg  and  α-La (Pinto et al., 2012).  Unmodified  β-Lg A and B 
were still present in all samples except milk powder. Lactosylated proteins in pasteurized milk were not 
detected as well as in raw milk. β-Lg A and B was lactosylated as well as α-La (1 lactose residue/ molecule) 
in UHT milk. In two studies, Lys47 and Lys100 of  β-Lg and Lys98, Lys114 or Lys122 of  α-La were lactosylated 
in UHT milk (Fogliano et al., 1998; Siciliano et al., 2000).  The  lactosylation  of  β-Lg A and B was higher in 
milk powder (6 lactose residues/molecule) than in milk protein powder (4 lactose residues/molecule). α-La 
was less lactosylated in the milk protein powder (3 lactose residues/molecule) than in milk powder (4 lactose 
residues/molecule). The different levels of lactosylation of proteins in the powder samples were probably due 
to the lower lactose content of ultrafiltered milk or whey. However, the Maillard reaction was incomplete 
even in the powdered milk preparations. The Amadori compound, the first intermediate in the Maillard 
reactions, is probably degraded by heat (Ledl & Schleicher, 1990) via the Strecker degradation (Yaylayan & 
Huyghues-Despointes, 1994). Thus, the lactosylation level of whey proteins increased steadily with 
temperature, progressively from pasteurization to spray-drying passing through to UHT. It seemed that 
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heating extensively enhanced lactosylation by exposing lysine residues on the surface of the proteins. The 
diffuse lactosylation of casein fractions expecially in the powdered samples due to the low resolution of 
MALDI, encouraged us to find the lactosylated markers of CPPs released in the different heat-treated milks. 
3.8.2 CPP evaluation in raw milk by MALDI-TOF analysis in the 1.2–5 kDa range 
Raw samples were examined by MALDI-TOF in the 1.2–5 kDa mass range before and after enrichment on 
HA (Figure 6).  
 
Figure 6. MALDI-TOF spectra of raw milk peptides in the 1.2–5 kDa mass range before (a) and after 
enrichment (b) using HA as concentrating probe. 
The peptides detected in raw milk are listed in Table 8. After enrichment on HA, only phosphorylated 
peptides were detected (Figure 6b, Table 8).  
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Table 8. List of the peptides identified in the MALDI spectra of raw milk (Figure 6) before and after 
enrichment on HA. 
Peptide  Expected mass  
Measured 
mass  
Number of 
phosphate 
groups  
N-terminal 
peptide bond 
cleavage 
C-terminal 
peptide bond 
cleavage  
αs2-CN (f198-207)
a
  1,251.5  1,252.7  0P  Lys197-Tyr 198 C-terminal peptide 
αs1-CN (f80-90)
a
  1,336.9  1,338.0  0P  Lys79-His80 Arg90-Tyr91  
β-CN (f195-209)
a
  1,589.9  1,591.1  0P  Gln194-Glu195 C-terminal peptide  
β-CN (f194-209)
a
  1,718.1  1,718.9  0P  Tyr193-Gln194 C-terminal peptide  
β-CN (f193-209)
a
  1,881.3  1,882.5  0P  Leu192-Tyr193 C-terminal peptide  
αs2-CN (f150-165)
a
  1,991.3  1,992.9  0P  Lys149-Lys150 Lys165-Lys166 
αs1-CN (f181-199)
a
  2,129.0  2,130.9  0P  Ser180-Asp181 C-terminal peptide  
αs1-CN (f180-199)
a
  2,216.5  2,217.7  0P  Phe179-Ser180 C-terminal peptide  
αs1-CN (f4-22)
a
  2,235.6  2,235.6  0P  Lys3-His4 Arg22-Phe23  
αs2-CN (f189-207)
a
  2,331.9  2,332.6  0P  Lys188-Ala189 C-terminal peptide  
αs1-CN (f4-23)
a
  2,382.3  2,383.0  0P  Lys3-His4 Phe23-Phe24  
αs1-CN (f1-21)
a
  2,460.4  2,461.6  0P  N-terminal peptide Leu21-Arg22  
αs1-CN (f4-24)
a
  2,529.4  2,529.6  0P  Lys3-His4 Phe24-Val25  
β-CN (f29-48)
a,b
  2,560.6  2,561.4  1P  Lys28-Lys29 Lys48-Ile49  
αs1-CN (f1-22)
a
  2,617.1  2,618.6  0P  N-terminal peptide Arg22-Phe23  
αs2-CN (f2-21)
b
  2,618.9  2,619.6  4P  Lys1-Asn2 Lys21-Gln22  
αs2-CN (f1-21)
a,b
  2,747.6  2,748.4  4P  N-terminal peptide Lys21-Gln22  
αs1-CN (f1-23)
a
  2,763.5  2,764.7  0P  N-terminal peptide Phe23-Phe24  
β-CN (f184-209)
a
  2,910.5  2,910.8  0P  Arg183-Asp184 C-terminal peptide  
αs2-CN (f1-24)
a,b
  3,132.9  3,133.3  4P  N-terminal peptide Lys24-Asn25  
β-CN (f1-25)
b
  3,122.9  3,122.6  4P  N-terminal peptide Arg25-Ile26  
β-CN (f1-27)
a,b
  3,349.4  3,350.1  4P  N-terminal peptide Asn27-Lys28  
β-CN (f1-28)
a,b
  3,478.4  3,478.4  4P  N-terminal peptide Lys28-Lys29  
β-CN (f1-29)
a,b
  3,606.6  3,607.7  4P  N-terminal peptide Lys29-Ile30  
β-CN (f1-32)
a,b
  3,977.0  3,977.5  4P  N-terminal peptide Lys32-Phe33  
a and b indicate the peptides identified in Figure 6a and 6b, respectively 
A high  number  of  peptides  belonging  to   the  β-CN,  αs2-CN  and  αs1-CN fractions were recorded in MALDI 
spectrum before enrichment (Figure 6a, Table 8). CPPs detected in the raw milk as well as in the other 
samples derived all from β-CN and αs2-CN (Figure 6b, Table 8). αs1-CN derived CPPs failed to form due to 
the internal location of the phosphorylation cluster. In contrast, they are released in long ripened cheeses 
(Ferranti et al., 1997). The most of peptides were released by PL-mediated hydrolysis of cleavage bonds 
containing N-terminal and C-terminal Lys or Arg. Other peptides with non-specific PL cleavage occurred 
probably because of the co-presence of active somatic cell proteinases. In order to verify the role played by 
proteolytic enzymes in CN hydrolysis, in vitro PL-mediated peptides were compared with those arose from 
raw milk (Figure 7).  
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* indicates the peptides detected also in the raw milk sample (Table 8) 
Figure 7. MALDI spectrum of peptides released by in vitro plasminolysis of bovine CN 
The choice of PL as the proteolytic enzyme depends on its role played during milk storage. In the PL digest 
(Figure  7),  there  are  many  peptides  detected  in  raw  milk  (Table  8),  including  β- and  αs2-CN CPPs that were 
released by PL. This agrees with the known activities of PL and other proteases associated with milk somatic 
cells. When CPP levels were higher than normal, milk was of poor quality because of higher activity of 
proteolytic enzymes.  
3.8.3 MALDI-TOF analysis of different commercial products  
The main objective of our work was to determine signature CPPs of heat-treated milk samples by using the 
HA-based procedure. 
Pasteurized, UHT, milk protein and milk powder samples were examined by MALDI-TOF and CPPs were 
enriched on HA. Similarly to raw milk, the major CPPs detected in raw milk were identified also in the other 
commercial milk samples (Figure 6b, Table 8). Moreover, our results showed that in all the milk samples, 
both native and lactosylated forms of  β-CN (f1-28)  4P  and  β-CN (f1-27) 4P were detected, except in raw and 
pasteurized milk (Figure 8).  
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Figure 8.  The  MALDI  spectra  show  mass  signals  of  β-CN derived CPPs enriched on HA microgranules for 
samples of pasteurized milk (a), UHT milk (b), milk protein powder (c), and milk powder (d). The spectra are 
zoomed in the the m/z values in the 3,200–3,950 Da mass range. Mono-lactosylated CPPs labelled with a red 
circle  correspond  to  β-CN (f1-27) 4P (m/z 3,675  Da),  β-CN (f1-28) 4P (m/z 3,803  Da)  and  β-CN (f1-29) 4P 
(m/z 3,931 Da).  
Therefore, none of these lactosylated CPPs occurred in the spectrum of pasteurized milk (Figure 8a). CPPs 
differed only in the level of lactosylation, which was extensive in milk powder, the most intensively treated 
sample. Milk powder contained all the  lactosylated  forms  of  β- and  αs2-CN derived CPPs as shown in Table 
9. 
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Table 9.  β- and  αs2-CN derived CPPs and relative lactosylated forms found in milk powder 
Measured mass (MH+) 
(Da) 
Expected mass 
(Da) CPP identification 
3,607.9 3,606.6 β-CN (f1-29) 4P 
3,931.2 3,930.8 β-CN (f1-29) 4P + 1 Lactose 
3,479.3 3,478.4 β-CN (f1-28) 4P 
3,803.3 3,802.9 β-CN (f1-28) 4P + 1 Lactose 
3,351.3 3,350.2 β-CN (f1-27) 4P 
3,675.2 3,674.5 β-CN (f1-27) 4P + 1 Lactose 
2,748.3 2,747.5 αs2-CN (f1-21) 4P 
3,072.5 3,071.8 αs2-CN (f1-21) 4P + 1 Lactose 
3,132.8 3,133.0 αs2-CN (f1-24) 4P 
3,459.3 3,457.9 αs2-CN (f1-24) 4P + 1 Lactose 
The  native  and  lactosylated  αs2-CN (f1-21) 4P co-exists in milk powder while the lactosylated forms of this 
CPP were not detected in the other samples.   We   have   identified   the   lactosylated   β-CN (f1-29) 4P as a 
signature CPP of milk proteins and powdered milk preparations because it was missing in raw, PM (Figure 
8a), intensely PM (121 °C for 2–4 sec) (spectrum not shown) and UHT milk (Figure 8b). It seemed that the 
level of lactosylation in milk was closely related to the intensity of the heating process. Thus, lactosylated 
CPPs may serve as suitable chemical markers of the intensity of heat treatment. 
The phosphorylation and lactosylation level of β-CN (f1-28) 4P was further confirmed by PSD-MS 
experiments (Figure 9). 
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Figure 9. PSD-MALDI-TOF-MS/MS  spectrum  of  lactosylated  β-CN (f1-28) 4P at m/z 3,802.9 Da exhibiting 
a prominent neutral loss of 340 Da (one lactosyl group) from the precursor ion at m/z 3,802.9 Da. Neutral 
loss of 98 Da (H3PO4) is consistent with a peptide containing 4 phosphate residues (A). PSD MALDI-TOF 
MS/MS spectrum shows the fragmentation of   lactosylated   β-CN (f1-28) 0P at m/z 3,483 Da after 
dephosphorylation. The signal at m/z 3,140.2 Da confirms the loss of one lactose group (B). 
The PSD spectrum of lactosylated β-CN (f1-28) 4P exhibited a prominent neutral loss of 340 Da (one 
lactosyl group) from the precursor ion at m/z 3,802.9 Da (Figure 9A). Moreover, the PSD spectrum of 
lactosylated β-CN (f1-28) 4P yielded a neutral loss of 98 Da (H3PO4), consistent with a peptide containing 4 
phosphoserine residues (Figure 9A). The  PSD  spectrum  of  lactosylated  β-CN (f1-28) 0P confirmed the loss 
of one lactose group (m/z 3,140.2 Da) from the peptide (Figure 9B).  
3.8.4  Quantification  of  β-CN (f1-28) 4P in raw milk by MALDI-TOF-MS 
Based on a set of naturally occurring peptides, β-CN (f1-28) 4P was chosen as it is the most abundant 
phosphorylated member that undergoes glycosylation during heat treatment. Specifically, a signature peptide, 
synthetic 25-residue analogue that was identical to the N-terminal 25-mer peptide except for the amino acid 
substitution Leu3 →  Trp3, was used as IS for the absolute quantification of the mono-lactosylated  β-CN (f1-
28) 4P (Table 7). The natural proteotypic peptide was mixed with IS in known concentrations and the 
MALDI intensity of the two co-occurring signals was measured (Figure 10).  
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Figure 10. MALDI spectra of natural and modified peptide β-CN (f1-25) 4P in four binary solutions 
containing indicated peptide ratios. MH+ 3,196.7 Da is molecular mass of the   β-CN (f1-25) 4P peptide 
containing the Leu3 →Trp3 modification; MH+ 3,478.6 Da is molecular mass of the  β-CN (f1-28) 4P natural 
CPP. 
MALDI measurements performed on four binary solutions containing natural peptide/IS ratios of 0.22/1, 
0.11/1, 0.055/1 and 0.0275/1 produced a line defined by the equation y= 6.2451x + 0.3635 (R2=0.9855) 
(mean  of  10  replicates).  Using  this  approach,  raw  milk  β-CN was found to have released ~4.3% of  the  β-CN 
(f1-28) 4P.  
3.8.5 Specific detection of lactosylated CPPs  
Raw milk is rejected by dairy processing plants whenever the sample is found to be contaminated with UHT 
or other heat-treated milk. The HA-based method could ensure that UHT milk and sterilized milk are not 
used for the production of pasteurized milk. To demonstrate this, aliquots of pasteurized milk were 
artificially spiked with 90, 70, 50, 30, 10, 5, or 1% UHT milk. The LOD was determined by MALDI 
searching for the  lactosylated  β-CN (f1-28) 4P, assumed as the signature CPP of UHT milk. The method did 
not discriminate UHT milk in amounts below 10%. 
Using improved MS equipment, in terms of mass resolution and sensitivity, the LOD could be substantially 
lowered. Trypsinolysis of HA-bound CPPs,   enhancing   the   signal   of   lactosylated   β-CN (f1-25) 4P, could 
further lower the LOD value. 
3.9 Conclusions 2 
Our results have shown that the extent of the casein lactosylation is a function of the heating intensity. 
Moreover, the ability to dynamically characterize lactosylation of CPPs can be regarded as a model for 
studying the accessibility of lactose to casein micelles. To detect lactosylated CPPs by MALDI analysis, both 
native and lactosylated CPPs have been concentrated on HA microgranules. This peculiarity makes the HA-
method able to detect low-abundance signature CPPs. Therefore, the results of our experiments have 
demonstrated that (i) native and lactosylated CPPs are equally bound to HA; (ii) CPPs have higher affinity 
for HA than non-phosphorylated peptides co-purifying with them using other methods; (iii) mono-
lactosylated β-CN (f1-28) 4P represents a distinct signature peptide that is detected distinctly from the native 
counterpart, making possible the detection of not less than 10% UHT milk spiking raw or pasteurized milk. 
However, the present procedure needs further signature peptides to distinguish thermized and pasteurized 
milks. Even with this limitation, the method could be applied at the molecular level to the design and control 
of any dairy product. 
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3.11 Topic 3: CPP profiling of Parmigiano Reggiano cheese at different ripening ages 
In the present work, CPP enrichment based on in-batch HA has been used for profiling CPPs from different 
varieties of cheese; particular attention has been given to the pH 4.6-soluble fraction of PR at different 
periods of ripening: 5, 15, 26 and 35 months (mo). The investigation has been mainly focused on CPPs 
derived from the enzymatic hydrolysis of cheese CN that are progressively shortened and dephosphorylated 
by the enzymes involved in ripening. Such profiles have greatly enabled us to characterize the proteolytic 
events that occur during ripening of brine-salted hard cheese. Moreover, the MALDI analysis of CPPs bound 
to HA allows the distinction of young PR cheeses (5- to 15-mo-old) from those aged more than 26-mo. 
3.12 Materials and methods 3 
3.12.1 Preparation of the pH 4.6-soluble fractions of cheese 
Samples of mold-ripened Gorgonzola (GR) (2-mo-old), semi-cooked Asiago d’Allevo (AA) (3-mo-old), 
semi-hard, pasta filata Provolone del Monaco (PMC) (6-mo-old) and grated PR cheese (5-, 15-, 26-, 30 and 
35-mo-old) (10 g) were suspended in 45 ml of 0.1 N HCl (Sforza et al., 2008). The suspension was 
homogenized for 1 min by an Ultra Turrax T50 (Janke & Kunkel IKA® Labortechnik, Staufen, Germany), 
adjusted to pH 4.6 with 1 M NaOH and then centrifuged at 4,000 x g for 10 min. After cooling, a thick layer 
of fat rose to the surface of the sample and was removed with the aid of spatula. The supernatant was filtered 
through filter paper; the resulting solution was adjusted to pH 7.0 with 1 M NaOH and freeze dried. 
3.12.2 HA-CPP enrichment from various cheese samples 
Lyophilized samples (10 mg) of the pH 4.6-soluble fraction of cheeses were dissolved in loading buffer (50 
mM Tris-HCl, 0.2 M KCl, 4.5 M urea and 10 mM DTT, pH 8.0) and enriched on HA (100 mg) as above 
described. The dried HA-CPP complexes were loaded on MALDI plate, covered with DHB (10 mg/ml) and 
analysed by MALDI as already described.  
3.12.3 LC-ESI-Q-TOF MS/MS analysis 
HA-bound CPPs (1 mg) were dissolved in a 5% aqueous PA solution (120 µL), desalted with a ZipTip C18 
pipette tip and analyzed using a CapLC nano-flow high-pressure pump system (Waters/Micromass, 
Manchester, UK) interfaced with a QTOF Micromass spectrometer (Waters/Micromass) operating in the 
positive ion mode. Chromatographic separations were performed on a reverse phase Atlantis dC18 capillary 
column  (75  µm  i.d.).  The  mobile  phase  was  water  (A)  and  ACN  (B)  with  0.1%  FA.  A  linear  gradient  from  
5% to 70% of B was applied to the pre-column and column over a 45-min period at a flow-rate of 
approximately 300 nl/min pre-column  splitting  using  a  pump  operating  at  5  µL  min−1. The source conditions 
were as follows: capillary voltage, 2.6 kV; cone voltage, 100 V; and RF1 lens, 40 V. Argon was used as the 
collision gas in the ESI-MS/MS experiments for peptide sequencing. Raw data were processed using 
MassLynx 4.0 ProteinLynx software. 
3.13 Results and discussion 3 
3.13.1 CPPs in a few cheese varieties  
A preliminary study was carried out on CPPs of pH 4.6 soluble fractions of GR, AA and PMC 6-mo-old 
cheeses. CPP fraction of hard PR (30-mo-old) was compared to cited cheeses; a further study was then 
carried out by comparing the enriched CPPs of 5-, 15-, 26- and 35-mo-old PR cheeses. 
Some CPPs enriched on HA were derived from the Lys-X or Arg-X cleavage by PL such as  β-CN (f1-28) 4P 
(Lys28-Lys29)   or   β-CN (f1-29) 4P (Lys29-Ile30),   αs1-CN (f61-79) 5P (Lys79-His80)   and   αs2-CN (f1-24) 4P 
(Lys24-Asn25). The native PL-derived CPPs were further hydrolyzed by cheese aminopeptidases and CPase 
into shorter peptides (Figure 11).  
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Figure 11. The MALDI spectra of CPPs isolated by the addition of HA to pH 4.6 soluble fractions of 
Gorgonzola (a), Asiago (b), Provolone del Monaco (c) and Parmigiano Reggiano (d) cheeses. The inset 
magnifies the m/z values in the lower molecular peptide mass range (0.8–4 kDa).  
The most abundant CPPs of GR, AA and PMC cheeses derived all from  the  peptide  β-CN (f1-28) 4P (3,478.4 
Da) (Figure 12).   β-CN (f1-28) 4P in AA cheese was the most abundant signal of the MALDI spectrum 
(Figure 11b and 12) and  it  results  partially  hydrolyzed  into  the  shorter  peptides  β-CN (f7-28)4P (2,708.5 Da), 
β-CN (f15-28)4P (1,869.7  Da)  and  β-CN (f17-28) 3P (1,589.6 Da).  
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Figure 12. Histogram representation of CPPs at 100% relative intensity and their performance in four 
cheeses.  
The   β-CN hydrolysis was particularly evident in PMC cheese made from raw milk for which the PL-
mediated  β-CN (f1-28) 4P peptide, representing ~0.1% of the CPPs, was almost completely hydrolyzed into 
the   shorter   peptides   β-CN (f11-28) 4P (2,341.1   Da),   β-CN (f12-28) 4P (2,212.0   Da),   β-CN (f11-25) 4P 
(1,985.7   Da)   and   β-CN (f12-25) 4P (1,856.6 Da) (Figure 11c and 12).   In   GR   cheese,   β-CN (f1-27) 4P 
(3,350.2 Da) was released from non-specific PL cleavage of the C-terminal Asn27-Lys28 bond (Figure 11a and 
12) or from the action of cheese CPases.  β-CN (f1-27) 4P was further hydrolyzed into the shorter  β-CN (f7-
27) 4P (2,580.4  Da),  β-CN (f10-27) 4P (2,270.0  Da),  β- CN (f12-27) 4P (2,083.8  Da)  and  β-CN (f15-27) 4P 
(1,742.4 Da). Profile of long ripened PR cheese CPPs was dissimilar from the other cheeses for its higher 
content  of  CPPs  derived  from  αs1-CN (f61-79) 5P;;  αs1-CN (f62-79) 5P (2,332.9 Da) was the most abundant 
CPP (Figure 11d and 12). In 30-mo-old PR, αs1-CN CPPs originated for the greater parts from the internal 
regions  of   the  amino  acid  sequence,  namely   from  αs1-CN (33-60) 3P  and  αs1-CN (61-79) 5P whereby they 
were released by a more intense proteolytic activity. In PR cheese, 23 CN-derived CPPs derived from the 
internal  region  of  αs1-CN, i.e. αs1-CN (f59-79) 5P, whereas they were not detected in AA (Figure 13). 
 
Figure 13. The number of CPPs derived  from  αs1-CN (f59-79) 5P in PR, PMC, AA and GR cheeses.  
The CPP profile depicts the mechanisms of both the proteolysis and dephosphorylation in a long ripened 
cheese.  αs1-CN (f61-79) 5P,  most  likely  arising  from  the  parent  peptide  αs1-CN (f1-79) 7P through cleavage 
at Met60-Glu61, was dephosphorylated and concurrently hydrolyzed into shorter peptides. Alkaline and/or 
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acid phosphatases acting on SerP residue dephosphorylated CPPs. N-terminal Ser was then exposed to 
aminopeptidase and released as a FAA. Bacterial CPase or exopeptidase such as cathepsin D/chymosin 
released αs1-CN (f61-74) 4P and other derived CPPs through cleavage at Asn74-SerP75. In PR aged 30 
months,  αs1-CN (f61-79) 5P (2,462.1  Da),  αs1-CN (f62-79) 5P (2,332.9  Da),  αs1-CN (f63-79) 5P (2,261.9 Da), 
αs1-CN (f64-79) 5P (2,132.8  Da),  αs1-CN (f64-79) 4P (2,052.8  Da),  αs1-CN (f65-79) 4P (1,965.7  Da),  αs1-CN 
(f62-74) 4P (1,681.3  Da),   αs1-CN (f64-74) 4P (1,481.2  Da),   αs1-CN (f64-74) 3P (1,401.2  Da)   and  αs1-CN 
(f65-74) 3P (1,314.1 Da) were the dominant CPPs (Figure 11d). Only 7 CPPs for PMC cheese and 11 CPPs 
for GR  were   derived   from  αs1-CN (f59-79) 5P among which the most abundant were αs1-CN (f61-79) 5P 
(2,462.1  Da)  and  αs1-CN (f61-74) 4P (1810.5 Da) (Figure 11a and c and 13).  
Considering  the  αs2-CN peptide, CPPs derived from the N-terminal  region  of  the  αs2-CN, i.e. αs2-CN (f1-24) 
4P. αs2-CN (f1-24) derived CPPs were similar in number but significantly different in the four cheese 
varieties (Figure 11a-d).  The  dominant  αs2-CN derived CPPs were  αs2-CN (f1-24) 4P (3,132.9  Da)  and  αs2-
CN (f1-21) 4P (2,747.6 Da) in AA cheese (Figure 11b).  The  most  abundant  αs2-CN derived CPPs were  αs2-
CN (f1-18) 4P (2,355.1  Da)   for  PM  and  αs2-CN (f6-18) 4P (1,751.4 Da), a shortened form of the primary 
CPP  αs2-CN (f1-18) 4P, for GR cheese (Figure 11a and c).  αs2-CN (f7-18) 4P (1,614.3 Da)  and  αs2-CN (f8-
18) 4P (1,515.1 Da) characteristically accumulated in PR cheese (Figure 5d). This means that a more extent 
proteolysis of casein fractions characterized the PR cheese. The CN hydrolysis became more evident when 
the chymosin retained in the cheese was largely inactivated by cooking the curd at high temperatures (~55 
°C). The CN proteolysis by chymosin was covered by that of PL, which becames the principal proteolytic 
enzyme in the cheese. The presence and integrity of PL-mediated products of CN was a function of the milk, 
whether raw or pasteurized. Pasteurization reduced the milk PL activity only by ~15 percent, whereas PL 
activity increased during milk storage. Heat treatments modified the peptide profile by increasing the content 
of larger peptides and the shorter CPPs accumulated in long-ripened cheeses made from raw milk. 
Considering exclusively the CPPs with molecular mass between 3,000 and 3,500 kDa, the intensity of longer 
CPPs characterized the MALDI spectra of AA and GR cheese; these peptides were further transformed into a 
number of progressively lower molecular weight CPPs (Figure 11). In long ripened cheeses, a significant 
accumulation of shorter peptides containing the multi-phosphorylated motif -SerP-SerP-SerP-Glu-Glu-, more 
resistant to proteolytic enzymes, were observed. Moreover, a heterogeneous CPP pattern also differentiated 
the cheese samples within a given form because of the phosphatase gradient amongst peripheral and central 
parts of the GP cheese form (3 105 vs. 3 102) (Pellegrino et al, 1997). This means that eating PR cheese 
increases the quota of the co-ingested mineral bound CPPs. Milk, ice cream and cheese have been observed 
to lower the incidence of dental caries in rats (Shaw et al., 1959) but the best results came out by eating 
cheese several times per week for the higher caries-protective effect (Papas et al., 1995).  
3.13.2 β-CN derived CPP proteolysis in PR cheeses at different age of ripening 
Most CPPs detected in milk, as discussed above, had C-terminal Lys, suggesting  the  PL  activity.  β-CN and 
αs2-CN were the   preferred   substrates   of   PL,   whereas   αs1-CN   and   κ-CN were resulted more resistant to 
enzyme digestion. In particular, β-CN, the CN fraction more affected by proteolysis, can be converted into 
pH 4.6-insoluble γ-CN and complementary soluble PP.  The  γ-CN detected by IEF analysis of cheese samples 
at 4- and 34-mo of ripening were considered good markers for GP ripening (Restani et al., 1996). Moreover, 
the   concentration   of   β-CN rapidly decreased during the first 15 mo until reaching a plateau; it was still 
detectable in 22-mo-old samples (Gaiaschi et al., 2001). These results seems to conflict with previous results 
on CN proteolysis indicating that β-CN degradation was completed within one year of PR cheese ripening 
(Addeo et al., 1988) while they are consistent with subsequent findings according to which low levels of β-
CN still remained intact in the 24-mo-old PR cheese (Addeo et al., 1995). Moreover, a trend inverse to that β-
CN  was  observed  for  γ1-CN  and  β-CN (f30-209), whose concentration increased until the 15-mo of ripening, 
and  for  γ2-CN  and  γ3-CN, whose production was greater between 15-mo and 22-mo (Gaiaschi et al., 2001). 
Previous results (data not published) have showed that the pH 4.6-insoluble N fraction represented 
approximately 70% (w/w) of defatted and freeze dried cheese for ripened 4- and 8-mo GP. After 14-38 mo, 
this fraction decreased to 50-55%, which indicated that CN fractions gave rise to an increased level of pH 
4.6-soluble N compounds.  
The analysis of HA-enriched CPPs of 5-, 15-, 26- and 35-mo-old PR samples has allowed to observe a 
progressive increase in the relative number of CPPs of mass ranged from 900 to 4,000 Da with aging. 
Approximately, 68% of β-CN derived CPPs occurring in the 5-mo-old PR cheese decreased to approximately 
58%, 45% and 39% in the 15-, 26- and 35-mo-old PR cheeses, respectively. Moreover, MALDI spectra 
showed that the profiles of β-CN  and  αs1-CN derived CPPs were very different after enrichment on HA, in 
the different samples (Figure 14). In the MALDI spectrum of 5-mo-old PR cheese, the majority of signals 
was associated to CPPs derived from β-CN (f1-28) 4P (3,479.4  Da)   and   β-CN (f29-57) 1P (3,570.5 Da) 
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(Figure 14, pink arrows). These MALDI signals lowly decreased in both number and intensity with increased 
ripening time (Figure 14, pink arrows). 
 
Figure 14. Comparison of different MALDI spectra recorded in the mass range of 0.9–4 kDa for cheese 
samples. Pink arrows indicate the most abundant signals of β-CN (f1-28) 4P derived CPPs and green arrows 
the most abundant signals of αs1-CN (f61-79) 5P derived CPPs in PR cheese at 5-, 15-, 26- and 35-mo of 
ripening. 
In 5- and 15-mo-old PR cheese samples, the degradation products of β-CN were more abundant than those 
derived from αs1-CN whereas an inverse trend was observed in the 26- and 35-mo-old PR samples (Figure 
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14). These findings are consistent with previous results indicating that 80% of β-CN was hydrolyzed within 
the first year of ripening; afterwards the hydrolysis rate decreased. Moreover, a 15% of β-CN was further 
hydrolyzed within 30-mo of ripening, whereas 5% of the residual β-CN remained in the older GP cheeses 
(not shown data).  
Eight PP, including two PP5 and two PP8 slow, raised from the two most common genetic variants, β-CNA1 
and A2, were identified in the semi-hard Herrgard cheese. In addition to these peptides, novel CPPs such as 
β-CN (f29-96) 1P, (f30-97) 1P, (f29-93) 1P and (f30-93) 1P, in the two β-CN A1 and A2 variants, 
accumulated in the Herrgard cheese (Ardö et al., 2007). After enrichment of CPPs from pH 4.6-soluble 
fraction of 5-mo-old PR cheese, some CPPs were shorter than those found in the semi-hard Herrgard cheese, 
suggesting the enzymatic cleavage of the Ser57-Leu58, Phe52-Ala53, Asp43-Glu44, Gln40-Thr41, Gln39-Gln40 
peptide bonds (Figure 15), some of which were also detected in 6-mo-old Beaufort cheese (Dupas et al., 
2009).  
 
 
Figure 15. Amino acid sequence of the CPPs found in the 5-mo-old PR cheese aligned with that of β-CN (f1-
57) 5P. The purple horizontal bar indicates CPPs derived from β-CN (f1-28)4P and the yellow bar indicates 
CPPs derived from β-CN (f29-57) 1P. The red shaded residue is a phosphoseryl residue. 
The major CPPs, derived from β-CN (f29-57) 1P, were hydrolyzed in cheeses older than 5-mo. 
The degradation mechanism of β-CN (f1-28) 4P in the different PR samples is similar to that found in GP 
(Ferranti et al., 1997) and involved the intervention of aminopeptidases to remove neutral amino acid from 
the N-terminus of oligopeptides as suggested by Roudot-Algaron (Roudot-Algaron et al., 1994). CPPs are 
shortened by the sequential removal of the phosphate group from the N-terminal SerP by phosphatases and 
the neutral Ser residue by aminopeptidases. The results obtained in the present study are not consistent with 
those from 6-mo-old Beaufort cheese that showed also CPPs with dephosphorylated residues in the internal 
positions of the peptide chain (Dupas et al, 2009). The dephosphorylation mechanism of Fiore Sardo CPPs 
was also different from that found, most likely due to the use of different rennet types (Pirisi et al., 2007). In 
PDO Fiore Sardo cheese, no apparent difference in susceptibility to dephosphorylation was found amongst 
the differently located SerP peptide residues. This resulted in the simultaneous occurrence of partly 
dephosphorylated peptides, either internally or externally. Moreover, β-CN (f16-22) 3P (978 Da) was the 
most abundant CPP in 38-mo-old ripened cheese (Ferranti et al., 1997), consistent with results from 24-mo-
old PR cheese using the IMAC procedure (Lund & Ardö, 2004). Conversely, in MALDI spectrum of HA-
enriched CPPs from 35-mo-old  PR  cheese,  β-CN (f16-22) 3P was most  intense  signal  among  β-CN derived 
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CPPs   but   lower   than   that   of   CPPs   derived   from   αs1-CN (f59-79) 5P (Figure 14). A comparison of CPPs 
derived  from  β-CN (f1-28) 4P, isolated from the pH 4.6-soluble fractions of 5-, 15-, 26- and 35-mo-old PR 
cheese, is shown in Table 10.  
Table 10.  Comparison  of  CPPs  derived  from  β-CN (f1-28) 4P detected in PR cheese at different ages. 
β-CN (f1-28) 4P derived CPP 
Measured mass 
MH+ 
Ripened PR 
5 mo-old 15 mo-old 26 mo-old 35 mo-old 
978.4 not detected (n.d.) β-CN (f16-22) 3P 
1,065.3 n.d. n.d. n.d. β-CN (f15-22) 3P 
1,192.4 n.d. β-CN (f16-24) 3P 
1,155.7 β-CN (f17-25) 2P 
1,235.6 β-CN (f17-25) 3P 
1,348.6 β-CN (f16-25) 3P 
1,435.7 β-CN(f15-25) 3P 
1,516.0 β-CN(f15-25) 4P 
1,857.2 β-CN (f12-25) 4P 
2,467.3 n.d. n.d. β-CN (f6-25) 4P 
2,838.3 β-CN (f3-25) 4P 
3,123.0 β-CN (f1-25) 4P 
1,575.0 β-CN (f16-27) 3P 
1,743.0 β-CN (f15-27) 4P 
2,084.8 β-CN (f12-27) 4P 
2,501.4 n.d. β-CN (f7-27) 3P 
2,581.6 n.d. β-CN (f7-27) 4P 
1,423.8 n.d. β-CN (f18-28)2P n.d. β-CN (f18-28) 2P 
1,591.2 β-CN (f17-28) 3P 
1,703.9 β-CN (f16-28) 3P 
1,791.7 β-CN (f15-28) 3P 
1,871.6 β-CN (f15-28) 4P 
1,999.7 β-CN (f14-28) 4P 
2,099.3 β-CN (f13-28) 4P 
2,213.1 β-CN (f12-28) 4P 
2,342.0 β-CN (f11-28) 4P 
2,399.2 β-CN (f10-28) 4P n.d. n.d. 
2,594.0 β-CN (f8-28) 4P n.d. 
2,709.6 β-CN (f7-28) 4P 
2,951.4 β-CN (f5-28) 4P n.d. 
3,080.7 β-CN (f4-28) 4P 
3,479.5 β-CN (f1-28) 4P 
2,470.2 β-CN (f11-29) 4P n.d. 
3,208.7 β-CN (f4-29) 4P n.d. 
3,607.9 β-CN (f1-29) 4P n.d. n.d. n.d. 
The  accumulation  of  β-CN (f16-22) 3P with PR cheese ripening  time  was  parallel  to  the  proteolysis  of  αs1-
CN  that  proceeded  more  quickly  than  that  of  β-CN. Moreover,  β-CN (f15-22) 3P (1065.3 Da) was detected in 
only 35-mo-old PR cheese (Table 10). Only a   few   longer   CPPs,   including   β-CN (f1-28) 4P, were still 
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detectable in 35-mo-old cheese as their degradation proceeded more quickly than their formation. However, 
because phosphorylation affects the proteolysis kinetics of cleavage sites proximal to the site of 
phosphorylation (Schlosser et al., 2001), multi-CPPs occurred with an increased frequency. Despite this, no 
specific marker of age has been found for PR cheese.  
3.13.3  αs1-CN-derived CPP proteolysis in PR cheeses at different age of ripening 
The fragment αs1-CN (f1-23)  and  its  complementary  fragment  αs1-I-CN (McSweeney et al., 1993) are mainly 
released from chymosin and then are further degraded by the cell wall proteinases of LAB (Fox & 
McSweeney, 1996). Chymosin plays an important role in the early stages of cheese making but it is rapidly 
denatured  when  the  PR  curd  is  heated  to  55  °C.  The  concentration  of  αs1-I-CN was very high during the first 
4-mo of ripening and then gradually decreased (Gaiaschi et al., 2000).  Moreover,  αs1-CN (f35-199)  and  αs1-
CN (f80-199) peptides released by PL action on the peptide bonds located between the Lys34-Glu35 and 
Lys79-His80 were found in GP and PR cheese as well as in other cheese varieties (Gaiaschi et al., 2000). The 
αs1-CN (f35-199) concentration was similar in all ripening cheeses until 22-mo as a result of the balance 
between   its   formation   and   its   breakdown   to   shorter   peptides.   The   increase   of   αs1-CN (f80-199) during 
ripening suggested a greater resistant to further proteolysis by endo and exopeptidases, even after 24 mo of 
ripening (Addeo et al., 1995; Gaiaschi et al., 2000). Cheese endoproteases were able   to  cleave  αs1-I-CN in 
three internal bonds such as the Phe32, Met60 and Lys79 residues releasing peptides such as (f33-60) 3P and 
αs1-CN (f61-79) 5P. Many CPPs  derived   from  αs1-CN (f61-79) 5P were captured by HA in PR cheeses of 
different  ages.  The  percentages  of  αs1-CN CPPs progressively increased from 12% to 18% in the 5- and 15-
mo-old PR cheese until a plateau reached at 35% and 36% in the 26- and 35-mo-old PR cheeses, 
respectively.  Thus,  the  most  abundant  MALDI  signals  were  associated  with  αs1-CN derived CPPs in the 26- 
and 35-mo-old PR samples (Figure 14, green arrows).  Therefore,  the  degradation  of  αs1-CN proceeded faster 
than that of β-CN, starting from 26-mo of ripening. 
The sequences of some CPPs derived from β-CN and αs1-CN were confirmed by LC-ESI-QTOF MS/MS as 
follows (Figure 16). 
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Figure 16. MS/MS analysis of the precursor ion at MH+=2,466.9, corresponding to β-CN (f6-25) 4P, 
identified in PR cheese samples at 26- and 35-mo of ripening and of selected precursor molecular ion at 
MH+= 2,133.3  Da,  corresponding  to  αs1-CN (64-79) 5P, identified in all the PR cheese samples. The mass 
loss of 98 Da corresponds to a phosphate group (H3PO4) so that this neutral loss value could be used to 
deduce the presence of a serine phosphate in the peptide chain. pS = phosphoserine residue. 
The mass losses of 98 Da from the terminal Y ion series were detected by analysis LC-ESI-Q-TOF MS/MS 
analysis, indicating the presence of serine phosphate in the peptide chain (Figure 16). 
The amino acid sequences of αs1-CN CPPs  are  aligned  to  that  of  the  parent  peptide  αs1-CN (f59-79) 5P and 
compared in the different samples of PR cheese (Figure 17).  
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Figure 17.  The  amino  acid  sequences  of  the  CPPs  aligned  with  that  of  αs1-CN (f59-79) 5P were compared in 
pairs, i.e. 5- and 15-, 15- and 26-, 26- and 35-mo-old PR cheese samples. The light blue horizontal bar 
indicates CPPs present in the samples and the green bar indicates those specific for PR cheese. The red 
shaded box indicates a phosphoseryl residue.  
αs1-CN (f61-79) 5P resulted differently hydrolyzed in 5-, 15- and 26-mo-old cheeses. Only three CPPs 
derived  from  αs1-CN (f61-79) 5P were actually found in the 5-mo-old PR cheese while CPPs  such  as  αs1-CN 
(f65-79) 4P,  αs1-CN (f64-79) (5P and 4P),  αs1-CN (f65-74) 3P and αs1-CN (f64-74) (4Pand 3P) were present 
in the 15-mo-old PR cheese (Figure 17). The formation of αs1-CN (f67-79) 3P (1,686.6  Da),  αs1-CN (f71-79) 
1P (1,094.2 Da), αs1-CN (f64-74) 2P (1,321 Da), αs1-CN (f66-74) 3P (1,201.1 Da) and  αs1-CN (f67-74) 2P 
(1,034.7 Da) in 26- and 35-mo-old cheeses may be ascribed to both proteolysis and dephosphorylation of the 
αs1-CN (f61-79) 4P peptide (Figure 17). Our results showed that longer PL-mediated peptides were degraded 
into shorter CPPs. No significant difference in the  proteolytic  patterns  of  αs1-CN (f59-79) 5P derived CPPs 
was observed between 26- and 35-mo-old PR when the accumulation of shorter CPPs plateaued. In 
particular,  the  signals  of  CPPs  such  as  αs1-CN (f65-74) 3P (1,314.7  Da)  and  αs1-CN (f64-74) 3P (1,401.9 Da) 
were the most intense in the MALDI spectrum of 35-mo-old  PR  cheese,  whereas  αs1-CN (f64-79) 5P (2,134.1 
Da)  and  αs1-CN (f62-79) 5P (2,334.1 Da) were the most intense in the 26-mo-old PR cheese (Figure 14). The 
amino acid sequences of accumulated CPPs were shorter for cheeses ripened for a long period of time, such 
as 35-mo-old PR cheese, at the expense of CPPs with longer amino acid sequences (Figure 14). This explains 
why the short-sequence  CPPs  such  as  αs1-CN (f67-74) 2P (1,034.7  Da)  and  αs1-CN (f66-74) 3P (1,201.1 Da) 
were well detected in 35-mo-old PR cheese. In contrast, same signals were found only by expanding the view 
of the m/z region in the MALDI spectrum of the 26-mo-old PR cheese (Figure 14).  
The different PR cheese samples contained similar percentages   of   CPPs   derived   αs2-CN (f1-24) 4P. For 
instance,   the   αs2-CN (f8-18) 3P   peptide,   one   of   the   shorter   αs2-CN CPPs, was found in all samples but 
variable rates of hydrolysis were observed for its conversion in shorter peptides.  
Our procedure has allowed to confirm that αs2-CN is more resistant to enzymes than αs1-CN and β-CN, unlike 
what was previously reported for milk. Furthermore, according to data available in the literature, no 
significant hydrolytic difference was measured for the hydrolysis of hydrophobic 1-105 fragment (para-κ-
CN) and water-soluble (glycomacropeptide, GMP) in the cheeses (Green & Foster 1974). This resistance to 
proteolysis   reflects   the   relatively   high   level   of   secondary   structure   in   κ-CN compared with the other CN 
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fractions (Swaisgood, 1992). In conclusion, the susceptibility of cheese CN fractions to hydrolysis proceeds 
at a decreasing rate according to the order β- >  αs1- > αs2-CN > κ-CN. 
3.14 Conclusions 3 
Patterns of CPP proteolysis are resulted comparable in the different varieties of bovine cheese, which 
indicated that mechanisms of formation and degradation of CPP are similar regardless of the cheese variety. 
However, ingested cheese carries an amount of pH 4.6 soluble CPPs variable according to the cheese. The 
rate of proteolysis and dephosphorylation of cheese CN could be a function of the milk, whether raw or 
pasteurized. In the milk made from raw milk, longer CPP were further hydrolyzed in shorter CPP. Moreover, 
the  presence  of  relatively  few  β-CN-derived CPPs of the various sizes and the low number of αs1-CN derived 
CPPs in PMC could be the effect of the enzyme decline from the optimum level of enzyme activity to zero 
activity. αs1-CN derived CPPs whose phosphorylated residues are hidden in the inner part of the sequence 
accumulated especially in long ripened PR. These CPPs failed to form in milk and began to form in very low 
amounts in young cheeses; conversely their amount increased with aging (Figure 14). Therefore, the different 
profile of CPPs could derive from the cheese variety and from the different length of ripening. The extent of 
proteolysis in a long ripened cheese depends on the enzymatic activity available as result of autolysis of 
starter or non-starter LAB and indigenous milk enzymes, especially PL. The latter has been recognized as the 
main  endoprotease  responsible  for  CN  degradation  of  hard  cheeses.  In  commercial  milks,  αs1-,  αs2-,  β- and  κ-
CN were preferentially hydrolyzed based on their affinity for PL according to the decreasing order:  β- >  αs2- 
> αs1- >  κ-CN. This affinity is quite different in PR cheese, where αs1-CN was hydrolyzed at higher amounts 
than αs2-CN, according to this different order: β- >  αs1- > αs2- >  κ-CN. This is particularly evident in CPP 
profiling of the 5- to 35-mo-old cheeses using enrichment on HA. Many CPPs derived from β-CN (f29-57) 
1P were detected in 5-mo-old PR cheese but they decreased or disappeared with aging (Figure 15). On the 
contrary, fewer αs1- and αs2-CN derived CPPs were detected in the younger PR cheese samples. This may 
indicate   that   β-CN   is   degraded   within   15   mo   of   ripening   faster   than   αs1-CN   and   αs2-CN, resulted more 
resistant   to   proteases.   In   contrast   to   αs2-CN-derived CPPs, a higher number of αs1-CN derived CPPs were 
frequently observed in 26- to 35-mo-old  cheeses.  Moreover,  shorter  length  αs1-CN  and  β-CN derived CPPs 
accumulated in the 35-mo-old cheese (Figure 14). Therefore, the MALDI profiles of CPPs from 5- or 15-mo-
old PR cheeses are very distinct from those of 26- or 35-mo-old PR cheeses.  
Notwithstanding the chromatographic procedure was ultimately unable to identify age-dependent signature 
CPPs in the pH 4.6-soluble fraction of PR cheese, it would be useful to distinguish between younger cheese 
(up to 15-mo) from that older than 26 mo. Perhaps separate profiles from the rind and core of younger and 
older cheeses would further help to find signature peptides as well as profiling the much more abundant non-
CPPs could be useful to detect age-dependent signature peptides. 
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3.16 Topic 4: Milk speciation through the monitoring of proteotypic CPPs 
Our strategy has combined direct MALDI-TOF-MS analysis and signature CPPs extracted from HA-CPP 
complexes to quantify species-specific casein peptides. Tryptic CPPs such as B β-CN (f1-25) 4P and WB β-
CN (f1-28) 4P have been identified and then used as markers of bovine milk contaminating water buffalo 
milk. The method provides an alternative analytical means for detecting adulterated milks/cheeses with 0.5% 
LOD. The analysis of Mozzarella cheese real tests has allowed to detect the percentage of B milk 
fraudulently added to WB milk in the production of marketed cheese.  
3.17 Materials and methods 4 
3.17.1 Milk and cheese samples 
Water buffalo and bovine milk samples were taken from herds located within the Campania region of Italy. 
Mixtures of WB milk containing 25%, 12.5%, 6.2%, 3.12%, 1.56% and 0.78% B milk (v/v) were prepared 
on a laboratory scale by weighing the exact amount of milk (~100 g final weight) to ±0.01 g for higher 
volumes and to ±0.001 g for lower volumes. Reference casein samples were obtained by isoelectric 
precipitation, according to the procedure described by Aschaffenburg & Drewry (Aschaffenburg & Drewry, 
1959), from skimmed milk by centrifuging at 4,500 x g for 10 min. The protein concentration in the samples 
was preliminarily determined by the Biuret method according to Bradford (Bradford, 1976) using a protein 
assay dye reagent (Bio-Rad, Hercules, CA).  
The extraction of CN from Mozzarella cheese was carried out according to the Official Journal of the 
European Communities (L 37/54, 7.2.2001). Dry mass of cheese (5 g) was suspensed in distilled water and 
homogenized for 1 min by an Ultra Turrax T50 (8,000 to 10,000 rpm). Suspension pH was adjusted to 4.6 
with diluted acetic acid and centrifuged (3,000 x g for 5 min). The pellet was washed with distilled H2O (40 
ml) and dichloromethane (20 ml), homogenized again and centrifuged (3,000 x g for 5 min). After removal of 
the CN layer that lies between the aqueous and organic phases with a spatula, both phases were decanted off 
and the procedure was repeated until both extraction phases were colourless (two to three times). The protein 
residue homogenized with acetone (50 ml) was allowed to dry in the air or a stream of nitrogen and then 
finely to pulverize in a mortar.  
3.17.2 Plasminolysis of milks in mixture and B and WB casein in ratio 1:1 
Milk mixtures (1 ml) were added to an equal volume of 0.2 M NH4HCO3 (pH 8.0); the resulting solutions 
were shaken on   a   vortex   for   few   seconds   and   then   allowed   to   stand   for   5   min.   A   500   µL   aliquot   was  
transferred to a plastic culture tube (15 mm × 10 mm), 10 µl   of 5 U ml-1 PL suspension was added 
(Boehringer; Mannheim, Germany) and the mixtures were incubated for 1 h in a water bath holder at 37 °C. 
An equal volume of 24% TCA (w/v) was added and the protein pellet was recovered by centrifugation for at 
4,500 x g 10 min at  room  temperature.  The  precipitate  was  solubilised  by  the  addition  of  9  M  urea  (250  µL).  
B and WB casein  (100  mg)  in  ratio  1:1  were  dissolved  in  2  ml  of  50  mM  AMBIC  at  pH  8.5  with  10  µl  of  PL  
suspension. After 4 h of incubation at 37 °C, the peptides were precipitated with TCA (12% final 
concentration), the supernatant was discarded and the pellet was washed (× 3 times, 1 ml) with dry acetone 
that had been kept at -20 °C. After each wash, the supernatant was discarded and the pellets were washed 
with diethyl ether (× 2.2 ml). Finally, the peptides were air-dried in a ventilated hood and kept at -20 °C until 
analysis. The PL-mediated peptides dissolved in a solution of 50% ACN and 0.1% TFA (1 mg/ml) from B 
and WB casein (1:1) were analysed by ESI-Q-TOF-MS and by MALDI-TOF before after enrichment as 
above described. 
3.17.3 Semi-preparative isoelectric focusing of CN plasminolysate 
Isoelectric focusing on ultra-thin-layer polyacrylamide isoelectric focusing gel (UTLIEF) was carried out 
according to the European reference method of analysis (Commission Regulation No 273/2008). The gel 
composition and pH gradient were the same for this apparatus and the PhastSystem apparatus (Moio et al., 
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1998). After migration, the gel was stained using CBB according to the procedure of Neuhoff et al. (Neuhoff 
et al., 1988). 
3.17.4 Peptide extraction from the gel bands and identification by MS 
Gel bands were cut with a razor blade within 24 h from CBB-stained UTLIEF polyacrylamide gels. Excised 
spots were disengaged from the polyester backing and destained by the addition of 50% ACN (ACN/H2O = 
50/50, v/v) with 1 h of shaking. The coloured supernatant was discarded and the process was repeated until 
the  supernatant  was  almost  colourless.  After  washing  twice  in  100  µl  of  distilled  water  for  15  min,  each  gel  
piece was suspended in 0.25 mM AMBIC at pH 8.0 and stored at -20 °C overnight. An equal volume of ACN 
0.1% TFA was then added and sonication was carried out for 1 h. The suspension was centrifuged at 12,000 
x g for 1 min at 4 °C and the supernatant transferred to a new, clean vial. After SpeedVac drying to half of 
the initial volume, the sample was directly analyzed by LC-ESI-Q-TOF-MS as described above. The 
molecular  mass  distributions  of  peptides  in  different  spot  hydrolysates  were  searched  against  the  WB  β-CN 
sequence (Q9TSI0) using FindPept tools available at www.expasy.ch. 
3.17.5 Calibration  curve   for  B  β-CN (f1-25)  and  WB  β-CN (f1-28) peptides by using known quantities of 
WB and B CN in mixtures 
WB casein containing 50%, 6.2%, 3.12%, 1.56% and 0.78% B CN (10 mg) and later CN isolated from 
Mozzarella cheese (10 mg) were adsorbed to microgranular HA (100 mg) previously equilibrated with the 
loading buffer (50 mM Tris-HCl, 0.2 M KCl, 4.5 M urea and 10 mM DTT, pH 8.0). After washing, the dried 
HA-bound CN/CPP trypsinolysis was performed in situ as described above. The HA-CPP complexes were 
deposited  onto  the  MALDI  plate,  covered  with  the  matrix  solution  (0.5  µL)  containing  10  mg/mL  DHB  in  
H2O/ACN/PA (49:50:1), which that promote co-crystallisation by air-drying at room temperature. The 
MALDI spectra were recorded as above. 
The  calibration  curve  was  obtained  by  plotting  the  bovine  β-CN (f1-25) 4P  and  water  buffalo  β-CN (f1-28) 
4P ratio against the composition of adulterated WB milk. 
3.18 Results and discussion 4 
3.18.1 Analysis  of  β-CN plasminolysate in bovine and buffalo water species 
The  B  and  WB  β-CN fractions are both very sensitive to hydrolysis by PL. The  primary  cleavage  sites  in  B  β-
CN are Lys28-Lys29, Lys105-His106 and Lys107-Glu108, cleavage of which leads to the formation of C-terminal 
polypeptides,   β-CN (f29-209) (γ1-CN),   β-CN (f106-209) (γ2-CN),   β-CN (f108-209) (γ3-CN),   β-CN (f1-
105/107) (PP  5),  β-CN (f29-105/107) (PP 8-slow)  and  β-CN (f1-28) (PP 8-fast) as indicated in Figure 18. 
Additional cleavage sites include Lys113-Tyr114 and Arg183-Asp184,  that  give  rise  to  β-(f114-209)  (γ4-CN) and 
β-CN (f184-209)  (γ5-CN), respectively (O'Malley et al., 2000).  β-CN (f69-209), called γ4-CN and originated 
from the early hydrolysis of Lys68-Ser69 bond  of  WB  β-CN by PL, has no counterpart in B milk (Trieu-Cuot 
& Addeo, 1981; Somma et al., 2008; Di Luccia et al., 2009). 
 
65 
 
 
Figure 18.   Amino   acid   sequence   of   bovine   (B)   and   water   buffalo   (WB)   β-CN. Arrows indicate bonds 
sensitive   to   plasmin.   γ1,   γ2,   γ3, B and WB γ4 and γ5 are   γ-CN. The red letters are amino acid residues 
differentiating  β-CN of two species. The green bar indicates PP8-fast; the purple bars indicate the two PP5, 
the blue ones the two PP8-slow. 
In a recent work, a plasminolysate of B and WB casein was analyzed by ESI-Q-TOF-MS (Figure 19) (Addeo 
et al., under review). 
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Figure 19. Partial view of the ESI-Q-TOF-MS spectra for the PL-mediated B (Panel a) and WB (Panel b) 
casein hydrolysate. 
Two   intense   ion   signals   (γ2-CN   and   γ3-CN) were detcted in both species while γ4-CN was exclusively 
observed in WB sample; the Asn68→Lys68 substitution   occurring   in   the   sequence   of  WB   β-CN added a 
further site of PL cleavage. The quantification of γ4-CN by MALDI-TOF MS has been used for the detection 
of B CN in WB Mozzarella cheese (Angeletti et al., 1998). Therefore, γ4-CN can be considered a molecular 
marker of the presence of water buffalo CN in any dairy product (Somma et al., 2008). 
Different methods for the detection of foreign milk involve the use of CN, a more useful indicator than heat-
sensitive whey proteins. The IEF-based method is the European reference that allows the distinct detection of 
B   and   WB   γ2- and   γ3-CN (Commission Regulation No 273/2008). PL hydrolysis of WB CN has been 
previously demonstrated to release a peptide comigrating with B γ2-CN. The occurrence of this peptide may 
lead to false-positive detection of cow’s milk for a genuine WB cheese if it is analyzed by applying a fast 
version of the European official method (Addeo et al., 2009). 
Reference samples of B (lane 1) and WB CN (lane 8) and WB milk in mixture with different % B milk (lanes 
2-7) were submitted to PL action. The separation by fast isoelectric focusing (FIEF) on mini-gel of PL-
mediated peptides is shown in Figure 20. 
 
Figure 20. Isoelectric focusing on a PhastSystem apparatus of PL-mediated peptides of WB milk in mixture 
containing 25% (lane 2), 12.5% (lane 3), 6.2% (lane 4), 3.12% (lane 5), 1.56% (lane 6) and 0.78% (lane 7) B 
milk (v/v). Reference samples of bovine (lane 1) and water buffalo whole CN (lane 8) are analysed on the 
same  gel.   Staining  has   been   carried   out  with  CBB.  The   faint   bands  at   similar   pI   of   bovine   γ2-CN in pure 
water buffalo milk have been highlighted and the peptides extracted by gel bands have been identified by 
LC-ESI-Q-TOF-MS. 
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Two faint bands migrated at   similar   pI   of   B   γ2-CN in pure WB milk, leading to false-positive detection. 
Direct LC-ESI-Q-TOF-MS analysis  of  peptides  extracted  by  two  bands  has  allowed  the  identification  of  β-
CN (f100-209)  and  β-CN (f69-209) in upper  band  and  γ2,  β-CN (f69-209),  β-CN (f106-176)  and  β-CN (f106-
188) in the lower band (Figure 20).  The  additional  peptides  β-CN (f106-176)  and  β-CN (f106-188) derived 
from  the  internal  cleavages  of  WB  γ2-CN. For this reason, an immunoblotting procedure based on the use of 
specific antipeptide antibody has been suggested as “gold standard” method in order to assurance WB milk 
purity and cheese genuineness (Addeo et al., 2009). Moreover, recently, the use of MALDI-TOF-MS has 
been suggested for confirmatory analysis. MALDI-TOF MS analysis of the tryptic digests of single-species 
defatted milk has allowed to detect the αs1-CN (f8-22) proteotypic peptide characterized by different 
molecular masses in the several species (1,686.9 Da in WB, 1,759.1 Da in B and 1,718.9 in ovine milks) 
(Cuollo et al., 2010). αs1-CN (f8-22) resulted an excellent signature peptides able to differentiate B, ovine and 
WB milks (Cuollo et al., 2010). 
The MALDI analisys of PL-mediated peptides from a mixture of B and WB casein (1:1) showed different 
possible candidate proteotypic peptides before and after enrichment on HA (Figure 21).  
 
Figure 21. MALDI spectra of plasminosate containing water buffalo (WB) and bovine (B) CN in equal 
amounts before A) and after B) enrichment on HA. The identification of non-CPPs A) and CPPs B) couples 
from the two species is reported. 
Proteotypic CPPs can be used as marker for B and WB milk only after enrichment for the great increase of 
their ionization (Figure 21B). The identification of CPPs released by PL and the relative sequence alignment 
is report in Figure 22. 
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Figure 22. Sequence alignment of the CPPs detected in the plasminosate containing water buffalo (WB) and 
bovine (B) CN in equal amounts. The amino acid substitution of the possible proteotypic CPPs derived from 
β-CN  and  αs2-CN are highlighted in red. pS = phosphoserine residue. 
The Arg25 (B  β-CN)→His25 (WB  β-CN), Asn2 (B  αs2-CN)→His2 (WB  αs2-CN), Phe147 (B  αs2-CN)→Ile147 
(WB  αs2-CN) amino acid substitutions in the analogue CPPs gave distinct mass MALDI signals allowing 
their use as signature peptides. The amino acid substitution appreciably perturbed the ionization efficiency of 
the  analogue  peptides.  In  particular,  the  signal  intensity  of  B  β-CN (f1-28) 4P was double than that of the WB 
analogue (Figure 21). Moreover, the PL action  on  β-CN released B and WB β-CN (f1-28) 4P but also a lower 
amount  of  B  β-CN (f1-25) 4P. Notwithstanding the fact that Arg25-X and Lys28-X are evenly susceptible to 
PL, the latter is approximately tenfold more efficient with Lys-X as a substrate than with Arg-X bond 
(Weinstein & Doolittle, 1972). The MALDI spectra of the HA-tryptic CPPs and HA-PL CPPs derived from 
B (50%) and WB (50%) CN mixtures are shown in Figure 23.  
 
Figure 23. MALDI-TOF spectrum of a plasminosate A) and a tryptic hydrolysate B) after enrichment on HA 
from WB and bovine B casein in  equal  amounts.  Ionization  efficiency  of  B  β-CN (f1-28) 4P (MH+ 3479.1 
Da)  and  WB  β-CN (f1-28) 4P (MH+ 3,460.0  Da)  was  not  comparable  A)  while   that  of  B  β-CN (f1-25)4P 
(MH+ 3,122.2  Da)   and  WB  β-CN (f1-28) 4P (MH+ 3,458.3 Da) was not appreciably affected by different 
length of two peptides. 
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WB and B β-CN (f1-28) 4P would occur in the CN plasminolysate of CN mixtures while trypsinolysis 
affords  the  formation  of  WB  β-CN (f1-28)  4P  and  B  β-CN (f1-25) 4P because of the amino acid substitution 
Arg25 (B)→His25 (WB) (Figure 23). The signals  of   the   tryptic  B  β-CN (f1-25)  and  WB  β-CN (f1-28) had 
almost the same amplitude, whereas those generated by PL were different (Figure 23). This difference can be 
explained by the formation in the B species of β-CN (f1-25) 4P simultaneously with lower amounts of β-CN 
(f1-28) 4P, the only peptide formed by the WB milk (Figure 23). 
3.18.2 Standard curve of molecular mass vs. adulterant bovine milk 
The analysis of triptic digests of B and WB mixtures is preferred to quantify the adulterant addition of B milk 
in WB milk. Consequently, for doubtful or low amounts of B milk, trypsin hydrolysates of milk or cheese 
CN were carried out. To this end, five samples of known composition were analyzed by MALDI-TOF-MS 
(Figure 24) in triplicate and spectra were obtained as outlined in the above described procedure.  
 
Figure 24. Identification  of  bovine  β-CN (f1-25) 4P (MH+ 3,122.6  Da)  and  water  buffalo  β-CN (f1-28) 4P, 
(MH+ 3,458.9 Da) peptides in tryspin digests containing different amounts of B CN (0.8-50%, w/w). 
Calibration curve were obtained by plotting the B β-CN (f1-25) 4P and WB β-CN (f1-28) 4P ratio against the 
composition of adulterated water buffalo milk. 
A linear relationship was established between  the  ratio  of  the  peak  heights  of  WB  β-CN (f1-28) 4P and the 
adulterant  B  β-CN (f1-25) 4P against percentage of B milk (y = 0.0159 – 0.0115, R2 = 0.9993) (Figure 24). 
Using this calibration curve, the actual percentages of B milk in adulterated WB milk samples were 
calculated with a LOD of 0.5%. The  detection  of  B  β-CN (f1-25) 4P in tryptic digests of CN isolated from 
WB Mozzarella cheese have allowed to measure the % of B adulterant that resulted of ~2 % for the tested 
cheese samples. Therefore, the direct MALDI-TOF-MS analysis of the tryptic CN digests could be a 
promising alternative method to the official European electrophoretic method of analysis (Commission 
Regulation No 273/2008) as it provides better separation and an appropriate discrimination between real and 
false signature peptides. 
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3.19 Conclusions 4 
Milk speciation through the monitoring whey proteins is not recommended because of their propensity for 
denaturation during heat and high-pressure processing. Heat-resistant CN is considered to be a better 
indicator for detecting WB milk adulteration. Two faint bands are resulted to migrate at  similar  pI  of  B  γ2-CN 
in pure WB milk; these bands contain some peptides responsible for false positive responses in B milk. This 
drawback limits the application of the European reference electrophoretic method of analysis for the 
authentication of WB milk/cheese. In order to prevent false positive responses, multiple proteotypic peptides 
could be detected for each parent CN. In this manner, the MS based methods become effective in 
discriminating pure or contaminated milk samples. The direct MALDI-TOF-MS and ESI-Q-TOF-MS 
analysis of the tryptic CN digests are promising alternative methods to the official European electrophoretic 
method of analysis providing both a better separation, similar sensitivity and specific detection of the 
proteotypic CPPs from adulterating bovine milk. In this regard, the analysis by ESI-Q-TOF-MS and MALDI-
TOF-MS of the protein plasminolysate could provide second-generation methods for authenticating pure 
water buffalo milk/cheese. These higher-resolution and cost-effective methods provide quantitative detection 
of low amounts of B milk in WB milk and derived Mozzarella cheese. 
Our method is based on the selective isolation of tryptic CPPs through the use of HA. The latter binds 
exclusively phosphorylated peptides, simplifying the MALDI spectra and the interpretation of the peptide 
profile. Moreover, a LOD of 0.5% has been achieved for tryptic B β-CN (f1-25) 4P for detecting B milk in 
adulterated water buffalo milk and derived mozzarella. The excellent specificity of proteotypic peptides 
opens the possibility to broaden the application to other species’ milk or to any food protein as long as the 
protein sequence is known. 
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3.21 GLOSSARY 
AA Asiago d’Allevo 
ACN Acetonitrile 
ACP Amorphous calcium phosphate 
ALP Alkaline phosphatase 
AMBIC Ammonium bicarbonate 
B Bovine 
CM Clinical mastitis 
CN Casein 
CPase Carboxypeptidase 
CPPs Casein phosphopeptides 
DHB 2,5-dihydroxybenzoic acid 
DTT Dithiothreitol 
EDT Ethanedithiol 
ESI-MS/MS Electrospray ionization-tandem mass spectrometry 
FA Formic acid 
GP Grana Padano 
GR Gorgonzola 
HA Hydroxyapatite 
HMM High-molecular mass  
HPLC High performance liquid chromatography 
ICAT Isotope coded affinity tags 
IEF Isoelectric focusing 
IMAC Immobilized metal-ion affinity chromatography 
IS Internal standards 
LAB Lactic acid bacteria 
LC-ESI-MS Liquid chromatography-electrospray ionisation-mass spectrometry  
LMM  Low-molecular mass  
LOD Limit of detection 
MALDI-TOF-MS Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
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MOAC Metal oxide affinity chromatography 
Month Mo 
MS/MS or MS2 Tandem mass spectrometry 
PA Phosphoric acid 
PL Plasmin 
PM Pasteurized milk 
PMC Provolone del Monaco 
PMNs Polymorphonuclear neutrophils 
PP Proteose peptones 
PR Parmigiano Reggiano 
PSD Post-source decay 
SC Somatic cell 
SCC Somatic cell counts 
SCM Subclinical mastitis 
TFA Trifluoroacetic acid 
Tris-HCl Tris(hydroxymethyl) aminomethane hydrochloride 
UHT Ultra High Temperature 
UTLIEF Ultrathin-layer isoelectric focusing 
WB Water buffalo 
α-La α-lactalbumin 
β-Lg β-lactoglobulin 
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Abstract Casein phosphopeptides (CPP) were identified in
small amounts in milks heated at various intensities by using
matrix-assisted laser desorption/ionization (MALDI) time-
of-flight mass spectrometry. CPP selectively concentrated
on hydroxyapatite (HA) were regenerated using phosphoric
acid mixed in the matrix. Unphosphorylated peptides not
retained by HA were removed by buffer washing. This
procedure enhanced the MALDI signals of CPP that are
ordinarily suppressed by the co-occurrence of unphosphory-
lated peptides. CPP, belonging to the β-casein (CN) family,
i.e., (f1-29) 4P, (f1-28) 4P, and (f1-27) 4P, and the αs2-CN
family, i.e., (f1-21) 4P and (f1-24) 4P, were observed in
liquid and powder milk. The lactosylated counterparts were
specific to intensely heated milks, but absent in raw and
thermized/pasteurized milk. Most CPP with C-terminal
lysines probably arose from the activity of plasmin; an
enzyme most active in casein hydrolysis. A CPP analogue
was used as the internal standard. The raw milk signature
peptide β-CN (f1-28) 4P constituted ~4.3% of the total β-
CN. Small amounts of lactosylated peptides, which varied
with heat treatment intensity, were detected in the milk
samples. The limit of detection of ultra-high-temperature
milk adjunction in raw or pasteurized milk was ~10%.
Keywords Hydroxyapatite-bound phosphopeptides (CPP)
MALDI analysis . Lactosylated CPP detection . Signature
CPP for heated milks
Abbreviations
ACN Acetonitrile
ALP Alkaline phosphatase
AMBIC Ammonium bicarbonate buffer
α-La alpha-Lactalbumin
β-Lg beta-Lactoglobulin
CN Casein
CPP Casein phosphopeptides
DHB 5-Dihydroxybenzoic acid
DTT Dithiothreitol
HA Hydroxyapatite
IMAC Immobilized metal affinity
chromatography
IS Internal standard
LOD Limit of detection
MALDI-TOF-MS Matrix-assisted laser desorption/
ionization time-of-flight mass
spectrometry
PA Phosphoric acid
PP Proteose peptones
PSD Post-source decay
SA Sinapinic acid
SCC Somatic cell count
TFA Trifluoroacetic acid
UHT Ultra high temperature
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Introduction
The European Union Directives (92/46 CEE and 94/71
CEE) set specific rules for the production of heat-treated
milk and milk-based products such as the use of specific
temperature/time combinations for pasteurized and ultra
high-temperature (UHT) milk. The use of low value ingre-
dients such as UHT and milk powder in mixtures with raw
or pasteurized milks is strictly prohibited. Nowadays, rapid
methods are mainly based on the evaluation of furosine, a
useful indicator of heat damage in processed milk. Studies
of milk adulterations are also focused on lactosylation of
milk proteins. Endogenous milk proteinases and those asso-
ciated with somatic cells in high counts hydrolyze caseins of
raw milk. Some heat-stable proteinases may continue to do
it during storage of heat-treated milks. The number of so-
matic cells should not exceed 200,000 cells/mL bulk raw
milk [1], although the European Union Directives (92/46
CEE and 94/71 CEE) set a limit of 400,000 cells/mL for
SCC for drinking milk. Alternatively, an indirect means to
monitor milk quality in relation to SCC would be to know
one or more signature peptides. Milk contains colloidal and
soluble casein subjected to hydrolysis by proteinases. Ca-
sein releases water-soluble peptides under the action of
plasmin (EC 3.4.21.7) and lysosomal proteases, such as
carboxylprotease and cathepsin D (EC3.4.23.5). While β-
casein (CN) and αs2-CN are the preferred substrates of
plasmin, αs1-CN [2] and κ-CN [3] are more resistant to
enzymatic degradation. Therefore, one would expect to find
β- and αs2-CN-derived peptides in milk. Indeed, β-CN is
the most hydrolyzed casein fraction partly converted into
pH 4.6 insoluble γ-CN and complementary soluble proteose
peptones (PP). PP include peptides such as β-CN (f1-105/
107) (component PP5), (f1-28) (component PP8-fast), (f29-
105/107) 1P (component PP8-slow) [4, 5], and others. Raw
milk of good quality has 1–2 mg/mL PP, which can increase
during storage. A significant PP5 accumulation has been
reported for commercially packaged pasteurized milk [6].
Because as much as 30–40% plasmin survives UHT treat-
ment [7], gelation could be caused for long-stored UHT
milk [8].
While the role of proteases in casein proteolysis has been
fully clarified, the subsequent lactosylation of water-soluble
peptides remains to be clarified. Although determined for
whey proteins and casein, lactosylation of milk peptides has
not been deeply studied with the objective of distinguishing
various types of milk [9]. For heat-treated liquid and powder
milk, a reaction could occur between the ε-amino group of
protein-bound lysine or amino-termini of peptides and the
carbonyl group of lactose. In the initial step of the Maillard
reaction, lactosylation occurs both during heating and, to a
lesser extent, during milk powder storage [10]. The degree
of lactosylation of β-CN increases steadily with temperature
between 37 °C and 60 °C [11]. Lactose specifically binds to
Lys-34 in αs1-CN and to Lys-107 in β-CN under moderate
heat treatment conditions (72–85 °C for 15–30 s). The
number of binding sites increases to seven for αs1-CN and
five for β-CN after intensive treatment (142–145 °C for
2–5 min) [12]. The extent of lactosylation measured under the
same conditions is 25% for β-lactoglobulins (β-Lg) and 35%
for β-CN [11]. Especially in drinking milk, but also in milk
powders, milk quality is greatly affected by the initial prote-
olysis of raw milk. Due to the specificity of plasmin, which
acts preferentially on Lys-X bonds, milk heating induces
lactosylation of the released peptide at basic C-terminal resi-
dues (mainly Lys or Arg). Even though the extent of lactosy-
lation affects drinking milks differently, little is known about
the impact of Maillard reactions on the formation of CPP
markers.
Several milk peptides have been shown to derive from
the proteolytic digestion of caseins [13]. Separation of sig-
nature peptides from other peptides may often be achieved
by chemical methods. Thus, to reduce the complexity of the
peptide fraction, the chromatography on hydroxyapatite
(HA) has been recently introduced [14]. This method
achieves the recovery of casein phosphopeptides (CPP)
from complex peptide mixtures [14, 15] as an alternative
to immobilized metal affinity chromatography (IMAC)-
based methods [16, 17] and other affinity-based methods
[18]. While unphosphorylated peptides are washed out, CPP
were retained on microgranules of HA. This was useful for
isolating CPP free of unphosphorylated peptides. A HA–
CPP complex was then spotted onto a matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF-MS) target plate for analysis [14]. Due to
plethora of milk peptides, we focused on signature CPP
released in definite number by milk proteinase(s). The effi-
cient separation of the unphosphorylated peptides also en-
hanced the MALDI signals of CPP. The research results
could demonstrate the nature and activity of milk protei-
nases and provide information about the proteolysis induced
thereof. We were interested to detect heated milk and quan-
tify peptides which undergo lactosylated once released by
proteinases. By direct MALDI analysis, in situ immobilized
CPP, both native and lactosylated, can be identified. Simi-
larly, lactosylation sites can be localized on peptide se-
quence by post-source decay (PSD) fragmentation. The
comparison between the potentially lactosylable and actually
lactosylated sites could serve to differentiate processed milks
according to heat intensity. The lactosylated CPP could serve
to discriminate raw and pasteurized from UHT milk. In this
work, we have realized a procedure for detecting UHTmilk in
amounts not lower than 10% spiking pasteurized milk. We
suggest extending this approach to the analysis of any dairy
products with suspected addition of UHT milk, milk protein,
or milk powder.
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Experimental
Chemicals
HA (Macro-Prep Ceramic Hydroxyapatite Type I) was
supplied by Bio-Rad (Milan, Italy). Tris(hydroxymethyl)
aminomethane hydrochloride (Tris–HCl), potassium chlo-
ride (KCl), urea, trifluoroacetic acid (TFA), acetonitrile
(ACN) for HPLC, 85% orthophosphoric acid (PA), and
AMBIC were from Carlo Erba (Milan, Italy). Dithiothrei-
tol (DTT) was from AppliChem (Darmstadt, Germany).
TPCK-treated trypsin from bovine pancreas was from
Sigma (St. Louis, MO, USA). Sinapinic acid (SA), 2,5-
dihydroxybenzoic acid (DHB), and sodium acetate
(AcNa) trihydrate were obtained from Fluka (St. Louis,
MO, USA). Acetic acid was purchased from Baker
Chemicals B.V. (Deventer, the Netherlands). Water was
prepared using a Milli-Q system (Millipore, Bedford,
MA, USA). Pooled raw milk was from local dairy farms.
The pasteurized UHT milks were purchased from a local
store. Milk protein powder and milk powder were supplied
by Sacco Industry (Milan, Italy).
Sample preparation
Pasteurized milk was added with UHT milk to a final
concentration of 90% to 1%. Then, each sample, including
isoelectric casein (sample I), milk protein powder (sample
V), or milk powder (sample VI) in solution, raw milk
(sample II), pasteurized milk (sample III), and UHT milk
(sample IV), was treated with HA as described below. The
chemical composition of milk samples as well as the time/
temperature combinations are reported in Table 1.
HA-based phosphoprotein/CPP enrichment from various
milk samples
HA (100 mg), previously equilibrated with the loading buffer
(50 mM Tris–HCl, 0.2 M KCl, 4.5 M urea, and 10 mM DTT,
pH 8.0), was put in contact with protein in solution (10 mg) or
equivalent amounts of raw and skimmedmilk. The HA-bound
proteins were incubated for 15 min at room temperature and
centrifuged for 5 min at 4,000×g per minute. The resin was
successively washed with three different buffers: loading
buffer (1 mL), 50 mM Tris–HCl at pH 8.0 (1 mL), and
20 mM Tris–HCl in 20% ACN (v/v) at pH 8.0 (1 mL). The
resin was washed with Milli-Q water (1 mL) and freeze-dried
with a SpeedVac concentrator system (Thermo Electron,
Milford, MA).
In order to confirm the degree of lactosylation, the dried
HA-bound CPP (1 mg) were dissolved in a 5% aqueous PA
solution (120 μL) and desalted with a ZipTip C18 pipette tip
before dephosphorylation with alkaline phosphatase (ALP),
carried out according to the procedure previously described
[14]. Assays were needed especially for CPP isolated from
milk protein and milk powder. However, since HA is known
to interact with phosphoprotein and CPP, the aqueous sus-
pension of HA was trypsinized according to the procedure
previously described [14]. The HA-bound tryptic CPP were
then analyzed by MALDI.
Matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry
MALDI-TOF mass spectra were recorded using a Voyager
DE-PRO mass spectrometer (Applied Biosystems, Framing-
ham, MA, USA) in positive linear mode. All spectra were
acquired in the range of 10–30 kDa (for proteins) and
1–5 kDa (for peptides) with the following settings: an acceler-
ating voltage of 25 kV (for proteins) or 20 kV (for peptides)
and a grid voltage of 93% (for proteins) or 95% (for peptides)
of the accelerating voltage, a guide wire of 0.15% (for proteins)
or 0.05% (for peptides), and a delayed ion extraction time of
485 ns (for proteins) or 175 ns (for peptides). The laser power
was set just above the ion generation threshold to obtain peaks
with the highest possible signal-to-noise ratio. All spectra were
acquired with 200 shots in three replicates. Measured molecu-
lar masses, with a ±0.5-Da tolerance, matching the calculated
masses, enabled the identification of ion signals. Different
MALDI matrix solutions were freshly made for different types
Table 1 Protein and lactose content in heat-treated commercial milk samples
Sample % protein % lactose Heating treatment Time/temperature combinations
I Isoelectric casein 100 0 No No
II Raw milk 3.2 4.9 No No
III Pasteurized milk 3.2 4.9 Pasteurization 15 s/71.7 °C
IV UHT milk 3.1 4.9 Direct ultra high-temperature processing 2 s/135 °C
V Milk protein powder 46 5 Membrane filtrationa and spray drying Air temperature at 200 °C
VI Milk powder 36 56 Spray drying Air temperature at 200 °C
a Concentrated commercial milk proteins were obtained by milk ultrafiltration on membrane
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of molecules to be analyzed. For phosphoprotein analysis,
10 mg/mL of SAwas dissolved in 50% ACN and 0.1% TFA
in an ultrasonic bath. For CPP, 10 mg/mL of DHB was dis-
solved in 1 mL of H2O/ACN/PA (49:50:1) using an ultrasonic
bath. Prior to HA enrichment, the samples were analyzed by
MALDI. Solid milk samples (1 mg/mL) were solubilized in
H2O/ACN (50:50) solution with 0.1% TFA. Liquid milk sam-
ples (10 μL) were diluted 1:100 with the above solution. Each
protein solution (1 μL) was loaded in one well of a MALDI
plate and covered with SA matrix (1 μL) for the preliminary
analysis. After enrichment, ~1,000 HA-phosphoprotein micro-
granules were deposited onto the MALDI plate and covered
with the SA matrix (1 μL) to promote analyte/matrix co-
crystallization in the presence of 0.1% TFA. For CPP, 1% PA
was included in the matrix solution to achieve maximum
ionization efficiency by MALDI and minimize binding of
CPP to HA [19].
PSD-MALDI-TOF experiments
PSD fragment ion spectra were acquired after isolation
of the appropriate precursor ions using timed ion selec-
tion. In this manner, the spectra of lactosylated β-CN
(f1-28) 4P (m/z3,803 Da) and its unphosphorylated
counterpart (m/z3,483 Da) were acquired. Acquisition
was performed with the following settings: accelerating
voltage, 20 kV; grid voltage, 80% of the accelerating
voltage; guide wire, 0.02; and delayed time, 100 ns.
Each spectrum was the average of 300 shots in three
replicates.
Synthesis of peptide analogues
The peptides were synthesized by solid-phase methods us-
ing the 9-fluorenylmethyloxycarbonyl (Fmoc) strategy on a
Pioneer peptide synthesizer (Synthesis System 9050 instru-
ment; PE-Biosystems, Framingham, MA, USA). The level
of the β-CN (1-28) 4P plasmin-derived fragment was cho-
sen as the index for quantification of casein proteolysis. The
method was applied to all of the milks to select a marker
specific for intensely heated milks. The natural and the
analogue-synthesized peptides (Table 2) were used to gen-
erate a calibration curve.
A constant concentration (10 μg/μL) of synthesized
modified peptides was used to spike different solutions of
synthesized natural peptides to create a calibration curve,
with the natural/modified area ratio as a function of the
concentration ratio of the corresponding peptides. The
amount of β-CN (f1-28) 4P was obtained by spiking
10 μL raw milk with 10 μg/μL internal standard (IS) and
calculating the quantity of this peptide according to the
equation of the calibration plot.
Results and discussion
Strategy of HA-based enrichment of casein and CPP
Isolation of casein/CPP is one of the most difficult tasks
because of the heterogeneity in the number of phosphate
groups (P), varying from 1 to 13, attached to specific serine
residues of the four casein fractions [20]. Phosphoproteins/
peptides compete for the C sites on ceramic HA over a wide
pH range [21], and both were eluted for MALDI analysis [15,
22]. Our procedure did not use elution because the HA-
phosphocaseins/CPP complex was directly solubilized by
spotting on the MALDI plate matrix mixed to TFA (for
casein) or PA (for CPP) [14]. In addition to this, PA enhances
the detection of phosphopeptide ions by MALDI-TOF [19].
The main objective of our work was to determine whether the
HA-based procedure is suitable for characterizing signature
peptides of heat-treated milk samples. Because the affinity of
CPP for HA could decrease with increasing nonspecific bind-
ing of the unphosphorylated peptides, a preliminary study
measured the bound and unbound proteins/peptides of raw,
pasteurized, UHT, milk protein powder (casein+whey), and
milk powder samples. Our results indicate that MALDI is
useful in identifying lactosylation, one of the most common
posttranslational protein modifications that occur during heat-
ing or spray drying. MALDI analysis provided molecular
mass value of peptides and information on the presence/ab-
sence of signature peptides. Thus, severe heating induced
changes of lactosylation in whey proteins of samples I to VI
(Electronic supplementary material (ESM) Table S1). The
signals of non-enzymatic lactosylation of β-Lg A and B and
α-lactalbumin (α-La) B dominated the MALDI-TOF spectra
of different samples (ESM Table S1 and Figs. S4 and S6). The
molecular masses of β-Lg B (unmodified m/z18,280.4) and
β-Lg A (unmodified m/z18,365.9) increased by 314.2 Da per
lactose molecule or multiple integrals up to 6 (ESMTable S1).
The lactosylation ofβ-Lg A and B compared with control raw
milk was higher in powdered milk (sample VI, six lactose
residues/molecule) than in protein milk powder (sample V,
four lactose residues/molecule) and UHT milk (sample IV,
one lactose residue/molecule). Unmodified β-Lg A and B
Table 2 Amino acid sequence of synthesized natural and modified
peptides
Synthetic natural peptide [M+H] Sequence
β-CN (f1-28) 4P 3,478.5 Da RELEELNVPGEIVESp
LSpSpSpEESITRINK
Synthetic modified peptide [M+H] Sequence
β-CN (1-25) 4P 3,196.3 Da REWEELNVPGEIVESp
LSpSpSpEESITR
Differentiating Trp residue is underlined. Sp indicates phosphorylated
serine residue
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were still present in all samples except milk powder (ESM
Table S1 and Fig. S6).α-La Bwas less lactosylated in the milk
protein powder (sample V, three lactose residues/molecule)
than in powdered milk (sample VI, four lactose residues/mol-
ecule). In UHT milk (sample IV), α-La B (unmodified m/z
1,4187.2) was lactosylated as β-Lg (one lactose residue/α-La
molecule). This seems to contrast at least partially with previ-
ous findings on casein lactosylation which occurs at similar
levels in UHT and in-bottle sterilized milk [12]. Indeed, the
extent of lactosylated proteins in pasteurized milk does not
differ from that measured in raw milk. In contrast, the different
levels of lactosylation of proteins in the powder samples were
probably due to the lower lactose content of ultrafiltered milk
or whey. It seems that heating extensively enhanced lactosyla-
tion by exposing lysine residues on the surface of the proteins.
However, Maillard reaction was incomplete even in the pow-
dered milk preparations. In recent studies, Lys-47, Lys-138,
and Lys-141 of β-Lg were lactosylated, while Lys-98, Lys-
114, or Lys-122 of α-La were lactosylated in UHT milk [23].
In general, the degree of lactosylation increases steadily with
temperature, progressively from pasteurization to spray drying
passing through to UHT. However, the Amadori compound,
the first intermediate in the Maillard reactions, is probably
degraded by heat [24] via the Strecker degradation [25]. As-
sessment of the whey protein powder quality in infant formula
on the basis of the number of lactose residues per protein
molecule can detect five lactoses/α-La and ten lactoses/β-Lg
[26]. In the solid state, all 15 lysine residues ofβ-Lg and the N-
terminal leucine were lactosylated [27], in addition to Arg-124,
for a total of 17 lactosylated amino acid residues [28].
While the effect of heat treatment on the whey protein
denaturation has been well established by many decades of
research, little is known about casein lactosylation. By ap-
plying our procedure, lactosylated casein would be detected
in heated milk (ESM Fig. S4 and S6). All of the MALDI
spectra for the milk samples actually contained the signals
of (1) unmodified κ-CN or the mono-lactosylated compo-
nent but milk powder (ESM Table S1 and Fig. S6); (2)
multi-phosphorylated αs2-CN after enrichment of isoelectric
casein on HA; (3) lactosylated β-CN A1 and A2, which
differed based on His67(β-CN A1) for Pro67(β-CN A2);
and (4) diffusely lactosylated β-CN and αs1-CN in milk
protein (V) and milk powder (VI) samples due to the low
resolution of MALDI (ESM Table S1 and Figs. S4 and S6).
However, monomer κ-CN was missing in the milk powder
sample because of its possible association with whey
proteins. On the whole, HA procedure provides a system for
the selective enrichment of caseins/CPP while whey proteins
are washed away (ESMTable S1 and Fig. S8 and S9 and S10).
Identification of HA-bound CPP and unphosphorylated
peptides
To follow the evolution of the peptide profile according to the
heating intensity, the MALDI-TOF spectra were explored in
the 10- to 14-kDa range. After enrichment on HA, raw
(Fig. 1b and ESM Table S2) and pasteurized milk (ESM
Fig. S11) had dominant signals of β-CN (f1-97) 5P
(11,362.3 Da) and αs2-CN(f53-150) 6P (11,860.4 Da). The
impact of UHT treatment and of milk and milk protein drying
seemed higher than in pasteurized milk (ESM Fig. S11).
The MALDI signals of unphosphorylated peptides sig-
nificantly decreased, while those of CPP considerably in-
creased. The results indicate that (1) a selective enrichment
occurred as a result of displacement of CPP bound to HA by
the addition of TFA; (2) the CPP enrichment reduced the
sample complexity; and (3) low-abundance CPP in mixtures
with unphosphorylated peptides can be detected directly
Fig. 1 MALDI-TOF spectra of
raw milk peptides in the 10- to
14-kDa mass range before (a)
and after enrichment (b) using
HA as concentrating probe.
Component identification is
reported in ESM Table S2
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“on-beads.” This is confirmed by unphosphorylated γ3- and
γ2-CN dominating the spectra of the raw milk (Fig. 1a) whose
signals were lost during the repeated buffer washes, while β-
CN (1-105) 5P and β-CN (1-107) 5P (complementary to
γ2-CN and γ3-CN, respectively; Fig. 1b) were detected in
HA-bound CPP. Taken together, these results demonstrate the
outstanding enrichment capacity of HA for MS analysis.
MALDI-TOF in the 1.2- to 5-kDa range
Raw, pasteurized, UHT, milk protein, and milk powder sam-
ples were examined by MALDI-TOF in the 1.2- to 5-kDa
range. As an example, the MALDI spectrum for raw milk is
shown in Fig. 2a (ESM Table S3). Here was registered a
substantial increase of peptides belonging to the β-CN, αs2-
CN andαs1-CN family. This occurred probably because of the
presence of active plasmin and somatic cell proteinases. After
enrichment on HA, only phosphorylated peptides were
detected, as shown in Fig. 2b (ESM Table S3).
Similarly, the major CPP were identified in the other com-
mercial milk samples (ESM Fig. S12). In all the milk samples,
both native and lactosylated forms of CPPwere detected, except
in raw and pasteurized milk. β-CN (f1-28) 4P, (f1-27) 4P, and
αs2-CN (f1-24) 4P were the main components of CPP (Fig. 3
and ESMTable S4). The native and lactosylatedαs2-CN (f1-21)
4P co-existed in milk powder. In this manner, we identified the
lactosylated β-CN (f1-29) 4P as a signature peptide of milk
proteins and powderedmilk preparations because it was missing
in other types of milk. It was missing in raw, pasteurized
(71.7 °C for 15 s; Fig. 3a), and intensely pasteurized milk
(121 °C for 2–4 s, spectrum not shown). αs1-CN-derived CPP
failed to form due to the internal location of the phosphorylation
cluster. In contrast, they are released in long-ripened cheese [29].
To screen lactosylated CPP, in vitro dephosphorylation was
carried out using ALP. The difference between the native and
dephosphorylated peptide mass values allowed us to assign the
phosphate groups correctly (one phosphate group080Da). The
results of CPP dephosphorylation are shown in Table 3 (Fig. 4).
Each peptide was a mono-lactosylated component. The degrees
of phosphorylation and lactosylation of β-CN (f1-28) 4P
were further confirmed by PSD MS experiments (Fig. 5).
The PSD spectrum in Fig. 5 exhibited a prominent neutral
loss of 340 Da (one lactosyl group) from the precursor ion atm/
z3,802.9 Da. Moreover, the PSD spectrum of lactosylated β-
CN (f1-28) 4P yielded a neutral loss of 98 Da (H3PO4), con-
sistent with a peptide containing four phosphoserine residues
(Fig. 5). The PSD spectrum of lactosylated β-CN (f1-28) 0P
confirmed the loss of one lactose group (m/z3,140.2 Da) from
the peptide (Fig. 6).
In vitro trypsinolysis of HA-bound CPP or caseins
from milk protein powder
Trypsinolysis of the HA-bound CPP in addition to the native
β-CN (f1-25) 4P and β-CN (f1-25) 3P (3,123.0 and 3.043.6 Da)
released mono-lactosylated counterparts (3,447.2 and
3,367.3 Da).
Notwithstanding the fact that Arg25-X and Lys28-X were
evenly susceptible to trypsin, Lys28-X was split by plasmin
because of the strict specificity of enzyme towards lysine
[30]. It is likely that lactosylation especially affects plasmin-
mediated peptides [31]. Heating produced a consistent
amount of lactosylated peptides. To observe this effect,
Fig. 2 MALDI-TOF spectra of
raw milk peptides in the 1- to
5-kDa mass range before (a) and
after enrichment (b) using HA as
concentrating probe. Component
identification is reported in ESM
Table S3
Fig. 3 TheMALDI spectra showmass signals of β-CN derived lactosy-
lated phosphopeptides (CPP) isolated by addition of hydroxyapatite (HA)
microgranules to samples of pasteurized milk (a), UHT milk (b), milk
protein powder (c), and milk powder (d). The inset magnifies the m/z
values in 1- to 5-kDa range that are expected to show mass peaks
corresponding to marker peptides. Monolactosylated CPP labelled with
a red circle correspond to β-CN (f1-27) 4P (m/z 3675 Da), β-CN (f1-28)
4P (m/z 3803Da) andβ-CN (f1-29) 4P (m/z 3931Da). As expected, none
of these lactosylated CPP occurred in the spectrum of pasteurized milk
(a). Identification of all the components is reported in ESM Table S4

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a shift of +324 Da was expected for peptides containing
a reactive NH2 group, yielding the so-called Amadori
product. If Arg25 were lactosylated, Arg25-X as well as
Lys28-X would be trypsin- and plasmin-resistant. Indeed, an
amount of N-terminally mono-lactosylated β-CN (f1-28) 4P
corresponding to ~3% total β-CN (f1-28) 4P was found in the
milk protein powder sample. In contrast, a higher quantity of
mono-lactosylated β-CN (f1-25) 4P, ~17% of the total β-CN,
was released by trypsinolysis of HA-bound casein/CPP. This
means that both lactosylated caseins and lactosylated CPP
combine to determine the levels of signature peptides.
Such peptides were found in dried milks before digestion
with trypsin.
Quantification of β-CN (f1-28) 4P in raw milk
by MALDI-TOF-MS
Based on a set of naturally occurring peptides, β-CN (f1-28)
4P was chosen because it is a phosphorylated member of a
plasmin-mediated CPP family that undergoes glycosylation
during heat treatment. Specifically, for the absolute quanti-
fication of the mono-lactosylated β-CN (f1-28) 4P signature
peptide, a synthetic 25-residue analogue that was identical
to the N-terminal 25-mer peptide except for the amino acid
substitution Leu3→Trp3 was used as IS. The natural proteo-
typic peptide was mixed with IS in known concentrations,
and the MALDI intensity of the two co-occurring signals
was measured (ESM Figs. S14 and S15). MALDI measure-
ments performed on four binary solutions containing natural
peptide/IS ratios of 0.22:1, 0.11:1, 0.055:1, and 0.0275:1
produced a line defined by the equation y06.2451x+0.3635
(R200.9855, mean of ten replicates; ESM Fig. S16). Using
this approach, raw milk β-CN was found to have released
~4.3% of the β-CN (f1-28) 4P (ESM Fig. S17).
Specific detection of lactosylated milk CPP
Raw milk is rejected by dairy processing plants if the sample
is found to be contaminated with UHT or other heat-treated
milk. The HA-based method could ensure that UHT milk
and sterilized milk are not used for the production of pas-
teurized milk. To demonstrate this, aliquots of pasteurized
milk were artificially spiked with 90%, 70%, 50%, 30%,
10%, 5%, or 1% UHT milk. The limit of detection (LOD)
was determined by MALDI searching for the lactosylated β-
CN (f1-28) 4P, assumed as the signature peptide of UHT
milk. The method did not discriminate UHT milk in
amounts below 10% (Fig. 7).
Using improved MS equipment, in terms of mass resolu-
tion and sensitivity, we think that the LOD could be substan-
tially lowered. Trypsinolysis of HA-bound CPP, enhancing
the signal of lactosylatedβ-CN (f1-25) 4P, could further lower
the LOD value.
Sequences of cleaved peptides
To verify the role played by proteolytic enzymes in casein
hydrolysis, the amino acid sequence of CPP was investigated
(Fig. 2b). The in vivo and in vitro plasmin-mediated peptides
that arose from raw milk were compared (ESM Fig. S18 and
Table S5).
Table 3 MALDI identification of lactosylated CPP after in vitro
dephosphorylation
Measured mass of
dephosphorylated peptide
(MH+) (Da)
Theoretical
mass (Da)
Identified
peptide
3611.5 3,610.9 β-CN (f1-29)
0P+1Lactose
3483.5 3,482.7 β-CN (f1-28)
0P+1Lactose
3355.0 3,354.6 β-CN (f1-27)
0P+1Lactose
The spectra shown in Fig. 4 have been taken for milk powder sample
Fig. 4 An example of determina-
tion of phosphorylation stoichiome-
try of lactosylated CPP by
combining alkaline phosphatase-
based dephosphorylation with
peptide identification by mass
spectrometry. By comparing the
MALDI spectra recorded for the
phosphatase-treated to the untreated
sample in Fig. 3, the candidate CPP
were identified. Because of 320 Da
mass shift (1 phosphate group=80
Da) each peptide, indicated with a
m/z value in theMALDI spectra, had
four phosphorylation sites
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The choice of plasmin as the proteolytic enzyme was
dictated by the role played by this enzyme during milk
storage. Because peptide bonds containing a C-terminal
Lys or Arg can be hydrolyzed by plasmin, the majority of
β- and αs2-CN CPP reported in ESM Table S3 must have
been released by plasmin. This agrees with the known
activities of plasmin and other proteases associated with
milk somatic cells. CPP differed only in the level of lacto-
sylation, which was absent in raw milk but extensive in milk
powder. Thus, lactosylated CPP may serve as suitable chem-
ical markers of the intensity of heat treatment. When CPP
levels are higher than normal, milk is of poor quality be-
cause it is rich in proteolytic enzymes. It seems that the level
of lactosylation in milk is related to the intensity of the heating
process.
Disadvantages and advantages of the HA procedure
Current techniques use gel electrophoresis and immunoblot-
ting for separating and detecting specifically proteins. Anti-
bodies developed against the Amadori compound containing
lactose as a glycating agent were used as a surrogate for
measuring furosine, distinguishing the lactosylated from
non-lactosylated caseins [32]. In general, anti-peptide or
monoclonal antibodies are specific reagents for measuring
lactosylated peptides [32]. The drawbacks of polyclonal
Fig. 5 Post-source decay (PSD)-
MALDI spectrum of a HA-bound
CPP occurring in the sample of
milk powder. The red circled peak
represents a peptide exhibiting a
neutral loss of 340 Da (a lactosyl
group) that was one of the most
intense ions, and 392 Da for phos-
phoric acid (1P= 98 Da) from the
precursor ion at m/z 3,802.9 Da.
These structural informations
allowed to assign four phosphates
and one lactose group unequivo-
cally to the peptideβ-CN (f1-28) at
m/z 3,803 Da that was present in
the milk powder sample
Fig. 6 PSD-MALDI-TOF-MS/
MS spectrum of lactosylated
β-CN (f1-28) 0P at m/z3,483
Da after dephosphorylation. The
signal at m/z3,140.2 Da
confirmed the loss of one
lactose group
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anti-peptide antibodies are mainly (1) the amino acid sequen-
ces of the peptides would be known in advance to target their
lactosylated proteins; (2) the antibodies might not recognize
native proteins; and (3) a cross-reactionwith other members of
the protein families would not be excluded a priori. On other
hand, concentration of low-abundance peptides/proteins by
gel electrophoresis carries the risk that water-soluble peptides
escape to the staining procedure with Coomassie Blue. Sepa-
ration of proteins by 2DE coupled with identification of
tryptic peptides through offline MALDI-TOF-MS is one of
the most commonly used techniques in proteomic analysis
[33]. Cumbersome 2D electrophoresis for protein separations
requires extensive manual manipulation for mostly qualitative
experiments. Online HPLC coupled with mass spectrometry
Fig. 7 Zoomed-in view of MALDI spectrum in the 1- to 5-kDa mass range of β-CN (f1-28) 4P signature lactosylated CPP from pasteurized milk
spiked with 30% (a), 10% (b), and 5% (c) UHT milk. Lactosylated β-CN (f1-28) 4P mass signal was magnified and circled in green
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have been widely used for concentrating/identifying low-
abundance peptides/proteins. However, one sample at a time
is evaluated by HPLC, so samples are analyzed multiple times
during a multi-sample sequence. In addition, low-abundance
lactosylated CPP have to be concentrated before injection into
the HPLC apparatus. The chromatographic techniques using
IMAC and titanium dioxide (TiO2) require both a preliminary
purification [34, 35] and elution step [36, 37] for isolating
phosphopeptides prior to MALDI analysis. The HA-based
procedure has the advantage of capturing distinctly the
plasmin-derived CPP and the counterparts that have under-
gone lactosylation under different heat treatments. The chem-
ical changes induced by processing milk to heating should be
confirmed by MS through identification of the amino acid
sites modified by lactose. The advantages of using lactosy-
lated signature peptides as analytical surrogates of the proteins
are that (1) it is easier to separate and detect peptides than
proteins, (2) structure of the lactosylated CPP does not alter
during the analysis, (3) native CPP do not interfere with
lactosylated counterparts, and (4) putative peptides suggested
from databases can be easily recognized and eventually syn-
thesized for external standards. Another advantage of the
procedure is that different mass range acquiring analysis can
be explored to detect co-existing HA-bound phosphoproteins
and CPP in three separated range masses of the MALDI
spectra. Once a lactosylated peptide is discriminative for the
heat treatment type, the relative signature peptide could be
detected and quantified within a restricted mass range.
Conclusion
The lactosylated phosphopeptides we detected were indicative
of the casein quality. The ability to dynamically characterize
lactosylation as a distinguished signature modification of
caseins could help monitor the heat-induced modifications
of casein micelles. CPP lactosylation can be regarded as a
model for studying the accessibility of lactose to casein
micelles. The major drawback encountered in concentrating
CPP was resolved by capturing CPP on HA. In addition to
this, the quality of MALDI signals of lactosylated CPP im-
proved. These peculiarities make the new method able to
detect also low-abundance signature peptides by MALDI.
The results of our experiments have demonstrated that (1)
native and lactosylated CPP are equally bound to HA; (2)
CPP have higher affinity for HA than unphosphorylated
peptides co-purifying with them using other methods; (3) as
expected, the extent of the casein lactosylation is a function of
the heating intensity; and (4) mono-lactosylated β-CN (f1-28)
4P represents a distinct signature peptide that is detected
distinctly from the native counterpart, making possible the
detection of not less than 10% UHT milk spiking raw
or pasteurized milk. However, the present procedure
needs further signature peptides to distinguish thermized
and pasteurized milks. Even with this limitation, the
method could be applied in the design and control of
any dairy product at the molecular level.
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A novel method for the selective enrichment of casein phosphoproteins/phosphopeptides (CPP) from
complexmixtures is reported herein. Thismethod employs ceramic hydroxyapatite (HA) as a solid-phase
adsorbent to efficiently capture phosphoproteins and CPP from complex media. Casein was chosen as
the model phosphoprotein to test the protocol. CPP immobilized on HA microgranules formed a com-
plex that was included in the matrix-assisted laser desorption/ionization mass spectrometry (MALDI)
matrix before desorbing directly from the well plate. Casein fractions with different levels of phospho-
rylation were desorbed based upon the specific concentration of trifluoroacetic acid (TFA) included in
theMALDImatrix. The HA-bound casein enzymolysis was performed in situ with trypsin to remove non-
phosphorylated peptides and isolate the immobilized CPP. The latter were recovered by centrifugation,
dried, and co-crystallized with a 1% phosphoric acid (PA) solution in the matrix that was appropriate for
detecting CPP in MALDI-MS spectra. This approach for the selection of casein/CPP resulted in the iden-
tification of 32 CPP by MALDI-time of flight (TOF). The analytical process involved two steps requiring
∼2h, excluding the time required for the enzymatic reaction. The alkaline phosphatase (AP)-assisted
de-phosphorylation of tryptic CPP allowed the phosphorylation level of peptides to be calculated con-
currently with MALDI-TOF MS and liquid chromatography-electrospray ionization–mass spectrometry
(LC–ESI–MS/MS). The effectiveness of the extraction procedure assayed on eggshell phosphoproteins
resulted in the identification of 5 phosphoproteins and 14 derived phosphopeptides with a phosphopro-
tein global recovery of ∼70% at least.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
Several reviews have described phosphoproteomics, which
attempts to studyprotein phosphorylation on a large scale by eluci-
dating the phosphorylation status of all proteins present in cells or
organisms. One of the most significant phosphoproteomic studies
described the “phosphokinome” of human cancer cell lines, iden-
tifying almost 1000 phosphorylation sites on 219 protein kinases
[1]. Given their often substoichiometric concentration, phospho-
peptides frequently escape detection because of a poor mass
spectrometric (MS) precursor response and the low m/z values
of MS2 fragment ions [2]. Moreover, proteins/peptides containing
multiple phosphorylation sites are detected with low efficiency
by MALDI-MS because of their attenuated or suppressed ioniza-
tion [3,4]. Prior enrichment of phosphoproteins/phosphopeptides
is one of the important methods to enhance the MS detection
of phosphoanalyte signals. The objective of any separation and
enrichment procedure from protein or peptide complex media is
the quantitative recovery of phosphorylated peptides free of the
∗ Corresponding author. Tel.: +39 081 2539346; fax: +39 081 7762580.
E-mail address: gabriella.pinto@unina.it (G. Pinto).
non-phosphorylated components. To date, several strategies have
been developed to fulfill this objective, most of which are based
upon enrichment and/or down-scaling strategies. These strategies
both reduce the amount of starting non-phosphorylated mate-
rial and increase the intensity of the phosphoanalyte peaks in
MS. Immobilized metal affinity chromatography (IMAC) [5–7],
which chelates phosphoanalytes on metal ions (e.g., Zn+2, Ga+3,
and Fe+3) through metal-phosphate ion–pair interactions, has
been suggested to be one of the best procedures for enriching
phosphorylated proteins and peptides. Another method utilizes
either titanium dioxide [8–11] (TiO2) or zirconium dioxide (ZrO2)
[12–14] to capture phosphoanalytes through bidentate interac-
tions [15], providing complementary information to IMAC [16].
Each affinity capture method has a particular specificity for the
phosphoproteins/phosphopeptides that it can isolate and, conse-
quently, isolates a different set of phosphopeptides. A comparative
study of three affinity methods concluded that different, partially
overlapping segments of the phosphoproteome were detected by
each method and that, at present, no single method is sufficient
for a comprehensive phosphoproteomic analysis [16]. In addition,
the extent of phosphopeptide identification with any approach is
highly dependent upon the sample and the laboratory perform-
ing the analysis [17]. The affinity techniques developed for the
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doi:10.1016/j.jchromb.2010.07.024
2670 G. Pinto et al. / J. Chromatogr. B 878 (2010) 2669–2678
selective enrichment of phosphoproteins/phosphopeptides from
complex samples gave reproducible but incomplete results [16]
due to the poor binding of phosphopeptides present in low con-
centrations and the insufficient recovery of peptides with multiple
phosphorylation sites [18]. IMAC also binds non-phosphorylated
peptides because the metal ions also chelate protein carboxy-
late groups. To overcome this drawback, binding and washing
are performed at low pH, at which carboxylic acid groups are
not ionized, while elution is subsequently accomplished by rais-
ing the pH [19]. Esterification of acidic residues can also reduce
the binding of non-phosphorylated peptides [20]. At the present
time, which of these affinity isolation procedures would yield the
best results is unclear. We developed a hydroxyapatite (HA)-based
procedure for the chromatographic isolation of casein fractions
according to the increasing phosphate content [21]. Since then,
there have been a few reports on the use of HA for the enrich-
ment of phosphoproteins/CPP [22,23]. Recent work has compared
the efficiency of HA- and TiO2-based methods, demonstrating that
both showedanalmost equal performance for CPPenrichment [22].
Basically, the HA-based protocol immobilizes CPP on HA micro-
granules after elution with a phosphate-containing buffer, which
are then identified by off-line MALDI-MS [22]. To speed up this
procedure for its routine application on a variety of samples, we
investigated the possibility of using MALDI-TOF for direct analysis
of the HA-bound phosphoproteins/CPP in a solution free of non-
phosphorylated analytes. The efficiency of an analytical method is
usually determined using model proteins. Whole casein was cho-
sen as the reference protein for this study because it is formed by
four protein families each having a known sequence and well doc-
umented phosphorylation sites [24]. Because a true standard for
how these CPP are reported has already been established, there
is no need to validate the assignment of peptides. Not all pre-
dicted masses, however, actually correspond to CPP. To reduce
the misidentification rate, the assignment and sequence of pep-
tides can be accomplished by MALDI-TOF post source decay and
LC–MS/MS, which are both able to identify phosphorylated amino
acids in the resultant mass spectra [25]. Because progress in mass
spectrometry in the field of proteomics is outside the scope of this
report, we mainly focus on the analysis of our hydroxyapatite-
based method, which specifically captures both phosphoproteins
and phosphopeptides aswell as eliminates the sample loss that can
occurwithelutionprior toMALDIanalysis [22]. Thishydroxyapatite
(HA)-based method provides a very efficient means to specifically
analyze microgranule-bound phosphoproteins and phosphopep-
tides.
2. Materials and methods
2.1. Materials and reagents
HA (Macro-PrepCeramicHydroxyapatite TYPE I)was purchased
from Bio-Rad (Milan, Italy). Tris(hydroxymethyl) aminomethane
hydrochloride (Tris–HCl), potassium chloride (KCl), urea, TFA, ACN
forHPLC, 85%orthophosphoric acid (PA), andammoniumbicarbon-
ate buffer (AMBIC) were purchased from Carlo Erba (Milan, Italy).
TPCK-treated trypsin from bovine pancreas was purchased from
Sigma (St. Louis, MO, USA). Sinapinic acid, sodium acetate trihy-
drate and 2,5-dihydroxybenzoic acid (DHB) were obtained from
Fluka (St. Louis, MO, USA). Acetic acid was purchased from Baker
Chemicals B.V. (Deventer, Netherlands). Alkaline phosphatase
(Grade I, 4000U) from calf intestine was supplied by Roche (Roche
Diagnostics, GmbH, Mannheim, Germany). Dithiothreitol (DTT)
was purchased from Applichem (Darmstadt, Germany). Water was
prepared using a Milli-Q system (Millipore, Bedford, MA, USA).
2.2. Sample preparation
Raw whole milk was collected from local dairy farms. The milk
was skimmed by centrifugation at 4000 rpm at 4 ◦C for 30min. Iso-
electric caseinwas prepared by the addition of 10% (v/v) acetic acid
to the resulting skim milk, followed by incubation for 30min at
35 ◦C and the subsequent addition of 1M NaOAc to produce a final
pH of 4.6. After an additional 30-min incubation, the suspension
was recentrifuged as above, the supernatant was discarded, the
casein was washed twice with buffer diluted 1:4 and twice with
Milli-Q water, and the sample was subsequently freeze-dried. The
shell proteins from fresh commercial egg chicken were recovered
according to the procedure previously described [26] from a local
store. The calcified layer was finely grinded and demineralized in
10% acetic acid at 4 ◦C for 24h with constant stirring. Insoluble
material was removed by centrifugation and the supernatant was
dialyzed against 5% acetic acid and lyophilized.
2.3. HA-based phosphoprotein/CPP enrichment
Lyophilized casein (10mg) was dissolved in 100!L of buffer
containing 50mM Tris–HCl, 0.2M KCl, 4.5M urea, and 10mMDTT,
pH 7.8. The casein solution was loaded onto 10mg of HA that
was previously packed with loading buffer. The HA-bound casein
was incubated for 15min at room temperature and centrifuged for
5min at 4000 rpm. The resin was successively washed with three
differentbuffers: 1mLof loadingbuffer, 1mLof50mMTris–HCl, pH
7.8 (washing buffer), and1mLof buffer containing 20mMTris–HCl,
pH 7.8 and 20% ACN (v/v). The resin was washed with 1mL of
Milli-Q water and freeze-dried with a SpeedVac concentrator sys-
tem (Thermo Electron, Milford, MA, USA). For eggshell proteins,
5mg/100!l buffer were loaded onto 5mg HA.
2.4. HA-based CPP enrichment
The HA-bound phosphoproteins/CPP enzymolysis was per-
formed in situ with trypsin, which was added to the suspension at
an enzyme/substrate ratio of 1:50 (w/w) in 50mM Tris–HCl buffer,
pH 7.8 containing 0.2M KCl, 4.5M urea, and 10mM DTT. The reac-
tionwas carried out at 37 ◦C overnight and stopped by centrifuging
the HA-CPP microgranules for 5min at 4000 rpm. The microgran-
uleswere thenwashed as described above for thephosphoproteins.
After washing with Milli-Q water, the microgranules were dried
with a SpeedVac apparatus.
2.5. MALDI-TOF MS
MALDI-TOF mass spectra were recorded using a Voyager DE-
PRO mass spectrometer (Applied Biosystems, Framingham, MA,
USA).Mass spectrawere acquired inpositive linearmodedue to the
known instability of CPP in the reflector mode [27]. This situation
is amplified by the multiply phosphorylated peptides generating
dephosphorylated peptide in the metastable decomposition [28].
In addition, the co-presence in high number of phosphorylated
peptides would complicate the reflector spectrum. Instead, inter-
pretation of the linear spectrum is straightforward, since it contains
only the [M+H]+ ion for each species. Moreover, higher molecular
weight peptides and phosphoproteins also show lower sensitivity
in the reflector mode than in the linear mode due to longer flight
path and action of reflector [29]. Finally, the LC–ESI–MS/MS exper-
iments were carried out to confirm the assignment of CPP identity
[30]. The spectra were acquired in the range of 15–30kDa (for pro-
teins) and 1–5kDa (for peptides) with the following settings: an
accelerating voltage of 25kV (for proteins) or 20kV (for peptides)
and a grid voltage of 93% (for proteins) or 95% (for peptides) of
the accelerating voltage, a guide wire of 0.15% (for proteins) or
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Fig. 1. Schematic representation of the HA-based technique for phosphoprotein enrichment. Phosphoproteins bind to HA through their phosphate groups, while the
non-phosphorylated components are removed using washing buffers. The dried HA-phosphoprotein microgranules are then analyzed directly by MALDI-TOF after co-
crystallization with sinapinic acid in an appropriate quantity of trifluoroacetic acid. !=phosphate group.
0.05% (for peptides), and a delayed ion extraction time of 485ns
(for proteins) or 175ns (for peptides). The laser power was set just
above the ion generation threshold to obtain peaks with the high-
est possible signal-to-noise ratio. All spectra were acquired with
200 shots in three replicates. Two different matrix solutions were
freshlymade eachday fromstocks of the required solvents and son-
icated for15min inanultrasonicwaterbath (Bransonic220,Mazian
Med Equip, Toronto, Canada) prior to use. The sample/wash (SW)
method was based on the sample/matrix/wash (SMW) method
described by Zhang et al. [31], with the exclusion of the wash step.
The HA-phosphoprotein microgranules (n=∼1000) were
deposited onto the MALDI plate, covered with the matrix solution
(10mg/mL sinapinic acid (SA) in 50% ACN, 1!L) to promote ana-
lyte/matrix co-crystallization and air-dried at room temperature in
the presence of increasing TFA concentrations (0.01%, 0.05%, 0.1%
and 0.5%). For HA-CPP, 1% PA was included in the matrix solution
(10mg/mL 2,5-dihydroxybenzoic acid (2,5-DHB) in 50% ACN) [32].
2.6. LC–ESI–MS/MS analysis
HA-CPP complexes (1mg) were solubilized with 120!L of 0.5%
PA and analyzed by a CapLC nano-flow high-pressure pump sys-
tem (Waters/Micromass, Manchester, UK) interfaced with a QTOF
Micromass spectrometer (Waters/Micromass) operating in the
positive ion mode. Chromatographic separations were performed
on a reverse phase Atlantis dC18 capillary column (75!m i.d.). The
mobile phase was water (A) and ACN (B) with 0.1% FA. A linear gra-
dient from5% to70%ofBwasapplied to thepre-columnandcolumn
over a 45-min period at a flow-rate of approximately 300nL/min
pre-column splitting using a pump operating at 5!Lmin−1. The
source conditions were as follows: capillary voltage, 2.6 kV; cone
voltage, 100V; and RF1 lens, 40V. Argon was used as the collision
gas in the ESI-MS/MS experiments for peptide sequencing. Raw
data were processed using MassLynx 4.0 ProteinLynx software.
2.7. Microscopic observation
The HA-CPP microgranules deposited onto a 96-well MALDI
target were observed by stereomicroscopy before and after
co-crystallization with the DHB matrix. The microscope (PBI
International, Milan, Italy) was equipped with a binocular head
illuminated with a 6-V, 20-W halogen lamp and a 100–230-V,
50/60-Hz power supply.
2.8. CPP de-phosphorylation
The HA-bound tryptic CPP complex (1mg) was treated with
15!L of a 5% aqueous PA solution to render soluble both the HA
and phosphorylated components. The solution was then loaded
on a Zip Tip C18 to obtain the salt-free phosphopeptide mixture
and freeze-dried in a SpeedVac apparatus. The residue was then
dissolved in a solution composed of 50!L 0.4% AMBIC, pH 9 and
1!L alkaline phosphatase (ALP) and incubated at 37 ◦C overnight.
The de-phosphorylated CPP diluted 10 times with 0.1% H2O/TFA
(1!L) was deposited in a MALDI well, covered with DHB matrix
(10mg/mL of the H2O/ACN/PA=49/50/1 solution) and allowed to
crystallize. Spectra were acquired as indicated above.
2.9. Phosphoprotein workflow
An integrated strategy for the experimental analysis of the
phosphoproteome combining MALDI-TOF analysis with the phos-
phoprotein enrichment steps is schematically illustrated in Fig. 1.
The suspension of HA microgranules in the loading buffer was
mixed with the protein solution to bind the target phosphory-
lated components to the adsorbent. The analytical method (Fig. 1)
requires six consecutive steps: (1) enriching and separating phos-
phoproteins using HA microgranules (HA: protein, 1:1 [w/w]); (2)
washing with the dilution/washing buffer to remove any non-
phosphorylated proteins from the casein-HA microgranule; (3)
drying the protein-HA microgranules; (4) loading the HA micro-
granules (n=∼1000) onto the multi-well MALDI target plate; (5)
covering themicrogranuleswith a sinapinic acidmatrix (10mg/mL
in 50% ACN) to promote co-crystallization of the analyte/TFA
(0.01–0.5%) mixture; and (6) in situ desorption of the phospho-
proteins by direct MALDI-MS analysis (Fig. 2).
2.10. Phosphopeptide workflow
Whole casein (or eggshell proteins) was converted to tryptic
digests for the selective enrichment of phosphorylated pep-
tides using HA chromatography (Fig. 3). Preliminary experiments
revealed that the highest CPP yield was obtained using a 1:1
HA-to-protein ratio (w/w), a 1:50 trypsin-to-protein ratio (w/w)
and an 18-h digestion period. After addition of trypsin to the
protein-HA microgranules, the supernatant, which contained
non-phosphorylated tryptic peptides and trypsin, was discarded.
The residue was sequentially washed with a loading/washing
buffer/water solution, recovered by centrifugation and freeze-
dried. The resultant dried phosphopeptide-HA microgranules,
mixed with a DHB and 1% PA solution, were left to co-crystallize
on a MALDI target plate and directly analyzed by MALDI-TOF.
This version of the protocol could further speed up our previously
developed procedure requiring phosphopeptide elution from HA
beforeMSanalysis [22]. Briefly,microgranulesdepositedon the tar-
get were covered by matrix solution containing 1% H3PO4, which
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Fig. 2. Schematic representation of the co-crystallization of HA-bound casein with
the sinapinic matrix on the MALDI target plate in the presence of increasing con-
centrations of TFA (0.01%, 0.05%, 0.1% and 0.5%).
dissolved the HA-captured CPP or eggshell phosphopeptides and
making their analysis by MALDI possible.
3. Results
The identification of phosphoproteins by MALDI-TOF is not as
straightforward as the identification of proteins due to their rela-
tively lowabundance, the variance in phosphorylation sites and the
possible presence of phosphatases. Given that de-phosphorylation
could occur even as the sample is processed, the results also
depend on the specific activity of alkaline phosphatase. There-
fore, phosphatase-free isoelectric casein was selected to study the
specificity of interactions with HA. HA possesses pairs of positively
charged C-sites and negatively charged P-sites [33] that are capable
Fig. 3. Schematic representation of the HA-based CPP enrichment technique.
HA-bound phosphoprotein enzymolysis is performed in situ with trypsin, and
non-phosphorylated peptides are released in the flow-through. The dried HA-CPP
microgranules included in the co-crystallizationmatrix are analyzed byMALDI-TOF
directly on the MALDI plate, as indicated in Fig. 2.
Fig. 4. Experimental scheme for the direct MALDI-MS analysis of phosphoproteins
and CPP bound to HA microgranules. The samples were analyzed as follows. An
aliquot of the solution containing casein and/or its derivative peptides was mixed
with the HA microgranules to capture the phosphorylated components. Another
aliquot containingHA-boundcaseinor trypticCPPwas spottedon the target, covered
with the MALDI matrix solution containing exogenous acids (TFA for phosphopro-
teins, shown in yellow; PA for CPP, shown in violet) and the protein/peptide ions
desorbed from the MALDI-TOF matrix. The HA-based protein/peptide enrichment
procedurewas tested usingMALDI-TOF to discriminate the phosphoanalytes in two
distinct mass ranges. The presence of phosphoanalytes in the mixture was verified
through phosphate-specific reactions (e.g., sensitivity to alkaline phosphatase). (For
interpretation of the references to color in this figure legend, the reader is referred
to the web version of the article.)
of interacting, under a wide range pH levels, with the side chain
groups of proteins/peptides. These characteristics allow the HA
surface to bind proteins with different pI [33]. In this study, HA
was first tested for its ability to bind the four major casein fam-
ilies through their variable number of phosphate groups present
in concentrations ranging from 1 to 13moles/molecule [21]. The
suspension of HA-bound casein complexeswas then assayed for its
susceptibility to trypsin in comparison to native casein in solution.
The detailed procedure for the phosphoprotein/phosphopeptide
enrichment and optimization is outlined in Fig. 4.
3.1. Analysis of phosphoproteins
Using the strategy depicted in Figs. 1 and 3, hydroxyapatite
was tested for its ability to chelate casein and be used in the sub-
sequent characterization of captured proteins using MALDI-TOF.
Using 0.01% TFA, those casein components with a low number
of phosphate groups were desorbed first from the on-bead HA
microgranules. The resulting spectral signals were assigned to the
corresponding!-CN 1P variant A and"-CN (Fig. 5, panel a; Table 1),
while those with multiple phosphorylation sites were desorbed by
theadditionof10-fold concentratedTFA (Fig. 5, panel b). The results
indicate that HA captured all casein fractions. Among the weakly
HA-bound fractions, the caseins with a low number of phospho-
rylation sites were desorbed first. Almost exclusively !-CN could
be desorbed by the inclusion of 0.005% TFA in the MALDI matrix
(Supplemental Figure S1). In addition, !-CN had been previously
found to elute first from a HA column using a buffer with a low
phosphate concentration (5mM) [21]. Based on the rationale that
the casein can be fractionated according to the phosphate concen-
tration of the eluent, a HA-based chromatographic method was
developed [22] to separate low- and high-phosphorylated CPP. If
this fractionation does not really apply to such CPP, however, the
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Fig. 5. MALDI-TOF analysis of phosphoproteins desorbed from HA microgranules by 0.01% TFA (a) or 0.1% TFA (b).
HA-boundpeptidesmightall beelutedsimultaneously [22]. Indeed,
HA-bound proteins can all be recovered by an adsorbent collapse
through TFA addition to the MALDI matrix. Because this procedure
does not require any prior chromatographic separation of the phos-
phoproteins, it canbeassumedtoenablea single-step identification
of the HA-bound phosphoproteins by comparing the measured
mass to the theoretical mass (Table 1). More precisely, four cou-
pled casein fractions, each with differing numbers of phosphate
groups were identified (Table 1). !-CN A1 and A2 differed by the
additional amino acid substitution His67 (!-CN A1)→Pro67 (!-CN
A2). Notwithstanding the presence of !-CN in amounts three-fold
higher than those of theheavily phosphorylated"s2-CN, the ioniza-
tion of the latter is not completely suppressed with respect to that
of !-CN. The results demonstrate that MALDI-TOF MS is capable of
identifying on-bead, immobilized casein fractions with single and
multiple phosphorylation sites. Although casein is a well known
model phosphoprotein, the method could present some limita-
tions inmore complex biologicalmatrices.We tested the analytical
power of our procedure by submitting the eggshell proteins to HA
enrichment as shown in Fig. 10. Herein, theMALDI spectrum of the
HA-bound eggshell phosphoproteins was more complex than that
of casein showing several overlapping signals (Fig. 10). Undoubt-
edly, the procedure described herein has advantages over previous
methods due to its simplicity, straightforwardness and reduced
work-up. Using this method, analytical tests for the detection of
multiple phosphoprotein markers can be developed.
3.2. Tryptic digestion and HA-based CPP enrichment
The casein digestion yielded the expected ratio of mono-
to penta-phosphorylated CPP, irrespective of protein weight
Table 1
List of the casein fractions identified in the MALDI-TOF spectra shown in Fig. 5.
Phosphoprotein Theoretical mass (Da) Measured mass (Da)
#-CN 1Pa,b 19,037.6 19,025.7
"s1-CN 8Pa 23,614.9 23,612.8
"s1-CN 7Pa 23,534.9 23,532.9
!-CN A1 5Pa,b 24,022.4 24,020.7
!-CN A2 5Pa 23,983.4 23,980.3
!-CN A1 4Pa 23,942.4 23,940.0
!-CN A2 4Pa 23,903.4 23,900.9
"s2-CN 12Pa 25,308.5 25,306.5
"s2-CN 11Pa 25,228.5 25,226.3
a,bSignals occurring in the MALDI spectra from Fig. 5, panels a and b, respectively.
A1 and A2, bovine !-casein A1 and A2 variants, respectively.
(1–10mg), bound to the same quantity of HA (1mg, Supplemental
Figure S2). In complex mixtures, the signals of highly phos-
phorylated peptides are usually suppressed by those of non-
phosphorylated peptides [4]. The analysis of the tryptic casein
digest without any prior enrichment (Fig. 6, panel a) revealed
a number of prominent signals that were assigned to non-
phosphorylated tryptic peptides. Four signals represented the
non-phosphorylated peptides "s1-CN (f91–100; m/z 1267), "s1-
CN (f8–22; m/z 1759), "s1-CN (f23–34; m/z 1383.7) and "s1-CN
(f133–151; m/z 2316.1). The high level of these peptides in the
washes (Fig. 6, panel b) accounts for their scarce affinity for
HA. This result confirms once again the low interaction of non-
phosphorylated peptides and the attenuation of C-sites by the
inclusion of 20% ACN in the HA loading/washing buffer [22]. In
vitro, a solution of salts in milk concentrations containing !-
casein (f1–25) 4P tryptic CPP caused the spontaneous formation
of calcium phosphate nanoclusters [34]. In milk, nanometer-sized
clusters of calcium phosphate are sequestered within the casein
micelles that have a larger colloidal dimension [35]. Therefore,
CPP would be expected to compete in a similar fashion as phos-
phoproteins with regard to the adsorption on HA C-sites. Indeed,
the MALDI-TOF mass spectra confirmed that the phosphorylated
peptides were selectively sequestered by the adsorbent (Fig. 7).
Trials were conducted to determine the best methods for sam-
ple and matrix preparation. The microscopic images of HA-CPP on
the MALDI well (Fig. 8, panel a) did not show signs of structural
modification in detectable amounts with respect to HA (data not
shown). Moreover, microgranule aggregation in the matrix solu-
tion was effectively prevented by employing dried HA-CPP. The
matrix solvent rapidly evaporated, yielding crystals with a large
surface area. As a consequence, the HA-CPP microgranules dis-
tributed within the DHB crystal matrix showed homogeneously
sized needles (Fig. 8, panel b). HA-bound CPP complexes were
checked by direct MALDI-TOF analysis of either microgranules
internalized into the acidified matrix or in solution. The resul-
tant spectra showed CPP peaks at the expected m/z with only a
few changes in their heights (Supplemental Figure S3). Further-
more, ionization was optimized by the presence of Arg and Lys in
C-terminal positions, which facilitated the identification of tryp-
tic peptides by MALDI-TOF. The inclusion of 1% PA in the MALDI
matrix solution improved the ionization efficiency for phosphory-
lated peptides in the mixture [32]. MALDI signals were improved
by the use of 1% PA in this study compared to 0.1% TFA. Spec-
tra were manually annotated, and the identification of tryptic
CPP was confirmed by using the FindPept tools available at the
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Fig. 6. Mass spectra of tryptic digests obtained after in situ hydrolysis of the HA-bound casein (a) and water soluble peptides from the last wash with 20mM Tris–HCl, pH
7.8 containing 20% ACN (v/v) (b).
Fig. 7. Mass spectra of HA-bound CPP co-crystallized with the DHB matrix containing 1% PA. The components are identified in Table 2.
www.expasy.ch site (http://www.expasy.org/tools/findpept.html).
As expected, the enriched CPP fraction contained a large num-
ber of peptides containing multiple phosphorylation sites (up to
five phosphate groups/molecule, Fig. 9 and Table 2) and no non-
phosphorylated peptides. The data shown in Table 2 emphasize
the importance of the enrichment step for the identification of
tryptic CPP. The MALDI-TOF spectra (Fig. 9) definitely confirmed
the identity of casein-derived tryptic CPP complexes on the basis
of the expected masses. Alternatively, alkaline phosphatase action
reduced the number of candidate peptides, leading to the char-
acteristic 80-Da mass shift that corresponds to –HPO3 group loss
or multiple integers. Thus, a simplified MALDI spectrum contain-
ing exclusively non-phosphorylated peptides was obtained (Fig. 9,
panel b). The number of P groups was calculated by the n (80-Da)
mass shift. The masses of native peptides were missing after the
alkaline phosphatase treatment (Fig. 9, panel a), and the tryptic CPP
annotatedwith respect to those expected (in parentheses) (Table 2)
that were raised from !-, "s1-, and "s2-CN were 6 (2), 7 (3), and
Fig. 8. Stereoscopic microscope images of HA-CPP complexes on the MALDI plate before (a) and after co-crystallization (b) of the HA-CPP sample with the DHBmatrix in PA
solution.
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Fig. 9. Mass spectra of HA-bound CPP (a) co-crystallized with the MALDI DHB matrix containing 1% PA or (b) fully de-phosphorylated using alkaline phosphatase.
10 (5), respectively. Neither GMP nor other tryptic !-CN peptides
were detected in the casein digest. The peptide modification (e.g.,
partial de-phosphorylation, oxidization and N-terminal residue
pyroglutamination) that occurred in the tryptic digests could
explain the increased number of CPP complexes that are derived
from the same phosphoprotein. For egg phosphoproteins in situ
trypsinolysis allowed to obtain HA-bound phosphorylated tryptic
peptides as shown in MALDI spectra (Fig. 11, Table 3). Fourteen
HA-bound tryptic phosphopeptides derived from 5 phosphopro-
teins were identified and some were partially dephosphorylated
as apparent from the characteristic 80-Da mass difference. The
number of peptides is partially consistent with the long list of
tryptic eggshell phosphopeptides recently reported [26]. Identifica-
tion of ovocleidin-116- and osteopontin-derived phosphopeptides
confirmed the co-presence of eggshell phosphoproteins with
multiple phosphorylation consensus sequences. The function of
these modifications is unknown although the phosphorylation
sites are preserved in the multiple phosphorylated proteins [26].
Table 2
List of the HA-bound tryptic native and de-phosphorylated CPP complexes identified in the MALDI spectra shown in Fig. 9.
Molecular mass (Da) Number of phosphate groups CPP identity
HA-bound CPP De-phosphorylated CPP
Expected Measured Expected Measured
1410.1 1411.1 1251.3 1252.3 2 "s2 (f126–136)
1466.1 1467.1 1385.6 1386.4 1 "s2 (f138–149)
1539.4 1540.0 1378.6 1379.4 2 "s2 (f126–137)a
1660.7 1661.1. 1580.7 1581.4 1 "s1 (f106–119)
1846.1 1847.0. 1766.7 1767.4 1 "s1 (f43–58)
1927.8 1928.0. 1766.7 1767.4 2 "s1 (f43–58)
1943.8 1944.2 1782.7 1783.4 2 "s1 (f43–58) +M (O)
1952.0 1952.0 1872.1 1872.3 1 "s1 (f104–119)
2060.1 2062.1 1981.8 1982.2 1 # (f33–48)
2158.8 2159.1 1998.8 1998.8 2 "s2 (f42–59)a
2238.8 2239.4 1998.8 1998.8 3 "s2 (f42–59)a
2410.8 2411.3 2170.9 2170.9 3 "s2 (f2–20)
2432.4 2432.1 2352.1 2352.0 1 # (f30–48)a
2490.8 2491.2 2170.9 2170.9 4 "s2 (f2–20)
2539.0 2539.1 2299.0 2299.2 3 "s2 (f2–21)
2598.0 2598.0 2438.1 2438.3 2 "s1 (f37–58)a
2618.1 2619.0 2299.0 2299.2 4 "s2 (f2–21)
2678.0 2678.0 2438.1 2438.3 3 "s1 (f37–58)a
2703.1 2703.1 2304.0 2304.3 5 "s1 (f59–79) pyroQ
2720.1 2720.1 2321.0 2321.3 5 "s1 (f59–79)
2746.1 2747.1 2427.1 2427.7 4 "s2 (f1–21)a
2759.6 2760.5 2439.2 2439.5 4 "s1 (f62–83)a
2855.0 2855.0 2695.2 2695.8 2 "s1 (f35–58)a
2886.0 2886.0 2646.3 2646.2 3 # (f2–25)
2935.0 2935.0 2695.2 2695.8 3 "s1 (f35–58)a
2966.0 2966.0 2646.3 2646.2 4 # (f2–25)
3007.1 3007.0 2688.2 2688.2 4 "s2 (f46–70)
3088.0 3087.0 2688.2 2688.2 5 "s2 (f46–70)
3042.0 3043.1 2802.4 2802.2 3 # (f1–25)a
3122.0 3122.0 2802.4 2802.2 4 # (f1–25)a
3132.0 3131.4 2812.3 2812.5 4 "s2 (f1–24)a
3448.3 3445.9 3128.4 3126.4 4 "s2 (f1–27)a
3477.1 3476.9 3157.6 3157.0 4 # (f1–28)a
3605.1 3605.0 3285.7 3285.4 4 # (f1–29)a
a Peptide with tryptic cleavage sites that were missed.
M, methionine oxidation.
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Table 3
List of the HA-bound tryptic phosphopeptide complexes from eggshell phosphoproteins identified in the MALDI spectra shown in Fig. 9.
Theoretical mass Measured mass M[H+] (Da) Identification Phosphate number
1806.9 1807.4 Ovocleidin-17 (f47–62) 1P
2275.2 2276.8 Ovocleidin-17 (f53–74) 2P
2089.1 2090.1 Ovalbumin (f340–359) 1P
1826.7 1827.0 Ovocleidin-116 (f704–719) 1P
1905.6 1906.6 Ovocleidin-116 (f704–719) 2P
1986.6 1986.7 Ovocleidin-116 (f704–719) 3P
2148.3 2148.6 Ovocleidin-116 (f389–407) 1P
3137.1 3138.7 Ovocleidin-116 (f690–719) 2P
3217.1 3218.7 Ovocleidin-116 (f690–719) 3P
3297.1 3298.6 Ovocleidin-116 (f690–719) 4P
1887.9 1888.0 Osteopontin (4–19) 1P
1966.8 1967.5 Osteopontin (4–19) 2P
1957.8 1958.7 Osteopontin (8–22) 3P
2147.0 2148.6 Ovocalyxin-32 (221–241) 1P
These authors have identified 39 phosphoproteins including low
abundance components containing at least 155 different phospho-
rylation sites with a ratio of pS/pT/pY of approximately 90:10:1.
We were able to identify only 5 high abundance phosphopro-
teins and 14 derived phosphopeptides each containing only the
phosphorylation site pS. In-depth study using fresh material and
use of alternative trypsin enzymes able to access hindered sites
to trypsin could afford the enrichment of more low abundance
peptides.
3.3. Localization of phosphate residues in CPP
The determination of phosphorylated site(s) could be impor-
tant for the establishment of the functional consequences of
the phosphorylation. In many cases, peptide flexibility depends
on the phosphorylated sequence (e.g., participation of the phos-
phorylated loop in a protein-protein interaction or reposition of
loops after de-phosphorylation). Fragmentation of the MS1 pre-
cursor ions by LC–ESI–MS/MS for the selective detection of CPP
ordinarily exhibits a strong neutral loss, although not for all phos-
phopeptides, when collisionally activated in positive mode [36].
For all chromatographic peaks, the fragmentation provided the
sequence information that was used to ultimately identify the
phosphorylated peptide. Supplemental Figures S4–S9). The !s2-
CN (f138–149) 1P peptide, which contains the residues Thr138
and Ser143 as candidates for phosphorylation, only had Ser143
phosphorylated (Supplemental Figure S4). Moreover, the !s2-CN
(f126–137) 2P peptide, which contains Ser129, Thr130 and Ser131
residues, had PSer129 and PSer131, but not Thr130, phosphorylated
(Supplemental Figure S5). This result was confirmed by the pres-
ence of PSer129, PSer131 and non-phosphorylated Thr130 in the
peptide !s2-CN(f126-136) 2P, which was longer by one residue.
Further examples of peptide sequences with a lower number of
phosphorylated Ser than was expected were !s1-CN (f43–58) 1P
and 2P, in which the candidate residues were Ser46 and Thr49,
with the phosphorylation of both resulting in the 2P form or phos-
phorylation of only Thr49 resulting in the 1P form (Supplemental
Figures S7 and S8). The co-presence of !s1-CN(f35–58) 2P and 3P,
!s1-CN (f37–58) 2P and 3P, and "-CN (f1–25) 4P and 3P peptides
(Supplemental Figure S9) provided confirmatory evidence of par-
tially phosphorylated parent casein fractions. Given these data, the
application of tandem MS/MS represents a major improvement
in peptide identification with respect to probability-based Data-
bank searches by resolving the problem posed by the presence
of multiple phosphorylation sites for proper peptide characteriza-
tion.
Whether the MALDI or LC–MS/MS technique was applied to
large-scale phosphoproteomics, a high number of phosphorylated
peptides immobilized on HA microgranules could be detected.
3.4. Quantification and recovery of CPP
In order to quantify the casein-derived tryptic CPP using HA
beads, two synthetic peptides, a natural and the modified coun-
terpart that differed by single amino acid substitution, were used
as internal standards (IS) (Table 4). The bovine !s1-CN (f43–58)
2P, the most abundant CPP in the phosphopeptide mixture, was
chosen to evaluate the recovery of CPP. The Ile44→Gly44 amino
acid substitution in the peptide analogues were introduced to give
rise to a distinct mass MALDI signal, without appreciable pertur-
bation of the ionization efficiency. The 0.9/1.0 quasi-equimolar
peptide mixture yielded a very similar MALDI ionization efficiency
(Supplemental Figure S10). In this manner, the natural peptide
analogues were able to function appropriately as IS. A constant
concentration (10#g/#l) of synthetic modified peptide was used
to spike solutions containing different concentration of synthetic
natural peptide (Supplemental Figure S11). Using synthetic nat-
ural/modified area ratio, obtained by integration via software, a
calibration curve was built up as a function of their concentra-
tion ratio (Supplemental Figure S12). The combined data yielded a
linear calibration curve, y=1.1147x+0.1001 (R2 =0.967) (mean of
10 replicates) for !s1-CN (f43–58) 2P. Standard deviations for the
measurements are indicated by error bars (Supplemental Figure
S12). For quantification purposes, IS (1#g) was added to HA-CPP
complex (1mg) and solubilized with a 0.5% aqueous PA solution.
The amount of !s1-CN (f43–58) 2P derived from whole casein
(0.05mg)was found tobe920ng (Supplemental Figure S13). There-
fore, the use of defatted milk tryptic digests in amount as low
as 0.1–100#l/mg dried HA allowed to detect 0.027–27ng !s1-CN
(f43–58) 2P. This means ∼70% CPP recovery from either milk or
casein (Figs. 10 and 11).
4. Discussion
Using the procedure described above, HA-bound phos-
phorylated peptides did not contain any non-phosphorylated
casein-derived $2- and $3-CN peptides. The new approach worked
Table 4
List of synthetic native and modified peptides used as internal standard. The
amino acid residues differentiating synthetic analogue from natural tryptic CPP are
underlined.
!s1-CN peptide Synthetic native
peptide [M+H]+
Native sequence
(f43–58) 2P 1926.7 DIGS(P)ES(P)TEDQAMEDIK
!s1-CN peptide Synthetic modified
peptide [M+H]+
Modified sequence
(f43–58) 2P 1870.6 DGGS(P)ES(P)TEDQAMEDIK
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Fig. 10. MALDI-TOF analysis of eggshell phosphoproteins desorbed from HA microgranules.
well with egg proteins as MALDI spectra did not contain non-
phosphorylated peptides in appreciable amounts. Therefore, the
proposed procedure and our application can accommodate a wide
variety of biological matrices.
Various strategies for the enrichment of phosphopeptides based
ondifferent chemical strategieshave improved theoverall recovery
of low-abundance proteins. Amongst the strategies for selec-
tive enrichment of phosphoproteins/phosphopeptides, the IMAC
(Fe3+)-based techniques have been claimed to allow recovery up
to 90% of phosphoproteins [37]. These methods could be coupled
to other fractionation steps to improve the overall recovery of
low-abundance proteins. Ourmethod is more selective, more cost-
effective and faster than any IMAC-based method as it is based
on one-step procedure inclusive of enrichment on HA and MALDI
analysis. Using a phosphorylated peptide analogues as internal
standard, !s1-casein was recovered up to 70% working either on
milk or derived casein.
In addition, when HA was deliberately overloaded with phos-
phoanalytes to saturate the adsorbent, the number of identified
CPP complexes did not vary, demonstrating a lack of preferen-
tiality amongst CPP absorption (Supplemental Figure S2). The
role of exogenous acid addition is important because its omis-
sion resulted in a complete lack of phosphoprotein signals in the
Fig. 11. Mass spectra of tryptic digests obtained after in situ hydrolysis of the HA-
bound eggshell proteins. The non-phosphorylated peptideswere eluted bywashing
buffer and the HA-bound CPP identified by FindPept tools and literature data [35].
MALDI matrix spectra. To achieve the goal of detecting weakly
phosphorylated species, very low TFA concentrations have to be
used. In contrast, more tightly bound proteins could be succes-
sively eluted by increasing concentrations of TFA. As in the classical
method for casein fractionation, the phosphorylated members of
this protein family were fractionated into sub-mixture pools by
controlling the desorption process on the MALDI plate. Basically,
the in situ fractional desorption of casein is controlled by the level
of phosphorylation, which also governs the affinity of CPP for HA.
Trypsinolysis released CPP according to the reactivity of the lysine
residues of the individual caseins that were either HA-bound or
in solution in the expected number. Only "-CN CPP was missing
in the HA-bound CPP because hydrolysis of "-CN by trypsin can
be insignificant [38]. Our results demonstrated that CPP could be
enriched for MS analysis within only a few minutes, showcasing
the outstanding enrichment capacity of HA. Two different mass
range acquiring analysis could be performed to demonstrate that
the co-existing bound phosphoproteins and CPP can be identified
in two separated zones of the MALDI spectra. Conversely, enzyme-
mediated CPP have been isolated from cheese and characterized
by MS [39,40], but the isolation procedures used in those studies
were long, tedious, cumbersome and not suitable for the analy-
sis of a large number samples. Our procedure has the advantage
of capturing phosphoproteins on HA and identifying the in situ
immobilizedCPPbydirectMALDIanalysiswitheasy samplemanip-
ulation. This procedure circumvents the leakage of CPP by in situ
desorption on the MALDI plate. Controlling the desorption process
to theequilibriumpoint atwhich therearenophosphoproteins/CPP
still binding HA, the procedure can be used for quantitative
purposes either for CPP or non-phosphorylated peptides con-
centrated to a known volume, provided that internal standards
are available. In summary, for the first time, HA-immobilized
phosphoproteins/CPP are directly analyzed on-bead by MALDI-
TOF MS without requiring a prior elution of the phosphorylated
components. This procedure demonstrates several possibilities:
(1) detecting phosphorylated proteins/peptides even in complex
mixtures, (2) determining phosphorylated and de-phosphorylated
sites, and (3) attaining information about both weakly and heav-
ily phosphorylated peptides. All of our results indicate that this
2678 G. Pinto et al. / J. Chromatogr. B 878 (2010) 2669–2678
method will allow proteins/peptides with different level of phos-
phorylation to be accurately measured. The time required for the
HA-based procedure, from the application of the soluble protein
mixture to the readoutof theMALDI spectra, is less than2h (exclud-
ing the trypsinolysis step). The development of such a specific
strategy opens up the possibility for quantitative applications in
phosphoproteomics.
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The possibility of detecting extraneous milk in singles species cheese-milk has been explored. A
mass spectrometry (MS)-based procedure has been developed to detect ’signature peptides’, corre-
sponding to the predefined subset of ’proteotypic peptides’, as matchless analytical surrogates of the
parent caseins. Tryptic digests of skimmedmilk samples from four species were analyzed bymatrix-
assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS. Amongst the candidate sig-
nature peptides that are able to differentiate milks from the four species, the as1-casein (CN) f8-22
peptide was selected as a convenient marker for bovine, ovine andwater buffalo milk while the f4-22
peptide was selected as a marker for the two caprine as1-CNA and B variants, which differ by a Pro
16
(B)->Leu16 (A) substitution. MALDI analysis of the digest allowed the detection of as1-CN f8-22 and
caprine as1-CN f4-22. The accurate evaluation of caprine milk in a quaternary mixture required the
development of a liquid chromatography/electrospray ionization (LC/ESI)-MS procedure. Five
synthetic signature peptide analogues, which differed from their natural counterparts by a single
amino acid substitution, were used as internal standards to quantify the as1-CN, whichwas chosen as
a referencemilk protein, from the different species. The limits of detectionwere 0.5% (1% for caprine)
for either theMALDI or the LC/ESI-MSmethod. The isotopic-label-free quantification of isoform- or
variant-specific signature peptides has disclosed a convenient approach for targeting proteins in
complex mixtures. Copyright # 2010 John Wiley & Sons, Ltd.
The use of non-bovine cheese milks contaminated with
cheaper all year long available bovine milk constitutes a
violation of the law regulating mono-species cheese, which
must be free of any foreign milk(s). In order to satisfy the
growing demand of consumers within European Union or
abroad, fraudulent substitution with bovine milk in the
manufacturing of water buffalo mozzarella cheese is
drastically increasing, especially during the summer peak
lean periodwhenmilk shortages occur. To give an idea about
the proportion for the adulterations of traditional Protected
Designation of Origin (PDO) Mozzarella di Bufala Campana,
according to official data from the Italian Ministry of
Agricultural, Food and Forestry Policies, nearly 10% of
sampled commercial cheese could be irregular for bovine
milk content ranging up to 30%.
The exclusive use of sheep’s milk is mandatory in the
manufacturing of several traditional worldwide diffused
high-grade ovine European PDO cheeses. Typical examples
are Feta cheese from Greece, Roquefort from France,
Idiazabal from Spain, and Pecorino Romano, Fiore Sardo,
Pecorino Sardo, Pecorino Toscano and Canestrato Pugliese
from Italy. Addition of cheaper cow’s milk to goat’s milk is
another common practice in cheese-making.1 The availability
of caprine and ovine milk is also subjected to seasonal
fluctuations. European legislation imposes to adequately
label the combined use of sheep’s and goat’s milk in cheeses,
which implies the loss of the PDO qualification. To protect
consumers from fraudulent practices, authenticity of the
cheese needs to be validated. Thus, an analytical method-
ology is required to verify the absence of any contaminating
milk in the target milk/cheese. Intensive research has
focused on the discovery of appropriate markers and relative
methods for detecting adulterating milks/cheeses. For this
purpose, quick immunological tests, chromatographic tech-
niques, and electrophoretic methods have been proposed.
The determination of IgG for the rapid detection of raw,
pasteurized and sterile bovine milk has been recommended
for immediate decision-making (!20 min).2 An indirect,
competitive enzyme-linked immunosorbent assay (ELISA)
has also been developed for the detection of bovine milk in
that of different species using anti-bovine IgG antibodies.3,4
No test kit is presently available for the simultaneous
detection of the four animal species in a milk sample. Bovine
milk adulterating water buffalo milk has been recognized by
high-performance liquid chromatography (HPLC) separ-
ation using the bovine marker b-lactoglobulin A.5 Similar
procedures have been developed for detecting bovinemilk in
binary6 or tertiary milk mixtures by capillary electropho-
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resis.7 Currently, cheese made from non-bovine milks is
considered adulterated when the error in the evaluation of
the extraneous milk does not exceed 1%.8 Fast detection
of bovine a-lactalbumin and b-lactoglobulin in water
buffalo and ovine milk using matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS) has recently been reported.9 Heating
milk over a wide range of temperatures/times denatures
whey proteins while the stability of caseins is not greatly
affected. For this reason, caseins rather than heat-denatured
whey proteins are better targets for the detection. Proteome
studies have not been widely developed as analytical tools in
solving problems relevant to milk adulteration. For complex
milk mixtures especially, such methods may not provide a
satisfactory response in identifying all the components.
Presently, the European Union reference method is based on
the detection of bovine g2- and g3-CN by gel isoelectric
focusing (IEF).8 A version using anti-peptide antibodies has
improved the bovine level detection to 0.2%10 and simplified
the IEF profile, by showing almost exclusively the g2-CN
band.11,12 A single electrophoretic test, which can specifically
discriminate between ovine and caprine milks, is not
available. Mass spectrometry has been increasingly used
to resolve highly complex protein mixtures. On the other
hand, any unfavorable analytical response requires confir-
mation by a subsequent technique or method. The European
Union has increasingly encouraged the diffusion of mass
spectrometry especially as confirmative technique to attest
cheese labeling. Angeletti et al.13 demonstrated the efficiency
of MALDI-TOF MS for the detection of bovine caseins in
water buffalo mozzarella cheese, through the relative
quantification of a ’X component’ exclusive of buffalo milk,
later identified as the buffalo b-CN f69-209.14 Here, a
MALDI-TOF-based method for the simultaneous detection
of casein-derived peptides in ternary (or quaternary) milk
mixtures is presented. To date, although a MALDI-TOF MS
analysis is generally applicable to the detection of any of the
peptides selected as markers, an on-line liquid chromatog-
raphy/electrospray ionization (LC/ESI-MS) procedure was
developed to profile quaternary milk mixtures. This strategy
combinesmilk protein trypsinolysis, MS detection of species-
specific casein peptides and quantification using synthetic
peptide analogues as internal standards.
EXPERIMENTAL
Materials
Milk samples were collected from local herds. All chemicals
were of the highest purity commercially available and were
used without further purification. Ammonium bicarbonate,
trifluoroacetic acid (TFA), sinapinic acid (SA), a-cyano-4-
hydroxycinnamic acid (4-CHCA), and TPCK-treated trypsin
were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Sequencing-grade modified trypsin was purchased from
Promega (Madison, WI, USA). HPLC-grade H2O and
CH3CN were provided by Carlo Erba (Milan, Italy).
Sample preparation
Milk samples were manually expressed into sterile poly-
styrene containers, immediately frozen, and stored at!208C
until use, to prevent undesired proteolysis. Ovine/caprine
milk, containing 0 and 1% cow’s milk (CRM 599), was
utilized as an external reference material and was obtained
from the Institute for Reference Materials and Measure-
ments (Geel, Belgium). Skim milk was obtained by
centrifugation at 3000 g for 20 min at 28C (Labofuge 400R,
Heraeus Instruments, Hanau, Germany). After the fat had
been removed with a spatula, isoelectric casein was
prepared by precipitation, according to Aschaffenburg
and Drewry.15 Briefly, 10mL of skimmed milk was diluted
threefoldwith distilledwater, acidifiedwith 1mL 10% (v/v)
acetic acid and adjusted to pH 4.6 with 1 M sodium acetate
buffer. Samples were kept for 30 min at 378C and then
centrifuged (4000 g, 58C, 10 min). The casein precipitate was
washed twice with 150mM sodium acetate buffer, pH 4.6,
washed twice with cold acetone and finally with diethyl
ether. The air-dried isoelectric casein was then stored at
!208C until analysis. Quaternary mixtures of the four raw
milks (water buffalo, caprine, ovine and bovine milk) were
obtained by mixing the same volume of milk. To determine
the limits of detection, water buffalo milk was added to 0.5,
1.0, and 5.0% of each foreign milk sample. The ternary
mixtures of milk were obtained similarly, except that
caprine milk was omitted. Isoelectric casein from the milk
mixtures was obtained as described above. Mixtures of
trypsinized milk proteins were also prepared by mixing
together trypsinized mono-species milks.
Tryptic digestion of casein
Dry isoelectric casein (10mg) was dissolved in 4 g/L
ammonium bicarbonate at pH 8.5. TPCK-treated or sequen-
cing-grade modified trypsin, dissolved in the same buffer,
was added to the casein solution at an enzyme/substrate (E/
S) ratio of 1:50 (w/w) and incubated for 4 h at 378C. Six
samples of casein tryptic digests were prepared by varying
the reaction time and the trypsin-to-casein ratio (w/w). The
enzymatic reaction wasmonitored at 1, 2, 3, and 4 h at an E/S
ratio of 1:150, 1:100, 1:50, 1:40, 1:30, and 1:20. Samples were
freeze-dried and then re-dissolved in 0.1% TFA at a 2mg/mL
concentration.
Reversed-phase (RP)-HPLC/ESI-MS analysis
RP-HPLC-ESI/MS analysis was carried out using an HP1100
modular chromatographer (Agilent Technology, Palo Alto,
CA, USA) coupled on-line to a single-quadrupole MSD
(Agilent) apparatus. Aliquots (15mL) of the casein tryptic
digests were diluted to 100mL with 0.1% TFA and loaded
onto a Vydac reversed-phase C18 column (250mm, 2.1mm
i.d.). Peptide mixtures were separated by applying a linear
gradient from 5% to 60% of solvent B (0.1% TFA in
acetonitrile, v/v) over 60 min at a constant flow rate of
0.2mL/min; solvent Awas 0.1%TFA inwater (v/v). Column
effluent was monitored by UV detection at 220 nm. Mass
spectrawere acquiredwith a scan range fromm/z 400–2300 at
a scan cycle of 4.90 s per scanwith a 0.1 s inter-scan delay. The
source temperature was 1808C. Spectra were acquired in the
positive ion mode, while the capillary voltage and the cone
voltagewere set to 3.6 kV and 40V, respectively. N2was used
as both the drying and nebulizing gas at a flow rate of 10L/
min. LC/MS patterns were elaborated using the LC/MSD
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ChemStation Data Analysis Software A.08.03 supplied with
the instrument, which allows integration and calculation of
the area of the ion extracted peaks.
MALDI-TOF MS
MALDI-TOFMS analyses were performed on a Voyager DE-
Pro spectrometer (PerSeptive BioSystems, Framingham,MA,
USA) equipped with an N2 laser (l¼ 337 nm). For the
analysis of peptides resulting from the hydrolysis of
proteins, 4-CHCA was used as the matrix, which was
prepared by dissolving 10mg of 4-CHCA in 1mL of aqueous
50% (v/v) acetonitrile containing 0.1% (v/v) TFA. The
instrument operated with an accelerating voltage of
20 kV. External mass calibration was performed with the
signal of the matrix dimer at [MþH]þ¼ 379.05 and with
the monoisotopic masses of peptide standards,
including angiotensin I ([MþH]þ¼ 1296.68), ovine as1-casein
1-23 peptide ([MþH]þ¼ 2764.55) and bovine insulin
([MþH]þ¼ 5730.61), thereby achieving an accuracy in the
measurement of the peptide mass of better than 75 ppm. For
the analysis of peptides, the mass spectra were acquired in
the positive reflector ion mode using delayed extraction (DE)
technology. In the reflector ion mode, resolution at the full
width/half maximum of the peak was normally #5000.
Higher mass ranges were explored operating in the linear
positive ion mode, using SA (10mg/mL in 50% acetonitrile/
0.1% TFA) as the matrix. Raw data were elaborated using the
software program Data Explorer version 4.0 (Applied
Biosystems).
Peptide recognition
Signals in the mass spectra were assigned to the correspond-
ing tryptic peptides according to the expected molecular
mass from the known casein sequences, taking into account
enzyme specificity, using several bioinformatics tools, such
as the GPMAW 7.0 software (Lighthouse Data, Odense,
Denmark) or other on-line resources.
Synthesis of peptide analogues
All peptides were synthesized by solid-phase methodology
using the Fmoc (9-fluorenylmethyloxycarbonyl)/t-butyl
strategy on a Pioneer peptide synthesizer (Synthesis System
9050 instrument; PE-Biosystems, Framingham, MA, USA).
For quantification of bovine, water buffalo, sheep, and goat
as1-CN, the synthetic peptides shown in Table 1 were used as
internal standards. The identity of peptides purified by RP-
HPLC was assessed by MALDI-TOF MS. The convergent
indications of retention time and molecular mass helped to
localize the signature peptide of goat as1-CN variant A
within the LC/MS profile, while the corresponding area of
the extracted ion was used for quantification.
RESULTS AND DISCUSSION
In proteomic experiments, the mass spectrometric analysis of
proteolytic digests rarely provides complete protein cover-
age. Peptides of interest, predicted on the basis of cleavage
enzyme specificity, often escape detection whereas other
fragments originating from diverse protein regions exhibit
an intrinsically higher detectability. Although information
about protein isoforms or variants can be lost, the detection
of proteotypic or ’signature’ peptides is sufficient to establish
protein parentage, whether or not the protein sequence has
previously been reported. Monitoring a signature peptide as
an analytical surrogate for a specific protein has the
advantage, in general, of not requiring the proteolytic digest
to be fractionated prior to MS, as peptides are detected at
higher specificity and sensitivity than their parent proteins.
One of the challenges in the application of this process
involves the selection of a proteotypic set of peptides that
best represents the target proteins. Therefore, verification of
the authenticity of a single-species milk sample would
necessitate the in silico prediction and the empirical
monitoring of proteotypic peptides by the tryptic digestion
of bovine, caprine, ovine and water buffalo casein.
Four species casein trypsinolysis
A preliminary study was conducted to define the most
convenient operating conditions for the casein trypsinolysis.
After a 240min incubation at a trypsin-to-casein ratio of 1:40,
casein was completely hydrolyzed. The equivalent effect,
without a significant change in theMALDImass spectrumof
the hydrolysate,was obtainedusing a trypsin-to-casein ratio
of 1:20 for 60 min. Longer incubation may yield non-specific
cleavages by trypsin that are incompatiblewith an analytical
procedure that requires the shortest time-to-result possible.
To overcome these shortcomings, we compared the
performance of TPCK-treated and sequencing-grade modi-
fied trypsin during casein digestion and probed for the
formation of autolysis products. As expected, proteomic
grade trypsin minimized autolysis and enabled higher
enzyme-to-substrate ratios (e.g., 1:20 to 1:150), thus enhan-
cing digestion efficiency. The exposure to higher sequen-
cing-grade trypsin concentrations that yielded the highest
level of peptides during hydrolysis involved a time period
for incubation of at least about 1 hour at an enzyme-to-
protein ratio of 1:20 (w/w).
Table 1. Analytical data from the synthesized peptides used as internal standards. The amino acid residues differentiating
synthetic analogues from natural tryptic peptides are underlined
as1-CN peptide
Native peptide
[MþH]þ Sequence Modified sequence
Synthetic peptide
[MþH]þ
Bovine 8-22 1759.95 HQGLPQEVLNENLLR HQGGPQEVLNENLLR 1703.88 (Gly11)
Water buffalo 8-22 1687.92 HQGLPQGVLNENLLR HQGGPQGVLNENLLR 1631.86 (Gly11)
Ovine Var. C 8-22 1718.92 HQGLSPEVLNENLLR HQGGSPEVLNENLLR 1662.86 (Gly11)
Caprine 4-22 Var. B 2164.13 HPINHQGLSPEVPNENLLR HPINHQGGSPEVPNENLLR 2108.06 (Gly11)
Caprine 4-22 Var. A 2180.16 HPINHQGLSPEVLNENLLR HPINHQGLSPEALNENLLR 2152.16 (Ala15)
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The direct MALDI mass spectrum of the tryptic digest of
bovine casein (Fig. 1) uncovered several signals, indicated by
arrows on the peak tops, which were selected as possible
signature peptides for bovine casein. MALDI MS screening
was reiterated for caseins from the other three species, thus
defining a restricted set of intense and unique signature
peptides (Table 2). Due to the enhanced ion production of the
Arg-terminating tryptic peptides,16 the spectrum appeared
dominated by the as1-CN-derived peptides, even though as1-
CN and b-CN occur approximately at the same level of
abundance in whole casein. b-CN contains three Arg
residues, among which Arg1 is in part released as a free
amino acid by tryptic cleavage or integrated, together with
Arg25, in a hardly detectable fourfold phosphorylated
peptide. The Arg-containing peptide ion signal of b-CN
f191-202 at m/z 1383.74, generated by a chymotrypsin-like
cleavage, is among the most prominent signals. On the other
hand as1-CN contains six Arg residues, five of which (except
Arg1) generate peptides of optimal molecular size to be
detected by both MALDI or ESI-MS.
In separate experiments, defatted milk was directly
incubated with trypsin for various periods of time by
adjusting the enzyme-to-casein ratio. None of the spectra for
defattedmilk tryptic digests containedwhey protein-derived
signals at a significant intensity to interfere with the as1-CN
signature peptides (Supplementary Fig. S1, see Supporting
Information). This may be mainly attributed to either the
proportion of whey proteins to casein (!20:80) or the lower
susceptibility of non-casein proteins to proteases. Once the
origins of the prominent signals from the signature peptides
had been confirmed, the most convenient operating con-
ditions for mass spectrometric milk speciation using direct
Figure 1. MALDI-TOF MS analysis of the tryptic digests of bovine casein. The peptide ion signals for as1-CN f8-22 (MH
þ
1759.83) and b-CN f53-97 Var. A1 (MHþ 4865.22, inset) are indicated by arrows.
Table 2. List of measured and expected masses of eligible signature tryptic peptides from the four casein families in the bovine,
water buffalo, ovine and caprine species. Themost widespread genetic variants of caseins have been considered. Peptides in bold
are prominent in the MALDI spectra of the tryptic digests
Molecular mass
Peptide Bovine Water buffalo Sheep Goat
Measured
Mass (MHþ)
Expected
Mass (MHþ)
1384.92 1384.72 as1-CN(23-34) 1384.92 1384.92 - -
1306.74 1306.71 as1-CN(23-34) - - 1306.74 1306.74
1759.13 1758.94 as1-CN (8-22) 1759.13 1686.92 1718.92 -
2164.36 2164.12 as1-CN (4-22) - - - 2164.36 Var. B
2181.14 2180.15 as1-CN (4-22) - - - 2181.14 Var. A
2062.12 2060.84 b(33-48) P# 2062.12 2092.14 2062.12 2062.12
2710.62 2709.40 as2-CN (92-113) 2710.62 2710.62 - -
2693.42 2693.37 as2-CN (93-114) - - 2710.62 2693.42
2866.72 2865.50 as2-CN (92-114) 2866.72 2866.72 - -
2849.52 2849.47 as2-CN (93-115) - - 2866.72 2849.52
3113.72 3112.70 b-CN (69-97) 3113.72 3126.72 3152.82 3152.82
4839.32 4838.63 b-CN (53-97) 4864.62 A1 4824.72 A2 4852.82 4839.32 4839.32
#P: phosphorylation.
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trypsinolysis of defatted milk were a time period for
incubation of at least about 1 h at 378C at an enzyme-to-
casein ratio 1:20.
Selection of signature peptides
Figure 2 reports the four-species sequence alignments of the
most frequent genetic variants of as1-CN and b-CN. To select
convenient proteotypic peptides, as1-CN and b-CN have
been preferentially considered due to their prevalence in
milk. Table 2 reports the list of eligible proteotypic peptides,
based on sequence alignments of the four casein families
from the four species. Here the expected signature and
detected peptides for milks from different species are
compared. While trypsin releases the as1-CN f8-22 from
bovine, ovine and buffalo milk, the Lys4!Asn4 substitution
in caprine as1-CN results in the production of the longer
tryptic peptide f4-22. Furthermore, the caprine as1-CN f4-22
peptide could occur under two distinct molecular masses,
i.e., [MþH]þ 2164.13 (variant B) or 2180.16 (variant A)
(Fig. 3). Therefore, bulk caprine milk is typified by at least
two signature tryptic peptides, i.e., as1-CN f4-22 Pro
16(A) and
Leu16(B), because of the high frequencies of the parent
proteins.15,16 The measured mass of as1-CN f4-22 A and B
was consistent with that expected. Thus, the as1-CN f4-22
and f8-22 peptides were the most convenient signature
peptides for assessingmilk adulteration because (i) they have
Figure 2. Sequence alignment of the four-species as1- and b-casein (ClustalW
25). Proteotypic as1-casein peptides are to
be localized into the shadowed region. According to the Uniprot database, alignment of primary structure takes into
consideration the most frequent as1- and b-casein variants. The high degree of homology among the casein sequences
restricts the choice of the signature peptides to a few options.
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molecular mass values that are different enough to
distinguish casein from the four species; (ii) they are derived
from the major as1-CN fraction; (iii) they have strong
ionization efficiency values, which were empirically deter-
mined; (iv) their relatively small size makes it suitable to
obtain low-cost synthetic analogue peptides; (v) they lack,
apart from rare exceptions, post-translational modifications,
which would complicate quantification; and (vi) they have
very few neighboring basic amino acids on either side of the
peptide (e.g., KRXX or XXRK), which might yield trypsin-
missed cleavages. MALDI spectra for the tryptic digests of
the four single-species milks are shown in Figs. 4(a)–4(d).
Compared with one another, a uniform degree of digestion,
regardless of the milk species, was detected.
Because most of the caseins occur in different genetic
variants, bulk tankmilks, composed of amixture of a number
of individual milks, would give tryptic peptide patterns that
were more complex than the individual samples carrying
one or two genetic variants. As an example, a gel isoelectric
focusing analysis for the bulk milk sample of our exper-
iments was found to contain exclusively ovine as1-CN C
(result not shown), although five variants (A to E) have been
described for the ovine as1-CN locus.
17 However, it must be
considered that some alleles have low frequencies and are
undetectable in bulk milk.18 Allele A, which differs from the
C counterpart by the Pro13!Ser13 substitution, does not
exceed 0.6%.17 A search for the signals from the predicted
tryptic peptides of the A variant was also conducted within
the MALDI spectra taking into account the two possible
forms of the phosphorylated or non-phosphorylated as1-CN
f8-22 peptide (m/z 1788.86 and 1708.90, respectively). Only
the variant C-derived peptide signal at m/z 1718.92 was
detected in the bulk milk sample. This finding is consistent
with a missing phosphorylation site on the as1-CN f8-22
peptide derived from the C variant, justified by the
unfavorable S12PE14 consensus sequence for casein kinase
recognition.19,20
Clearly, the presence of additional protein variants would
necessitate the consideration of other possible proteotypic
peptides.
Quantification and limit of detection of
signature peptides in bulk milks by MALDI-
TOF MS
Comparisons of the MALDI-TOF spectra allowed the
discrimination of signature peptides according to their milk
species. As an initial test, spectra were acquired for tryptic
digests of the four-species milks mixed in equal volumes
(Fig. 5(a)). Then, quantitative evaluations were carried out by
MALDI-TOFMS for the fourmilks inmixtures, comparing the
concentrations of the proteotypic peptides and their syn-
thetically modified counterparts, which were being used as
internal standards (IS) (Fig. 5(b)). TheLeu11!Gly11 aminoacid
substitution in the peptide analogues was introduced to give
rise to a distinct mass MALDI signal, with respect to the
natural peptides, without appreciably perturbing the ioniz-
ation efficiency of the peptide mixtures. This represents the
ultimate proof that the analogues of the natural peptides
function appropriately as IS. Afterwards, for quantification
purposes, fixedamounts of ISwereadded to the trypticdigests
of milk samples and the individual peak heights compared to
that of the respective native tryptic proteotypic peptides.
Because of the non-predictable peptide-dependent MALDI
MS ion production, the relative or absolute concentration of
proteotypic peptides cannot be directly inferred from the
signal intensity.21 The incorporation of IS into the MALDI
matrix/analyte mixture provided a means to achieve a
quantitative estimationof theproteotypic peptides. In contrast
to other approaches, in which whole sets of tryptic peptides
are used as IS to determine the relative changes of protein
Figure 3. Caprine as1-CN f4-22 occurred under two distinct molecular masses, i.e., [MH]
þ 2164.13 (variant B) and 2180.16
(variant A), in the reflector ion mode MALDI-TOF spectrum for the tryptic digest of defatted goat milk. The isotopic signal
cluster of as1-CN f4-22 Var. A partially overlaps that of b-CN f114-132 ([MH]
þ 2183.07).
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amounts,21 our strategy did not require complicated algor-
ithms for normalization. It must be noted that a preliminary
examination confirmed that equimolar amounts of each
synthetic peptide reproducing natural sequence and its
modified counterpart (Table 1) gave rise to two nearly
identical MALDI intensity peaks (Supplementary Figs. S2–
S5, see Supporting Information). Thismeans that if IS peptides
are added to a milk sample, at a value that corresponds to 1%
adulteration, the intensity of the proteotypic tryptic peptide
signal fromanyof the four species couldbe compared in terms
of quantity to the adulterated milk (lower, higher or equal to
1%). The latter represents the maximum error allowed
according to the European Union Official Method of analysis
for assessing adulteration. To determine the limit of detection
Figure 4. MALDI-TOF MS identification of the signature peptides in the tryptic digests of
single-species defatted milk. as1-CN f8-22 in (a) water buffalo, (b) bovine and (c) ovine milk
digests, and as1-CN f4-22 Var. A in caprine (d) milk digests are indicated by arrows.
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(LOD) of the analytical procedure, assays were performed
involving the spiking ofwater buffalomilkwith known scalar
amounts of extraneousmilks, i.e., 5, 1, or 0.5% simultaneously.
This rangeof additions reproduces the actual adulteratedmilk
lots that are frequently delivered to cheese plants.We verified
that the progress of the tryptic digestion was independent of
the concentrationof adulteratingmilkwithin the explored0.5–
5% range. MALDI-TOF MS was able to detect bovine and
ovine milk, distinct from their analogue water buffalo
counterpart, until the 0.5% adulteration threshold (Supple-
mentary Fig. S6, see Supporting Information). However, the
LOD for caprine milk was 1% (Supplementary Fig. S7, see
Supporting Information). This is likely attributable to (i) the
casein composition of caprinemilk, which has a lower as1-CN
content compared to that of the other species and (ii) the
splitting of the signature tryptic as1-CN f4-22 peptide into two
signals (as1-CN f4-22 A and B variants) because of the amino
acid substitution Pro16(A)!Leu16 (B), each with high, though
different, frequencies within the caprine breeds of different
countries.22,23The rare caprineas1-CNCvariant is restricted to
hardly any breeds.24 The derived tryptic peptide containing
the amino acidHis8(C)!Ile8 (B) substitutionwas not found in
thebulkmilkused in this study.As thisfindingcanundermine
the evaluation issue, the reliability of theMALDI-TOFmethod
was assessed by characterizing systematically varied compo-
sition samples. To this end, the natural trypticas1-CNpeptide,
which forms in quantities that correspond to the degree of
adulteration in themain dispersingmilk,was evaluated using
the four synthetic peptide analogues as IS. The areas of the
MALDIMSsignals, obtainedby integrationvia software,were
used to build up a calibration curve as a function of the
signaturepeptide concentration.The ratio of thepeakheightof
each member of a species of interest to that of the
corresponding IS was plotted as a function of the percentage
ofwater buffalomilk adulteration. The combineddata yielded
calibration curves with equations y¼ 3.9605x (R2¼ 0.9996)
and y¼ 4x (R2¼ 0.9999) for bovine and the other two milks
(Supplementary Figs. S8–S11, see Supporting Information),
respectively, showing a nearly optimal linearity. The absolute
amount of total as1-CN for each contaminating species was
calculated bymeasuring the peptide signal thatwasgenerated
by the parent protein, using the peptide signature as reference.
The calibration curve (mean of 10 replicates) was used to
measure the amount of peptide (expressed in ng), yielding
reproducible results for the as1-CN content over at least one
order of magnitude, between 0.02 (or below) and 0.2 ng/mL.
Figure 5. MALDI-TOF MS spectrum of tryptic digests from an equi-volume quaternary milk mixture (a); spiked with
synthetic modified analogues that were used as internal standards (b). Natural proteotypic peptides are indicated by arrows,
while asterisks label the synthetic analogue counterparts containing the Leu11!Gly11 amino acid substitution.
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Standard deviations for the measurements are indicated by
error bars (Supplementary Figs. S8–S11, see Supporting
Information). The lowest concentration of detectable peptide
was 0.0065 ng or 5 fmol, at a signal-to-noise (S/N) ratio of
approximately 20:1 (in linear mode) and 10:1 (in reflector
mode). The weight of as1-CN f8-22 from the extraneous
species, evaluated according to the relevant calibration
curve, was directly converted into adulteration percentage.
Consider, for example, an experiment where the adulteration
of sheep milk with bovine milk has been measured in very
low percentages (Supplementary Fig. S12, see Supporting
Information).
The described procedure allows the estimation of
individual as1-CN peptides in milk mixtures. This was
not exactly equivalent to determining the percentage of the
contaminating milks because the as1-CN peptides con-
tributing to bulk milks are either species- or sample-
dependent. Therefore, for the calculation it was necessary to
assume a fixed as1-CN-to-milk ratio or to use a standard
mixture of ovine/goat and bovine milk (1% batch) as a
reference sample (CRM 599, BCR) (Supplementary Fig. S12,
see Supporting Information). However, neither the as1-CN
nor total casein contents of singlemilks in reference samples
are specified. The availability of such standard samples (or
others) minimally biases the quantification while the
systematic errors of the measurement are eliminated after
correcting for the spectral background with non-adulter-
ated reference materials (0% batch). The significant
difference between caprine and other signature peptides
give clearly identifiable and unique signals even in the
tryptic digests of defattedmilk. However, we found that the
isotopic cluster of the caprine signature peptide at [MþH]þ
2180.16 (variant A) partially overlaps the caprine b-CN
f114-132 peptide ([MþH]þ 2183.07). Moreover, unmodified
trypsin generated 50-69 peptide at [MþH]þ 2163.05 by
autolysis, which interfered with the signature peptide as1-
CN f4-22 variant B signal at [MþH]þ 2164.13. Thus, because
of the many interfering components, the MALDI-TOF-
based procedure could overestimate the level of caprine
milk in adulterated milks.
LC/ESI-MS-based strategy for quantification of
goat as1-CN
To overcome this drawback, an LC/ESI-MS-based protocol
was developed to separate the caprine as1-CN f4-22 variant A
and B peptides. Trypsinized four-species milk was spiked
with diverse quantities of the caprine as1-CN f4-22 variant A
analogue (MHþ 2152.16, see Table 1). By LC/ESI-MS analysis
the mixtures gave rise to a total ion current (TIC) pattern
fromwhich the ions of the natural as1-CN f4-22 variant A and
the relative IS were easily localized by ion extraction
(Supplementary Fig. S13, see Supporting Information).
Retention times for the target peptides were determined
earlier by separate injections of the respective synthetic
peptides. The convergent indications of chromatographic
retention time and molecular mass of the components
eliminated the possible interfering peptides. Interestingly,
the evaluation of goat milk in complex mixtures was then
unaffected by the typology of commercial trypsin. The peaks
of the extracted ions were integrated and the area ratios were
plotted against the IS concentration (Supplementary Figs.
S14–S18, see Supporting Information). Moreover, the area
ratios of the natural peptide as1-CN f4-22 variant A and the IS
ions, for equal volumes of four-species milks, were plotted
against the IS concentrations (Supplementary Figs. S14–S18,
see Supporting Information).
In both cases, a usable linear relationship was found in the
investigated concentration range, as already demonstrated
by the relative calibration curves. In an analogous way, a
linear response was also found for the natural peptide as1-
CN f4-22 variant B, as shown in Supplementary Figs. S19 and
S20 (see Supporting Information). In this case, the amino acid
substitution Pro16!Leu16 did not affect the ionization
efficiency of the peptides. Therefore, the use of a single
synthetic proteotypic peptide analogue allowed for the
evaluation of both caprine as1-CN variants. The results
clearly indicate that LC/ESI-MS, when used to test very
small volumes of goat’s milk, has a LOD as low as 1%
(Supplementary Fig. S18, see Supporting Information). The
MALDI-based procedure, simultaneously monitoring
multiple peptides, has allowed the detection of four
signature peptides (one for each species). Using LC/ESI-
MS, five proteotypic peptides were distinctly detected, of
which two were derived from caprine as1-CN variants. In
principle, a single LC/ESI-MS analysis of a tryptic digest of a
milk sample spiked with the entire set of synthetic analogues
would allow the one-step milk speciation also encompassing
quantitative determination. The practicability of such a
strategy will be the focus of further investigations. In any
case, the MALDI-based screening offers a series of evident
advantages, such as the quickness of the analysis, the
minimal sample handling, the immediateness of the data
interpretation, all combinedwith a specificity and robustness
of the analytical response comparable to that from LC/MS.
For forensic purposes, both the MS-based methods (i.e.,
MALDI and LC/ESI-MS) provided precise and reliable
quantitative results.
In effect, the presence of extraneous caseins in milks that
are suspected of adulteration could be confirmed by a longer
list of candidate proteotypic peptides (Table 2). In other
words, to prevent false positive responses, multiple peptides
could be detected for each parent casein. The possibility of
quantifying samples based on additional proteotypic pep-
tides also permits the minimization of the magnitude of
fluctuations depending on several experimental factors,
including changes in ionization efficiency over time and
matrix effects leading to ion suppression or enhancement
from co-eluting components, that cannot be accurately
controlled in MS-based analyses. In this manner, the MS-
based procedures in the above outlined versions become
effective in discriminating pure or contaminated milk
samples. The excellent specificity of proteotypic peptides
opens the possibility of universally applying MS-based
methods to any protein of any food as long as the protein
sequence is known. Therefore, provided that opportune IS
are available, each of the selected proteotypic peptides can
potentially serve as a probe for protein abundance within a
complex sample. The sensitivity and specificity of the MS-
based detection of signature peptides could be further
enhanced by the selected reaction monitoring technique.21
Copyright # 2010 John Wiley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2010; 24: 1687–1696
DOI: 10.1002/rcm
Quantification of casein proteotypic peptides for milk speciation 1695
SUPPORTING INFORMATION
Additional supporting information may be found in the
online version of this article.
Acknowledgements
This publication is in partial fulfillment of the requirements
for the degree of PhD in ’Biological Processes and Biomole-
cules’ (M. C.). The authors gratefully acknowledge the
’Centro di Competenza per la Produzioni Agroalimentari
della Regione Campania’ for permitting the use of the MS
facilities. This work was not supported by special funds from
public institutions or private companies.
REFERENCES
1. Guarino C, Fuselli F, La Mantia A, Longo L, Faberi A,
Marianella RM. Rapid Commun. Mass Spectrom. 2010; 24: 705.
2. Midland BioProducts Co. Available: www.midlandbio.com.
3. Hurley IP, Coleman RC, Ireland HE, Williams JHH. J. Dairy
Sci. 2004; 87: 543.
4. R-biopharm Food and Feed Analysis. Available: www.
r-biopharm.com.
5. Official Gazette of the Republic of Italy 11 June 1996. Off. J.
Ital. Rep. 1996; 135: 12.
6. Official Gazette of the Republic of Italy 17 April 2003. Off. J.
Ital. Rep. 2003; 90: 9.
7. Herrero-Martinez JM, Simo-Alfonso EF, Ramis-Ramos G,
Gelfi C, Righetti PG. J. Chromatogr. A 2000; 878: 261.
8. European Commission, 2001 European Commission, EC
213/2001. Off. J. Eur. Comm. 2001; 44: L37/31.
9. Cozzolino R, Passalacqua S, Salemi S, Garozzo D. J. Mass
Spectrom. 2002; 37: 985.
10. Wu FY, Tsao PH, Lin S, Chai YJ, Kuo JW, You ZK. J. Chin. Soc.
Anim. Sci. 2000; 29: 337.
11. Hurley IP, Ireland HE, Coleman RC, Williams JHH. Int. J.
Food Sci. Technol. 2004; 39: 1.
12. Moio L, Chianese L, Rivemale M, Addeo F. Lait 1992; 72:
87.
13. Angeletti R, Gioacchini AM, Seraglia R, Piro R, Traldi P.
J. Mass Spectrom. 1998; 33: 525.
14. Di Luccia A, Picariello G, Trani A, Alviti G, Loizzo P, Faccia
M, Addeo F. J. Dairy Sci. 2009; 92: 1319.
15. Aschaffenburg R, Drewry J. 15th Int. Dairy Congress, London,
1959; 3: 1631.
16. Krause EH, Wenschuh H, Jungblut PR. Anal. Chem. 1999; 71:
4160.
17. Chianese L, Garro G, Mauriello R, Laezza P, Ferranti P,
Addeo F. J. Dairy Res. 1996; 63: 49.
18. Brignon G, Mahe MF, Ribadeau-Dumas B, Mercier JC, Gro-
sclaude F. Eur. J. Biochem. 1990; 193: 237.
19. Ferranti P, Malorni A, Nitti G, Laezza P, Pizzano R, Chianese
L, Addeo F. J. Dairy Res. 1995; 63: 281.
20. Mamone G, Caira S, Garro G, Nicolai A, Ferranti P, Picariello
G, Malorni A, Chianese L, Addeo F. Electrophoresis 2003; 24:
2824.
21. Lange V, Picotti P, Domon B, Aebersold R. Mol. Syst. Biol.
2008; 4: 222.
22. Albenzio M, Santillo A, D’Angelo F, Sevi A. J. Dairy Res.
2009; 76: 83.
23. Picariello G, Ferranti P, Caira S, Fierro O, Chianese L, Addeo
F. Rapid Commun. Mass Spectrom. 2009; 23: 775.
24. Sacchi P, Chessa S, Budelli E, Bolla P, Ceriotti G, Soglia D,
Rasero R, Cauvin E, Caroli A. J. Dairy Sci. 2005; 88:
1561.
25. Available: www.expasy.org.
Copyright # 2010 John Wiley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2010; 24: 1687–1696
DOI: 10.1002/rcm
1696 M. Cuollo et al.
Chapter 1 
 
 
 
 
© 2012 Pinto et al., licensee InTech. This is an open access chapter distributed under the terms of the 
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Bioactive Casein Phosphopeptides in Dairy 
Products as Nutraceuticals for Functional Foods 
Gabriella Pinto, Simonetta Caira, Marina Cuollo, 
Sergio Lilla, Lina Chianese and Francesco Addeo 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/50725 
1. Introduction 
Nutraceuticals, a term combining the words “nutrition” and “pharmaceutical”, is a food or 
food product that provides medical or health benefits including the prevention and treatment of 
diseases. A functional food essentially provides a health benefit beyond the basic nutrition, 
whereas nutraceutical is used to describe an isolated or concentrated molecular extract of 
bioactive compounds. Milk is a unique food providing a variety of essential nutrients 
necessary to properly fuel the body. Inactive food proteins can release encrypted bioactive 
peptides in vivo or in vitro by digestive enzymatic hydrolysis. Bioseparation protocols offer 
unique possibilities for a number of application areas, e.g., hydrolyzate-based nutraceutical 
ingredients for functional foods, dietary supplements and medical foods. 
Many ingredients are included in the wide range of nutraceuticals, such as essential amino 
acids, conjugated fatty acids, vitamins, minerals and polyphenols. They have already been 
patented and incorporated in functional foods and nutritional beverages. Such components 
are believed to improve overall health and well-being, reducing the risk of specific diseases 
or minimizing the effects of other health concerns. However, milk is devoid of flavonoids, 
the most common group of vegetable polyphenolic compounds, which act as antioxidants 
and free radical scavengers. In contrast, the ingestion of soy and green tea extract may 
reduce the risk of developing prostate cancer and may protect against various other types of 
cancer [1-2]. An interesting patented invention has made available an extended-release form 
of polyphenols and riboflavin (vitamin B2) coated with methylcellulose [3]. Coating slows 
down the release of polyphenols in the nutraceutical preparation [3]. Possible applications of 
coating technology could be extended to all of the bioactive peptides susceptible to digestive 
enzymes. For example, glutathione can be maintained in human blood at normal levels by 
supplying it as dry-filled capsules [4]. Nutrients and bioactive compounds may be 
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microencapsulated by using mixtures of proteins or peptides and oils. Encapsulation of Ν-3 
fatty acids (FA) enhances the stability and bioavailability of bioactive food ingredients [5]. By 
these means, new transparent bioavailable beverages containing Ν-3 rich oils, phospholipids 
and minerals in an oxidatively stable food system were created [6]. Iron or calcium casein 
phosphopeptides (CPP) were embedded in the chitosan lactate fiber as a protective agent 
against oil oxidation [6]. A recent patent relates to a nutraceutical composition consisting of 
a sweetener admixture for food or drink comprising calcium lactate, calcium acetate, 
vitamin D3 and sucralose (for fortified zero calorie formulation) or sugar (white/brown; for 
fortified sugar preparation) [7]. Milk proteins playing a physiological role include proteins 
such as Ά-lactoglobulin, ΅-lactalbumin, immunoglobulins, lactoferrin, heat-stable proteose 
peptones, serum albumin and various acid soluble phosphoglycoproteins. Casein (CN), 
representing 80% of total milk proteins, consists of four ΅s1-, ΅s2-, Ά-, and Ύ-CN families in 
the approximate ratio 38:11:38:13. Research performed in recent years has shown that 
caseins and whey proteins are rich in encrypted biologically active peptides such as 
exorphins (casomorphins), CPP and immunopeptides [8]. The peptides are released by 
enzymes in the form of mature bioactive components or the precursors thereof [9]. They are 
3- to 20-residue long peptides released during in vivo gastrointestinal digestion. Historically, 
the opioid peptides were discovered as the result of a systematic search for exogenous 
substances, namely (i) first discovered in 1979, opioid agonist peptides derived from milk 
proteins were characterized in 1986; (ii) in 1982, angiotensin-converting enzyme (ACE)-
inhibitory peptides were found to be antihypertensive peptides; (iii) then, fibrinogen-like 
sequences with antithrombotic activity were found; (iv) phagocytic activity and lymphocyte 
proliferation of numerous immunomodulating peptides were observed; (v) CPP facilitating 
the absorption of minerals, especially calcium, magnesium and iron were found; and (vi) 
antimicrobial peptides were discovered [10]. There are many milk peptides that possess 
multifunctional activities, i.e., they can play two or more hormone-like roles. Bioactive 
peptides grouped according to their function in human well-being are shown in Figure 1. 
Nutraceutical products comprising short bioactive peptides showing in vitro or in vivo 
antimicrobial, ACE-inhibitory activity and/or antihypertensive and/or antioxidant activity 
are being considered for possible use by the pharmaceutical industry. The CN hydrolyzates 
could serve as food preservatives to reinforce the body's natural defenses or as 
pharmaceutical products for facilitating the control of blood and/or bacterial infections [12]. 
Much research has been devoted to increasing mineral transport by phosphorylated groups 
of peptides [13]. CPP in commercial hydrolysed casein (Tatua Cooperative Dairy Co. Ltd, 
New Zealand and Arla Foods Ingredients and Sweden) seem to help the absorption of 
chelated calcium, iron, copper, zinc and manganese in the intestine (Table 1). Thus, CPP-
bound amorphous calcium phosphate (ACP) displayed anticariogenic effect when added to 
dentifrices or oral care products by localizing calcium and phosphate ions at the tooth 
surface. Similarly, it has been claimed that a chewing gum or other confectionery product 
containing a combination of CPP-ACP and sodium bicarbonate as active ingredients can 
provide dental health benefits [14]. In experiments on humans, synthetic CPP-ACP 
nanocomplexes incorporated in mouth rinses and sugar-free chewing gums have been 
proven to be potential anticariogenic agents [15] (Table 1). 
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Figure 1. Main bioactivity of peptides formed by the enzymatic digestion of milk proteins (source: [11]). 
ACP= amorphous calcium phosphate; CPP= Casein phosphopeptides 
Table 1. Commercial dairy products and ingredients with health or function claims based on CPP 
content (source: modified from [16]). 
2. Bioactive peptides released in vitro by the hydrolysis of milk proteins  
Peptides with various bioactivities can be produced according to two different methods: i) in 
vitro fermentation of milk inoculated with starter cultures and ii) in vitro digestion of milk 
proteins by one or more proteolytic enzymes.  
Brand name Product type Claimed functional 
bioactive peptides
Health/function claims Manufacturer
HCP102/HCP 105 Hydrolysate ingredient CPP Helps mineral absorption Tatua (New Zealand)
Capolac Hydrolysate ingredient CPP Helps mineral absorption Arla Foods Ingredients (Sweden)
Recaldent Chewing gum ACP-CPP Anticariogenic Cadbury Adams (USA)
Recaldent Toothpaste ACP-CPP Anticariogenic GC Tooth Mousse (USA)
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(i) The proteolytic system of lactococci is able to degrade milk proteins using cell-wall-
bound proteinases by releasing di-, tri-, and/or oligo-peptides and amino acids supporting 
the growth of bacteria. In addition, lactococcal peptidases released into the curd/cheese 
consequently to autolysis can further degrade the internalized peptides to amino acids [17]. 
The higher the exopeptidase activity in cheeses, the greater the age of the cheese [18]. 
Consistently, yogurt and other cultured dairy drinks have some of the highest counts of cells 
that actually survived and thus possessed the lowest number of peptides derived from the 
aminopeptidase activity. In a comprehensive review of literature, no enzyme with 
carboxypeptidase (CPase) activity has been reported for either lactococci or other LAB [19-
20]. The bacterial peptidases have different and partly overlapping specificities (Figure 2).  
 
Figure 2. A simplified model presenting proteolysis, transport, peptidolysis and regulation of the 
proteolytic system of Lactococcus lactis on casein breakdown [20-22]. Intracellular peptidases PepO and 
PepF are endopeptidases, PepN/PepC/PepP are general aminopeptidases, PepX is X-prolyldipeptidyl 
aminopeptidase, PepT is tripeptidase, PepQ is prolidase, PepR is prolinase, PepI is proline 
iminopeptidase, and PepD and PepV are dipeptidases D and V. The role of PepN, PepC, PepI, PepP and 
PepA and PepO, PepF, PepX, PepQ, PepR, PepV, PepT and peptidolytic cycles are depicted 
schematically (various alternative routes of breakdown are possible for most peptides).  
Although the intracellular endopeptidases PepN and PepC are unable to hydrolyze casein 
molecules, the X-prolyl dipeptidyl aminopeptidases (PepX) are active on oligopeptides 
hydrolyzing the internal bonds of casein-derived peptides. Taken together, these enzymes 
are able to remove the N-terminal residues from peptides, with the specificity primarily 
depending on the nature of the N-terminal amino acid [20-21]. Di- and tripeptides generated 
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by endopeptidases, general aminopeptidases and PepX are next subjected to additional 
cleavage by the tripeptidase, PepT, and dipeptidases, PepV and PepD (Figure 2). Other 
peptidases with more specific substrate specificities include PepA, which liberates N-
terminal acidic residues from 3- to 9-residue long peptides; PepP, which prefers tripeptides 
carrying proline in the middle position; PepR and PepI, which act on dipeptides containing 
proline in the penultimate position; PepQ, which cleaves dipeptides carrying proline in the 
second position; and PepS, which shows preference for peptides containing two to five 
residues with Arg or aromatic amino acid residues in the N-terminal position [20-21,23] 
(Figure 2). This proteolytic system is able to support LAB growth to high cell densities (109–
1010 cfu/mL) in milk containing only small amounts of hydrolytic products that are 
transportable into the cells for assimilation. Lb. helveticus and Lb. delbrueckii ssp. bulgaricus 
possess cell wall proteinase activity stronger than that of lactococci. The number of 
intracellular proteins released by St. thermophilus is greater than that by Lb. helveticus [24]. 
Proteins released in cheese from a starter-based thermophilic LAB, such as Lb. helveticus, Lb. 
delbruecki subsp. lactis and Streptococcus salivarius subsp. thermophilus and Propionibacterium 
freudenreichii, have been identified using 2D-PAGE and mass spectrometry (MS) analysis 
[24]. Similarly, bioactive peptides have been determined using High Performance Liquid 
Chromatography (HPLC) and offline Matrix-Assisted Laser Desorption/Ionization Mass 
Spectrometry-Time-Of-Flight (MALDI-MS-TOF) [25]. These peptides were all generated 
from CN and released upon proteolysis depending on the bacterial strain [26]. In this 
manner, proteinases play a primary role, as they are able to generate specific bioactive 
peptides. Recombinant human ΅s1-casein digested by trypsin gave rise to several ACE-
inhibitory peptides and calcium-binding CPP. These peptides did not form in cheese whey, 
although they can be formed from CN during fermentation using various commercial dairy 
starters [27]. The combination of the LAB bacteria and proteolytic enzymes could serve to 
increase the range of bioactive peptides. 
(ii) In vitro hydrolysis of CN by pepsin and trypsin could produce many bioactive peptides. 
Pepsin, an endopeptidase with broad specificity, preferentially cleaves hydrophobic, 
preferably aromatic, residues. Trypsin specifically hydrolyses peptide bonds just after a 
lysine or an arginine residue of Ά-casein A1 and A2 variant (11 and 4, respectively); Ύ-
casein A and B (9 and 5); ΅s2-CN A (24 and 6); or ΅s1-CN B (14 and 6). In this manner, 
tryptic hydrolysates of CN contain uneven peptides of up to 8159 Da and also free amino 
acids [28]. We have demonstrated that CN hydrolysate by pepsin (P) and trypsin (T) in 
succession does not contain peptides with molecular mass greater than 2431 Da. Ά-CN 
resulted extensively hydrolyzed into a high number of oligopeptides by using proteases 
with well defined cleavage specificity. Controlled partial hydrolysis by proteinases could 
lead to the formation of partially degraded proteins critical for obtaining new functional 
products. The choice of digestion enzymes needs to be evaluated carefully because 
influences the hydrolysate final composition. A high number of peptides with 
antimicrobial, anti-hypertensive and opiod-like activity has been identified (Table 2), 
some of which exactly matched those described in the literature for potential bioactivity 
(Table 2). The potent opioid Ά-CM7 peptide retained part of its original opioid activity-
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like food hormone when progressively shortened. The synthetic Ά-casomorphin 
derivatives have been shown to be highly specific and potent Ά-type opioid receptor 
ligands [29]. 
We also performed sequential milk protein (powder sample) digestions using various 
endoproteases facilitating a consistent partial hydrolysis. The high degree of specificity in 
terms of cleaving peptide bonds exhibited by a cocktail of enzymes (P, T and P432 from 
Biocatalysts, U.K) yielded a limited number of CPP. After fractionation on an HA column, 
 
 
PT= Pepsin and Trypsin action; P= Phosphate group. 
 
Table 2. Identity of bioactive peptides found in the PT digest of milk protein powder sample. The 
bioactivity of the peptide from which they derive and the references are reported. 
Identity of bioactive 
peptides 
Bioactivity References PT peptides 
ȕ-CN (f60-70); (f59-61); 
(f59-64); (f60-68)
Opiod [29-30] (f58-68); (f59-63); (f59-62)
ȕ-CN (f74-76) (f69-80); (f71-80); (f75-80)
ȕ-CN (f80-90); (f84-86) (f80-88); (f81-89); (f81-88); (f81-92); (f81-93); 
(f81-94)
ȕ-CN (f108-113) (f108-103)
ȕ-CN (f140-143) (f139-142)
ȕ-CN (f177-183) (f177-183); (f177-184); (f179-182)
ȕ-CN (f169-174) (f169-176); (f172-176)
ȕ-CN (f193-198) (f193-199)
ȕ-CN (f193-202) (f193-202)
ȕ-CN (f1-25)4P 
Mineral carrier, 
immunomodulatory, 
cytomodulatory
[34-38]
(f12-17)1P; (f12-25)3P; (f12-25)4P; (f15-25)2P; 
(f15-25)3P; (f19-25)1P; (f19-25)2P
ȕ-CN (f29-41)1P Mineral carrier [13] (f33-42)1P; (f33-43)1P; (f33-44)1P
ȕ-CN (f84-86) (f80-87); (f81-88); (f81-89); (f81-92); (f81-93); 
(f81-94)
Įs1-CN (f23-34) (f24-32)
Įs1-CN (f25-27) (f25-31)
Įs1-CN (f90-96); (f90-95); 
(f91-95)
Opiod (agonist) [39-41] (f92-95); (f91-95); (f90-95)
Įs1-CN (f142-147) (f142-145); (f143-146); (f143-150); (f144-149)
Įs1-CN (f157-164) (f155-164)
Įs1-CN (f194-199) (f194-199); (f197-199); (f193-199)
Įs1-CN (f110-119)1P
Įs1-CN (f41-55)1P; (f68-79)2P
Įs2-CN (f174-179) (f174-179)
Įs1-CN (f189-193) (f189-193)
Įs2-CN (f138-146)1P
Įs2-CN (f124-137)2P; (f126-136)2P; (f126-137)2P
ț-CN (f33-38) Opiod (antagonist) (f58-65)1P
[31-33]
[31-33]
[31-33]
[13]
[31-33]
[13]
ACE-Inhibitory
ACE-Inhibitory
ACE-Inhibitory
ACE-Inhibitory
Mineral carrier
Mineral carrier
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both non-CPP and CPP were identified as shown in Table 3. Different oxidation rates of Met 
residues in the same protein resulted in formation of the peptides with different molecular 
mass. In most cases, a single Met-containing peptide and its oxidized counterpart were 
identified. However, in many cases, when proteins contained several consecutive 
endoprotease sensitive bonds, different long peptides containing the same Met-oxidation 
site(s) were identified. The data in Table 3 suggest that the cocktail enzymes containing 
amino- and CPases, in addition to P and T, progressively reduce the size of peptides without 
altering the degree of phosphorylation. Evaluation of protein/peptide quality can take 
advantage of the tandem MS for the detection of native, partly oxidized and partly 
dephosphorylated peptides. 
By this means, phosphorylated peptides (2 and 3P/mole) of a precursor of lactophorin (LP) 
(28 kDa milk glycoprotein), proteose-peptone component 3, and glycosylation-dependent 
adhesion molecule 1 were detected. In addition, three low molecular weight non-CPP 
derived from LP were detected. 
Native milk proteins used as the substrate for digestion by enzymes did not form CPP. 
This suggests that denatured LP and other whey proteins could have the tendency to form 
low molecular-mass peptide aggregates characterized by a poor solubility. For this reason, 
the use of milk protein and/or any milk substrate powder must be discouraged to 
eliminate phosphates and salts from the substrate. The enzymatic hydrolysis of the casein 
implies the use of endoproteases. However, the protein hydrolysate with alcalase is used 
in infant formulae, dietetic foods, nutraceuticals, ice creams, dressings, fermented 
products, yogurts, and personal care products. CPP released by alcalase are truncated 
with respect to those released by trypsin. The identified peptides can be categorized into 
two groups, one containing multiphosphorylated peptides and the other tri-, di- and 
mono CPP. Each group contained a number of variously long peptides due to the broad 
specificity of alcalase cleaving peptide bonds mainly on the carboxyl side of Glu, Met, 
Leu, Tyr, Lys, and Gln. The exoproteases responsible for the hydrolysis are inactivated by 
heating for ~10 min to ~85 °C. The in vitro sequential use of pepsin, pancreatic proteases 
and extracts of human intestinal brush border membranes, mimicking the respective 
gastric, duodenal and jejuneal in vivo digestion of CN, exhibited significant bioactive 
effects. A limited number of CN and whey protein peptides survived the in vitro 
simulated gastro-intestinal digestion. The anionic character seems to confer a marked 
resistance to multi-phosphorylated CPP hydrolysis by endoprotease. Ten out of 19 CPP 
contained SerP available for binding minerals, and four of these peptides, ΅s1-CN (f57-
90)5P, ΅s1-CN (f56-90)5P, ΅s1-CN (f55-76)5P, Ά-CN (f1-52)5P, were reported for the ﬁrst 
time in the CN digests [42]. Only Ά-CN (f1-25)4P, 3P and 2P survived the simulated 
gastrointestinal digest of CN [43].  
The ingress of foreign material in general, such as CPP, across the mucosal brush-border 
into the enterocyte is conditioned by the efficient dephosphorylation of peptides by alkaline 
phosphatase. This aspect deserves more in-depth investigation.  
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Phosphoserine residues are coloured red. 
 
 
Table 3. Native and partly Met-oxidized CPP isolated from a three enzyme (Pepsin, trypsin and P432) 
milk protein hydrolyzate. 
Expected Calculated
Įs1-CN 1222.5 1222.5 110 - 119 (L)EIVPNSAEER(L) 1P
 1517.8 1517.6 68 - 79 (S)SEEIVPNSVEQK(H) 2P
 1525.7 1525.5 41 - 53 (L)SKDIGSESTEDQA(M) 2P
 1586.6 1586.5 43 - 55 (K)DIGSESTEDQAME(D) 2P; Oxidation (Met) 
 1672.7 1672.6 41 - 54 (L)SKDIGSESTEDQAM(E) 2P; Oxidation (Met) 
 1785.8 1785.6 41 - 55 (L)SKDIGSESTEDQAME(D) 2P
 1801.7 1801.6 41 - 55 (L)SKDIGSESTEDQAME(D) 2P; Oxidation (Met) 
 1963.9 1963.8 39 - 55 (N)ELSKDIGSESTEDQAME(D) 1P; Oxidation (Met)
 1989.9 1989.7 37 - 52 (K)VNELSKDIGSESTEDQ(A) 3P
 2060.7 2060.7 37 - 53 (K)VNELSKDIGSESTEDQA(M) 3P
Įs2-CN 900.4 900.3 58 - 65 (S)SEESAEVA(T) P
937.4 937.3 141 - 147 (D)MESTEVF(T) 1P; Oxidation (Met)
1067.4 1067.3 57 - 65 (S)SSEESAEVA(T) 2P
1089.5 1089.4 138 - 146 (K)TVDMESTEV(F) 1P
 1105.4 1105.4 138 - 146 (K)TVDMESTEV(F) 1P; Oxidation (Met)
 1252.6 1252.5 138 - 147 (K)TVDMESTEVF(T) 1P; Oxidation (Met)
 1410.6 1410.5 126 - 136 (R)EQLSTSEENSK(K) 2P
 1538.7 1538.6 126 - 137 (R)EQLSTSEENSKK(T) 2P
 1623.7 1623.6 1 - 13 KNTMEHVSSSEES(I) 2P
 1639.7 1639.5 1 - 13 KNTMEHVSSSEES(I) 2P; Oxidation (Met) 
 1680.8 1680.6 124 - 136 (L)NREQLSTSEENSK(K) 2P
 1719.7 1719.5 1 - 13 KNTMEHVSSSEES (I) 3P; Oxidation (Met) 
 1808.9 1808.7 124 - 137 (L)NREQLSTSEENSKK(T) 2P
ȕ-CN 639.3 639.3 12 - 16 (E)IVESL(S) 1P
 900.5 900.4 19 - 25 (S)SEESITR(I) 1P
 1067.4 1067.4 18 - 25 (S)SSEESITR(I) 2P
 1354.6 1354.5 15 - 25 (E)SLSSSEESITR(I) 2P
 1434.6 1434.5 15 - 25 (E)SLSSSEESITR(I) 3P
 1447.7 1447.5 33 - 43 (K)FQSEEQQQTED(E) 1P
 1576.7 1576.6 33 - 44 (K)FQSEEQQQTEDE(L) 1P
 1689.8 1689.6 33 - 45 (K)FQSEEQQQTEDEL(Q) 1P
 1775.8 1775.7 12 - 25 (E)IVESLSSSEESITR(I) 3P
 1855.6 1855.6 12 - 25 (E)IVESLSSSEESITR(I) 4P
ț-CN 968.4 968.4 145 - 152 (A)TLEDSPEV(I) 1P
 1734.7 1734.7 147 - 161 (L)EDSPEVIESPPEINT(V) 1P
Lactophorin  1226.5 1226.51 34 - 43 (L)SKEPSISRED(L) 1P
 1306.6 1306.5 34 - 43 (L)SKEPS ISRED(L) 2P
 1419.6 1419.56 34 - 44 (L)SKEPS ISREDL(I) 2P
 1499.7 1499.5 34 - 44 (L)SKEPS ISREDL(I) 3P
Molecular mass (Da)Parent 
protein
Start End Peptide sequence Peptide modifications
 
Bioactive Casein Phosphopeptides in Dairy Products as Nutraceuticals for Functional Foods 11 
3. In vivo digestion of casein, formation of CPP and their physiological 
importance 
Among the biologically active peptides, CPP characterized by SerP and/or ThrP residues 
account for ~30% of monoesters of hydroxyl amino acids. They mainly occur in the Ser/Thr-
Xaa-SerP/Glu/Asp sequence consensus, where Xaa is any amino acid residue but Pro. The 
three-phosphorylated motif -SerP-SerP-SerP-Glu-Glu- occurs in ΅s1-CN (f66-70), ΅s2-CN (f8-12), 
΅s2-CN (f56-60), and Ά-CN (f17-21). According to the current CN nomenclature, bovine ΅s1-CN, 
΅s2-CN, Ά-CN, and Ύ-CN possess 8-9, 11-13, 4-5, and 1-2 phosphate (P) residues, respectively, 
and the P number could change according to the casein variant [44]. For example, Ά-CN D has 
one SerP residue less than the A counterpart due to the substitution Lys18 ĺ Ser18. 
The in vivo digestion of milk proteins takes place mainly in the stomach under the action of 
pepsins, gastric digestive proteinases that are able to digest ~20% proteins. Afterwards, the 
pepsin digests pass to the duodenum where peptides are further hydrolyzed by pancreatic 
enzymes. The digestion is completed by membrane proteases and a variety of peptidases 
embedded in the brush border of the small intestine and released by the intestinal microflora. 
These peptidases release an amino acid residue or a dipeptide from the N- and C-terminal side 
of oligopeptides [45-47]. Phosphatase(s) located in the brush border of the apical membrane of 
enterocytes, act(s) in removing phosphate groups, thus promoting partial or full peptide 
dephosphorylation of peptides in different body districts. The phosphorylated sequence is 
responsible, at the intestinal pH, for binding Ca++, Zn++, and Mg++ and for the in vivo resistance 
of the complex to gastrointestinal proteases [48]. Fe complexed to Ά-CN (f15-25)4P was 
scarcely hydrolyzed throughout the digestion, suggesting that the coordination of iron ions to 
CPP inhibits the action of both phosphatase and peptidases [49]. Brush border enzyme alkaline 
phosphatase activity could improve the absorption of Fe complexed CPP by releasing Fe from 
peptides. Moreover, Fe complexed to Ά-CN CPP was absorbed more than Fe complexed to ΅s1-
CN CPP [50]. The differences in protein composition between cow and breast milk could 
explain some of the differences in the Fe bioavailability of the latter [50]. Iron deficiency, a 
major worldwide nutritional problem, can be reduced by CPP. Fe complexed CPP prevents the 
formation of poorly absorbed high molecular weight ferric hydroxides. Zinc absorption can 
also be enhanced by the formation of Zn complexed to CCP, in particular to Ά-CN (f1-25)4P 
[51]. Some portion of the mineral complexed CPP formed in the small intestine was resistant to 
the digestive and enteric bacteria enzymes and found in the feces of rats fed a casein-based 
diet [52]. Although literature data regarding intestinal CPP absorption are conflicting, the 
peptides seem to interact directly with the plasma membrane. One possible mode of CPP 
action on the transmembrane flux of calcium is that CPP might insert themselves into the 
plasma membrane and form their own calcium selective channels or act as calcium-carrier 
peptides rapidly internalized via endocytosis or other processes and eventually provide 
ionized calcium in the cytosol [53]. Cellular uptake studies of fluorine-18 labeled CPP in 
human colorectal adenocarcinoma cell line (HT-29) and human head and neck squamous cell 
carcinoma line (FaDu) cells at 37 °C and 48 °C showed a poor cell penetration because of the 
poor transport of the phosphopeptides through the cell membrane [54]. The results from in 
vivo studies are still too controversial, as there are many factors affecting Ca availability, such 
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as the various co-present dietary compounds in the intestinal lumen [55]. Despite the vigor of 
the saturable active transport process by the duodenum, most of the absorption of ingested 
calcium occurs in the ileum (88% of calcium), jejunum (4%) and duodenum (8%) [56]. An 
important factor determining the contribution of the ileum to overall calcium absorption is the 
relatively long transit time of calcium in the segments of the small intestine, accounting for 
approximately 102 min in the ileum and 6 min in the duodenum [57]. The higher absorption of 
calcium occurred when inorganic P was added to the Ca-CPP preparation. CPP exhibit a 
potent ability to form soluble complexes with Ca2+ and other trace elements, preventing the 
formation of Ca-phosphate precipitate in the intestine. CPP could limit the inhibitory effect of 
phosphate on Ca availability and increase Ca transport across the distal small intestine [55]. All 
components of the diet reaching the ileum make calcium soluble or keep it in solution within 
the ileum. Several molecules, particularly CPP, stimulate the passive diffusion of minerals. 
CPP have been for the ﬁrst time detected in human ileostomy ﬂuid, conﬁrming their ability to 
survive gastrointestinal passage into the human distal ileum [58]. CPP released during milk 
digestion appeared to be stable for up to 8 h in ileostomy contents [58]. The in vivo formation of 
bovine CPP was demonstrated in the small intestinal ﬂuid of minipigs after ingestion of a diet 
containing casein [59] and in the stomach and duodenum after ingestion of milk or yogurt [60]. 
The in vivo survival of CPP to the prolonged intestinal passage in the distal small intestine is a 
prerequisite for their function as bioactive substances [58]. CPP are protected from 
degradation in the gut by the milk matrix, provided that they are ingested as milk constituents 
and not as isolated CPP. Whole casein or individual casein fractions are used as raw materials 
to obtain CPP as dietary supplements. Ca could be bound to either SerP or Glu residues [61], 
suggesting that CPP may enhance the solubility of calcium in the intestinal lumen, thereby 
increasing the mineral availability for absorption in the small intestine [62,13]. Chemically 
synthesized CPP, i.e., Ά-CN (f1-25)4P and ΅s1-CN (f59-79)5P, carrying the characteristic cluster 
Ser(P)-Ser(P)-Ser(P)-Glu-Glu, increase the intracellular calcium uptake by the human cultured 
HT-29 tumor cells [63], Caco-2 cells [64] and osteoblasts [65]. A more pronounced effect has 
been observed for Ά-CN-derived peptides than for ΅s1-CN-counterparts. It has been suggested 
that CPP promote calcium binding, which would depend on the structural conformation 
conferred by the two phosphorylated ‘acidic motif’ and the N-terminal sequence of Ά-CN [63].  
Dental caries are initiated via the demineralization of tooth hard tissue by organic acids 
directly from the diet or produced from fermentable carbohydrate by dental plaque 
cariogenic bacteria. CPP can help to replace the minerals that were previously lost 
consequently to caries [66-67]. Hence, there is a great interest in developing CPP as 
nutraceutical ingredients for the formulation of functional foods. 
4. CPP enrichment by different techniques 
CPP preferably comprise components released by four different casein families, each having 
a molecular weight greater than 500 Da. Multiply and singly, tryptic CPP can be 
simultaneously detected using MALDI-TOF, and the location of phosphate groups by a 
combination of tandem mass spectrometry and computer-assisted database search 
programs, such as SEQUEST (Trademark, University of Washington, Seattle Wash) [68-69]. 
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Nano-electrospray MS/MS has been used for phosphopeptide sequencing and exact 
determination of phosphorylation sites [70]. However, mass spectrometric analysis of 
proteolytic digests of proteins rarely provides full coverage of the phosphorylated sequence, 
with parts of the sequence often going undetected. In addition, protein phosphorylation is 
often sub-stoichiometric, such that ionization of CPP present in lower abundance in complex 
hydrolysates is ordinarily suppressed by strongly ionizable non-phosphorylated peptides. 
The MALDI-MS desorption/ionization efficiency for phosphopeptides was reported to be an 
order of magnitude lower than that recorded for the non-phosphorylated counterpart, and 
ionization became more difficult as the number of phosphate groups increased [71]. Direct 
analysis of phosphopeptides utilizes two orthogonal MS scanning techniques, both based on 
the production of phosphopeptide-specific marker ions at m/z 63 and/or 79 in the negative 
ion mode. These scanning methods combined with the liquid chromatography (LC)-
electrospray mass spectrometry (ESI) and nano-electrospray MS/MS allow the selective 
detection and identification of phosphopeptides even in complex proteolytic digests. Thus, 
even when the signal of the phosphopeptide is indistinguishable from the background, as in 
the conventional MS scan, low-abundant and low-stoichiometric phosphorylated peptides 
can be selectively determined in the presence of a large excess of non-phosphorylated 
peptides. This strategy is particularly well suited to phosphoproteins that are 
phosphorylated to varying degrees of stoichiometry at multiple sites [72]. However, the 
identification and characterization of phosphoproteins would be greatly improved using 
selective enrichment of CPP prior to MS analysis. An ancient technique for phosphoprotein 
enrichment consisted of the precipitation of phosphopeptides as insoluble barium salts and 
recovery by centrifugation, as according to the Manson & Annan method [73]. High-
throughput phosphoproteome technologies currently rely on combining pre-separation of 
proteins, most commonly by high-resolution two-dimensional polyacrylamide gel, in-gel 
tryptic cleavage of proteins, and subsequent MALDI-TOF or ESI-MS/MS mass spectrometry 
analysis of peptides [74]. The high resolving power of 2-DE with the sensitive MS requires 
extensive manual manipulation of samples. Alternative methods are based on chemical 
derivatization. For example, for Ά-elimination, a strong base such as NaOH or Ba(OH)2 is 
used to cleave the phosphoester bonds of phosphoserine and phosphothreonine and form 
dehydroalanine or dehydroaminobutyric acid, respectively, each able to react with different 
nucleophiles, such as ethanedithiol (EDT) or dithiothreitol (DTT). This procedure provides a 
considerably simpler method to enrich CPP. By using cross-linking reagents with affinity 
tags, such as biotin, interfering non-cross-linked peptides are eliminated, and CPP are 
highly enriched [75]. Although the chemical derivatization methods are highly selective, 
they are not widely applied in phosphoproteome studies due to sample loss by the multiple 
reaction steps and unavoidable side reactions [76]. Immobilized metal-ion affinity 
chromatography (IMAC, with Fe3+, Ga3+, Ni2+ and Zr4+ metal ions) and metal oxide affinity 
chromatography (MOAC, with TiO2, ZrO2, Al2O3 and Nb2O5) have been widely used for the 
quantitative binding of CPP on resin or adsorbent. Iminodiacetic acid (IDA, a tridentate 
metal-chelator) or nitrilotriacetic acid (NTA, a quadradentate metal chelator) are often used 
as IMAC functional matrices reacting with multivalent metal ions to form chelated ions with 
positive charges useful for the purification of phosphopeptides. Usually Fe3+, Ga3+ and Al3+ 
are bound to a chelating support prior to fractionating the complex mixture of peptides 
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before MS analysis [77-78]. Ga3+ showed selectivity for CPP higher than Fe3+ and Al3+ [77,79]. 
Phosphopeptides bound to IMAC resin are successively recovered in the column effluent by 
increasing either pH or the phosphate concentration in the buffer [80]. The negatively 
charged CPP selectively interact with TiO2 microspheres via bidentate binding at the 
dioxide surface [81-83]. TiO2-MOAC showed higher specificity than immobilized gallium 
(Ga3+), immobilized iron (Fe3+), or zirconium dioxide (ZrO2) affinity chromatography for 
phosphopeptide enrichment. The main problem associated with the chelating resins is the 
metal-ion leaching, which leads to CPP loss during the enrichment procedure. The 
selectivity of these methods was somewhat compromised by the detection of several acidic 
non-CPP that were also retained by the TiO2 column [84]. To overcome this drawback, the 
carboxyl groups are methyl esterified which eliminates the non-specific adsorption of acidic 
peptides on IMAC [85]. Considerable efforts have been expended to remove acidic non-CPP 
by washing the resin with 2,5-dihydroxybenzoic acid (DHB) [86] or phthalic acid [87]. It has 
been found that aliphatic hydroxyl acid modified metal oxide works more efficiently and 
more specifically than aromatic modifiers such as DHB and phthalic acid in titania and 
zirconia MOC [88]. However, all affinity techniques developed for the current enrichment 
strategies of CPP gave reproducible but incomplete results due to poor binding of low 
concentrations of CPP and the insufficient recovery of multiple phosphorylated peptides [89]. 
Recently, a specific hydroxyapatite (HA)-based enrichment procedure has been developed 
for complex mixtures of phosphoprotein/CPP [90]. Salt such as calcium phosphate, also 
occurring in bone and tooth tissue in the HA form, with the formula [Ca10(PO4)6(OH)2], has 
been previously used to enrich bone proteins [91]. The phosphate groups of 
phosphoproteins interact with crystalline lattice Ca2+ [92] more strongly than do the carboxyl 
groups [93]. Moreover, increasing protein phosphorylation leads to tighter binding of the 
proteins/CPP to HA [92]. One might conclude that the affinity of the multi-phosphorylated 
proteins/peptides for HA is significantly higher than that of the same components with 
lower phosphorylation. Essentially, the HA-based protocol immobilizes on HA 
microgranules proteins/peptides through their phosphate groups, while the non 
phosphorylated components are washed out using various buffers. In a previous article, 
CPP immobilized on HA were progressively eluted, increasing phosphate in the elution 
buffer, and then identified by off-line MALDI-MS [94]. This procedure was accelerated, and 
loss during elution was minimized by spotting HA-CN/CPP microgranules onto a MALDI 
target and analyzing the peptides directly by MALDI-TOF [90]. This method was useful for 
measuring the phosphorylation level of phosphoproteins/CPP quickly, with less than 2 h 
elapsing from the fractionation of the protein/CPP to the readout of the MALDI spectra 
(excluding the trypsinolysis step).  
The more important advantages of the procedure are the possibility of (1) detecting 
phosphorylated proteins/peptides even in complex mixtures, (2) determining phosphorylated 
sites and those dephosphorylated by phosphatase, (3) attaining information regarding 
weakly and heavily phosphorylated peptides and (4) adding the HA-CPP complex directly to 
food, which is enabled by the use of an edible resin such HA [90]. Moreover, use of available 
commercial CPP preparations by the food industry is difficult for three primary reasons: i) 
the matrix bound to CPP is often not edible and such products can be hazardous; ii) the 
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preparation of CPP is a long and a laborious procedure that requires cumbersome and 
expensive manipulation; and iii) CPP have an unpleasant taste even in modest amounts, 
which disadvantageously limits their direct utilization as a human food ingredient. A novel 
HA-based method for food grade CPP preparation has been performed on tryptic digests of 
casein. HA captured all CPP free of non-CPP [90]. There were approximately 32 HA bound 
CPP, and all non-CPP peptides were eluted [90]. HA-based enrichment procedure has been 
successfully applied to phosphopeptide recovery from complex biological fluids such as 
human serum thus providing a great source of potential biomarkers of disease. Four primary 
phosphopeptides derived from fibrinogen were enriched from human serum (Figure 3a-b, 
Table 4). A similar set of phosphorylated peptides was previously obtained using a modified 
IMAC strategy coupled to iterative mass spectrometry-based scanning techniques [95], using 
the titanium ion-immobilized mesoporous silica particles and MALDI-TOF [96] and cerium 
ion-chelated magnetic silica microspheres [97].  
 
 
 
Figure 3. MALDI-MS-TOF spectra for the human serum before (a) and after (b) enrichment by HA 
(insert is the zoomed between 700 and 3000 Da). 
Fibrinopeptide A (FPA) (f1-16)1P, (SerP3), a 16-residue long peptide (1615 Da) (Table 4), is 
the segment anchored on the thrombin surface [98]. The other three phosphopeptides, (f1-
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15)1P, (f2-15)1P and (f2-16)1P (Table 4), are hydrolytic products of FPA. The serum level of 
fibrinogen and its hydrolytic products may reflect the expression and activation of enzymes 
including kinase, phosphatase, and protease [99]. An altered ratio of FPA (f2-15) and FPA 
(f1-16) is detected in patients affected by hepatocellular carcinoma; the 
D2[pS]GEGDFLAEGGGV15 peptide is upregulated, and the A1D[pS]GEGDFLAEGGGVR16 
peptide is down-regulated greatly. The other two peptides, A1D[pS]GEGDFLAEGGGV15 
and D2[pS]GEGDFLAEGGGVR16, varied only slightly between the two groups [96]. The 
proportions of fibrinogen and their phosphorylation products offer new opportunities for 
basic research in exploring new frontiers in bio-marker discovery. 
 
 
 
Phosphoserine residues are coloured red. 
Table 4. Identification of phosphorylated fibrinogen fragments from human serum immobilized on 
HA. 
4.1. CPP in commercial milk as specific indicators of heated milks 
Because of the lower value, the addition of UHT and milk powder to raw or pasteurized 
milk is prohibited (EU Directives 92/46 CEE and 94/71 CEE) for cheese milk. The intensity of 
heat treatment was found to correlate with the furosine content. Glycated proteins and 
peptides formed during the initial stages of the Maillard reaction are indirectly evaluated 
through the furosine content [100-101]. The Amadori compound formed upon the reaction 
of lysine residue with a lactose molecule will prevent the digestive enzymes from reaching 
the binding sites. Native and lactosylated forms of Ά-CN (f1-28)4P, (f1-27)4P and ΅s2-CN (f1-
24)4P, although typical of UHT milk and milk powder, are missing in raw, pasteurized milk 
(71.7 °C for 15 s) and intensely pasteurized milk. The lactosylated peptides that varied with 
heat treatment characterize UHT milk added in amounts not lower than 10% to raw and 
pasteurized milk [102]. Milk delactosed with microbial Ά-galactosidase did not suppress the 
Maillard reaction; indeed, the furosine concentration increased to 35-400 mg/100 g of protein 
[103]. As expected, a lactose-reduced UHT milk had Ά-CN (f1-28)4P glycated mainly by its 
monosaccharides (Figure 4a).  
Therefore, the nonenzymatically glycated CPP derived from the reaction of one molecule of 
glucose or galactose with a lysine residue (m/z 3641) can be considered to be the signature 
peptide of lactose-reduced milk (Figure 4). 
Theoretical Measured MH+ 
1388.5 1389.4 D2SGEGDFLAEGGGV15 1
1459.5 1460.5 A1DSGEGDFLAEGGGV15 1
1544.6 1545.5 D2SGEGDFLAEGGGVR16 1
1615.6 1616.5 A1DSGEGDFLAEGGGVR16 1
Molecular Mass (Da)
Fibrinogen Į-chain sequence Phosphorylation 
sites
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Figure 4. Enlarged view of the MALDI spectrum of Ά-CN (f1-28)4P (MH+ = 3479 Da) signature 
glycosylated CPP in lactose-reduced UHT milk (a) and lactosylated CPP in UHT milk (b). The mass 
differences corresponded to lactose and glucose/galactose residues. 
4.2. CPP in yogurt  
Yogurt is a fermented milk defined as the “food produced by culturing one or more of the 
optional dairy ingredients (cream, milk, partially skimmed milk, and skim milk) with a 
characteristic bacteria culture that contains the lactic acid-producing bacteria, Lactobacillus 
delbrueckii subsp. bulgaricus and Streptococcus thermophilus”. A heat treatment of 90 °C for 10 
min is considered optimal to obtain a good quality yogurt [104], and the addition of milk 
powder increases the content of furosine to more than 300 mg/100 g protein [105]. In yogurt, 
enzymes could give rise to the liberation of a particularly high number of bioactive peptides, 
among them CPP, which could be partly due to LAB proteolytic activity. Comparison of 
CPP in raw, pasteurized and intensely heated milks has previously shown that there is a 
plethora of milk peptides among which a few were glycosylated CPP [102]. Yogurt is 
prepared from intensely heated milk instead of low-pasteurized drinking milk. The CPP of 
two preparations were enriched on HA and analyzed by MALDI-TOF (Table 5). The 
proportion of CPP with molecular masses between 2.5 and 4 kDa was significantly higher in 
yogurt than in pasteurized milk as shown in Table 5. Only four fragments of CPP-derived 
peptides produced during yogurt preparation occur in pasteurized milk (Table 5). 
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n.d. not detected; * CPP detected in vitro because it was liberated by plasmin in raw milk and enriched on HA. 
Table 5. List of HA-enriched CPP identified in commercial samples of yogurt and pasteurized milk. Relative 
intensity of each peak is reported. 
Yogurt
Pasteurized 
milk
Measured MH+ Theoretical 
1327.5 1326.4 Įs1-CN (f44-54)2P 0.3 n.d.
5009.1 5008.7 Įs1-CN (f39-79)6P 0.6 n.d.
5089.3 5088.7 Įs1-CN (f39-79)7P 1.2 n.d.
6959.0 6958.7 Įs1-CN (f35-90)8P 0.6 n.d.
7087.1 7086.9 Įs1-CN (f34-90)8P 0.2 n.d.
1493.6 1492.7 Įs2-CN (f139-150)1P 1.2 n.d.
1617.5 1616.5 Įs2-CN (f1-12)3P 2.0 n.d.
1931.7 1930.8 Įs2-CN (f1-15)3P 8.6 n.d.
2007.9 2006.7 Įs2-CN (f7-21)4P 0.4 n.d.
2356.2 2355.1 Įs2-CN (f1-18)4P 20.8 n.d.
2666.7 2665.4 Įs2-CN (f51-72)4P 2.3 n.d.
2748.6 2747.5 Įs2-CN (f1-21)4P* 3.0 26.9
2876.8 2875.7 Įs2-CN (f1-22)4P 1.8 n.d.
3005.2 3004.8 Įs2-CN (f2-24)4P 0.4 n.d.
3134.3 3133.0 Įs2-CN (f1-24)4P* 24.2 46.0
3382.0 3381.1 Įs2-CN (f49-76)4P 8.4 n.d.
3461.9 3461.1 Įs2-CN (f49-76)5P 1.4 n.d.
3666.0 3665.9 Įs2-CN (f16-45)2P 0.9 n.d.
4166.4 4165.3 Įs2-CN (f115-149)3P* 0.6 n.d.
4294.7 4293.5 Įs2-CN (f115-150)3P* 0.6 n.d.
960.5 959.9 ȕ-CN (f30-36)1P 0.8 n.d.
1462.5 1461.4 ȕ-CN (f17-27)3P 1.8 n.d.
1511.6 1510.4 ȕ-CN (f17-28)2P 0.6 n.d.
1515.5 1514.4 ȕ-CN (f15-25)4P 1.3 n.d.
1591.4 1590.4 ȕ-CN (f17-28)3P 19.5 n.d.
1628.9 1628.3 ȕ-CN (f15-26)4P 0.7 n.d.
1645.4 1644.3 ȕ-CN (f14-25)4P 1.1 n.d.
1743.8 1742.5 ȕ-CN (f15-27)4P 16.0 n.d.
1791.4 1790.6 ȕ-CN (f15-28)3P 7.9 n.d.
1871.6 1870.6 ȕ-CN (f15-28)4P 100.0 n.d.
1999.8 1998.7 ȕ-CN (f14-28)4P 0.4 n.d.
2240.4 2239.0 ȕ-CN (f8-25)4P 1.6 n.d.
2709.4 2708.5 ȕ-CN (f7-28)4P 4.1 n.d.
2967.4 2966.7 ȕ-CN (f1-24)4P 0.2 n.d.
3080.5 3079.9 ȕ-CN (f4-28)4P 0.6 n.d.
3123.2 3122.9 ȕ-CN (f1-25)4P* n.d. 5.8
3351.6 3350.2 ȕ-CN (f1-27)4P 3.2 14.8
3479.9 3478.4 ȕ-CN (f1-28)4P* 70.1 100.0
3607.8 3606.6 ȕ-CN (f1-29)4P* 13.2 6.0
3803.8 3802.4 ȕ-CN (f1-28)4P + 1 lactose 0.7 n.d.
3849.3 3848.8 ȕ-CN (f1-31)4P 0.1 n.d.
3978.2 3977.0 ȕ-CN (f1-32)4P n.d. 0.5
6229.8 6228.8 ț-CN (f106-163)1P 0.3 n.d.
6788.5 6787.5 ț-CN (f106-169)1P 0.1 n.d.
ț-CN derived CPP
Molecular Mass (Da)
Įs1-CN derived CPP
Įs2-CN derived CPP
ȕ-CN derived CPP
CPP sequence
Relative Intensity
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For example, Ά-CN (f1-28)4P, a peptide representing 100% intensity (assumed as base peak) 
of the signals in MALDI spectra, was reduced by approximately 30%; this loss was 
associated with the transformation of pasteurized milk into yogurt. One can deduce that the 
original peptide undergoes degradation even considering the higher number of formed CN 
peptides. In yogurt, Ά-CN (f1-28)4P, the most common CPP in pasteurized milk, was 
hydrolyzed into the peptide Ά-CN (f15-28)4P, which thus becomes the most abundant CPP.  
Ά-CN (f1-29)4P, Ά-CN (f1-28)4P, Ά-CN (f1-25)4P, Ά-CN (f1-24)4P, ΅s2-CN (f1-24)4P, ΅s2-CN 
(f1-21)4P, resulting from the CN hydrolysis by plasmin and enriched on HA, were also 
found as C-terminally shortened peptides. During fermentation and storage, ΅s2-CN (f115-
150)3P and ΅s2-CN (f115-149)3P derived by plasmin action did not react further to produce 
shorter peptides, most likely because of the absence of proteolytic enzymes. In the yogurt 
fraction recovered by centrifugation, only five multi-phosphorylated ΅s1-CN and two low-
phosphorylated Ύ-CN, Ύ-CN (f106-163)1P and Ύ-CN (f106-169)1P, were identified. Few CPP 
were less phosphorylated than the native peptides due to the presence of milk phosphatase, 
which was denatured in all pasteurized cheese-milks. The presence of lactosylated Ά-CN (f1-
28)4P CPP was indicative of yogurt made with high-heat treated or milk fortified with milk 
protein powder [102]. Proteolysis of milk proteins in model yogurt systems has shown a 
similar set of primary CPP (Table 5). Therefore, the question is raised how CPP, derived 
from the enzymatic hydrolysis of yogurt CN are digested and absorbed in adult humans. 
For this reason, it is important to know the gastrointestinal resistance of CPP if used as a 
functional ingredient for fruit beverages. In the various stages of human digestion, a large 
quantity of CPP is produced in the stomach by partial hydrolysis of CN through pepsin 
action and in the small intestine by trypsin; these peptides are successively refined by 
endoproteases/exopeptidases. Although analysis of the intestinal contents of milk and 
yogurt ingestion has revealed the presence of CPP [60], their further resistance to 
gastrointestinal enzymes is poorly documented. Fragment Ά-CN (f1-24)4P has been 
previously identiﬁed in the lumen contents of rats after 60 min of digestion as a Ά-CN (f1-
25)4P derived peptide [106]. Moreover, after yogurt ingestion, Ά-CN (f1-32)4P CPP was 
released in the human stomach [60] and Ά-CN (f1-31)4P was found in a yogurt sample. The 
fragment Ά-CN (f1-28)4P constitutes a clear example of the multi-functionality of milk-
derived peptides because some regions in the primary structure of caseins contain 
overlapping peptide sequences that exert different biological effects, in this case both 
mineral binding and immunostimulatory action [107]. Even with the difference in the 
peptide pattern, it is evident that CPP binding iron (or other metal ions) remains soluble in 
the digestive tract, where they escape further enzyme digestion [106]. The authors have 
studied in depth the simulated digestion of CPP from peptide precursors. These studies 
greatly benefit from the knowledge of enzyme specificities and degradation mechanisms. 
CPase and chymotryptic activity of pancreatin exhibits broad speciﬁcity, cleaving bonds on 
the carboxyl side of several amino acid residues of CPP. The latter, which are in the mass 
range 960-7087 Da (Table 5), are good candidates for intestinal absorption and for playing a 
possible physiological role in mineral bioavailability. However, there are conflicting results 
on the lack of ΅s1-CN (f43-52)2P and ΅s2-CN (f1-19)4P identified by other authors after CN 
hydrolysis with pancreatin, an enzyme used during the intestinal step of simulated 
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physiological digestion [108]. Generally, the physiological effects of CPP may not always be 
extended to precursor peptides, although they are structurally similar. There are not enough 
data concerning the effects of CPP addition to probiotic acid fermented milks. However, 
probiotic bacteria such as Lactobacillus acidophilus and Bifidobacterium spp., selected because 
of their beneficial action, which they may manifest on the health of the consumer, grow 
slowly in milk because of the lack of the proteolytic activity [109]. For this reason, and also 
to reduce the fermentation time, probiotic yogurt is manufactured by yogurt bacteria 
(Streptococcus thermophilus and Lactobacillus delbrueckii ssp. bulgaricus) with the addition of 
probiotic culture. In parallel, non-digestible food ingredients, i.e., “prebiotics”, resist 
digestion in the small intestine and reach the colon, where they act as a growth factor for 
Bifidobacterium species and are metabolized into short chain fatty acids by a limited number 
of the microorganisms also comprising the colonic microflora. Prebiotics are principally 
oligosaccharides (fructo-oligosaccharides, inulins, isomalto-oligosaccharides, lactilol, 
lactosucrose, lactulose, pyrodextrins, soy oligosaccharides, transgalacto-oligosaccharides, 
and xylo-oligosaccharides) that stimulate bifidobacteria growth. In probiotic yogurt 
containing inulin as a prebiotic, the number of bioactive peptides increased, which means 
that elevation in the proteolytic activity has a synergistic effect with probiotic counts of 
yogurt cultures. Therefore, the most proteolytic strains of St. thermophilus and Lb. delbrueckii 
subsp. bulgaricus, spp. enhance the growth of Lb. acidophilus and Bifidobacterium. In our 
studies, the overall opiate activity of the bio-yogurt preparation containing Lb. acidophilus 
and Bifidobacterium spp. and inulin as a prebiotic was approximately twice that typical of 
traditional yogurt. In addition, the above yogurt preparation contained a variety of opioid 
agonistic and antagonistic, immunomodulation, anti-thrombotic, ACE-inhibitor, and anti-
microbial activities. Traditional and probiotic yogurt both possess a characteristic soluble 
fraction composed by peptides exhibiting biological activity, amongst others. This fraction 
was found to include CPP, Ά-casomorphins and antithrombotic peptide precursors that did 
not differ greatly from one another. In a study comparing the proteolytic, amino-, di-, tri- 
and endopeptidase activity of nine strains of St. thermophilus, six strains of Lb. delbrueckii, 
fourteen strains of Lb. acidophilus and thirteen strains of Bifidobacterium spp., aminopeptidase 
activity was detected for all bacterial strains – traditional yogurt strains and probiotic 
bifidobacteria - both at the extracellular and intracellular levels. High dipeptidase activity 
was demonstrated by all bacterial strains for Lb. delbrueckii ssp. bulgaricus, Lb. acidophilus, 
and Bifidobacterium spp., whereas St. thermophilus had greater dipeptidase activity at the 
extracellular level. 
4.3. CPP in a few cheese varieties 
Whole milk contains a variety of endogenous plasmin-mediated CN peptides. In addition, 
CPP were released following cell lysis and release of intracellular LAB enzymes. This 
phenomenon was observed especially at the end of ripening in long-ripened cheeses, such 
as Comté [110], Grana Padano [111], Parmigiano-Reggiano and semi-hard Herrgard cheese 
[112]. In Grana Padano cheese, 45 CPP were identified, of which 24 originated from Ά-casein, 
16 from ΅s1-casein and 5 from ΅s2-casein. These CPP formally derive from three parent 
peptides, namely Ά-CN (f7-28)4P, ΅s1-CN (f61-79)4P and ΅s2-CN (f7-21)4P [111]. By 
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comparing CPP of Grana Padano and Herrgard cheese, it was clear that CPP were all 
progressively shortened and dephosphorylated during ripening. CPP were very resistant to 
enzymatic degradation, especially when SerP residue was at the N-terminal end. The 
number of CPP identified according to the different procedures was comparable for Grana 
Padano [111] and Herrgard cheese [112]. In both the cheeses, CPP were progressively 
shortened and dephosphorylated during ripening, with both cheeses constituting 
heterogeneous mixtures of peptides phosphorylated at various sites sharing N- and C-
terminally truncated CPP. However, some peptides proved very resistant to enzymatic 
degradation, especially when SerP residue was present at the N-terminal end of CPP [111]. 
The only SerP residue located at the N-terminus of CPP was subjected to 
dephosphorylation, exposing the dephosphorylated residue to aminopeptidase action. A 
heterogeneous CPP pattern also differentiated the cheese samples within a given form 
because of the phosphatase gradient amongst peripheral and central parts of the Grana 
Padano cheese form (3 105 vs. 3 102). This is due to heat sensitivity in the temperature range 
57 and 62 °C and the acid pH at which these enzymes are denatured. These data explain the 
discrepancy in the amount of serine, which varied by as much as 50% of SerP from the 
periphery towards the center of the cheese form [113]. In contrast, the CPP fraction of 
Herrgard cheese was more uniform, with the two cheese varieties sharing active plasmin 
and amino-peptidases from lactic acid bacteria. Because milk pasteurization denatures 
alkaline phosphatase while it activates plasmin [114], proteolysis in the above cheese is 
plasmin-dependent. It is therefore likely that CPP of pasteurized milk cheeses are 
intrinsically more stable than raw milk cheeses [111]. CPP in artisanal PDO ovine Fiore 
Sardo cheese have been previously reported [115]. Patterns of CPP similar to that observed 
for bovine cheese indicated that mechanisms of formation and degradation of CPP were 
similar regardless of the milk species and cheese variety. The dephosphorylation mechanism 
in Fiore Sardo was different from that found in Grana Padano cheese, most likely because of 
the use of different rennet types. In PDO Fiore Sardo cheese, no apparent difference in 
susceptibility to dephosphorylation was found amongst the differently located SerP peptide 
residues. This resulted in the simultaneous occurrence of partly dephosphorylated peptides, 
either internally or externally. CPP enrichment by HA, for example of pH 4.6 soluble 
fractions of hard Parmigiano Reggiano (PR) (30-mo-old), semi-hard, pasta filata Provolone 
del Monaco (PM) (6-mo-old), semi-cooked Asiago d’Allevo (AA) (3-mo-old) and mold-
ripened cheese Gorgonzola (GR) (2-mo-old) cheese, has allowed the identification of CPP in 
high number (Figure 5) which may explain the broad-specificity of the cheese enzymes 
involved in CN proteolysis. Some CPP were derived from the Lys-X or Arg-X cleavage by 
plasmin primarily located in the N-terminal region of caseins, such as Ά-CN (f1-28)4P (Lys28-
Lys29) or Ά-CN (f1-29)4P (Lys29-Ile30), ΅s1-CN (f61-79)5P (Lys79-His80) and ΅s2-CN (f1-24)4P 
(Lys24-Asn25). The native plasmin-derived CPP were then further hydrolyzed by cheese 
aminopeptidases and CPase into shorter peptides.  
It is likely that ingested cheese carries a concentrated pH 4.6 soluble CPP fraction and a 
variable number of CPP according to the cheese variety. Above all, the presence and 
integrity of plasmin-mediated products of CN is a function of the milk, whether raw or 
pasteurized. Pasteurization reduces the milk plasmin activity only by ~15 percent, whereas 
plasmin activity increases during milk storage. UHT does not inactivate the plasmin in milk, 
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Figure 5. The MALDI spectra of CPP isolated by the addition of HA to pH 4.6 soluble fractions of 
Gorgonzola (a), Asiago (b), Provolone del Monaco (c), and Parmigiano Reggiano (d) cheeses. The inset 
magnifies the m/z values in the lower molecular mass peptide range 0.8-4 kDa.  
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and proteolytic activity will continue to damage milk. Heat treatments modify the peptide 
profile by increasing the content of larger peptides. The CN breakdown occurring during 
the ripening of PR cheese proceeded more slowly in PM cheese.. This means that eating PR 
cheese increases the quota of the co-ingested mineral bound CPP. In contrast, GR cheese 
show a different CPP level such as that of Ά-CN (f1-27)4P (3350.2 Da), resulting the most 
abundant CPP, when compared with hard cheeses (Figure 5a and 6); Ά-CN (f1-27)4P was 
further hydrolyzed into the shorter Ά-CN (f7-27)4P (2580.4 Da), Ά-CN (f10-27)4P (2270.0 Da), 
Ά- CN (f12-27)4P (2083.8 Da) and Ά-CN (f15-27)4 (1742.4 Da). The most abundant CPP in all 
three cheeses derived from the peptide Ά-CN (f1-28)4P, but long-ripened PR cheese was 
dissimilar from the other cheeses in its content of ΅s1-CN (f62-79)5P (2332.9 Da) (Figure 5d 
and 6). 
 
Figure 6. Histogram representation of CPP at 100% relative intensity and their performance in four 
cheeses.  
Ά-CN (f1-28)4P (3478.4 Da) in AA cheese was the most abundant signal of the MALDI 
spectra and it was partially hydrolyzed into the shorter peptides Ά-CN (f7-28)4P (2708.5 Da), 
Ά-CN (f15-28)4P (1869.7 Da) and Ά-CN (f17-28)3P (1589.6 Da) (Figure 5b and 6). Considering 
exclusively the CPP molecular mass in the 3-3.5 kDa range of AA and GR cheese, the 
intensity of a high number of peptides transformed into a number of progressively lower 
molecular weight CPP, with accompanying liberation of peptides (Figure 5). The most 
common group of CPP occurred in the mass range of 1.7-2.9, reaching the maximum 
intensity for Ά-CN (f12-28)4P (2212.0 Da) in PM and ΅s1-CN (f62-79)5P (2332.9 Da) in PR 
cheese (Figure 5c-d and 6). The presence of Ά-CN (f16-22)3P (977.7 Da) was discovered in 
both AA and PR cheeses and was not detected in the PM and GR cheeses (Figure 5). Our 
results show that longer plasmin-mediated peptides degraded into shorter CPP. These 
peptides became more evident when the chymosin retained in the cheese was largely 
inactivated by cooking the curd at high temperatures (~55 °C). The hydrolysis of CN by 
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chymosin was covered by that of plasmin, which became the principal proteolytic enzyme 
in the cheese. This phenomenon is particularly evident in PM raw milk cheese for which the 
plasmin-mediated Ά-CN (f1-28)4P peptide, representing ~0.1% of the CPP, was almost 
completely hydrolyzed into the shorter peptides Ά-CN (f11-28)4P (2341.1 Da), Ά-CN (f12-
28)4P (2212.0 Da), Ά-CN (f11-25)4P (1985.7 Da) and Ά-CN (f12-25)4P (1856.6 Da) (Figure 5c). 
When comparing the PR and PM cheese, the former had a high extent of Ά-CN (f1-28)4P as 
judged by the higher levels of the peptide. This demonstrates that CPP of PR cheese are 
progressively transformed into a number of lower-molecular-weight peptides. In contrast, 
the quasi-total absence in the PM cheese of Ά-CN (f1-28)4P and relatively few of the various 
sizes Ά-CN-derived CPP (Figure 6) could be the effect of the enzyme decline from the 
optimum level of activity to zero enzyme activity. 
΅s1-CN CPP originated for the greater parts from the internal regions of the amino acid 
sequence, namely ΅s1-CN (f61-79)5P and ΅s1-CN (f33-60)3P.  
 
Figure 7. The number of CPP derived from ΅s1-CN (f59-79)5P and ΅s2-CN (f1-24)4P in Parmigiano 
Reggiano, Provolone del Monaco, Asiago and Gorgonzola cheeses.  
In PR cheese, 23 casein-derived CPP were found to derive from the internal region of ΅s1-
CN, i.e., ΅s1-CN (f59-79)5P, whereas they were not detected in AA (Figure 7).  
 
Figure 8. Amino acid sequence of the ΅s1-CN (f59-79) 4P peptide and the CPP identified in PR cheese. 
Phosphoserine residues are indicated by red boxes. 
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The profile of the CPP depicts the mechanisms of both the proteolysis and 
dephosphorylation in a long ripened cheese. Peptide ΅s1-CN (f61-79)5P, most likely arising 
from the parent peptide ΅s1-CN (f1-79)7P through cleavage at Met60-Glu61, was 
dephosphorylated and concurrently hydrolyzed into shorter peptides. Alkaline and/or acid 
phosphatases acting on SerP residue dephosphorylated CPP. N-terminal Ser was then 
exposed to aminopeptidase and released as a free amino acid. Bacterial CPase or 
exopeptidase such as cathepsin D/chymosin release ΅s1-CN (f61-74)4P and other derived 
CPP through cleavage at Asn74-SerP75 (Figure 8). In PR aged 30 months, ΅s1-CN (f61-79)5P 
(2462.1 Da), ΅s1-CN (f62-79)5P (2332.9 Da), ΅s1-CN (f63-79)5P (2261.9 Da), ΅s1-CN (f64-79)5P 
(2132.8 Da), ΅s1-CN (f64-79)4P (2052.8 Da), ΅s1-CN (f65-79)4P (1965.7 Da), ΅s1-CN (f62-74)4P 
(1681.3 Da), ΅s1-CN (f64-74)4P (1481.2 Da), ΅s1-CN (f64-74)3P (1401.2 Da) and ΅s1-CN (f65-
74)3P (1314.1 Da) were the dominant CPP (Figure 5d and 8). Indeed, only 7 CPP for PM 
cheese and 11 CPP for GR were derived from ΅s1-CN (f59-79)5P, namely ΅s1-CN (f61-79)5P 
(2462.1 Da) and ΅s1-CN (f61-74)4P (1810.5 Da) (Figure 5a and c and 7). Considering the ΅s2-
CN peptide, the ΅s2-CN (f1-24)4P CPP were similar in number but significantly different in 
the case of the four cheese varieties (Figure 6). The dominant ΅s2-CN-derived CPP were ΅s2-
CN (f1-24)4P (3132.9 Da) and ΅s2-CN (f1-21)4P (2747.6 Da) in AA cheese (Figure 5b). The 
most abundant ΅s2-CN-derived CPP were ΅s2-CN (f1-18)4P (2355.1 Da) for PM and ΅s2-CN 
(f6-18)4P (1751.4 Da), a shortened form of the primary CPP ΅s2-CN (f1-18)4P, for GR cheese 
(Figure 5a and c). ΅s2-CN (f7-18)4P (1614.3 Da) and ΅s2-CN (f8-18)4P (1515.1 Da) 
characteristically accumulated in PR cheese (Figure 5d). Similar and discrete 
phosphorylated CPP derived species for ΅s2-CN (f1-24) (3P and 4P) and Ά-CN (f1-28) (3P and 
4P) occurred in all cheeses. For the other casein fractions, primary CPP are fully 
phosphorylated, such as ΅s1-CN (f61-79)5P, whereas the derived peptides show a level of 
phosphorylation less than native form as observed in PM and GR. A higher 
dephosphorylation level characterized the CPP profile of PR cheese (Figure 8). The different 
profile of CPP could derive from the different length of ripening and from the cheese 
variety. 
CPP in ovine cheeses 
Cheeses that contain CPP are also manufactured from ovine milk. Proteolytic enzymes in 
Pecorino cheese originate from chymosin, pepsin and other clotting preparations such as paste 
rennet. These enzymatic activities are complemented by those secreted by the vegetative 
spores of Penicillium roqueforti during the maturation of blue-veined cheeses. The CPP patterns 
of Pecorino and Roquefort cheese have been characterized and main components identified. 
The sequence alignment of the CPP released throughout the hydrolysis of the Ά-CN (f1-28)4P 
in Pecorino and Roquefort cheeses are compared in Figure 9. 
In PR cheese of different ages, the released CPP were progressively degraded at C- and N-
terminal ends. CPases work from the C-terminal end and aminopeptidases from the N-
terminal end, both removing the terminal amino acid residues incrementally. LAB does not 
produce CPases; thus, the ability to liberate the carboxyterminal amino acid and peptides is 
typical of the mold. The N-terminal amino acid seemed to be released faster than the C-
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terminal residues because of the lower activity of CPases. There are negligible differences in 
the CPP level of different cheese lots primarily because of the action of the enzymes from P. 
roqueforti after its sporulation in blue-veined cheese. More long-chain CPP Ά-CN, such as Ά-
CN (f1-28)5P-4P, Ά-CN (f1-27)5P-4P and Ά-CN (f1-24)5P-4P, were detected in Pecorino 
cheese, whereas Ά-CN (f7-28)5P-4P and Ά-CN (f7-27)5P-4P resulted from the longer CPP in 
Roquefort cheese (Figure 9). In these cheese varieties, both ΅s1- and Ά-CN have been 
described as completely hydrolyzed at the end of ripening. This contradicts other findings 
indicating ~50% CN hydrolysis. Plasmin, NSLAB, and Lactobacilli contaminating flora 
proteinases are mainly responsible for extensive proteolysis in Parmigiano-Reggiano cheese, 
which is ripened for ~24 months at ~18-20 °C [116]. Here, chymosin is denatured by the high 
cooking temperature used during the manufacture of cheese. Molds develop at 
approximately 2 to 5 weeks of ripening, concurrently degrading CN into peptides of various 
sizes [117]. A similar mechanism for Ά-CN-derived CPP was found in Grana Padano cheese. 
Ser was proteolytically cleaved by aminopeptidases, and SerP hindered cleavage by the 
latter and continued its action after dephosphorylatation of SerP.  
 
Figure 9. Amino acid sequence of the Ά-CN (f1-28)4P peptide and the CPP identified in Pecorino (blue 
line) and Roquefort (yellow line) cheeses. CPP common to the two cheeses are indicated by crosses, and 
phosphoserine residues are indicated by red boxes. 
5. Anticariogenic effect of CPP in yogurt and cheese 
Due to proteolytic activity, a great number of CPP are formed in raw milk cheese. In 
contrast, the enzymatic digestion of proteins to peptides can be reduced by milk 
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pasteurization. Notwithstanding this, yogurt remains a consistent source of bioavailable 
CPP even if milk is heated to high temperatures (90 °C, 30 min) to create an inoculation 
medium in which the bacteria can grow and produce lactic acid. LAB provide plenty of 
CPP in the form of soluble complexes with Ca2+ that are effective in avoiding the life-
threatening calcium phosphate precipitation, enhancing the intestinal absorption of 
minerals and retention in the human body [34,118]. The mineral-binding power of CPP 
also depends on the number of binding sites and their relative accessibility [119]. Dairy 
products such as cheese and yogurt are both rich in multi-phosphorylated peptides 
capable of interacting with colloidal calcium phosphate to manifest anticariogenic 
properties in human and animal [120-121,13]. The mechanism of anticariogenicity might 
be due to a direct chemical effect of casein and calcium phosphate components [122]. 
Tooth enamel is a polymeric substance consisting of crystalline calcium phosphate, 
embedded in a protein matrix. Thus, CPP can significantly enhance localization of ACP at 
the tooth surface, inhibiting enamel demineralization and promoting remineralization. In 
the development of teeth and bone, CPP act as hydroxyapatite nucleator and control the 
growth of the crystals, resulting in unique crystal morphology. A new calcium phosphate 
remineralization technology has been recently developed based on the complex CPP-ACP 
[RecaldentTM CASRN691364-49-5] [66]. This preparation is claimed to stabilize calcium 
and phosphate ions in high concentrations by binding ACP to pellicle and plaque of the 
tooth surface. Moreover, CPP-ACP inhibited the adhesion of Streptococcus mutans to the 
tooth surface producing a copious reservoir of bioavailable calcium ions [67]. Cheese and 
yogurt CPP have the ability to stabilize calcium phosphate in solution, forming small 
CPP-ACP nanocomplexes. The calcium-binding ability of CPP has been applied by clinical 
dentists to show that CPP stabilize high concentrations of calcium, phosphate, and 
fluoride ions on the tooth surface by binding them to pellicle and plaque [66,123]. In 
dental plaque, CPP-ACP binds onto the surface components of the intercellular plaque 
matrix. Incorporation of CPP-ACP into the plaque will increase the calcium and 
phosphate content by forming a stable supersaturated solution of calcium phosphate. 
Thus, the availability of calcium in plaque provides a natural anticaries protective effect, 
either by suppression of demineralization promoted by fermentative acids in mouth, 
through an increased remineralization by binding calcium ions to teeth enamel, or 
possibly a combination of both. An inverse relation between plaque calcium and caries 
incidence has been evidenced [124-125]. Reynolds (1997) [126] has demonstrated that 
CPP-ACP can actually remineralize subsurface lesions in human enamel, and this is 
indeed the basis of one claim of his patent [127]. The diffusion of available CPP-ACP in 
the mouth is controlled by two main factors: i) the molecular weight of the diffusing 
species, the square of which is inversely proportional to the diffusion coefficient; and ii) 
the binding characteristics of the diffusing species, which dictate how much CPP-ACP is 
free to diffuse at a given time [128]. At neutral pH, calcium diffusion is limited by the 
quantity of bound calcium, reducing the effective diffusion coefficient (De) and creating a 
measurable restricted effective diffusion coefficient (rDe), where rDe =De/(R + 1) and R is 
the ratio of bound to free calcium. A large number of potential binding sites for calcium 
can have significant effects on the calcium diffusion coefficient; this effect is maintained at 
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low pH, although overall diffusion is slightly faster [129-130]. Conversely, one may infer 
that ACP may also bind to dental plaque and tooth enamel, thus having beneficial effects 
on teeth remineralization [67]. In addition, SerP residues of the CCP-HA complex are 
exposed to intestinal alkaline phosphatase, which favors metal ion bioavailability by 
releasing inorganic phosphate. Milk, ice cream, and cheese have been observed to lower 
the incidence of dental caries in rats [131]. Elderly people that eat cheese several times per 
week had a lower incidence of root surface caries development [132]. CPP of yogurt have 
been observed to have an inhibitory effect on demineralization and are able to promote 
remineralization of dental enamel [133]. Moreover, anticariogenic activity has also been 
reported for egg phosphopeptides (viz. phosvitin and phosphophorin) [134-135]. The 
heating process affects the bioavailability of CPP; for example, milk sterilization can 
induce dephosphorylation of phosphoseryl residues and dehydroalanine residue 
formation [136]. 
6. CPP as nutraceutical ingredients in functional foods  
6.1. Examples of commercial CPP preparation 
Some commercial products have been developed containing moderately hydrolyzed milk 
proteins as the sole protein source. Hypoallergenic formulas are based on partially or 
extensively hydrolyzed proteins. Both formulae are better tolerated by small premature 
infants than native cow milk protein. Ultrafiltered micellar casein and microfiltered whey 
protein concentrate are known to slow down the digestive process. Typical composition 
data of commercial phosphopeptide preparations (m/m) include 91.3% (TN x 6.47) or 94.8 
(dry basis) protein, 16.0% CPP, and 6.0% free amino acids. Compared with the expected CPP 
composition, the commercial preparation contained ~5% undigested protein, ~30% peptides 
in the intermediate molecular mass 5000-20000 Da range, and ~48% of molecular mass in the 
500-5000 Da range (Tatua, New Zealand). The preparation is generally very complex and 
dependent on the procedure used to perform casein hydrolysis. Therefore, commercial 
products can be considered to be an enriched-CCP preparation containing 16% CPP 
without specification of the peptide size and phosphorylation degree. Preliminary 
analysis performed by MALDI-TOF analysis indicated that the signal in the mass spectra 
originated exclusively from the Ά-CN digestion. The intensity of non-CPP such as Ά-CN 
(f191-209), Ά-CN (f184-209), Ά-CN (f177-209) and Ά-CN (f170-209) was sufficiently high to 
obscure other CN peptides (MALDI spectrum not shown). As reported above, a number 
of available techniques allow the separation of CPP and non-CPP. To reduce the large 
dynamic range of non-CPP, HA was used for CPP enrichment [90,94,102]. CPP included 
multiply phosphorylated peptides (up to 4 phosphorylation residues). CPP Ά-CN (f1-
28)4P and 3P, Ά-CN (f1-25)4P, 3P and 2P and Ά-CN (f2-25)4P, 3P and 2P were found and 
may be indicative of the progressive CPP dephosphorylation (MALDI spectrum not 
shown). Interestingly, in addition to Ά-CN, the commercial CPP (Tatua, NZ) also 
displayed ΅s1- or ΅s2-CN-derived CPP, invisible or weakly visible before the sample was 
treated with HA (Table 6). 
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Finally, a method for reducing the complexity of peptide mixtures was the separation of 
non-CPP and CPP by trapping CPP on HA under neutral conditions. This could be the 
principle for an industrially based production of CPP.  
* indicates a CPP containing the alternative non-allelic deletion of Gln78 [137]; Phosphoserine residues are coloured red. 
Table 6. CPP identified in a commercial CPP preparation (Tatua Co-operative Dairy Company Ltd) by 
tandem MS sequencing. 
6.2. Examples of industrial methods for CPP preparation 
Starting from CN, the overall preparation process gave 16% CPP (Figure 10), less than the 
theoretical yield of 23% (Ytheor =22.8%), which means approximately 20% yield on the basis of 
weight, a yield higher than that obtained by other researchers [138-140]. In their production 
Measured Theoretical 
Įs1-CN 1138.4 1138.4 115 - 123 (N)SAEERLHSM(K) 1P
1526.7 1526.7 35 - 47 (K)EKVNELSKDIGSE(S) 1P
1831.9 1831.8 75 - 89 (N)SVEQKHIQKEDVPSE(R) 1P
1859.9 1859.9 75 - 89 (N)SVEKHIQKEDVPSER(Y)* 1P
1926.5 1926.7 43 - 58 (K)DIGSESTEDQAMEDIK(Q) 2P
1950.9 1950.9 104 - 119 (K)YKVPQLEIVPNSAEER(L) 1P
1988.0 1987.9 75 - 90 (N)SVEQKHIQKEDVPSER(Y) 1P
2054.7 2054.7 43 - 59 (K)DIGSESTEDQAMEDIKQ(M) 2P
2185.8 2185.8 43 - 60 (K)DIGSESTEDQAMEDIKQM(E) 2P
2400.9 2400.9 41 - 60 (L)SKDIGSESTEDQAMEDIKQM(E) 2P
2597.0 2597.0 37 - 58 (K)VNELSKDIGSESTEDQAMEDIK(Q) 2P
2856.1 2856.1 37 - 60 (K)VNELSKDIGSESTEDQAMEDIKQM(E) 2P
3113.2 3113.3 35 - 60 (K)EKVNELSKDIGSESTEDQAMEDIKQM(E) 2P
3193.2 3193.3 35 - 60 (K)EKVNELSKDIGSESTEDQAMEDIKQM(E) 3P
3699.6 3699.5 61 - 90 (M)EAESISSSEEIVPNSVEQKHIQKEDVPSER(Y) 4P
3779.6 3779.5 61 - 90 (M)EAES ISSSEEIVPNSVEQKHIQKEDVPSER(Y) 5P
3974.5 3974.6 59 - 90 (K)QMEAESISSSEEIVPNSVEQKHIQKEDVPSER(Y)  4P; Oxidation (Met)
4479.0 4479.0 23 - 60 (R)FFVAPFPEVFGKEKVNELSKDIGSESTEDQAMEDIKQM(E) 2P
Įs2-CN 1432.6 1432.6 135 - 146 (N)SKKTVDMESTEV(F) 1P
1538.6 1538.6 126 - 137 (R)EQLSTSEENSKK(T) 2P
1578.6 1578.6 123 - 134 (T)LNREQLSTSEEN(S) 2P
1694.7 1694.7 125 - 137 (N)REQLSTSEENSKK(T) 2P
1793.7 1793.7 123 - 136 (T)LNREQLSTSEENSK(K) 2P
1921.8 1921.8 123 - 137 (T)LNREQLSTSEENSKK(T) 2P
2715.3 2715.3 115 - 137 (R)NAVPITPTLNREQLSTSEENSKK(T) 2P
3051.3 3051.2 1 - 24 KNTMEHVSSSEESIISQETYKQEK(N) 3P
3131.2 3131.2 1 - 24 KNTMEHVSSSEESIISQETYKQEK(N) 4P
3786.6 3786.6 115 - 146 (R)NAVPITPTLNREQLSTSEENSKKTVDMESTEV(F) 3P
4034.6 4034.8 115 - 148 (R)NAVPITPTLNREQLSTSEENSKKTVDMESTEVFT(K) 3P
ȕ-CN 1600.7 1600.7 29 - 40 (K)KIEKFQSEEQQQ(T) 1P
1785.7 1785.7 35 - 48 (Q)SEEQQQTEDELQDK(I) 1P
1945.8 1945.8 29 - 43 (K)KIEKFQSEEQQQTED(E) 1P
2559.2 2559.1 29 - 48 (K)KIEKFQSEEQQQTEDELQDK(I) 1P
2805.2 2805.2 1 - 24 RELEELNVPGEIVESLSSSEESIT(R) 2P
2885.2 2885.2 1 - 24 RELEELNVPGEIVESLSSSEESIT(R) 3P
2906.3 2906.3 29 - 51 (K)KIEKFQSEEQQQTEDELQDKIHP(F) 1P
2961.3 2961.3 1 - 25 RELEELNVPGEIVESLSSSEESITR(I) 2P
2965.3 2965.2 1 - 24 RELEELNVPGEIVESLSSSEESIT(R) 4P
3041.2 3041.3 1 - 25 RELEELNVPGEIVESLSSSEESITR(I) 3P
3053.4 3053.4 29 - 52 (K)KIEKFQSEEQQQTEDELQDKIHPF(A) 1P
3121.1 3121.3 1 - 25 RELEELNVPGEIVESLSSSEESITR(I) 4P
3396.5 3396.5 1 - 28 RELEELNVPGEIVESLSSSEESITRINK(K) 3P
3476.5 3476.5 1 - 28 RELEELNVPGEIVESLSSSEESITRINK(K) 4P
Molecular Mass (Da) Start End Peptide Sequence Peptide 
Modifications
Parent 
Protein
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experiments, the authors obtained a CPP preparation as high as 18.8% degree of hydrolysis 
(DH).  
 
Figure 10. Schematic representation of the process-scale isolation of tryptic CPP from caseinate, 
showing the protein flow through the process (source: [141]). 
The example of 2000 L Na-caseinate solution containing 180 kg protein and 1 kg trypsin 
yielded 29 kg of calcium-enriched CPP, corresponding to a yield of ~16% (w/w) [141]. A 
variety of raw materials such as acid casein, sodium caseinate, and calcium caseinate, as 
well as skimmed raw milk, milk concentrate by ultrafiltration, pasteurized and UHT milk 
near the limit date for consumption, may be used as the substrate for CPP production. The 
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optimal parameters for the hydrolysis with trypsin were 37 °C and pH between 7.5 and 8.5. 
The casein hydrolysate solution was roughly fractioned by ultrafiltration with appropriate 
membranes to obtain soluble CPP both in the “permeate” and “retentate”. Lower-molecular 
peptides/phosphopeptides occurred in the “permeate” and larger in the “retentate”. The 
diafiltrate containing the tryptic casein digest was loaded on the ion exchange resin, and the 
non-CPP flowed through and were recovered for further use, e.g., as substrate for bacterial 
culture. Bound CPP, free of non-CPP, are eluted using sodium hydroxide, e.g., 0.2 M, and 
conductivity and absorbance monitored at 280 nm. The eluate containing CPP is collected 
and then concentrated, typically by reverse osmosis. Peptides were pasteurized (85 °C, 15 s) 
and spray dried, yielding sodium enriched CPP (Na-CPP). In other cases, to obtain calcium-
enriched CPP, the concentrate is added with CaCl2 in excess, diafiltered, and then CPP 
solution concentrated by reverse osmosis until the filtrate conductivity was negligible (less 
than 3 mS cm-1). The concentrate is spray dried, and the product is labeled as calcium-
enriched CPP (Ca-CPP).  
6.3. Traditional and new processes for the use of CPP in alimentary products  
A Ca2+/ethanol selective precipitation procedure was used to produce a CPP and non-CPP 
concurrently from an alcalase digest of whole casein in which the traditional and new 
processes for CPP production were reported [142]. CN is trypsinized, and the pH of the 
solution is adjusted to 4.6 to separate the non-peptide material. The CPP-Ca2+ aggregation 
was induced by ethanol addition in the supernatant and recovered as precipitate for freeze 
drying. In the novel process, the step of non-peptide material removal was omitted, and 
non-CPP (CNPP) was recovered as supernatant for use in alimentary products. For casein, 
the use of alcalase, a cheap enzyme suitable for industrial application, for hydrolysis was 
suggested [142]. The CN hydrolysates were separated into the two types of peptides using 
combined treatment with CaCl2 and ethanol. CPP and non-CPP comprised components with 
molecular weight lower than 2509 Da and 2254 Da, respectively, as determined using size 
exclusion HPLC. A DH of 20% for the CN hydrolysate was achieved. At the end, the 
recovery of CPP reached 24%. The phosphorus component of CPP was 3.08%, and nitrogen 
recovery was approximately 76% [142]. CPP generally had an improved solubility and 
transparency even under acid conditions and could be used as ingredient for beverages such 
as sport drinks, soft drinks, health drinks, fermented products, vitamin concentrates, fruit or 
fruit fractions.  
6.4. Patented methods for CPP production as ingredients for alimentary products 
A method for the preparation of selected anticariogenic CPP comprised the steps of 
complete digestion of CN as soluble monovalent cation salt with a proteolytic enzyme: the 
addition of a mineral acid to the solution to adjust the pH to approximately 4.7; the removal 
of any produced precipitate; the addition of CaCl2 to a concentration of approximately 1.0% 
(w/v) to cause the aggregation of CPP; the separation of the aggregated CPP from the 
solution through a filter with a molecular weight exclusion limit within the range 10000 to 
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20000 while passing the bulk of the remaining CPP in solution; the diafiltration of the 
separated CPP with water through a filter; the concentration of the solution; and the drying 
the retentate [143]. Peptides not included in the aggregation were removed by 
ultrafiltration/diafiltration. By this means, anticariogenic CPP at purity greater than 90% 
were obtained [143]. CPP including calcium, magnesium or both salts (or zinc, ferric or other 
salts) are produced by submitting CN to proteolytic enzyme hydrolysis, ultrafiltering the 
resulting hydrolyzate to produce a permeate containing CPP, adding a bivalent cation salt to 
the peptides to form CPP aggregates, and separating by ultrafiltration the CPP aggregates 
and non-CPP [144]. When CPP salts need to be converted to free phosphopeptides, they can 
be restored by acidification with HCl; the solution is then diafiltered extensively through a 
1000 molecular weight cut-off membrane to remove excess calcium chloride. 
6.5. Example of CPP applications as nutraceuticals in functional foods 
The CPP-salts complex can be added to different foods. A stable acidic beverage or other 
alimentary products can be obtained by digesting casein with trypsin, precipitating the 
insoluble components at acid pH, adjusting the pH of the obtained supernatant to 
approximately 6.0, then adding calcium chloride and ethanol to recover an acid-soluble 
calcium complex of CPP and the reaction product and adding them to a soft drink [145]. The 
acid-soluble calcium complex of CPP enhances calcium absorption from food because 
calcium may be absorbed by the body in the form of soluble calcium. Acid-soluble CPP is a 
mixture of ΅s1-, ΅s2- and Ά-CPP, forming essentially no turbidity in solution at pH of 3.0 or 
less, and having purity greater than 90%, molecular weights between approximately 2500 
and 4600 Da, and the ability to solubilize at least 100 ppm calcium at a concentration of 0.5 
mg/ml CPP. The acid-soluble CPP produced in vitro also have a solubilizing capability on 
iron. It is widely believed that iron must be solubilized for absorption through the small 
intestine. Accordingly, health may also be enhanced by the absorption of the soluble iron in 
the drink by the human body. Similarly, magnesium may be solubilized in a drink or edible 
product of this type [145]. Therefore, in addition to drinks, preparation of CPP with high 
negative charge could be used as additive for healthy foods or for dietetic or pharmaceutical 
compositions, as they are capable of increasing the in vivo absorption of calcium or other 
ions [146]. Another interesting invention relates to processes and the compositions that are 
useful to remineralize the teeth of mammals, particularly humans, and impart acid 
resistance thereto. These compositions included a gum base or carrier, sweetening agents, 
CPP-ACP preparation and food-grade acids [147]. Because many chewing gum and 
confectionery products usually contain acids, many consumers enjoying chewing gum and 
confectionery products ingest acids causing demineralization of the tooth surface. CPP-
calcium phosphate complexes are known to have anticariogenic teeth strengthening effects 
that could be used address the problem of dissolution or demineralization of tooth enamel 
and the resultant formation of dental caries. Exogenous CPP-ACP preparations have also 
been added to milk in 2.0-5.0 g⁄L amounts to remineralize enamel subsurface lesions, which 
actually increased with respect to the control [148]. 
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These inventions create functional foods with undoubted beneficial effects on human health, 
possibly promoting recalcification of bones, protecting the tooth enamel from decay and 
other possible health benefits. 
7. Conclusion 
Proteins are no longer considered merely nutritional components because they possess 
encrypted peptides with possible biological properties [149-153]. The cited literature has 
highlighted that bioactive peptides may be released in vitro or in vivo by digestive and bacterial 
enzymes starting from casein or generally inactive precursors [151,154-155]. We have 
examined the case of casein-derived phosphopeptides that can be applied as dietary 
supplements in “functional foods” and produced on an industrial scale. With this, it has been 
demonstrated that, each time a health-enhancing nutraceutical is required for a functional 
food, an appropriate enzymatic hydrolysis of casein needs to be designed [156-157]. In 
addition to the anticariogenic activity, the most important function displayed by CPP is that 
soluble and encrypted casein phosphopeptides can arrive without modification of the 
phosphorylated sequence to the brush border membrane. It is postulated that short-sequence 
peptides reach their putative receptors in many tissues without modification. Whether they 
enter blood circulation or whether their action is restricted to a peripheral circle are current 
questions that await response. In conclusion, this review has considered milk and cheese CPP 
for specific food ingredients. The contribution of in vitro casein digests by gastric proteases to 
potential biologically active substances in the intestine must be simultaneously considered. 
Scientists are currently involved in investigations to define the in vivo fate of all of the bioactive 
peptides. The in vitro studies have allowed the scientists to compare the predicted and the 
experimental sequence of CPP. This step is preliminary to the clinical investigations designed 
to determine the bioactivity of the milk hydrolysates. These findings open an industrial 
perspective that will permit the unrestricted use of CPP in healthy promoting food application. 
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1. Introduction 
Adverse reactions to food are currently classified into toxic and non-toxic reactions. There is 
a normal range of concentrations of naturally occurring toxic compounds, which can easily 
increase during food processing. For example, thermal processing can cause the unintended 
and undesirable formation of toxic compounds, such as acrylamide in fried potato chips and 
furan in sterilized canned vegetables, together with losses of certain nutrients. The incidence 
of non-toxic reactions depends on individual susceptibility to a specific food or food 
ingredient, although these reactions are often dose-dependent. The non-toxic types may be 
divided further into immune- and non immune-mediated reactions. The term 
“hypersensitivity” is used for immune-mediated reactions, and the term 'intolerance' is used 
for non immune-mediated reactions (Figure 1). Immune-mediated reactions may be IgE-
mediated (i.e., allergy or type I hypersensitivity) or non-IgE-mediated, whereas food 
intolerance may be enzymatic, pharmacologic or undefined. The incidence of immune-
mediated adverse reactions to foods has increased in recent decades. In healthy subjects, 
orally ingested dietary proteins induce antigen-specific systemic hyporesponsiveness, 
termed oral tolerance. This phenomenon is well described in animal models, although the 
mechanisms remain unknown. Abrogation of oral tolerance or failure to induce oral 
tolerance may result in the development of food hypersensitivity. Immune reactions that 
cause tissue damage may be mediated by four reaction types that were defined by Coombs 
and Gell [1] (Figure 2). Type I, or anaphylactic hypersensitivity, is mediated by the reaction 
of an antigen with specific IgE antibodies that are strongly bound through their Fc receptor 
(CD23, IgΉR) to the surface of the mast cell. Crosslinking of IgΉ receptors by divalent hapten 
leads immediately to the release of mediators, for example, some cytokines [primarily 
interleukin 4 (IL4)] and histamine, which are both activities of eosinophil chemotactic factor 
(ECF) and neutrophil chemotactic factor (NCF) (Figure 2A). This type of hypersensitivity 
occurs within minutes of antigen exposure. Some reaction mediators produce local skin, 
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gastrointestinal and respiratory tract manifestations, and a systemic allergic reaction to an 
allergen that is associated with a dangerously low blood pressure. Moreover, some of the 
mediators exhibit chemoattractant activity and induce the infiltration of neutrophils, 
eosinophils, macrophages, lymphocytes and basophils within 6-12 h after challenge. The 
localized late-phase inflammatory response may also be mediated partly by cytokines that 
are released from mast cells. In type II or antibody-dependent cytotoxic hypersensitivity, 
antibodies recognize antigens on the surface of specific cells or tissues. Once activated, the 
complement system can initiate a variety of responses that can lyse and destroy cells. 
Phagocytic and cytotoxic K cells, which have receptors for the Fc-part of IgG or an activation 
component of complement, i.e., C3b, may also destroy cells (Figure 2B). In type III, or 
immune complex-mediated hypersensitivity, the soluble antigen can activate the 
complement and deposited phagocytes. Leucocytes may release tissue-damaging mediators 
and activate phagocytes, culminating in tissue damage. The complex can also induce 
thrombin-mediated platelet aggregation and release a vasoactive amine (Figure 2C). Type IV 
reaction, or delayed-type hypersensitivity, arises more than 24 h after an encounter with the 
antigen. Type IV reactions are mediated by antigen-sensitized CD4+ T cells (T helper cells) 
that release inflammatory mediators [e.g., IL2 and interferon-y (lFN-y)], attract phagocytes 
to site of infection, activate an inflammation response and lyse invading cells (Figure 2D). 
Because lytic enzymes are secreted from the phagocytic cells into the surrounding tissue, 
localized tissue destruction can progress. 
 
Figure 1.  
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Figure 2. Types of Allergy Mechanisms according to Coombs and Gell [1]. 
The mechanisms underlying of allergic sensitization to food include genetic susceptibility, 
aberrant barrier functions of the skin epithelium and gut mucosa and dysregulation of 
immune functions. Despite a wide range of clinical manifestations, there are at least two 
common prerequisites for the development of a general food allergy (FA). First, intraluminal 
antigens must penetrate the mucosal barrier of the intestine. Second, the absorbed antigens 
must cause harmful immune responses [2]. 
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2. Adverse reaction to milk 
Non-toxic adverse reactions to milk are primarily caused by either lactose intolerance or 
milk allergy. 
2.1. Lactose intolerance 
Milk intolerance is due to the inherited lack of the specific enzyme, Ά-galactosidase that is 
required to hydrolyze lactose. For lactose malabsorption, the most common therapeutic 
approach excludes lactose-containing milk from the diet. To make yogurt edible, exogenous 
Ά-galactosidases that hydrolyze yogurt lactose or probiotics for their bacterial lactase 
activity are added. However, further studies are required to clarify the role probiotics play 
in lactose intolerance therapy, which includes considering their well-known beneficial 
effects on intestinal function, gas metabolism and motility [3]. A prolonged contact time 
between Ά-galactosidase and lactose delays the gastrointestinal transit time and chronic 
lactose ingestion to improve colonic adaptation. It is known that high concentrations of Ά-
galactosidase are physiologically present in neonates, but a genetically programmed and 
irreversible decline of the activity occurs after weaning [4], which results in primary lactose 
malabsorption. The secondary hypolactasia because of intestinal mucosa brush border 
damage that increases the gastrointestinal transit time is a transient and reversible condition 
[5]. Bloating, flatulence, abdominal pain, the passage of loose and watery stools, excessive 
flatus and diarrhea are gastrointestinal symptoms of lactose intolerance [6]. However, 
lactose occurring in the colonic lumen does not necessarily produce gastrointestinal 
symptoms because of the variable amount of residual intestinal mucosal lactase activity that 
possibly digests lactose. The availability of recombinant Ά-galactosidase as an exogenous 
lactase has resolved problems concerning bacteria that release Ά-galactosidase during gastric 
passage. By this means, lactose is partially or fully degraded to glucose and galactose and is 
therefore easily eliminated by simple dietary adjustments that mediate the effects of lactose 
intolerance [7]. An accurate diagnosis of lactose intolerance can significantly reduce patient 
anxiety and avoid unnecessary examinations and treatments [8]. 
2.2. Milk allergy 
Cow's milk allergy (CMA) is a complex disorder that implies an immunologically mediated 
hypersensitivity reaction with varying mechanisms and clinical presentations. The type I 
reactions appear to be the most common immune reaction to milk. However, the dominance 
of IgE reactions (Type I) may be an artifact as the reaction is easy to diagnose because of an 
immediate IgE measurement, whereas other reaction types are more difficult to diagnose. 
Non-IgE-mediated hypersensitivity has been increasingly diagnosed, and it is likely that 
several mechanisms operate in an individual patient. In clinical work, hypersensitivities are 
classified as IgE- and non-IgE-mediated or as immediate and late reactions based on the 
appearance of the first types of symptoms [9]. Cow’s milk is a member of the “Big-8” food 
allergens that include egg, soy, wheat, peanuts, tree nuts, fish and shellfish in terms of 
prevalence [9]. The incidence of CMA varies with age. CMA is prevalent in early childhood 
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with reported incidences between 2 and 6% [10-12] and decreases into adulthood to an 
incidence of 0.1–0.5% [13-14]. It has been suggested that infants have milk allergies because 
milk is usually the first source of foreign antigens that they ingest in large quantities, and 
the infant intestinal system is insufficiently developed to digest and immunologically react 
to milk proteins. When milk is eliminated, the inflammation response is controlled. After 
several years, oral tolerance is developed, and milk can again be tolerated [15]. Most milk-
allergic children are considered symptom-free by 3 years of age, but several studies have 
indicated that older children may also have immune reactions to milk. Children whose 
CMA has been diagnosed at an age older than 3 years do not tend to outgrow the problem. 
In adults, CMA is less common than lactose intolerance [16-17], even though it has been 
reported that approximately 1% of the adult population has milk-specific IgE antibodies. 
However, studies on CMA in adults are scarce. Little is known about the clinical symptoms, 
eliciting doses, and allergens involved. It has established that CMA in adults is rare but 
serious [18]. In a study by Stöger et al. [19], the main target organs in adult CMA were the 
skin and the respiratory tract. Gastrointestinal (mild to moderate) and cardiovascular 
(severe) symptoms were observed less often in adults compared with children. Milk 
allergies and hypersensitivity may be more common now than they were several decades 
ago. Further, the prevalence of atopic diseases has also increased in recent decades. Because 
genetic diversity has not changed over a short period, environmental factors are believed to 
have influenced the phenotype. Such factors may include increased air pollution, such as 
passive smoking, and dietary factors, such as the duration of breastfeeding, amount of 
antioxidants and the type of dietary fats (favoring saturated fat and n-6 fatty acids). Another 
approach is the hygiene hypothesis, which states that early exposure to microbial antigens 
may reduce the risk of having allergies [20]. For as long as milk allergy and hypersensitivity 
have been experienced, and still may be, these conditions may be misdiagnosed as a disease 
other than an allergy/hypersensitivity, particularly if symptoms are delayed. Classical IgE-
mediated milk allergies with objectively recorded skin reactions may have been diagnosed 
easily, whereas hypersensitivity with subjective gastrointestinal reactions may have been 
diagnosed as lactose intolerance, irritable bowel syndrome or some other intestinal disorder. 
In adults, viral infection, antibiotic treatment or stress may alter intestinal integrity so that 
its balance is disturbed and the number of protecting agents, such as microflora and 
mucosal immunity, are altered [21]. This process may result in milk hypersensitivity. Over 
one-third of women with IgE-mediated reactions to milk proteins have been reported to 
exhibit their first symptoms of hypersensitivity during or shortly after pregnancy, and one-
quarter reported the first symptoms during a period of severe emotional stress [22]. 
3. Milk allergens 
No single major allergen has been identified in cow’s milk according to either challenge tests 
or laboratory procedures; [23]. Indeed, clinical challenge tests demonstrate that most CMA 
patients react to several protein fractions of cow’s milk and each allergenic protein may 
have several epitopes, which are widely spread along the molecules. The cow milk proteins 
prevalently implicated in allergic responses in children are the whey proteins ΅-
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Lactalbumin (΅-La)(Bos d 4) and Ά-Lactoglobulin (Ά-Lg) (Bos d 5), in addition to the casein 
(CN) fraction (Bos d 8) [24-26]. In adults, the predominant allergen is CN, whereas 
sensitization to whey proteins is rare. Biochemical characteristic of allergenic cow milk 
proteins are reported in Table 1. Currently, milk allergen analyses are generally based on 
immunoassay methods, such as enzyme-linked immunosorbent assay (ELISA) [27]. 
Commercial test kits are available for the determination of CN, Ά-Lg, or total milk proteins 
(CN and Ά-Lg) [28]. Interlaboratory studies were performed to evaluate the reliability and 
reproducibility of these kits [29]. Antibody cross-reactivity has been reported for some milk 
proteins [30]. Confirmatory tests are required to corroborate ELISA detection results and 
improve the detection specificity of undeclared milk allergens. For the last several decades, 
mass spectrometry has become the dominant technology for the identification of peptides and 
proteins. The primary current approaches used for protein identification are top-down [31-33] 
and bottom-up [34] sequencing. Top-down sequencing involves introducing the intact protein 
into the gas phase. The protein is identified by measuring either the protein molecular weight 
or its fragmentation pattern using various techniques [35]. The bottom-up approach is more 
common. The sample is usually digested with an enzyme, such as trypsin, followed by 
accurate sequence analysis by tandem mass spectrometry (MS/MS) of the proteolytic 
fragments. For protein identification, an algorithm is used for database searching based on 
amino acid sequence assignments.  
 
Table 1. Chemical characteristics of cow’s milk proteins and their inclusion in the official list of 
allergens 
3.1. Casein 
The CN fraction is composed of four proteins  ΅s1-,  ΅s2-, Ά-, and Ύ-CN, in approximate 
proportions of 40%, 10%, 40%, and 10%, respectively, and ΅s1-CN is a major allergen 
according to IgE and T cell recognition data [36-39]. The specificity of the IgE response to the 
different purified CNs has been analyzed on 58 sera from patients allergic to whole-CN [40]. 
Cow’s Milk 
Proteins (100% )  Protein
Allergen 
Name Allergenicity
Total 
Protein %
MW 
(kDa) pI
Amino Acid 
Residues
Calcium 
sensitivity
Phosphate 
groups
Caseins (80%) Įs1-Casein Bos d 8  Major 32 26.6 4.9 - 5.0 199 +++ 8-9
Įs2-Casein " " 10 25.2 5.2 - 5.4 207 ++++ 10-13
ȕ-Casein " " 28 24,0 5.1 - 5.4 ++ 4-5
Ȗ1-Casein " " Traces 20,5 5.5 181 + 1
Ȗ2-Casein " " Traces 11,9 6.4 104
Ȗ3-Casein " " Traces 11.5 5.8 102
ț-Casein " " 10 19 5.4 - 5.6 169
Whey proteins 
(20%)
Į-Lactalbumin Bos d 4  Major 5 14.2 4.8 123
ȕ-Lactoglobulin Bos d 5  Major 10 18.3 5.3 162
Immunoglobulins Bos d 7 – 3 150 – – – 1-3
BSA Bos d 6 – 1 66.3 4.9 - 5.1 582
Lactoferrin – – Traces 80 8.7 703
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Multi-sensitization was observed, which most likely corresponded to a co-sensitization to 
the different CN components after the disruption of the CN micelles. The CN fractions 
cross-link to aggregates termed nanoclusters, which combine into micelles. In the new state 
of aggregation, there is a hydrophobic central part and peripheral hydrophilic one that 
include phosphorylation sites. Although the primary structure of CNs is known, the micelle 
structure remains relatively unknown. ΅s2-, ΅s1-, and Ά-CN bind calcium to form a core that 
is covered with a Ύ-CN layer. The Ύ-CN latter protects CN micelles from precipitation in the 
presence of milk constitutive calcium ions. During the last five decades, different models for 
the structure of the bovine CN micelle have been proposed. Walstra has summarized the 
common structural elements into a “ball-shaped model” [41]. According to Walstra, a well-
accepted model considers the CN micelle as follows: (i) it is roughly spherical; although it 
does not have a smooth surface; (ii) it is built of smaller units, termed sub-micelles, which 
mainly contain CN and have a mixed composition; (iii) sub-micelles vary in composition 
and consist of two main types-one primarily consists of ΅s and Ά-CNs and the other 
primarily consists of ΅s- and Ύ-CNs; (iv) the sub-micelles can be linked together by small 
calcium phosphate clusters bridging them; (v) the sub-micelles aggregate until they have 
formed a micelle in which those with Ύ-CN are outside; and (vi) consequently, molecular 
chains of the C-terminal end of Ύ-CN protrude from the micelle surface to form a “hairy” 
layer that prevents any further aggregation of sub-micelles by steric and electrostatic 
repulsion. The hairy layer is also held responsible for the stability of the micelles against 
flocculation. Destabilization of CN micelles can be made by treating milk with milk clotting 
enzymes, which limitedly degrade Ύ-CN affording to CN micelle fusion and formation of a 
para-Ύ-CN aggregate. Finally, a variable proportion, up to 5% total, consists of a 
heterogeneous group of CNs termed ·-CNs (·-CN) that result from the limited proteolysis 
of Ά-CN by plasmin, the native milk protease. Plasmin disperses in low amounts from blood 
to milk during secretion to generate CN fragments whose structure are shown in Figure 7 
with peptides labeled according to the current nomenclature [42]. CNs are highly sensitive 
to proteolysis and do not maintain a unique folded conformation [43], which has led them to 
being termed rheomorphic. Because the folded structure is limited, heating does not 
generally change the structure and hence its IgE binding [44]. ΅s1-CN, ΅s2-CN, and Ά-CN can 
chelate Ca2+, Zn2+, and Fe3+, respectively. The four CNs share little sequential homology, but, 
despite this lack of homology, simultaneous sensitization is often observed.  
3.1.1. ΅s1-CN 
΅s1-CN consists of major and minor polypeptides that include the same amino acid sequence 
but have different degrees of phosphorylation [45]. Allergenic epitopes were identified by 
Spuergin et al. [46] in ΅s1-CN regions 19–30, 93–98 and 141–150 as immunodominant 
epitopes. Some sequential IgE-binding regions were recognized at AA 17–36, 39–48, 69–78, 
93–102, 109–120, 123–132, 139–154,159–174, and 173–194 using sera from nine older children 
(> 9 years old), and the epitopes AA 69–78 and 175–192 were recognized by 60% and 80% of 
sera, respectively, from older children [47]. A later study by Elsayed et al. [48] has 
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demonstrated that the N- and C-terminal peptides, AA 16–35 and 136–155, respectively, 
have the highest human IgE-binding affinity, and AA 1–18 and 181–199 exhibited high 
binding to rabbit IgG. cDNA coding for ΅s1-CN from a bovine mammary gland cDNA 
library with allergic patients’ IgE Abs has been isolated. IgE epitopes of ΅s1-CN were 
determined with recombinant fragments and synthetic peptides that spanned the ΅s1-CN 
sequence using microarray components and sera from 66 cow’s milk-sensitized patients. 
The allergenic activity of recombinant ΅s1-CN and the ΅s1-CN-derived peptides exhibited IgE 
reactivity, but mainly the intact recombinant ΅s1-CN induced strong basophil degranulation. 
The results indicate that ΅s1-CN contains several sequential IgE epitopes, but the isolated 
peptides were less potent than the complete allergen in initiating effector cell degranulation. 
These results suggest that primarily intact ΅s1-CN or larger IgE-reactive portions thereof are 
responsible for IgE-mediated symptoms of FA [49]. 
3.1.2. ΅s2-CN 
΅s2-CN is the most hydrophilic of the four CNs because of an anionic group cluster. ΅s2-CN 
consists of two major and several minor components that exhibit varying levels of 
phosphorylation. ΅s2-CN contains two cysteines and forms disulfide-linked dimers. Using 99 
synthetic decapeptides, 10 regions binding IgE from the sera were identified as allergenic, 
i.e., 31–44, 43–56, 83–100, 93–108, 105–114, 117–128, 143–158, 157–172, 165–188, and 191–200 
[50]. Studies on the presence of ΅s2-CN epitopes 87–96 and 159–168 with weak binding to 
145–154 and 171–180 with originate from individuals with persistent cow’s milk allergy. 
Patients with transient allergies exhibited only weak binding to ΅s2-CN peptides [51]. 
3.1.3. E-CN 
Ά-CN is the most hydrophobic component of total CN. Sequence variants are known 
because of both partial proteolysis and variant genes [42]. Ά-CN is less phosphorylated than 
΅s1-CN and ΅s2-CN, with five potential phosphorylated sites located in the N-terminal 
region. Plasmin cleaves Ά-CN into ·1-, ·2-, and ·3-CN. Synthetic decapeptides were used to 
estimate the Ά-CN region that binds IgE of patients, and peptides 1–16, 45–54, 55–70, 83–92, 
107–120, 135–144, 149–164, 167–184, and 185–208 were described as typical for patients with 
persistent CMA. Sera from eight young patients exhibited a simpler IgE pattern because the 
sera were bound to peptides 1–16, 45–54, 83–92, 107–120, and 135–144 with weak binding to 
residues 57-66 and the C-terminal region [52]. 
3.1.4. Ύ-CN 
Ύ-CN consists of a major carbonate-free component and a mini-bonded polymer that ranges 
from dimers to octamers. Ύ-CN plays an important role in the stability and coagulation 
properties of milk [89]. Ύ-CN is most likely more structured than ΅s- and Ά-CN and contains 
specific disulfide bonds [53-54]. The Ά-CN can rearrange on heating [55]. Ύ-CN is sensitive to 
proteolysis and is hydrolyzed by chymosin to produce para-Ύ-CN and caseinomacropeptide 
in the cheese-making process. Allergenic potential sequences remain in cooked cheeses. Ύ-
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CN is essential to the stability of CN micelles [55]. Diagnosing patients with persistent cow’s 
milk allergies with the use of 80 overlapping synthetic decapeptides helped to identify some 
regions that bind to IgE from sera, specifically sequences 15–24, 37–46, 55–80, 83–92, and 
105–116 [37]. 
3.2. Whey proteins 
Whey proteins contain two major allergens, Ά-Lg and ΅-La, and minor constituents, e.g., 
lactoferrin, bovine serum albumin (BSA), and immunoglobulins. In this fraction, proteolytic 
fragments of CN and fat globule membrane proteins can occur. 
3.2.1. Ά-Lg 
Ά-Lg (Bos d 5) is the major whey protein in ruminant milks, comprising 50% of the total 
whey protein. Ά-Lg is found in the milk of other mammals but is missing from the milk from 
rodents, lagomorphs and humans. Notably, 13-76% of patients are found to react with Ά-Lg. 
Ά-Lg has a molecular weight of approximately 18 kDa [37] and belongs to the lipocalin 
superfamily. The Ά-Lg (Bos d 5) allergen is capable of binding lipids, including retinol, Ά-
carotene, saturated and unsaturated fatty acids, and aliphatic hydrocarbons, and 
transporting hydrophobic molecules, which is an important function [56-57]. Under 
physiological conditions, Ά-Lg is an equilibrium mixture of monomeric and dimeric forms. 
The proportion of monomers increases after heating to 70°C. Ά-Lg contains five cysteine 
residues, of which four are engaged in intra-chain disulfide bridges. Because of the single 
unpaired cysteine, Ά-Lg predominantly exists as a stable dimer that tends to dissociate into 
monomers at a pH between 2 and 3 [58]. Ά-Lg is present in several variants, i.e., A, B, and C, 
that are found in the Jersey breed. Ά-Lg is sensitive to thermal processes. Ehn et al. [59] 
reported that heating Ά-Lg to 74°C and 90°C reduced IgE binding significantly. Heating to 
90 °C reduced IgE binding more extensively. Chen et al. [60] reported that nearly 90% loss 
and denaturation of Ά-Lg are observed in processed milk and that high heat is the major 
cause of protein aggregation. Circular dichroism demonstrated no significant conformational 
changes at temperatures below 70°C for as long as 480 s. The rapid changes of Ά-Lg occurred 
between 80°C and 95°C. Fifty percent of the maximal changes could be reached within 15 s. 
Guyomarc’h et al. [61] reported that large micellar aggregates, 4 × 106 Da, are formed upon 
heating milk that contained 3:1 ratios of Ά-Lg and ΅-La together with Ύ-CN and ΅s2-CN. 
Proteolysis and use of monoclonal antibodies proved that Ά-Lg possesses many allergenic 
epitopes spread over the Ά-Lg structure [62]. Major human IgE epitopes for Ά-Lg amino acid 
fragments are composed of residues 41–60, 102–124, and 149–162; intermediate 1–8, 25–40, and 
92–100; and minor 9–14, 84–91, 125–135, and 78–83 [63]. Similar IgE epitope regions (21–40, 40–
60, 107–117, and 148–168) were reported for a rat model of Ά-Lg allergy [64,65]. 
3.2.2. ΅-La 
΅-La (Bos d 4) is a homologue of C-type lysozymes. It is a member of glycohydrolyase 
family 22 and Pfam family and weighs 14,186 Da in the mature form and between 15,840 to 
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16,690 Da for the glycosylated forms. ΅-La is stabilized by binding to calcium. Polverino de 
Laureto et al. [66] reported that ΅-La is cleaved by pepsin at pH 2 in the region of residues 
34–57, which produces large fragments. Veprintsev et al. [67] reported that differential 
scanning calorimetry of ΅-La at pH 8.1 exhibited transitions at 20°C–30°C with calcium 
chelator ethylene glycol tetra-acetic acid and near 70°C with the addition of calcium. 
McGuffey et al. [68] investigated the heating effects of purified ΅-La and demonstrated that 
the extent of irreversible aggregation varies at temperatures between 67°C and 95°C. When 
milk is heated to 95°C, ΅-La denatures more slowly than Ά-Lg. The folded ΅-La structure is 
destabilized at low pHs with the formation of a molten globule[69]. The stability to 
denaturation is also strongly lowered by the reduction of disulfides [70]. Disulfide exchange 
can occur during thermal denaturation, which leads to the formation of aggregates [71]. 
Although evolved from a lysozyme [72], the function of ΅-La is to form a complex with 
galactosyltransferase, which alters the substrate specificity and increase the lactose synthase 
rate in milk. The galactosyltransferase and ΅-La is termed lactose synthase [73]. ΅-La alone 
does not have any catalytic activity as a lysozyme or a synthase. Several other properties of 
΅-La and possible additional functions have been described [74], which include binding of 
several ligands and antimicrobial activity, both as a complete molecule [75] or as peptides 
[76]. The cytotoxic effects against mammalian cells have also been investigated [77]. The 
major component of ΅-La is unglycosylated. However, a mass spectrum of ΅-La contains at 
least 15 distinct peaks [78], and a minor glycosylated form (approximately 10%) results from 
asparagine 45 glycosylation. A study concerning the allergenic properties of ΅-La 
demonstrated that in 60% of the study patients, allergic sera were specific for intact ΅-La 
with only 40% binding to peptides obtained after tryptic hydrolysis. Residue 17–58 was the 
most frequently recognized in the sequence 59–93, 99–108, and 109–123 [79]. The linear 
epitopes were identified by using sera of patients suffering from persistent allergies and IgE 
to cow’s milk levels > 100 kU(A)/L. Serum IgE bound most strongly to peptides 1–16, 13–26, 
47–58, and 93–102 [80]. 
3.2.3. Minor allergens 
Bovine serum albumin (BSA) (Bos d 6), which is a heat-labile protein, is a major allergen in 
beef but a minor allergen in milk [81-84]. Accordingly, beef allergic individuals are at risk of 
being allergic to cow's milk and vice versa. BSA allergies account for 0-88% of sensitization 
events, whereas clinical symptoms occur in up to 20% of patients. BSA is one of the proteins 
most frequently involved in binding with circulating IgE [85-86]. Bovine immunoglobulins 
(Bos d 7) may be also responsible for clinical symptoms in CMA. 
4. Post-translational modifications 
In evaluating the allergenic potential of a protein, post-translational modifications of amino 
acid residues should be considered in addition to sequential and conformational IgE 
binding domains. Notably, such modifications may either generate additional IgE epitopes 
or induce changes in protein folding that affect IgE-protein interactions. Accordingly, 
recombinant allergens do not generally have the IgE-binding capacity of their natural 
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counterparts, most likely because of a deficiency in the post-translational events [87]. 
Regarding milk proteins, selective phosphorylation of serine residues in all of the four CNs, 
O-glycosylation of threonine residues in Ύ-CN and N-glycosylation of asparagine residues 
in ΅-La have been long described. 
4.1. Phosphorylation 
The removal of phosphate groups from CNs significantly reduces the CN-binding capacity 
of IgE from patients who suffer from milk allergies, which indicates that at least part of anti-
CN IgE is directed against CN domains that comprise a major phosphorylation site [88, 89]. 
It has been suggested that currently observed co- and cross-sensitization to the different 
CNs that are encoded by different genes and display few amino acid sequence homologies 
can be caused by the occurrence of common highly conserved major sites of 
phosphorylation, i.e., the Ca2+ binding CN sequence SerP-SerP-SerP-Glu-Glu that 
corresponds to ΅s1-CN 66-70, Ά-CN 17-21 and ΅s2-CN 8-12 and 56-60 [87]. Most likely, 
sensitization to milk is caused by a large release of phosphopeptides that are resistant to 
further degradation by digestive enzymes [90] during intestinal proteolysis of milk proteins. 
However, serine phosphorylation poorly affects the overall antigenic potential of individual 
CNs. Notably, antisera raised against native Ά- and ΅s2-CNs can recognize their targets after 
dephosphorylation or deletion of a major phosphorylation site [87]. Furthermore, polyclonal 
antisera that are produced in rabbits using a bovine Ά-CN 1-28 phosphorylated peptide as 
an antigen have been utilized to detect all of the tryptic phosphopeptides that originate 
exclusively from the 1-28 region of Ά-CN, regardless of the content of the phosphorylated 
Ser residues, and none of those generated by the other bovine CN fractions [91]. Ά-CN from 
human milk contains the phosphopeptide cluster 5Glu-Ser-Leu-SerP-SerP-SerP-Glu-Glu12, 
also found in the bovine Ά-CN sequence 14-21; however, a lower level of phosphorylation 
has been generally observed. For example, according to the phosphopeptide analysis of 
human milk that is reported in Table 2 and Figure 3, the 2092.8 Da component, which 
corresponds to Ά-CN(f2-18)2P, caused the third peak in intensity order in combination with 
the fully phosphorylated components. This lower phosphorylation level is lacking in its 
bovine counterpart. The overall higher degree of phosphorylation of bovine CNs can play a 
role in sensitizing humans to bovine milk. 
4.2. Glycosylation 
The effect of glycosylation on the allergenic potential of milk proteins has been long 
disregarded despite efforts to identify the domains responsible for the allergenicity of milk 
proteins, mostly based on an epitope mapping approach. Notably, the role of carbohydrate 
epitopes in initiating an allergic reaction is still unclear [92]. Potential glycosylation sites 
have been identified in major milk proteins, i.e., N45 and N71 of mature ΅-La [93] and T131, 
T133, T135, T136, T142, and S141 of mature Ύ-CN [94]. Approximately 10% of ΅-La has been found 
glycosylated at N45, giving rise to at least 14 distinct peaks by electrospray-ionization mass 
spectrometry analysis [95]. However, these glycosylated forms were not included among the 
IgE epitopes in a study because they were not detected by matrix-assisted laser 
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desorption/ionization time-of-flight (MALDI-TOF) analysis of ΅-La; notwithstanding in the 
same study, IgE reactivity of sera from patients allergic to ΅-La were proven to be sensitive 
to periodic acid treatment [93]. As reported in Table 3, the genetic variant A of water buffalo 
΅-La that carries an N45䲑D45 substitution cannot be glycosylated. To assess the effect of 
glycosylation on the allergenicity of ΅-La, it might be used as substrate for IgE reactivity 
testing of sera from patients sensitized to ΅-La. 
 
Table 2. Identification of human milk soluble TCA 12% peptide fractions enriched on hydroxyapatite 
after MALDI-TOF analysis by FindPept (http://www.expasy.org/tools/findpept.html) software. 
Despite some indications that the allergenic character has been identified in the glycosidic 
moiety of native Ύ-CN [96], at present this issue remains to be settled. Glycated forms of Ύ-
CN account for approximately 40% of the Ύ-CN that normally occurs in bovine milk, but 
glycans are not randomly distributed among potential glycosylation sites. The hierarchy of 
glycan addition proceeds according to the order T131, T142, T133, whereas the other sites 
remain latent until these sites are occupied [97]. Ύ-CN is cleaved by chymosin during the 
primary stage of cheese making at the peptide bond F105-M106. The C-terminal 106-169 
fragment, known as glycopeptide because all of the glucides originally present in Ύ-CN are 
Theoretical Measured MH+
2488.1 2489.1 ȕ-CN (f1–18)5P
2408.1 2409.1 ȕ-CN (f1–18)4P
2328.2 2329.1 ȕ-CN (f1–18)3P
2248.2 2249.3 ȕ-CN (f1–18)2P
2168.2 2169.2 ȕ-CN (f1–18)1P
2252.0 2252.7 ȕ-CN (f2–18)4P
2172.0 2173.0 ȕ-CN (f2–18)3P
2092.0 2093.0 ȕ-CN (f2–18)2P
2012.0 2013.0 ȕ-CN (f2–18)1P
3100.8 3101.0 ȕ-CN (f1–23)5P
3020.8 3021.8 ȕ-CN (f1–23)4P
2940.9 2941.0 ȕ-CN (f1–23)3P
2860.9 2861.9 ȕ-CN (f1–23)2P
2780.9 2781.9 ȕ-CN (1–23)1P
3077.0 3078.9 Įs1-CN (f15–38)3P
3068.1 3069.1 Įs1-CN (f12–36)2P
2488.5 2489.5 Įs1-CN(f8–27)2P
2408.5 2409.5 Įs1-CN (f8–27)2P
2118.8 2119.5 Įs1-CN (f68–83)5P
Molecular mass (Da)
CPP identification
Human ȕ-Casein
Human Įs1-Casein
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retained, is released and lost in the whey. Therefore, cheese is devoid of any glycosylated 
major component. Potential allergenicity of Ύ-CN glycoforms has been suggested by 
analyzing the IgE binding capacity of an individual human serum from an adult atopic 
patient who had outgrown a cow milk allergy in early childhood. Bovine Ύ-CN has been 
selectively recognized by IgE immunostaining of an electrophoretic profile of milk proteins. 
No additional IgE-reactive proteins other than bovine Ύ-CN have been found in either 
bovine cheese, regardless of the cheese making technology and time ripening, or in ewe, 
goat and water buffalo milk. Moreover, chemical removal of glucide chains from bovine Ύ-
CN has not impaired IgE binding, thus proving a primary involvement of the glycoside 
moiety of the protein in IgE recognition. According to the specificity displayed by IgE, N-
acetylneuraminic acid as a terminal unit of a tetrasaccharide chain has been argued to be an 
IgE epitope [98]. 
 
Figure 3. Mass spectrum of human milk soluble TCA 12% fraction enriched on hydroxyapatite by 
MALDI-TOF. 
 
Table 3. Position and amino acid differences among the genetic variant of ΅-La from four animal 
species. 
Species
Bovine A Gln Gly Asn
Bovine B Arg Gly Asn
Water buffalo A Arg Asp Asp
Water buffalo B Arg Asp Asn
Caprine Gln Asp Asn
Ovine Gln Asp Asn
Site 10 17 45
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5. “Allergenomics”  
The application of proteomic methodologies for the analysis of food allergens has been 
termed “allergenomics” [99]. For “type I” FA, IgE-binding indicates that the target carries 
the risk to be an allergen. MS-based proteomic methods have identified many proteins and 
allergens. MALDI [100] and electrospray ionization (ESI) [101] and MS/MS sequencing are 
the techniques most widely used to produce high-quality spectra of post-translationally 
modified peptides [102-104] or intact proteins (see [105]). The characterization of 
glycosylated allergens has been partly overcome by specific enrichment using lectin or 
hydrophilic resins (HILIC) prior to MS analysis [106,107]. Native and de-glycosylated 
peptides are analyzed by MALDI or ESI-MS. Because of the difficulty of profiling 
oligosaccharides released by glycoprotein [108-110], glycan profiles are obtained after 
permethylation of the oligosaccharide chains according to the procedure of Das et al. [111]. 
By this means, glycosylated site(s) are identified together with the peptide backbone. 
Although widespread, several studies are dedicated to milk protein analysis for the 
detection of allergenic proteins or peptides in dairy products. Thus is determined by the 
concentration of allergenic compounds in food products that are often secondarily masked 
by dominant non-allergenic proteins. Among the various methods currently used to detect 
allergens in food products, immunochemical techniques that rely on antibody-binding 
properties have been developed. Commercially based kits are used for rapid screening, and 
enzyme-linked immunosorbent assays (ELISA) provide evaluations. Limits of detection 
(LOD) attained by ELISA tests are in the range of 1–5 ppm. Because the epitopes to be 
detected and their possible cross-reactivity with matrix components are unknown, detection 
reliability strongly depends on various factors that include the thermal changes of whey 
proteins, which are of primary importance. Furthermore, in several foods, linear epitopes 
can be released by parent protein hydrolysis, whereas retain their allergenic potential. As 
cited above, MS measurements can be finalized to evaluate the molecular mass of proteins 
and derived-peptides (MS1), determine the amino acid sequence and identify post-
translational modifications (MS/MS or MSn). Two-dimensional electrophoresis (2DE) 
separates proteins according to the pI (i.e., first dimension, isoelectric focusing, IEF) and 
subsequently molecular weight (SDS-PAGE) in an orthogonal dimension. By this means, the 
separation of thousands of proteins has been achieved using highly specific stains that 
visualize specific protein classes, i.e., phosphoproteins, or nonspecific stains that 
simultaneously target total proteins without particular functional groups. Protein spots are 
localized, excised from the gel and subjected to an in-gel tryptic digestion. Mass 
spectrometry analysis either by MALDI reflectron TOF or microcapillary liquid 
chromatography MS-MS detects the proteins based on the expected masses of peptides 
available in databases and other plant proteins in pollen diffusates. More directly, tandem 
mass spectrometry is used to identify the peptide sequence and search for allergens in 
databases. More elegantly, allergens are localized on the gels after a one- or two-
dimensional electrophoretic separation followed by a nitrocellulose transfer of the proteins 
(i.e., western blotting), which is stained with sera from allergic patients as a source of 
specific IgE. Combined with the analysis by mass spectrometry of electrophoretically 
separated allergens, immunoblotting is useful for the rapid determination of allergen 
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identities. Allergen–IgE complexes are also detected using conjugated anti-human IgE as a 
secondary antibody. Once localized in a 2DE map, the allergen can be monitored using 
allergen specific antibodies [112,113]. Immune-reactive allergenic protein(s) are identified 
along the immunoblots by comparison with a reference electrophoretic map. All of the 
major milk proteins are allergen candidates because sera of allergic patients contain various 
percentages of immune-reactive proteins that are recognized by IgE [114]. The order of milk 
protein allergenicity is as follows: ΅s2-CN>΅s1-CN>Ά-CN>Ύ-CN>Ά-Lg> serum albumin > IgG-
heavy chain>Lf. This list contains allergenic proteins that have been identified by 
experiments on several MS platforms [115]. Thus far, it is quite difficult to find a separation 
method that can accommodate the diversity of proteins equally. Therefore, modern 
separation techniques have been performed off-line or by online ion-exchange/reversed 
phase liquid chromatography prior to MS analysis. ESI-MS is currently the interface most 
frequently used to perform an LC separation of intact proteins. The protein identification is 
most commonly achieved after a proteolytic digestion and molecular weight determination 
of the LC-separated peptides. “Shotgun” proteomics is the most effective LC/MS-based 
strategy because a trypsin-digested protein sample generates thousands of peptides that are 
subsequently separated by LC prior to MS/MS sequencing [103,116]. Proteins with at least 
one matching peptide are candidates to occur in the sample. However, with CNs, it is 
difficult to determine which fractions are present in the sample if they share the same set of 
phosphopeptides or have only one constituent peptide detected. LC-Q/TOF MS/MS has 
been used to detect wine CN as a fining agent. Two peptides were identified from ΅s1-CN 
and four peptides from the tryptic digestion of ΅- and Ά-CNs [117]. A similar strategy could 
be applied to monitoring allergens in processed milk products. Signature peptides could be 
identified as CN or whey protein allergens by submitting protein concentrates to 
trypsinolysis. In this manner, information on the molecular weight of the intact allergen is 
lost, but cross-reactive immunogenic peptides can be discriminated. Because of the higher 
sensitivity of MS in the detection of peptides, MS expands the dynamic range of the protein 
species detected. MS is a method for discovering “hidden” or traces of allergens. Proteomics 
has become pivotal to the development of modern structural immunology and to the 
understanding of interacting systems that are involved in immune responses, regardless of 
FA status. 
5.1. Allergen quantiﬁcation methods 
Difference gel electrophoresis (DIGE) is utilized to compare multiple proteins in samples 
migrating in parallel in the same chamber. The proteins are labeled with three distinct 
ﬂuorescent dyes on the same 2D gel and differentially visualized via ﬂuorescence at 
different wavelengths. This methodology enables the detection of a differential presence of 
proteins and small differences in protein abundance. Allergens can be quantiﬁed by LC–MS. 
An accurate evaluation of the protein/peptide requires a suitable standard. In the direct 
quantiﬁcation of intact proteins, the intensity of multi-charged analyte ions is compared 
with that of an internal or external standard. For example, quantification of cow’s milk 
allergens in fruit juice samples [118] and whey drink [119] was performed by 
simultaneously monitoring several multiple-charged ions of whey protein components. 
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With a similar approach, internal standard Ά-Lg was used to quantify non-bovine Ά-Lg in 
different milk-derived products [120]. The use of “bottom-up” methods, such as SILAC, 
ICAT, and iTRAQ, for quantitative analysis in proteomics has progressively increased 
[121,122]. Quantiﬁcation of allergens in complex samples requires simple and precise 
methods of analysis, such as selected reaction monitoring (SRM) [123]. SRM is presently 
considered the gold standard for absolute quantiﬁcation, whereas multiple reaction 
monitoring (MRM) can monitor the masses of selected signature peptides. For an allergen 
evaluation, internal reference peptides are required for food product monitoring by LC–
SRM MS [124]. Hydrolyzed protein samples are spiked with known amounts of synthetic 
peptides and monitored by LC–MS in the SRM mode. Absolute amounts of peptide(s) are 
determined by the ratio of the ion intensities of natural and synthetic peptides (Figure 4). 
 
Figure 4. Mass Spectrometry procedure analysis for protein absolute quantiﬁcation. Proteotypic 
peptides are selected with a preliminary fullscan. For quantitative analysis whole protein extracts are 
trypsinized and the peptide mixture is spiked with external standard peptide. Proteotypic peptides 
(blue colored) selected as analytical probes of the target protein(s), are quantiﬁed by comparing the 
ionic intensities.  
This strategy has demonstrated its validity for using signature peptides as analytical 
surrogates to measure allergens in crude protein extracts. One advantage of the SRM 
procedure is the possibility of one-step monitoring of a variety of allergens. Recently LC–
triple quadrupole MS operating in an MRM mode has been effectively demonstrated to 
simultaneously detect allergens from seven different potentially allergenic matrices, such as 
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milk, eggs, soy, hazelnuts, peanuts, walnuts and almonds. The detection limits were in the 
10-1000 µg/g range. However, prior knowledge of allergens was required to monitor the 
most suitable allergenic peptides [125]. Based on the above-specified considerations, 
allergen evaluation requires the following: (i) allergen extraction from the food; (ii) enzyme 
proteolysis, usually trypsinolysis; and (iii) identification of signature peptides that are 
characteristic of food proteins or food ingredients. The signature peptides should be 
determined experimentally by prior LC/MS analysis of food-derived digested protein 
extracts.  
5.2. Standardization of allergen preparations 
Although the search for clinically relevant allergens has progressed, the characterization of 
allergens still requires studies on milk proteins as starting material. Pure native and 
recombinant allergens are needed as reference materials to calibrate methods among 
different laboratories. Recently, a panel of 46 food plant and animal allergens [126,127,128] 
has been made available within an EU-funded research project. In a recent 2DE application, 
calibration has been utilized for microbial complex protein systems using data obtained by 
MS [129]. Developing more allergen standards could be realized in the near future. 
Moreover, the search for allergenic sequence stretches would comprise only those immuno-
dominant produced during digestion that can to translocate the gut barrier and reach the 
mucosal immune system. Among the digestion/adsorption models of food protein stability, 
pepsin digestion has been included in the Food and Agriculture Organization/World Health 
Organization to assess food safety [130]. A model study has established milk-derived 
peptide candidate-mediated resistance to proteases to display allergic effects. The survival 
of milk protein epitopes [131,114] requires structure determination. To this end, a simulated 
digestion of bovine milk proteins in vitro that includes the sequential use of pepsin, 
pancreatic proteases, and extracts of human intestinal brush border membranes, has 
allowed the identification of produced peptides by MS. The presence of characteristic Ά-
Lg resistant peptides could implicate Ά-Lg in the case of a cow’s milk allergy [132]. The 
identiﬁcation by MS of peptides arising from simulated digestion is complicated by a lack 
of enzyme speciﬁcity. Currently, there is no treatment to fully resolve or provide long-
term remission from FA allergies. The research for therapy is mainly focused on the 
introduction of anti-IgE antibodies and speciﬁc oral tolerance induction. Immunotherapy 
appears to be an attractive approach; however, the risk of anaphylaxis should be 
considered. To this purpose, engineered proteins have been designed, i.e., anaphylaxis-
initiating epitopes have been removed within these proteins, while preserving the 
tolerance-inducing epitopes [133-135]. It appears clear that to successfully pursue similar 
strategies, the precise identiﬁcation of epitopes is necessary. It is expected that such 
approaches will be extended to an increasing number of food sources, whereby MS will 
play a key role for characterizing novel protein entities. The accurate characterization of 
the offending sequences could also be the starting point for developing less allergenic 
food products through the use of enzymatic, microbiological and technological processes 
to effectively remove allergens [136–139]. 
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6. Dairy research versus CMA 
6.1. Milk and dairy products from mammals different from cow 
According to the current clinical approach to FA and intolerance based on an elimination 
diet, the treatment of choice is complete avoidance of cow milk. Although of moderate 
importance in an adult diet, cow milk elimination has a significant nutritional significance in 
the infant diet, especially during early childhood. Milk from other mammals has been 
suggested as a possible alternative to cow milk. At first, goat milk had been proposed as a 
hypoallergenic infant food or cow milk substitute in human diet, but much of this thesi has 
no credible scientific evidence. Despite the immunological cross-reactivity between cow and 
goat milk proteins, due to the close biochemical similarity associated with the same 
phylogenetic origin [140], it has been estimated that from 40 to 100% of patients allergic to 
cow milk proteins can tolerate goat milk intake [141]. However, clinical and 
immunochemical studies aimed at evaluating goat milk safety for cow milk allergic subjects 
have demonstrated that goat milk cannot be a substitute for cow milk without risk of 
anaphylactic reactions [142,143]. It has been suggested that evidence for goat milk tolerance 
in clinical trials can be due, at least in part, to a higher number of genetic polymorphisms in 
goat CNs, especially for ΅s1-CN [144]. Null or reduced expression of ΅s1-CN in individual 
goats; consequently, the overall ΅s1-CN content in goat bulk milk is lower than that found in 
cow bulk milk. According to this general finding, and taking into account that little Ά-Lg 
persists in cheese, fresh cheese produced from raw milk has been suggested to be a 
promising hypoallergenic protein source [145]. Unexpectedly, water buffalo milk yogurt has 
successfully been employed as an alternative food for children with cow milk allergies [146] 
despite homologous proteins from cow and water buffalo milk [147]. In contrast, several 
studies have reported the existence of allergies to goat and sheep milk [148-151] and cheese 
[152,153] in patients with tolerance to cow milk proteins. Overall, this type of allergy is less 
common and occurs later than that initiated by cow milk proteins, which is likely because 
goat and sheep dairy products are not usually included in an infant diet. Moreover, IgE 
epitopes have been widely recognized in the CN components of goat and sheep milk. 
Differences in the degree of CN phosphorylation, on average lower in goat and sheep milk 
than in cow milk, rather than differences in IgE epitope sequences, may be involved in 
initiating selective allergies to goat and sheep milk, as observed in recent cases. In addition 
to the four ruminant species of dairy interest (i.e., cow, water buffalo, sheep and goat), other 
monogastric mammals produce milk for human consumption, such as mares and donkeys. 
Mare milk, which is more similar to human than cow milk, has been proven to be an 
acceptable substitute of cow milk for children with severe IgE-mediated cow milk allergy; 
although the evidence of its tolerability by a supervised oral challenge test is recommended 
[154]. However, mare milk availability is limited, and its collection is difficult. Donkey milk 
provides nutritional adequacy and excellent palatability similar to that of mare milk but is 
more readily available. The composition of donkey milk is more similar to human milk than 
cow milk because of the higher lactose content (6.5 vs. 5 g/100 mL), lower protein content 
(1.2 vs. 3.2 g/100 mL), lower CN/whey protein ratio (approximately 1 vs. 4) and a higher 
non-protein nitrogen fraction level (0.29 vs. 0.18%) [155]. These features have prompted 
clinicians to propose donkey milk as a valuable breast milk substitute. Additionally, donkey 
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milk intake has demonstrated positive effects in the diet therapy of patients allergic to cow 
milk proteins [156]. Although the mechanism of this tolerance is unclear, the reduced 
allergenic properties of donkey milk can be related to the structural differences compared 
with bovine milk. Because of scientific and clinical interest in donkey milk, characterization 
of the whey protein fraction [157], caseome [158], and the minor protein components [159] of 
donkey milk have been recently provided. Presently, milk from mammals with a 
geographically restricted distribution area, such as reindeer living in Northern Europe, has 
been utilized to overcome immunological cross-reactivity among proteins from mammals 
other than cows. In particular, Ά-Lg from reindeer milk, although belonging to the lipocalin 
family and similar to its homologous bovine protein, lacks several IgE epitopes of bovine Ά-
Lg that are involved in CMA [160]. Recently, camel milk, mainly available in the Gulf area 
and Mauritania, is of growing interest to both nutritionists and pediatricians because of its 
high nutritive value and unique electrophoretic protein patterns, which strongly suggest a 
different immunological reactivity of camel milk proteins with respect to the bovine 
counterparts [161]. 
6.2. Gut microflora 
It has been suggested that gut flora may be involved in the etiology of atopic diseases. It has 
been demonstrated that the gut microflora differs in children with high or low rates of 
allergy. Commensal gut flora play a role in inducing an oral tolerance, and the importance 
of the intestinal microbiota in developing food allergies is essential at early ages when the 
mucosal barrier and immune system are still immature. Probiotics interact with the mucosal 
immune system by the same pathways as commensal bacteria. A recent study has 
demonstrated that probiotic bacteria induced in vivo increased plasma levels of IL-10 and 
total IgA in children with allergic predisposition. Many clinical studies have reported 
significant benefits by probiotics supplementation in FA prevention and management. 
However, not everyone agrees on the effectiveness of probiotics supplementation. The 
differences are most likely related to the selected populations and probiotic strains used. 
The hygiene hypothesis proposes that disturbances in the gastrointestinal microbiota are 
associated with increased prevalence of allergic and autoimmune diseases [162]. Changes in 
the establishment of gut microbiota have been observed in Western infants [163,164]. This is 
most likely because of improved hygiene and cleanliness in Western countries and excessive 
use of antibiotics, which causes a reduced bacterial stimulus. Several clinical studies have 
reported differences in the composition of bacterial communities in the feces of children 
with and without allergic diseases. Many of those studies have highlighted the involvement 
of Bifidobacterium and Bacteroides in the protection against the development of atopy [165-
168], but this observation remains a matter of debate [162]. Moreover, the mechanisms 
underlying such protective effects remain elusive. There is increasing evidence that T-
regulatory cells derived from the thymus or induced in the periphery including the gut 
mucosa [169,170] are key players of immune regulation [171-173]. Using a single strain 
mouse model and defined bacterial communities and conventional mice, it has been recently 
demonstrated that the gut microbiota plays a protective role against allergen sensitization 
and allergic response in a mouse model of FA [174]. The difference between healthy and 
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allergic children may be in their microflora. At 3 weeks of age, infants in whom atopy 
developed then had more Clostridia and fewer bifidobacteria in their feces compared with 
infants who remained healthy. Moreover, fecal bifidobacteria microflorae were different 
between healthy and allergic children; the healthy infants' microflora was mainly 
Bifidobacterium bifidum, whereas the microflora was mainly Bifidobacteria adolescentis in the 
allergic infants. It can be hypothesized that individual species, rather than an entire genus, 
can affect the manifestation of allergy. In a recent study, the microflorae of milk-
hypersensitive and control adults before and after a 4-week supplementation with probiotic 
bacteria (Lactobacillus rhamnosus GG, ATCC 53103) have been studied. The anaerobic 
microflora before supplementation was comparable between the healthy and hypersensitive 
subjects, whereas the response after supplementation was different. The number of 
bifidobacteria in the healthy subjects increased significantly after supplementation. However, 
this did not occur with the supplementation in milk-hypersensitive subjects; this may be 
because of altered intestinal integrity. However, other studies have suggested a beneficial 
effect of probiotic bacteria in milk-hypersensitive subjects. In one study, symptoms of 
hypersensitivity abated along with an elimination diet in 28% of the patients in 4 years. It 
can be hypothesized that with milk elimination and long-lasting probiotic treatment, the 
intestinal severity of IgE-mediated hypersensitivity reactions may increase the intestinal 
microflora or even eliminate them.  
6.3. Reduction of allergenicity of milk proteins by hydrolysis 
The main objective of the milk industry is to supply products while preserving both the 
nutritive value and safety against developing allergies. Nutritional value is preserved by 
exposing liquid or powdered milk to low heat treatments to reduce heat susceptible amino 
acid side chain modifications and preserve the integrity of triacylglycerols, native vitamins 
and other milk components. As noted above, infants can develop milk allergies because of 
increased gut permeability to large molecules, in addition to other causes [175]. This result is 
supported by measurements of unmodified proteins or partially modified proteins in the 
sera of infants and adults [176]. Milk proteins have a molecular mass between 14 and 80 
kDa. To reduce allergenicity, milk proteins can be submitted to different hydrolysis 
procedures. Attempts to classify products by protein hydrolysis include “extensive” or 
“high degree” hydrolysis and “partial” or “low degree” hydrolysis. The rationale of such a 
classification is the spectrum of peptide molecular weights or the ratio of ΅ amino acids to 
total nitrogen. For quality assurance, in vitro product characterization requires size 
measurements of the peptides that are generated by protein hydrolysis and then an in vivo 
allergenicity determination. The in vivo step would include evaluating immunogenic or 
allergenic effects in a recipient infant. The European Union regulates that infant formulas 
contain immunoreactive proteins in quantities lower than 1% of nitrogen compounds [177] 
to reduce allergenicity knowing that only pure amino acids are strictly non-allergenic. This 
criterion could be encountered by milk proteins that have undergone extensive hydrolysis 
partially to cleave amino acids [178-180]. In contrast, formulas with moderately reduced 
allergenicity (partially hydrolyzed) are not recommended for the treatment of allergies 
because of the high amounts of residual allergens [181]. The low quantity of native proteins  
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or residual high molecular mass peptides may produce adverse effects in highly sensitive 
patients. Therefore, a milk hydrolysate can be considered safe and non-allergenic if the 
nitrogen fraction does not contain unmodified milk proteins or high molecular mass 
peptides [178-180]. In the latter case, the product could be classified in the “low degree” 
protein hydrolysate category. However, the antigenic properties of protein hydrolysates 
may not be dependent on the molecular size of the peptide components alone [182]. By 
comparing protein structures with known allergens and allergen epitopes, protein 
allergenicity has been predicted [183]. Although this is true for crystallized proteins, such as 
΅-La, Ά-Lg and Lf, this procedure cannot be applied to uncrystallized CNs. Because infants 
who are diagnosed for milk protein allergies must ingest foods that exclude the causal 
protein, including those ingested by the mother and filtered in breast milk, extensively 
hydrolyzed milk formulas are used for the development of appropriate dietary and 
management strategies. Preclinical testing of infant formulas is necessary to characterize the 
molecular properties and residual antigenicity of proteins [184-186]. Stringent criteria 
specify that extensively hydrolyzed CN with a molecular weight below 5000 Da should be 
reduced by at least 99.99%. There is a need for accurate diagnostic methods to confirm the 
amount of extensively hydrolyzed CN. Milk for allergic infants would consist of extensively 
hydrolyzed CN and whey proteins of which at least 99.99% of the hydrolysis products have 
molecular weights below 5000 Da. The crucial criterion is for the level of allergens to be 
sufficiently low as to cause no significant reaction, even in infants who are highly allergic to 
cow's milk. There have been no reports of adverse reactions because of whey [187, 188] and 
CN hydrolysates [189-191]. Therefore, caution must be maintained that milk formulas 
destined to infants with milk allergies contain correctly hydrolyzed proteins. This generic 
indication requires that molecular properties and residual antigenicity of proteins would be 
characterized [184-186]. In vitro incubation of milk proteins with pepsin, trypsin, and 
chymotrypsin causes the cleavage of numerous peptides of various sizes. Bacterial, fungal 
and plant proteases may also act as hydrolyzing agents. Various enzyme combinations, such 
as alcalase, pancreatin and enzymes from fungal sources, have been utilized to produce 
protein hydrolysates. Commercial hypoallergenic products are currently characterized by 
an average degree of hydrolysis (DH) of the protein components. The DH 19 milk protein 
value is calculated from the increase of the number of primary amino groups compared to 
that of native proteins. In practice, the DH value could vary from 1 to 100% in the case of 
total hydrolysis of the proteins. In the case of partly hydrolyzed proteins, intact and partly 
hydrolyzed proteins are visible bands along an electrophoretic pattern of the products. Two 
commercial formula preparations with DH values of 6.3 and 1.3% contained some intact Ά-
Lg and peptides with an Mr between 6000 and 8000 Da [192]. Using gel permeation 
chromatography, quantitative results on peptides with an Mr larger than 10 kDa were 
obtained [192]. Regardless of the technique used, descriptive information was obtained on 
either the molecular mass or the origin of the peptides. As a result, consumption of infant 
formulas by allergic patients cannot be attributed to one specific protein or high molecular 
mass peptide. To suppress or reduce the antigenicity of peptides, natural enzyme cleaving  
 
Milk Protein 
 
194 
of many or most of the peptide bonds is required. In this manner, epitopes that determine 
the antigenicity of the protein molecules are destroyed. This result proves that evaluation of 
the adequacy of infant formula composition in preventing or delaying antigenicity is not 
based solely on DH or Mr determination. In highly sensitized infants with IgE-mediated 
cow's milk allergies, life-threatening anaphylactic shock usually develops shortly after the 
consumption of claimed hypoallergenic milk products in which a number of epitopes would 
have survived in the highly proteolytic environment. The possibility of using well-
characterized monoclonal antibodies in ELISA tests can be used for assessing the origin of 
immunoreactive bovine milk proteins. Because the clinical significance of residual 
antigenicity requires prior molecular approaches, hypoallergenic products may first be 
screened for peptide identification in hydrolyzed milk products. Although protein 
hydrolysates can provide a positive effect, they can contain undefined peptide 
components, which are undesirable for pharmaceutical production purposes. In many 
cases, hydrolysates are produced by methods that are not well-controlled. Other 
complications arise from the raw starting material and differences in processing that lead 
to lot-to-lot hydrolysate composition variability. For these reasons, constant chemically 
defined products are needed. The data presented here represent the initial steps that have 
been taken to identify peptides treated with pepsin (P) and trypsin (T) and were used in 
succession to hydrolyze commercial milk protein powder (PT hydrolysate). To mimic 
commercial milk hydrolysates, the protein powder was treated with enzymes after a 
thermal shock deactivation treatment. Subsequently, the peptides are identified. RP-
HPLC fractionation was used to aid with the peptide separation. In Figure 5, the 
hydrolysate was analyzed to demonstrate a correlation between proteolytic enzymes and 
the presence of peptides. Commercial milk protein hydrolysates may contain trace 
amounts of allergenic proteins whose molecular weights were determined by MALDI-
TOF analysis. Among the number of peptides present in the hydrolyzed sample, the 
proteins/peptides exhibited molecular masses less than or equal to 2431 Da (Figure 6). 
This means that the CNs and whey proteins were digested by pepsin and trypsin into 
peptides with masses less than 3000 Da. This type of hydrolysate is not expected to elicit 
allergic reactions in already sensitized allergic patients (neither anaphylactic shock nor 
positive passive cutaneous anaphylaxis), as verified in experimental animals [193]. LC-
ESI-MS/MS analysis was performed on the hydrolysate to identify peptides occurring 
herein. No sequence peptides with 3 or 4 residues were detected because the MALDI 
signals were acquired at a mass gate of m/z 400. Because some short peptides were in the 
hydrolysate, milk proteins were hydrolyzed by P and T into oligopeptides with different 
biological activities. In Figure 7, the amino acid sequence of the four bovine CN fractions 
and Ά-Lg are reported with a subscript that indicates the number of amino acid residues 
in MS/MS-identified fragment. 
The proteins in the milk powder sample, which contained modified amino acid residues 
that may indicate the quality of the protein in milk powder, were not examined within the 
present work.  
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Figure 5. MALDI spectra of a sample of milk powder before and after sequential hydrolysis with 
pepsin and trypsin. A search for residual intact proteins and high molecular derived peptides (a) and 
measurements of molecular mass value of oligopeptides in the mixture (b). No peptide at a molecular 
mass higher than 3430.97 Da was observed in the MALDI spectrum. 
 
Figure 6. MALDI analysis of a milk sample after sequential hydrolysis with pepsin and trypsin. A 
molecular mass value corresponds to that of oligopeptides in mixture. No peptide at a molecular mass 
higher than 2207.1 Da was observed in the MALDI spectrum. 
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Figure 7. Primary structure of bovine Ά-, ΅s1-, ΅s2-, Ύ-CN and Ά-Lg together with identified peptides in 
commercial milk protein powder sample hydrolysed by sequential action of pepsin and trypsin. 
Protein/enzyme ratio 100/1 (w/w). Incubation with each enzyme was carried out for 16h at appropriate 
pH. Ends of horizontal bars indicate first and last amino acid residue of peptides isolated within this 
work. Arrows indicate casein peptide bonds broken by pepsin (P) and trypsin (T) as reported by 
Pelissier [194].  
7. Oral immunotherapy as future perspective in CMA management 
The primary treatment for managing food allergies is eliminating the offending food from 
the diet. In the case of milk, it is extremely difﬁcult to achieve complete elimination because 
milk can be masked in any number of foods, which may lead to unwanted severe reactions. 
The natural course of a cow’s milk protein allergy is the acquisition of tolerance 
spontaneously through an elimination diet, and 85% of patients overcome CMA by the time 
they are 4-5 years old [195-198]. In recent years, a number of studies have been published 
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regarding desensitization or oral tolerance to food antigens, particularly to cow’s milk. 
Major advances in understanding the immunological processes involved in the 
development of CMA have revealed a considerable number of allergenic epitopes and the 
heterogeneity of allergic responses. Importantly, an elimination diet of dairy foods has 
negative consequences in terms of inadequate calcium and vitamin intake. In the literature, 
several conflicting studies have reported on possible desensitizing therapies in the treatment 
of FA allergies. The possibility to obtain an oral desensitization is now gaining acceptance 
widely, even if the mechanism is still unclear. Oral tolerance or desensitization is the active 
non-response of the immune system to an antigen through sublingual, oral administration. 
Tolerance or the long-term loss of allergic reactivity follows a desensitization treatment. In 
the literature, several studies have reported on possible physiopathogenetic mechanisms of 
oral desensitization, but the exact mechanism is still unknown. That tolerance may be involved 
in the mechanism of desensitization is still uncertain [199-201]. A growing understanding of 
the molecular and cellular mechanisms of oral tolerance is reinforcing advances in potential 
therapies for food allergies and is pivotal to eventually curing allergies in sensitized 
individuals. Oral desensitization should be taken into consideration in the management of 
food-allergic patients even if the physiopathogenetic mechanisms are still unexplained. 
Moreover, this treatment should be considered, particularly for children, because elimination 
from the diet of some foods (e.g., milk and eggs) for these patients could cause psychological 
and/or nutritional problems. Oral immunotherapy (oral desensitization) may be a promising 
treatment strategy for cow’s milk allergy in children and valuable for other foods, such as eggs 
or peanuts. Although the mechanisms of IgE-mediated allergies are fairly well understood, the 
immunology and variety of non-IgE-mediated reactions remains largely unknown. A better 
understanding of these allergy mechanisms is a prerequisite to the development of improved 
diagnostics, which in turn will facilitate an improved understanding of the epidemiology of 
CMA, particularly for non-IgE-mediated reactions. 
8. Conclusions 
A better understanding will also aid the development of hypoallergenic dairy products, 
especially for adults with CMA for whom there is currently a dearth of suitable low-
allergenic dairy products. Some of the risk factors for developing CMA have been identified; 
a familiar history of atopy is one of the main determinants. However, the mechanisms of 
allergic sensitization and the precise interactions between genetics and various 
environmental factors that lead to CMA remain unclear. The first few months of life, during 
which the immune system is still maturing, appear to be a critical risk period for allergic 
sensitization. For at-risk infants with at least one atopic parent, breastfeeding during this 
period is currently the best identified preventative strategy; the use of hydrolyzed formulas 
is recommended for babies who cannot be breastfed. The use of immunomodulatory dietary 
adjuvants, such as probiotics, is an emerging approach with considerable promise for 
primary prevention. For CMA sufferers, the avoidance of dietary milk proteins remains the 
only effective management strategy but carries with it nutritional implications, particularly 
for adequate vitamin and calcium intake as well as protein and energy where unorthodox 
 
Milk Protein 
 
200 
alternative diets are implemented. Increasing knowledge of the molecular and cellular 
mechanisms of oral tolerance reinforces the advances in potential FA therapies and is 
pivotal to eventually curing allergies in sensitized individuals. Unraveling the links between 
innate and adaptive immunity and characterizing the roles of dendritic cells and T cells in 
directing immune responses and homeostasis to environmental antigens are likely to remain 
a focus of fundamental FA research in the coming years. 
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